{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1182.311","meta":{"versionId":"5","lastUpdated":"2019-11-11T01:00:18.000-05:00"},"text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \u003ch2\u003eComplications of Care\u003c/h2\u003e\n      \u003cp\u003eThis value set includes codes from the following code systems:\u003c/p\u003e\n      \u003cul\u003e\n        \u003cli\u003eInclude these codes as defined in \n          \u003ccode\u003ehttp://hl7.org/fhir/sid/icd-10-cm\u003c/code\u003e\n          \u003ctable class\u003d\"none\"\u003e\n            \u003ctr\u003e\n              \u003ctd\u003e\n                \u003cb\u003eCode\u003c/b\u003e\n              \u003c/td\u003e\n              \u003ctd\u003e\n                \u003cb\u003eDisplay\u003c/b\u003e\n              \u003c/td\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA36.81\u003c/td\u003e\n              \u003ctd\u003eDiphtheritic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA38.1\u003c/td\u003e\n              \u003ctd\u003eScarlet fever with myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.50\u003c/td\u003e\n              \u003ctd\u003eMeningococcal carditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.51\u003c/td\u003e\n              \u003ctd\u003eMeningococcal endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.52\u003c/td\u003e\n              \u003ctd\u003eMeningococcal myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eA39.53\u003c/td\u003e\n              \u003ctd\u003eMeningococcal pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB26.82\u003c/td\u003e\n              \u003ctd\u003eMumps myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.20\u003c/td\u003e\n              \u003ctd\u003eViral carditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.21\u003c/td\u003e\n              \u003ctd\u003eViral endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.22\u003c/td\u003e\n              \u003ctd\u003eViral myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.23\u003c/td\u003e\n              \u003ctd\u003eViral pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB33.24\u003c/td\u003e\n              \u003ctd\u003eViral cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB37.6\u003c/td\u003e\n              \u003ctd\u003eCandidal endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB44.81\u003c/td\u003e\n              \u003ctd\u003eAllergic bronchopulmonary aspergillosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eB58.81\u003c/td\u003e\n              \u003ctd\u003eToxoplasma myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external upper lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external lower lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of external lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lip, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lip, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lip, unspecified, inner aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of commissure of lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC00.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lip, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of base of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of dorsal surface of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of border of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ventral surface of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior two-thirds of tongue, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lingual tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC02.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tongue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper gum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower gum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC03.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of gum, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC04.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of floor of mouth, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hard palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of soft palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uvula\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC05.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of palate, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cheek mucosa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vestibule of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of retromolar area\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.89\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of other parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC06.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mouth, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC07\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parotid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of submandibular gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sublingual gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC08.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of major salivary gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsillar fossa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsillar pillar (anterior) (posterior)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC09.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tonsil, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vallecula\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior surface of epiglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of branchial cleft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC10.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of oropharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of superior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior wall of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC11.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nasopharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pyriform sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of postcricoid region\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of aryepiglottic fold, hypopharyngeal aspect\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC13.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hypopharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of Waldeyer\u0027s ring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC14.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of lip, oral cavity and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower third of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC15.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of esophagus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of fundus of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pyloric antrum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pylorus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lesser curvature of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of greater curvature of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC16.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of stomach, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.3\u003c/td\u003e\n              \u003ctd\u003eMeckel\u0027s diverticulum, malignant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC17.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of small intestine, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of hepatic flexure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of splenic flexure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC18.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of colon, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC19\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cloacogenic zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC21.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of rectum, anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.0\u003c/td\u003e\n              \u003ctd\u003eLiver cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.1\u003c/td\u003e\n              \u003ctd\u003eIntrahepatic bile duct carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.2\u003c/td\u003e\n              \u003ctd\u003eHepatoblastoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.3\u003c/td\u003e\n              \u003ctd\u003eAngiosarcoma of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.4\u003c/td\u003e\n              \u003ctd\u003eOther sarcomas of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.7\u003c/td\u003e\n              \u003ctd\u003eOther specified carcinomas of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of liver, primary, unspecified as to type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC22.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of liver, not specified as primary or secondary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC23\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of gallbladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of extrahepatic bile duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ampulla of Vater\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of biliary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC24.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of biliary tract, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of head of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of tail of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pancreatic duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocrine pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other parts of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC25.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pancreas, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of intestinal tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC26.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ill-defined sites within the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC30.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nasal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC30.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle ear\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of maxillary sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ethmoidal sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of frontal sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of sphenoid sinus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC31.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of accessory sinus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of glottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of supraglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of subglottis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of laryngeal cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC32.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of larynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC33\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left main bronchus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper lobe, left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of middle lobe, bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower lobe, left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of unspecified bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of right bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC34.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of left bronchus or lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC37\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mediastinum, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC38.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of heart, mediastinum and pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC39.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper respiratory tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC39.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower respiratory tract, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scapula and long bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of long bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of short bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of right limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bone and articular cartilage of left limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of right limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC40.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified bones and articular cartilage of left limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bones of skull and face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of mandible\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vertebral column\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ribs, sternum and clavicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pelvic bones, sacrum and coccyx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC41.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bone and articular cartilage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.0\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.10\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.11\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.111\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.112\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.12\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.121\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.122\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.20\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.21\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.22\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.30\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.31\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.39\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.4\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.51\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.52\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.59\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.60\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.61\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.62\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.70\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.71\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.72\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.8\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC43.9\u003c/td\u003e\n              \u003ctd\u003eMalignant melanoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.00\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.01\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.02\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.09\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.101\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.102\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1021\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1022\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.109\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1091\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1092\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.111\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.112\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1121\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1122\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.119\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1191\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1192\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.121\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.122\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1221\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1222\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.129\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1291\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1292\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.131\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1321\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1322\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1391\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1392\u003c/td\u003e\n              \u003ctd\u003eSebaceous cell carcinoma of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.191\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.192\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1921\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1922\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.199\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1991\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.1992\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.201\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.202\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.209\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.211\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.212\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.219\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.221\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.222\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.229\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.291\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.292\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.299\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.300\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.301\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.309\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.310\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.311\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.319\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.320\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.321\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.329\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.390\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.391\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.399\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.41\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.42\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.49\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.500\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.501\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.509\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.510\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.511\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.519\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.520\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.521\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.529\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.590\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.591\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.599\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.601\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.602\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.609\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.611\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.612\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.619\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.621\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.622\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.629\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.691\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.692\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.699\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.701\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.702\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.709\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.711\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.712\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.719\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.721\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.722\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.729\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.791\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.792\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.799\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.80\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.81\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.82\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.89\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of overlapping sites of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified malignant neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.91\u003c/td\u003e\n              \u003ctd\u003eBasal cell carcinoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.92\u003c/td\u003e\n              \u003ctd\u003eSquamous cell carcinoma of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC44.99\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.0\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.1\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.2\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of pericardium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.7\u003c/td\u003e\n              \u003ctd\u003eMesothelioma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC45.9\u003c/td\u003e\n              \u003ctd\u003eMesothelioma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.0\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.1\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.2\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.3\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.4\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of gastrointestinal sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.50\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of unspecified lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.51\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of right lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.52\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of left lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.7\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC46.9\u003c/td\u003e\n              \u003ctd\u003eKaposi\u0027s sarcoma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC47.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peripheral nerves and autonomic nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of specified parts of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of peritoneum, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC48.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of retroperitoneum and peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of connective and soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of connective and soft tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A0\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A1\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A2\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A3\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A4\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A5\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC49.A9\u003c/td\u003e\n              \u003ctd\u003eGastrointestinal stromal tumor of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.0\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.10\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.11\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.111\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.112\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.12\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.121\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.122\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.20\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.21\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.22\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.30\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.31\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of nose\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.39\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.4\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.51\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.52\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of skin of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.59\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.60\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.61\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.62\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.70\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.71\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.72\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.8\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma of overlapping sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC4A.9\u003c/td\u003e\n              \u003ctd\u003eMerkel cell carcinoma, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.011\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.012\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.019\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.021\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.022\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.029\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of nipple and areola, unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.111\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.112\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.119\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.121\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.122\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.129\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central portion of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.211\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.212\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.219\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.221\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.222\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.229\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-inner quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.311\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.312\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.319\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.321\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.322\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.329\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-inner quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.411\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.412\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.419\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.421\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.422\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.429\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of upper-outer quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.511\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.512\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.519\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.521\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.522\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.529\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lower-outer quadrant of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.611\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.612\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.619\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.621\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.622\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.629\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of axillary tail of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.811\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.812\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.819\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.821\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.822\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.829\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.911\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.912\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.919\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified female breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.921\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.922\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC50.929\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified male breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of labium majus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of labium minus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of clitoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC51.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vulva, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of exocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC53.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cervix uteri, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of isthmus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of myometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of fundus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of corpus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC54.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of corpus uteri, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC55\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uterus, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC56.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left fallopian tube\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left broad ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left round ligament\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parametrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of uterine adnexa, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC57.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC58\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of prepuce\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of glans penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of body of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC60.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of penis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC61\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified undescended testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of undescended right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of undescended left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified descended testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descended right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of descended left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC62.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left testis, unspecified whether descended or undescended\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC63.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC64.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified kidney, except renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC65.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC66.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of trigone of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of dome of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lateral wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of anterior wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of posterior wall of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bladder neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of ureteric orifice\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urachus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC67.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of bladder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of paraurethral glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC68.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of urinary organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.51\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.60\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.61\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.62\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.80\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of unspecified eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.81\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of right eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.82\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of left eye and adnexa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC69.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified site of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC70.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebrum, except lobes and ventricles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of frontal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of temporal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parietal lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of occipital lobe\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebral ventricle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.6\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cerebellum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.7\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of brain stem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of overlapping sites of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC71.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cauda equina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.20\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.21\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.22\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left olfactory nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.30\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.31\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.32\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left optic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left acoustic nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified cranial nerve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.59\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC72.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC73\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.00\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.01\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.02\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of cortex of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.10\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.11\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.12\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of medulla of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.90\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.91\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC74.92\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified part of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.4\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.5\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm with pluriglandular involvement, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC75.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of endocrine gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.0\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.1\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.3\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.40\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.41\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.42\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.50\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.51\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.52\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC76.8\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of other specified ill-defined sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.0\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph nodes of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.1\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.2\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.3\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.4\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.5\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.8\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph nodes of multiple regions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC77.9\u003c/td\u003e\n              \u003ctd\u003eSecondary and unspecified malignant neoplasm of lymph node, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.00\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.01\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.02\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.1\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.2\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.30\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified respiratory organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.39\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.4\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.5\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of large intestine and rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.6\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of retroperitoneum and peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.7\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of liver and intrahepatic bile duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.80\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified digestive organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC78.89\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.00\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.01\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.02\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left kidney and renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.10\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.11\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.19\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.2\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.31\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.32\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.40\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified part of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.49\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other parts of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.51\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.52\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of bone marrow\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.60\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.61\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.62\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.70\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.71\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.72\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.81\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.82\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.89\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC79.9\u003c/td\u003e\n              \u003ctd\u003eSecondary malignant neoplasm of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.00\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.010\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.011\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.012\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.019\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the small intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.020\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.021\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.022\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.023\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.024\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.025\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.026\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.029\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the large intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.090\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.091\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.092\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.093\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.094\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the foregut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.095\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the midgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.096\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumor of the hindgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.098\u003c/td\u003e\n              \u003ctd\u003eMalignant carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.1\u003c/td\u003e\n              \u003ctd\u003eMalignant poorly differentiated neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7A.8\u003c/td\u003e\n              \u003ctd\u003eOther malignant neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.00\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.01\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of distant lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.02\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.03\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.04\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.09\u003c/td\u003e\n              \u003ctd\u003eSecondary carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.1\u003c/td\u003e\n              \u003ctd\u003eSecondary Merkel cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC7B.8\u003c/td\u003e\n              \u003ctd\u003eOther secondary neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.0\u003c/td\u003e\n              \u003ctd\u003eDisseminated malignant neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.1\u003c/td\u003e\n              \u003ctd\u003eMalignant (primary) neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC80.2\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm associated with transplanted organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.00\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.01\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.02\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.03\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.04\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.05\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.06\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.07\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.08\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.09\u003c/td\u003e\n              \u003ctd\u003eNodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.10\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.11\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.12\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.13\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.14\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.15\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.16\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.17\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.18\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.19\u003c/td\u003e\n              \u003ctd\u003eNodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.20\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.21\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.22\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.23\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.24\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.25\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.26\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.27\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.28\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.29\u003c/td\u003e\n              \u003ctd\u003eMixed cellularity Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.30\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.31\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.32\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.33\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.34\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.35\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.36\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.37\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.38\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.39\u003c/td\u003e\n              \u003ctd\u003eLymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.40\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.41\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.42\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.43\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.44\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.45\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.46\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.47\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.48\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.49\u003c/td\u003e\n              \u003ctd\u003eLymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.70\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.71\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.72\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.73\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.74\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.75\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.76\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.77\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.78\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.79\u003c/td\u003e\n              \u003ctd\u003eOther Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.90\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.91\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.92\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.93\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.94\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.95\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.96\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.97\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.98\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC81.99\u003c/td\u003e\n              \u003ctd\u003eHodgkin lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.00\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.01\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.02\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.03\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.04\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.05\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.06\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.07\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.08\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.09\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade I, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.10\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.11\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.12\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.13\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.14\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.15\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.16\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.17\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.18\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.19\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade II, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.20\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.21\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.22\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.23\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.24\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.25\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.26\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.27\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.28\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.29\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade III, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.30\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.31\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.32\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.33\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.34\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.35\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.36\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.37\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.38\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.39\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIa, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.40\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.41\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.42\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.43\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.44\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.45\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.46\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.47\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.48\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.49\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma grade IIIb, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.50\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.51\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.52\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.53\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.54\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.55\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.56\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.57\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.58\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.59\u003c/td\u003e\n              \u003ctd\u003eDiffuse follicle center lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.60\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.61\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.62\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.63\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.64\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.65\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.66\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.67\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.68\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.69\u003c/td\u003e\n              \u003ctd\u003eCutaneous follicle center lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.80\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.81\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.82\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.83\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.84\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.85\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.86\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.87\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.88\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.89\u003c/td\u003e\n              \u003ctd\u003eOther types of follicular lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.90\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.91\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.92\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.93\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.94\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.95\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.96\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.97\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.98\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC82.99\u003c/td\u003e\n              \u003ctd\u003eFollicular lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.00\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.01\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.02\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.03\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.04\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.05\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.06\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.07\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.08\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.09\u003c/td\u003e\n              \u003ctd\u003eSmall cell B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.10\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.11\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.12\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.13\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.14\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.15\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.16\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.17\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.18\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.19\u003c/td\u003e\n              \u003ctd\u003eMantle cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.30\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.31\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.32\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.33\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.34\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.35\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.36\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.37\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.38\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.39\u003c/td\u003e\n              \u003ctd\u003eDiffuse large B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.50\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.51\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.52\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.53\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.54\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.55\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.56\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.57\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.58\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.59\u003c/td\u003e\n              \u003ctd\u003eLymphoblastic (diffuse) lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.70\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.71\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.72\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.73\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.74\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.75\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.76\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.77\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.78\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.79\u003c/td\u003e\n              \u003ctd\u003eBurkitt lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.80\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.81\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.82\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.83\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.84\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.85\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.86\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.87\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.88\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.89\u003c/td\u003e\n              \u003ctd\u003eOther non-follicular lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.90\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.91\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.92\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.93\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.94\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.95\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.96\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.97\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.98\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC83.99\u003c/td\u003e\n              \u003ctd\u003eNon-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.00\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.01\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.02\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.03\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.04\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.05\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.06\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.07\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.08\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.09\u003c/td\u003e\n              \u003ctd\u003eMycosis fungoides, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.10\u003c/td\u003e\n              \u003ctd\u003eSézary disease, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.11\u003c/td\u003e\n              \u003ctd\u003eSézary disease, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.12\u003c/td\u003e\n              \u003ctd\u003eSézary disease, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.13\u003c/td\u003e\n              \u003ctd\u003eSézary disease, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.14\u003c/td\u003e\n              \u003ctd\u003eSézary disease, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.15\u003c/td\u003e\n              \u003ctd\u003eSézary disease, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.16\u003c/td\u003e\n              \u003ctd\u003eSézary disease, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.17\u003c/td\u003e\n              \u003ctd\u003eSézary disease, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.18\u003c/td\u003e\n              \u003ctd\u003eSézary disease, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.19\u003c/td\u003e\n              \u003ctd\u003eSézary disease, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.40\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.41\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.42\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.43\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.44\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.45\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.46\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.47\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.48\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.49\u003c/td\u003e\n              \u003ctd\u003ePeripheral T-cell lymphoma, not classified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.60\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.61\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.62\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.63\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.64\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.65\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.66\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.67\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.68\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.69\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.70\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.71\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.72\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.73\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.74\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.75\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.76\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.77\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.78\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.79\u003c/td\u003e\n              \u003ctd\u003eAnaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.90\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.91\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.92\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.93\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.94\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.95\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.96\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.97\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.98\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.99\u003c/td\u003e\n              \u003ctd\u003eMature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A0\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A1\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A2\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A3\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A4\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A5\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A6\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A7\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A8\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.A9\u003c/td\u003e\n              \u003ctd\u003eCutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z0\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z1\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z2\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z3\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z4\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z5\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z6\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z7\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z8\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC84.Z9\u003c/td\u003e\n              \u003ctd\u003eOther mature T/NK-cell lymphomas, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.11\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.12\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.13\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.14\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.15\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.16\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.17\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.18\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.19\u003c/td\u003e\n              \u003ctd\u003eUnspecified B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.20\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.21\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.22\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.23\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.24\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.25\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.26\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.27\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.28\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.29\u003c/td\u003e\n              \u003ctd\u003eMediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.80\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.81\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.82\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.83\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.84\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.85\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.86\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.87\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.88\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.89\u003c/td\u003e\n              \u003ctd\u003eOther specified types of non-Hodgkin lymphoma, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.90\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.91\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.92\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.93\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.94\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.95\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.96\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.97\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, spleen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.98\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC85.99\u003c/td\u003e\n              \u003ctd\u003eNon-Hodgkin lymphoma, unspecified, extranodal and solid organ sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.0\u003c/td\u003e\n              \u003ctd\u003eExtranodal NK/T-cell lymphoma, nasal type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.1\u003c/td\u003e\n              \u003ctd\u003eHepatosplenic T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.2\u003c/td\u003e\n              \u003ctd\u003eEnteropathy-type (intestinal) T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.3\u003c/td\u003e\n              \u003ctd\u003eSubcutaneous panniculitis-like T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.4\u003c/td\u003e\n              \u003ctd\u003eBlastic NK-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.5\u003c/td\u003e\n              \u003ctd\u003eAngioimmunoblastic T-cell lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC86.6\u003c/td\u003e\n              \u003ctd\u003ePrimary cutaneous CD30-positive T-cell proliferations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.0\u003c/td\u003e\n              \u003ctd\u003eWaldenström macroglobulinemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.2\u003c/td\u003e\n              \u003ctd\u003eHeavy chain disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.3\u003c/td\u003e\n              \u003ctd\u003eImmunoproliferative small intestinal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.4\u003c/td\u003e\n              \u003ctd\u003eExtranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.8\u003c/td\u003e\n              \u003ctd\u003eOther malignant immunoproliferative diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC88.9\u003c/td\u003e\n              \u003ctd\u003eMalignant immunoproliferative disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.00\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.01\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.02\u003c/td\u003e\n              \u003ctd\u003eMultiple myeloma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.10\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.11\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.12\u003c/td\u003e\n              \u003ctd\u003ePlasma cell leukemia in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.20\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.21\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.22\u003c/td\u003e\n              \u003ctd\u003eExtramedullary plasmacytoma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.30\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.31\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC90.32\u003c/td\u003e\n              \u003ctd\u003eSolitary plasmacytoma in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.00\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.01\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.02\u003c/td\u003e\n              \u003ctd\u003eAcute lymphoblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.10\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.11\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.12\u003c/td\u003e\n              \u003ctd\u003eChronic lymphocytic leukemia of B-cell type in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.30\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.31\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.32\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of B-cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.40\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.41\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.42\u003c/td\u003e\n              \u003ctd\u003eHairy cell leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.50\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.51\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated), in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.52\u003c/td\u003e\n              \u003ctd\u003eAdult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.60\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.61\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.62\u003c/td\u003e\n              \u003ctd\u003eProlymphocytic leukemia of T-cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.90\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.91\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.92\u003c/td\u003e\n              \u003ctd\u003eLymphoid leukemia, unspecified, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A0\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A1\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.A2\u003c/td\u003e\n              \u003ctd\u003eMature B-cell leukemia Burkitt-type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z0\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z1\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC91.Z2\u003c/td\u003e\n              \u003ctd\u003eOther lymphoid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.00\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.01\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.02\u003c/td\u003e\n              \u003ctd\u003eAcute myeloblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.10\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.11\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.12\u003c/td\u003e\n              \u003ctd\u003eChronic myeloid leukemia, BCR/ABL-positive, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.20\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.21\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.22\u003c/td\u003e\n              \u003ctd\u003eAtypical chronic myeloid leukemia, BCR/ABL-negative, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.30\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.31\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.32\u003c/td\u003e\n              \u003ctd\u003eMyeloid sarcoma, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.40\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.41\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.42\u003c/td\u003e\n              \u003ctd\u003eAcute promyelocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.50\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.51\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.52\u003c/td\u003e\n              \u003ctd\u003eAcute myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.60\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.61\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.62\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with 11q23-abnormality in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.90\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.91\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.92\u003c/td\u003e\n              \u003ctd\u003eMyeloid leukemia, unspecified in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A0\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A1\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.A2\u003c/td\u003e\n              \u003ctd\u003eAcute myeloid leukemia with multilineage dysplasia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z0\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z1\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC92.Z2\u003c/td\u003e\n              \u003ctd\u003eOther myeloid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.00\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.01\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.02\u003c/td\u003e\n              \u003ctd\u003eAcute monoblastic/monocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.10\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.11\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.12\u003c/td\u003e\n              \u003ctd\u003eChronic myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.30\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.31\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.32\u003c/td\u003e\n              \u003ctd\u003eJuvenile myelomonocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.90\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.91\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.92\u003c/td\u003e\n              \u003ctd\u003eMonocytic leukemia, unspecified in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z0\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z1\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC93.Z2\u003c/td\u003e\n              \u003ctd\u003eOther monocytic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.00\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.01\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.02\u003c/td\u003e\n              \u003ctd\u003eAcute erythroid leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.20\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.21\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.22\u003c/td\u003e\n              \u003ctd\u003eAcute megakaryoblastic leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.30\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.31\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.32\u003c/td\u003e\n              \u003ctd\u003eMast cell leukemia, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.40\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.41\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.42\u003c/td\u003e\n              \u003ctd\u003eAcute panmyelosis with myelofibrosis, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.6\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic disease, not classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.80\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.81\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC94.82\u003c/td\u003e\n              \u003ctd\u003eOther specified leukemias, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.00\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.01\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.02\u003c/td\u003e\n              \u003ctd\u003eAcute leukemia of unspecified cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.10\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.11\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.12\u003c/td\u003e\n              \u003ctd\u003eChronic leukemia of unspecified cell type, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.90\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified not having achieved remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.91\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified, in remission\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC95.92\u003c/td\u003e\n              \u003ctd\u003eLeukemia, unspecified, in relapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.0\u003c/td\u003e\n              \u003ctd\u003eMultifocal and multisystemic (disseminated) Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.2\u003c/td\u003e\n              \u003ctd\u003eMalignant mast cell neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.20\u003c/td\u003e\n              \u003ctd\u003eMalignant mast cell neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.21\u003c/td\u003e\n              \u003ctd\u003eAggressive systemic mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.22\u003c/td\u003e\n              \u003ctd\u003eMast cell sarcoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.29\u003c/td\u003e\n              \u003ctd\u003eOther malignant mast cell neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.4\u003c/td\u003e\n              \u003ctd\u003eSarcoma of dendritic cells (accessory cells)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.5\u003c/td\u003e\n              \u003ctd\u003eMultifocal and unisystemic Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.6\u003c/td\u003e\n              \u003ctd\u003eUnifocal Langerhans-cell histiocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.9\u003c/td\u003e\n              \u003ctd\u003eMalignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.A\u003c/td\u003e\n              \u003ctd\u003eHistiocytic sarcoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eC96.Z\u003c/td\u003e\n              \u003ctd\u003eOther specified malignant neoplasms of lymphoid, hematopoietic and related tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.00\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of oral cavity, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.01\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of labial mucosa and vermilion border\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.02\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of buccal mucosa\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.03\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of gingiva and edentulous alveolar ridge\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.04\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of soft palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.05\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of hard palate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.06\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.07\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.08\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD00.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.40\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified part of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.49\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of liver, gallbladder and bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.7\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other specified digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD01.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of digestive organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD02.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of respiratory system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.0\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.10\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.11\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.111\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.112\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.12\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.121\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.122\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.20\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.21\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.22\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.30\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.39\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.4\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.51\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of anal skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.52\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of breast (skin) (soft tissue)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.59\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other part of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.60\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.61\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.62\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.70\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.71\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.72\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.8\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD03.9\u003c/td\u003e\n              \u003ctd\u003eMelanoma in situ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.10\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.11\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.111\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.112\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.12\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.121\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.122\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.30\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.39\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.60\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.61\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.62\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.70\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.71\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.72\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.8\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD04.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.00\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.01\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.02\u003c/td\u003e\n              \u003ctd\u003eLobular carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.10\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.11\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.12\u003c/td\u003e\n              \u003ctd\u003eIntraductal carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.80\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.81\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.82\u003c/td\u003e\n              \u003ctd\u003eOther specified type of carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.91\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD05.92\u003c/td\u003e\n              \u003ctd\u003eUnspecified type of carcinoma in situ of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of endocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of exocervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.7\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other parts of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD06.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of cervix, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of endometrium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.1\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.2\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.30\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.39\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.4\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.5\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.60\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.61\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD07.69\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.0\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.10\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified urinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.19\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.20\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.21\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.22\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.3\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of thyroid and other endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.8\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD09.9\u003c/td\u003e\n              \u003ctd\u003eCarcinoma in situ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of floor of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.39\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of mouth\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of tonsil\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of oropharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of nasopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of hypopharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD10.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pharynx, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of parotid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other major salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD11.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of major salivary gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of colon, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of rectosigmoid junction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD12.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of anus and anal canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.39\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other parts of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of extrahepatic bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of endocrine pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD13.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ill-defined sites within the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of middle ear, nasal cavity and accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD14.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of respiratory system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD15.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of intrathoracic organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scapula and long bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of unspecified upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of right upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of left upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of long bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of unspecified lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of right lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of short bones of left lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bones of skull and face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lower jaw bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vertebral column\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of ribs, sternum and clavicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pelvic bones, sacrum and coccyx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD16.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bone and articular cartilage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.0\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.1\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.20\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.21\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of right arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.22\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of left arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.23\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.24\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.30\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.39\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of skin and subcutaneous tissue of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.4\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.5\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of intra-abdominal organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.6\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of spermatic cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.71\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.72\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of other genitourinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.79\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD17.9\u003c/td\u003e\n              \u003ctd\u003eBenign lipomatous neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.00\u003c/td\u003e\n              \u003ctd\u003eHemangioma unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.01\u003c/td\u003e\n              \u003ctd\u003eHemangioma of skin and subcutaneous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.02\u003c/td\u003e\n              \u003ctd\u003eHemangioma of intracranial structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.03\u003c/td\u003e\n              \u003ctd\u003eHemangioma of intra-abdominal structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.09\u003c/td\u003e\n              \u003ctd\u003eHemangioma of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD18.1\u003c/td\u003e\n              \u003ctd\u003eLymphangioma, any site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD19.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of mesothelial tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD20.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of soft tissue of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD20.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of soft tissue of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of head, face and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD21.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of connective and other soft tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.0\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.10\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.11\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.111\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.112\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.12\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.121\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.122\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.20\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.21\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.22\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.30\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.39\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.4\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.5\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.60\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.61\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.62\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.70\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.71\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.72\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD22.9\u003c/td\u003e\n              \u003ctd\u003eMelanocytic nevi, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.0\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.10\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.11\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.111\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.112\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.12\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.121\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left upper eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.122\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left lower eyelid, including canthus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.20\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.21\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.22\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left ear and external auricular canal\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.30\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified part of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.39\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of other parts of face\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.4\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of scalp and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.5\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.60\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.61\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.62\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.70\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of unspecified lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.71\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of right lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.72\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin of left lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD23.9\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of skin, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD24.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.0\u003c/td\u003e\n              \u003ctd\u003eSubmucous leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.1\u003c/td\u003e\n              \u003ctd\u003eIntramural leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.2\u003c/td\u003e\n              \u003ctd\u003eSubserosal leiomyoma of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD25.9\u003c/td\u003e\n              \u003ctd\u003eLeiomyoma of uterus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.0\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.1\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of corpus uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.7\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of other parts of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD26.9\u003c/td\u003e\n              \u003ctd\u003eOther benign neoplasm of uterus, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD27.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vulva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of uterine tubes and ligaments\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD28.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of penis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of scrotum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD29.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.8\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD30.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of urinary organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left conjunctiva\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left cornea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.20\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.21\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.22\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left retina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.30\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.31\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.32\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.40\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.41\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.42\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left ciliary body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.50\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.51\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.52\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left lacrimal gland and duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.60\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of unspecified orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.61\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of right orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.62\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified site of left orbit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.90\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of unspecified eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.91\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of right eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD31.92\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified part of left eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD32.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, supratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, infratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified parts of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD33.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD34\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.00\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.01\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.02\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.1\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.2\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.3\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.4\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.5\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.6\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD35.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of endocrine gland, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.0\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.10\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.11\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.12\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.13\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.14\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.15\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.16\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.17\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.7\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD36.9\u003c/td\u003e\n              \u003ctd\u003eBenign neoplasm, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.01\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of lip\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.02\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.030\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the parotid salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.031\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the sublingual salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.032\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the submandibular salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.039\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the major salivary glands, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.04\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of the minor salivary glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.05\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.09\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified sites of the oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of liver, gallbladder and bile ducts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD37.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of digestive organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of trachea, bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pleura\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of mediastinum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD38.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of respiratory organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of placenta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD39.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of female genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.00\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.010\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.011\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the jejunum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.012\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the ileum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.019\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the small intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.020\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the appendix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.021\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the cecum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.022\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the ascending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.023\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the transverse colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.024\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the descending colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.025\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the sigmoid colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.026\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.029\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the large intestine, unspecified portion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.090\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.091\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.092\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.093\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.094\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the foregut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.095\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the midgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.096\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumor of the hindgut, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.098\u003c/td\u003e\n              \u003ctd\u003eBenign carcinoid tumors of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD3A.8\u003c/td\u003e\n              \u003ctd\u003eOther benign neuroendocrine tumors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD40.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of male genital organ, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.00\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.01\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.02\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.20\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.21\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.22\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of urethra\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD41.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified urinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of cerebral meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of spinal meninges\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD42.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of meninges, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, supratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, infratentorial\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of brain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of cranial nerves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of spinal cord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.8\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified parts of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD43.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of central nervous system, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of thyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.10\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.11\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.12\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left adrenal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of parathyroid gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pituitary gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of craniopharyngeal duct\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of pineal gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of carotid body\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of aortic body and other paraganglia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD44.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified endocrine gland\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD45\u003c/td\u003e\n              \u003ctd\u003ePolycythemia vera\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.0\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia without ring sideroblasts, so stated\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.1\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with ring sideroblasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.20\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.21\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.22\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia with excess of blasts 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.4\u003c/td\u003e\n              \u003ctd\u003eRefractory anemia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.9\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic syndrome, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.A\u003c/td\u003e\n              \u003ctd\u003eRefractory cytopenia with multilineage dysplasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.B\u003c/td\u003e\n              \u003ctd\u003eRefractory cytopenia with multilineage dysplasia and ring sideroblasts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.C\u003c/td\u003e\n              \u003ctd\u003eMyelodysplastic syndrome with isolated del(5q) chromosomal abnormality\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD46.Z\u003c/td\u003e\n              \u003ctd\u003eOther myelodysplastic syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.0\u003c/td\u003e\n              \u003ctd\u003eMast cell neoplasms of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.01\u003c/td\u003e\n              \u003ctd\u003eCutaneous mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.02\u003c/td\u003e\n              \u003ctd\u003eSystemic mastocytosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.09\u003c/td\u003e\n              \u003ctd\u003eOther mast cell neoplasms of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.1\u003c/td\u003e\n              \u003ctd\u003eChronic myeloproliferative disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.2\u003c/td\u003e\n              \u003ctd\u003eMonoclonal gammopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.3\u003c/td\u003e\n              \u003ctd\u003eEssential (hemorrhagic) thrombocythemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.4\u003c/td\u003e\n              \u003ctd\u003eOsteomyelofibrosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z1\u003c/td\u003e\n              \u003ctd\u003ePost-transplant lymphoproliferative disorder (PTLD)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z2\u003c/td\u003e\n              \u003ctd\u003eCastleman disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD47.Z9\u003c/td\u003e\n              \u003ctd\u003eOther specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of bone and articular cartilage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of connective and other soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of peripheral nerves and autonomic nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of peritoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.60\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.61\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of right breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.62\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of left breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD48.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of uncertain behavior, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.0\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.1\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.2\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of bone, soft tissue, and skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.3\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.4\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.5\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other genitourinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.511\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.512\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.519\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.59\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other genitourinary organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.6\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.7\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of endocrine glands and other parts of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.81\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of retina and choroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.89\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eD49.9\u003c/td\u003e\n              \u003ctd\u003eNeoplasm of unspecified behavior of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eE31.22\u003c/td\u003e\n              \u003ctd\u003eMultiple endocrine neoplasia [MEN] type IIA\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eE31.23\u003c/td\u003e\n              \u003ctd\u003eMultiple endocrine neoplasia [MEN] type IIB\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.601\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, not intractable, with status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.609\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, not intractable, without status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.611\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, intractable, with status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG43.619\u003c/td\u003e\n              \u003ctd\u003ePersistent migraine aura with cerebral infarction, intractable, without status migrainosus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.0\u003c/td\u003e\n              \u003ctd\u003eVertebro-basilar artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.1\u003c/td\u003e\n              \u003ctd\u003eCarotid artery syndrome (hemispheric)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.2\u003c/td\u003e\n              \u003ctd\u003eMultiple and bilateral precerebral artery syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.3\u003c/td\u003e\n              \u003ctd\u003eAmaurosis fugax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.4\u003c/td\u003e\n              \u003ctd\u003eTransient global amnesia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.8\u003c/td\u003e\n              \u003ctd\u003eOther transient cerebral ischemic attacks and related syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG45.9\u003c/td\u003e\n              \u003ctd\u003eTransient cerebral ischemic attack, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.0\u003c/td\u003e\n              \u003ctd\u003eMiddle cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.1\u003c/td\u003e\n              \u003ctd\u003eAnterior cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.2\u003c/td\u003e\n              \u003ctd\u003ePosterior cerebral artery syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.3\u003c/td\u003e\n              \u003ctd\u003eBrain stem stroke syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.4\u003c/td\u003e\n              \u003ctd\u003eCerebellar stroke syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.5\u003c/td\u003e\n              \u003ctd\u003ePure motor lacunar syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.6\u003c/td\u003e\n              \u003ctd\u003ePure sensory lacunar syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.7\u003c/td\u003e\n              \u003ctd\u003eOther lacunar syndromes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG46.8\u003c/td\u003e\n              \u003ctd\u003eOther vascular syndromes of brain in cerebrovascular diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eG93.3\u003c/td\u003e\n              \u003ctd\u003ePostviral fatigue syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.0\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.1\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.2\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.8\u003c/td\u003e\n              \u003ctd\u003eOther acute rheumatic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI01.9\u003c/td\u003e\n              \u003ctd\u003eAcute rheumatic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI02.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic chorea with heart involvement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic mitral valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI05.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic mitral valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic aortic valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI06.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic aortic valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid stenosis and insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic tricuspid valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI07.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic tricuspid valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both mitral and aortic valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both mitral and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.2\u003c/td\u003e\n              \u003ctd\u003eRheumatic disorders of both aortic and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.3\u003c/td\u003e\n              \u003ctd\u003eCombined rheumatic disorders of mitral, aortic and tricuspid valves\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.8\u003c/td\u003e\n              \u003ctd\u003eOther rheumatic multiple valve diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI08.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic multiple valve disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.0\u003c/td\u003e\n              \u003ctd\u003eRheumatic myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.1\u003c/td\u003e\n              \u003ctd\u003eRheumatic diseases of endocardium, valve unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.2\u003c/td\u003e\n              \u003ctd\u003eChronic rheumatic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.81\u003c/td\u003e\n              \u003ctd\u003eRheumatic heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.89\u003c/td\u003e\n              \u003ctd\u003eOther specified rheumatic heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI09.9\u003c/td\u003e\n              \u003ctd\u003eRheumatic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI10\u003c/td\u003e\n              \u003ctd\u003eEssential (primary) hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI11.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart disease with heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI11.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart disease without heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI12.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI12.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.10\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.11\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI13.2\u003c/td\u003e\n              \u003ctd\u003eHypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.0\u003c/td\u003e\n              \u003ctd\u003eRenovascular hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.1\u003c/td\u003e\n              \u003ctd\u003eHypertension secondary to other renal disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.2\u003c/td\u003e\n              \u003ctd\u003eHypertension secondary to endocrine disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.8\u003c/td\u003e\n              \u003ctd\u003eOther secondary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI15.9\u003c/td\u003e\n              \u003ctd\u003eSecondary hypertension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.0\u003c/td\u003e\n              \u003ctd\u003eHypertensive urgency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.1\u003c/td\u003e\n              \u003ctd\u003eHypertensive emergency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI16.9\u003c/td\u003e\n              \u003ctd\u003eHypertensive crisis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.0\u003c/td\u003e\n              \u003ctd\u003eUnstable angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.1\u003c/td\u003e\n              \u003ctd\u003eAngina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI20.9\u003c/td\u003e\n              \u003ctd\u003eAngina pectoris, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.01\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left main coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.02\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.09\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.11\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving right coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.19\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.21\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving left circumflex coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.29\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction involving other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.3\u003c/td\u003e\n              \u003ctd\u003eST elevation (STEMI) myocardial infarction of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.4\u003c/td\u003e\n              \u003ctd\u003eNon-ST elevation (NSTEMI) myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.9\u003c/td\u003e\n              \u003ctd\u003eAcute myocardial infarction, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.A1\u003c/td\u003e\n              \u003ctd\u003eMyocardial infarction type 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI21.A9\u003c/td\u003e\n              \u003ctd\u003eOther myocardial infarction type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.0\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of anterior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.1\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of inferior wall\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.2\u003c/td\u003e\n              \u003ctd\u003eSubsequent non-ST elevation (NSTEMI) myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.8\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI22.9\u003c/td\u003e\n              \u003ctd\u003eSubsequent ST elevation (STEMI) myocardial infarction of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.0\u003c/td\u003e\n              \u003ctd\u003eHemopericardium as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.1\u003c/td\u003e\n              \u003ctd\u003eAtrial septal defect as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.2\u003c/td\u003e\n              \u003ctd\u003eVentricular septal defect as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.3\u003c/td\u003e\n              \u003ctd\u003eRupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.4\u003c/td\u003e\n              \u003ctd\u003eRupture of chordae tendineae as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.5\u003c/td\u003e\n              \u003ctd\u003eRupture of papillary muscle as current complication following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.6\u003c/td\u003e\n              \u003ctd\u003eThrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.7\u003c/td\u003e\n              \u003ctd\u003ePostinfarction angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI23.8\u003c/td\u003e\n              \u003ctd\u003eOther current complications following acute myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.0\u003c/td\u003e\n              \u003ctd\u003eAcute coronary thrombosis not resulting in myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.1\u003c/td\u003e\n              \u003ctd\u003eDressler\u0027s syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of acute ischemic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI24.9\u003c/td\u003e\n              \u003ctd\u003eAcute ischemic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.10\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery without angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.110\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with unstable angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.111\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.118\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with other forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.119\u003c/td\u003e\n              \u003ctd\u003eAtherosclerotic heart disease of native coronary artery with unspecified angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.2\u003c/td\u003e\n              \u003ctd\u003eOld myocardial infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.3\u003c/td\u003e\n              \u003ctd\u003eAneurysm of heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.41\u003c/td\u003e\n              \u003ctd\u003eCoronary artery aneurysm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.42\u003c/td\u003e\n              \u003ctd\u003eCoronary artery dissection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.5\u003c/td\u003e\n              \u003ctd\u003eIschemic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.6\u003c/td\u003e\n              \u003ctd\u003eSilent myocardial ischemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.750\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with unstable angina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.751\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.758\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.759\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.811\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native coronary artery of transplanted heart without angina pectoris\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.82\u003c/td\u003e\n              \u003ctd\u003eChronic total occlusion of coronary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.83\u003c/td\u003e\n              \u003ctd\u003eCoronary atherosclerosis due to lipid rich plaque\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.84\u003c/td\u003e\n              \u003ctd\u003eCoronary atherosclerosis due to calcified coronary lesion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.89\u003c/td\u003e\n              \u003ctd\u003eOther forms of chronic ischemic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI25.9\u003c/td\u003e\n              \u003ctd\u003eChronic ischemic heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.01\u003c/td\u003e\n              \u003ctd\u003eSeptic pulmonary embolism with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.02\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of pulmonary artery with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.09\u003c/td\u003e\n              \u003ctd\u003eOther pulmonary embolism with acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.90\u003c/td\u003e\n              \u003ctd\u003eSeptic pulmonary embolism without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.92\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of pulmonary artery without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI26.99\u003c/td\u003e\n              \u003ctd\u003eOther pulmonary embolism without acute cor pulmonale\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.0\u003c/td\u003e\n              \u003ctd\u003ePrimary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.1\u003c/td\u003e\n              \u003ctd\u003eKyphoscoliotic heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.2\u003c/td\u003e\n              \u003ctd\u003eOther secondary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.20\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.21\u003c/td\u003e\n              \u003ctd\u003eSecondary pulmonary arterial hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.22\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension due to left heart disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.23\u003c/td\u003e\n              \u003ctd\u003ePulmonary hypertension due to lung diseases and hypoxia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.24\u003c/td\u003e\n              \u003ctd\u003eChronic thromboembolic pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.29\u003c/td\u003e\n              \u003ctd\u003eOther secondary pulmonary hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.81\u003c/td\u003e\n              \u003ctd\u003eCor pulmonale (chronic)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.82\u003c/td\u003e\n              \u003ctd\u003eChronic pulmonary embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.83\u003c/td\u003e\n              \u003ctd\u003eEisenmenger\u0027s syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.89\u003c/td\u003e\n              \u003ctd\u003eOther specified pulmonary heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI27.9\u003c/td\u003e\n              \u003ctd\u003ePulmonary heart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.0\u003c/td\u003e\n              \u003ctd\u003eArteriovenous fistula of pulmonary vessels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.1\u003c/td\u003e\n              \u003ctd\u003eAneurysm of pulmonary artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.8\u003c/td\u003e\n              \u003ctd\u003eOther diseases of pulmonary vessels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI28.9\u003c/td\u003e\n              \u003ctd\u003eDisease of pulmonary vessels, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.0\u003c/td\u003e\n              \u003ctd\u003eAcute nonspecific idiopathic pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.1\u003c/td\u003e\n              \u003ctd\u003eInfective pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.8\u003c/td\u003e\n              \u003ctd\u003eOther forms of acute pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI30.9\u003c/td\u003e\n              \u003ctd\u003eAcute pericarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.0\u003c/td\u003e\n              \u003ctd\u003eChronic adhesive pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.1\u003c/td\u003e\n              \u003ctd\u003eChronic constrictive pericarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.2\u003c/td\u003e\n              \u003ctd\u003eHemopericardium, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.3\u003c/td\u003e\n              \u003ctd\u003ePericardial effusion (noninflammatory)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.4\u003c/td\u003e\n              \u003ctd\u003eCardiac tamponade\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.8\u003c/td\u003e\n              \u003ctd\u003eOther specified diseases of pericardium\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI31.9\u003c/td\u003e\n              \u003ctd\u003eDisease of pericardium, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI32\u003c/td\u003e\n              \u003ctd\u003ePericarditis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI33.0\u003c/td\u003e\n              \u003ctd\u003eAcute and subacute infective endocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI33.9\u003c/td\u003e\n              \u003ctd\u003eAcute and subacute endocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) prolapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic mitral valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI34.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic mitral valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic (valve) stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic aortic valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI35.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic aortic valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid (valve) stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic tricuspid valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI36.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic tricuspid valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.0\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve stenosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.1\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.2\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve stenosis with insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.8\u003c/td\u003e\n              \u003ctd\u003eOther nonrheumatic pulmonary valve disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI37.9\u003c/td\u003e\n              \u003ctd\u003eNonrheumatic pulmonary valve disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI38\u003c/td\u003e\n              \u003ctd\u003eEndocarditis, valve unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI39\u003c/td\u003e\n              \u003ctd\u003eEndocarditis and heart valve disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.0\u003c/td\u003e\n              \u003ctd\u003eInfective myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.1\u003c/td\u003e\n              \u003ctd\u003eIsolated myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.8\u003c/td\u003e\n              \u003ctd\u003eOther acute myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI40.9\u003c/td\u003e\n              \u003ctd\u003eAcute myocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI41\u003c/td\u003e\n              \u003ctd\u003eMyocarditis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.0\u003c/td\u003e\n              \u003ctd\u003eDilated cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.1\u003c/td\u003e\n              \u003ctd\u003eObstructive hypertrophic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.2\u003c/td\u003e\n              \u003ctd\u003eOther hypertrophic cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.3\u003c/td\u003e\n              \u003ctd\u003eEndomyocardial (eosinophilic) disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.4\u003c/td\u003e\n              \u003ctd\u003eEndocardial fibroelastosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.5\u003c/td\u003e\n              \u003ctd\u003eOther restrictive cardiomyopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.7\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy due to drug and external agent\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.8\u003c/td\u003e\n              \u003ctd\u003eOther cardiomyopathies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI42.9\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI43\u003c/td\u003e\n              \u003ctd\u003eCardiomyopathy in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.0\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, first degree\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.1\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, second degree\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.2\u003c/td\u003e\n              \u003ctd\u003eAtrioventricular block, complete\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrioventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.39\u003c/td\u003e\n              \u003ctd\u003eOther atrioventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.4\u003c/td\u003e\n              \u003ctd\u003eLeft anterior fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.5\u003c/td\u003e\n              \u003ctd\u003eLeft posterior fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.60\u003c/td\u003e\n              \u003ctd\u003eUnspecified fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.69\u003c/td\u003e\n              \u003ctd\u003eOther fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI44.7\u003c/td\u003e\n              \u003ctd\u003eLeft bundle-branch block, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.0\u003c/td\u003e\n              \u003ctd\u003eRight fascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified right bundle-branch block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.19\u003c/td\u003e\n              \u003ctd\u003eOther right bundle-branch block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.2\u003c/td\u003e\n              \u003ctd\u003eBifascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.3\u003c/td\u003e\n              \u003ctd\u003eTrifascicular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.4\u003c/td\u003e\n              \u003ctd\u003eNonspecific intraventricular block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.5\u003c/td\u003e\n              \u003ctd\u003eOther specified heart block\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.6\u003c/td\u003e\n              \u003ctd\u003ePre-excitation syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.81\u003c/td\u003e\n              \u003ctd\u003eLong QT syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.89\u003c/td\u003e\n              \u003ctd\u003eOther specified conduction disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI45.9\u003c/td\u003e\n              \u003ctd\u003eConduction disorder, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.2\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest due to underlying cardiac condition\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.8\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest due to other underlying condition\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI46.9\u003c/td\u003e\n              \u003ctd\u003eCardiac arrest, cause unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.0\u003c/td\u003e\n              \u003ctd\u003eRe-entry ventricular arrhythmia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.1\u003c/td\u003e\n              \u003ctd\u003eSupraventricular tachycardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.2\u003c/td\u003e\n              \u003ctd\u003eVentricular tachycardia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI47.9\u003c/td\u003e\n              \u003ctd\u003eParoxysmal tachycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.0\u003c/td\u003e\n              \u003ctd\u003eParoxysmal atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.1\u003c/td\u003e\n              \u003ctd\u003ePersistent atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.2\u003c/td\u003e\n              \u003ctd\u003eChronic atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.3\u003c/td\u003e\n              \u003ctd\u003eTypical atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.4\u003c/td\u003e\n              \u003ctd\u003eAtypical atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.91\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrial fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI48.92\u003c/td\u003e\n              \u003ctd\u003eUnspecified atrial flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.01\u003c/td\u003e\n              \u003ctd\u003eVentricular fibrillation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.02\u003c/td\u003e\n              \u003ctd\u003eVentricular flutter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.1\u003c/td\u003e\n              \u003ctd\u003eAtrial premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.2\u003c/td\u003e\n              \u003ctd\u003eJunctional premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.3\u003c/td\u003e\n              \u003ctd\u003eVentricular premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.49\u003c/td\u003e\n              \u003ctd\u003eOther premature depolarization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.5\u003c/td\u003e\n              \u003ctd\u003eSick sinus syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.8\u003c/td\u003e\n              \u003ctd\u003eOther specified cardiac arrhythmias\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI49.9\u003c/td\u003e\n              \u003ctd\u003eCardiac arrhythmia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.1\u003c/td\u003e\n              \u003ctd\u003eLeft ventricular failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.20\u003c/td\u003e\n              \u003ctd\u003eUnspecified systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.21\u003c/td\u003e\n              \u003ctd\u003eAcute systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.22\u003c/td\u003e\n              \u003ctd\u003eChronic systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.23\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic systolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.31\u003c/td\u003e\n              \u003ctd\u003eAcute diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.32\u003c/td\u003e\n              \u003ctd\u003eChronic diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.33\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.40\u003c/td\u003e\n              \u003ctd\u003eUnspecified combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.41\u003c/td\u003e\n              \u003ctd\u003eAcute combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.42\u003c/td\u003e\n              \u003ctd\u003eChronic combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.43\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic combined systolic (congestive) and diastolic (congestive) heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.810\u003c/td\u003e\n              \u003ctd\u003eRight heart failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.811\u003c/td\u003e\n              \u003ctd\u003eAcute right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.812\u003c/td\u003e\n              \u003ctd\u003eChronic right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.813\u003c/td\u003e\n              \u003ctd\u003eAcute on chronic right heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.814\u003c/td\u003e\n              \u003ctd\u003eRight heart failure due to left heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.82\u003c/td\u003e\n              \u003ctd\u003eBiventricular heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.83\u003c/td\u003e\n              \u003ctd\u003eHigh output heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.84\u003c/td\u003e\n              \u003ctd\u003eEnd stage heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.89\u003c/td\u003e\n              \u003ctd\u003eOther heart failure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI50.9\u003c/td\u003e\n              \u003ctd\u003eHeart failure, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.0\u003c/td\u003e\n              \u003ctd\u003eCardiac septal defect, acquired\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.1\u003c/td\u003e\n              \u003ctd\u003eRupture of chordae tendineae, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.2\u003c/td\u003e\n              \u003ctd\u003eRupture of papillary muscle, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.3\u003c/td\u003e\n              \u003ctd\u003eIntracardiac thrombosis, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.4\u003c/td\u003e\n              \u003ctd\u003eMyocarditis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.5\u003c/td\u003e\n              \u003ctd\u003eMyocardial degeneration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.7\u003c/td\u003e\n              \u003ctd\u003eCardiomegaly\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.81\u003c/td\u003e\n              \u003ctd\u003eTakotsubo syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.89\u003c/td\u003e\n              \u003ctd\u003eOther ill-defined heart diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI51.9\u003c/td\u003e\n              \u003ctd\u003eHeart disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI52\u003c/td\u003e\n              \u003ctd\u003eOther heart disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.00\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.01\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.02\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.10\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.11\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.12\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.2\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from anterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.30\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.31\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.32\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left posterior communicating artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.4\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.50\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.51\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.52\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.6\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from other intracranial arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.7\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage from unspecified intracranial artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.8\u003c/td\u003e\n              \u003ctd\u003eOther nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI60.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subarachnoid hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.0\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, subcortical\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.1\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, cortical\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.2\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in hemisphere, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.3\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in brain stem\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.4\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage in cerebellum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.5\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, intraventricular\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.6\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, multiple localized\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.8\u003c/td\u003e\n              \u003ctd\u003eOther nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI61.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracerebral hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.00\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subdural hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.01\u003c/td\u003e\n              \u003ctd\u003eNontraumatic acute subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.02\u003c/td\u003e\n              \u003ctd\u003eNontraumatic subacute subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.03\u003c/td\u003e\n              \u003ctd\u003eNontraumatic chronic subdural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.1\u003c/td\u003e\n              \u003ctd\u003eNontraumatic extradural hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI62.9\u003c/td\u003e\n              \u003ctd\u003eNontraumatic intracranial hemorrhage, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.00\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.011\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.012\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.013\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.019\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.02\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.031\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.032\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.033\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.039\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.09\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of other precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.10\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.111\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.112\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.113\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.119\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.12\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.131\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.132\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.133\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.139\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.19\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of other precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.20\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.211\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.212\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.213\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.219\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.22\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.231\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.232\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.233\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.239\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.29\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.30\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.311\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.312\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.313\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.319\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.321\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.322\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.323\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.329\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.331\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.332\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.333\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.339\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.341\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.342\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.343\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.349\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.39\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to thrombosis of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.40\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.411\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.412\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.413\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.419\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.421\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.422\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.423\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.429\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.431\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.432\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.433\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.439\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.441\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.442\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.443\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.449\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.49\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to embolism of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.50\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.511\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.512\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.513\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.519\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.521\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.522\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.523\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.529\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.531\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.532\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.533\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.539\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.541\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.542\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.543\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.549\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.59\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to unspecified occlusion or stenosis of other cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.6\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction due to cerebral venous thrombosis, nonpyogenic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.8\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.81\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction due to occlusion or stenosis of small artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.89\u003c/td\u003e\n              \u003ctd\u003eOther cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI63.9\u003c/td\u003e\n              \u003ctd\u003eCerebral infarction, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.01\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.02\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.03\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral vertebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.09\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.1\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of basilar artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.21\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.22\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.23\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral carotid arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.29\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.8\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI65.9\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified precerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.01\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.02\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.03\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral middle cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.09\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified middle cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.11\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.12\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.13\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral anterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.19\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified anterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.21\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of right posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.22\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of left posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.23\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of bilateral posterior cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.29\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified posterior cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.3\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of cerebellar arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.8\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of other cerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI66.9\u003c/td\u003e\n              \u003ctd\u003eOcclusion and stenosis of unspecified cerebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.0\u003c/td\u003e\n              \u003ctd\u003eDissection of cerebral arteries, nonruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.1\u003c/td\u003e\n              \u003ctd\u003eCerebral aneurysm, nonruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.2\u003c/td\u003e\n              \u003ctd\u003eCerebral atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.4\u003c/td\u003e\n              \u003ctd\u003eHypertensive encephalopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.5\u003c/td\u003e\n              \u003ctd\u003eMoyamoya disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.6\u003c/td\u003e\n              \u003ctd\u003eNonpyogenic thrombosis of intracranial venous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.7\u003c/td\u003e\n              \u003ctd\u003eCerebral arteritis, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.81\u003c/td\u003e\n              \u003ctd\u003eAcute cerebrovascular insufficiency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.82\u003c/td\u003e\n              \u003ctd\u003eCerebral ischemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.83\u003c/td\u003e\n              \u003ctd\u003ePosterior reversible encephalopathy syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.841\u003c/td\u003e\n              \u003ctd\u003eReversible cerebrovascular vasoconstriction syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.848\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular vasospasm and vasoconstriction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.850\u003c/td\u003e\n              \u003ctd\u003eCerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.858\u003c/td\u003e\n              \u003ctd\u003eOther hereditary cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.89\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI67.9\u003c/td\u003e\n              \u003ctd\u003eCerebrovascular disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.0\u003c/td\u003e\n              \u003ctd\u003eCerebral amyloid angiopathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.2\u003c/td\u003e\n              \u003ctd\u003eCerebral arteritis in other diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI68.8\u003c/td\u003e\n              \u003ctd\u003eOther cerebrovascular disorders in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.00\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.01\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.010\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.011\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.012\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.013\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.014\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.015\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.018\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.019\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.020\u003c/td\u003e\n              \u003ctd\u003eAphasia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.021\u003c/td\u003e\n              \u003ctd\u003eDysphasia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.022\u003c/td\u003e\n              \u003ctd\u003eDysarthria following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.023\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.028\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.031\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.032\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.033\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.034\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.039\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.041\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.042\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.043\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.044\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.049\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.051\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.052\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.053\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.054\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.059\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.061\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.062\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.063\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.064\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.065\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.069\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.090\u003c/td\u003e\n              \u003ctd\u003eApraxia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.091\u003c/td\u003e\n              \u003ctd\u003eDysphagia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.092\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.093\u003c/td\u003e\n              \u003ctd\u003eAtaxia following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.098\u003c/td\u003e\n              \u003ctd\u003eOther sequelae following nontraumatic subarachnoid hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.10\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.11\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.110\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.111\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.112\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.113\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.114\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.115\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.118\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.119\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.120\u003c/td\u003e\n              \u003ctd\u003eAphasia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.121\u003c/td\u003e\n              \u003ctd\u003eDysphasia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.122\u003c/td\u003e\n              \u003ctd\u003eDysarthria following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.123\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.128\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.131\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.132\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.133\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.134\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.139\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.141\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.142\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.143\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.144\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.149\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.151\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.152\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.153\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.154\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.159\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.161\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.162\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.163\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.164\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.165\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.169\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.190\u003c/td\u003e\n              \u003ctd\u003eApraxia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.191\u003c/td\u003e\n              \u003ctd\u003eDysphagia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.192\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.193\u003c/td\u003e\n              \u003ctd\u003eAtaxia following nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.198\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of nontraumatic intracerebral hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.20\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.21\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.210\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.211\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.212\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.213\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.214\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.215\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.218\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.219\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.220\u003c/td\u003e\n              \u003ctd\u003eAphasia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.221\u003c/td\u003e\n              \u003ctd\u003eDysphasia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.222\u003c/td\u003e\n              \u003ctd\u003eDysarthria following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.223\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.228\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.231\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.232\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.233\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.234\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.239\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.241\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.242\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.243\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.244\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.249\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.251\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.252\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.253\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.254\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.259\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.261\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.262\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.263\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.264\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.265\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.269\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.290\u003c/td\u003e\n              \u003ctd\u003eApraxia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.291\u003c/td\u003e\n              \u003ctd\u003eDysphagia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.292\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.293\u003c/td\u003e\n              \u003ctd\u003eAtaxia following other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.298\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of other nontraumatic intracranial hemorrhage\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.30\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.31\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.310\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.311\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.312\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.313\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.314\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.315\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.318\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.319\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.320\u003c/td\u003e\n              \u003ctd\u003eAphasia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.321\u003c/td\u003e\n              \u003ctd\u003eDysphasia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.322\u003c/td\u003e\n              \u003ctd\u003eDysarthria following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.323\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.328\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.331\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.332\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.333\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.334\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.339\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.341\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.342\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.343\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.344\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.349\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.351\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.352\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.353\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.354\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.359\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.361\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.362\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.363\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.364\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.365\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.369\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following cerebral infarction affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.390\u003c/td\u003e\n              \u003ctd\u003eApraxia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.391\u003c/td\u003e\n              \u003ctd\u003eDysphagia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.392\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.393\u003c/td\u003e\n              \u003ctd\u003eAtaxia following cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.398\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of cerebral infarction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.80\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.81\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.810\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.811\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.812\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.813\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.814\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.815\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.818\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.819\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.820\u003c/td\u003e\n              \u003ctd\u003eAphasia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.821\u003c/td\u003e\n              \u003ctd\u003eDysphasia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.822\u003c/td\u003e\n              \u003ctd\u003eDysarthria following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.823\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.828\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.831\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.832\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.833\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.834\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.839\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.841\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.842\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.843\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.844\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.849\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.851\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.852\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.853\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.854\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.859\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.861\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.862\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.863\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.864\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.865\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.869\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following other cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.890\u003c/td\u003e\n              \u003ctd\u003eApraxia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.891\u003c/td\u003e\n              \u003ctd\u003eDysphagia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.892\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.893\u003c/td\u003e\n              \u003ctd\u003eAtaxia following other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.898\u003c/td\u003e\n              \u003ctd\u003eOther sequelae of other cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified sequelae of unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.91\u003c/td\u003e\n              \u003ctd\u003eCognitive deficits following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.910\u003c/td\u003e\n              \u003ctd\u003eAttention and concentration deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.911\u003c/td\u003e\n              \u003ctd\u003eMemory deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.912\u003c/td\u003e\n              \u003ctd\u003eVisuospatial deficit and spatial neglect following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.913\u003c/td\u003e\n              \u003ctd\u003ePsychomotor deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.914\u003c/td\u003e\n              \u003ctd\u003eFrontal lobe and executive function deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.915\u003c/td\u003e\n              \u003ctd\u003eCognitive social or emotional deficit following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.918\u003c/td\u003e\n              \u003ctd\u003eOther symptoms and signs involving cognitive functions following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.919\u003c/td\u003e\n              \u003ctd\u003eUnspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.920\u003c/td\u003e\n              \u003ctd\u003eAphasia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.921\u003c/td\u003e\n              \u003ctd\u003eDysphasia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.922\u003c/td\u003e\n              \u003ctd\u003eDysarthria following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.923\u003c/td\u003e\n              \u003ctd\u003eFluency disorder following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.928\u003c/td\u003e\n              \u003ctd\u003eOther speech and language deficits following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.931\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.932\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.933\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.934\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.939\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.941\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.942\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.943\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.944\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.949\u003c/td\u003e\n              \u003ctd\u003eMonoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.951\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.952\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.953\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.954\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.959\u003c/td\u003e\n              \u003ctd\u003eHemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.961\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.962\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.963\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.964\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.965\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.969\u003c/td\u003e\n              \u003ctd\u003eOther paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.990\u003c/td\u003e\n              \u003ctd\u003eApraxia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.991\u003c/td\u003e\n              \u003ctd\u003eDysphagia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.992\u003c/td\u003e\n              \u003ctd\u003eFacial weakness following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.993\u003c/td\u003e\n              \u003ctd\u003eAtaxia following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI69.998\u003c/td\u003e\n              \u003ctd\u003eOther sequelae following unspecified cerebrovascular disease\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.0\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.1\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.201\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.202\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.203\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.208\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.209\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis of native arteries of extremities, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.211\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.212\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.213\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.218\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.219\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.221\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.222\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.223\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.228\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.229\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with rest pain, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.231\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.232\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.233\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.234\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.235\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.238\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.239\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of right leg with ulceration of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.241\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.242\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.243\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.244\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.245\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.248\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.249\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of left leg with ulceration of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.25\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of other extremities with ulceration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.261\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.262\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.263\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.268\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.269\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of native arteries of extremities with gangrene, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.291\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.292\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.293\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, bilateral legs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.298\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, other extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.299\u003c/td\u003e\n              \u003ctd\u003eOther atherosclerosis of native arteries of extremities, unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.8\u003c/td\u003e\n              \u003ctd\u003eAtherosclerosis of other arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.90\u003c/td\u003e\n              \u003ctd\u003eUnspecified atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.91\u003c/td\u003e\n              \u003ctd\u003eGeneralized atherosclerosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI70.92\u003c/td\u003e\n              \u003ctd\u003eChronic total occlusion of artery of the extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.00\u003c/td\u003e\n              \u003ctd\u003eDissection of unspecified site of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.01\u003c/td\u003e\n              \u003ctd\u003eDissection of thoracic aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.02\u003c/td\u003e\n              \u003ctd\u003eDissection of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.03\u003c/td\u003e\n              \u003ctd\u003eDissection of thoracoabdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.1\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.2\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.3\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.4\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.5\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic aneurysm, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.6\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic aneurysm, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.8\u003c/td\u003e\n              \u003ctd\u003eAortic aneurysm of unspecified site, ruptured\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI71.9\u003c/td\u003e\n              \u003ctd\u003eAortic aneurysm of unspecified site, without rupture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.0\u003c/td\u003e\n              \u003ctd\u003eAneurysm of carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.1\u003c/td\u003e\n              \u003ctd\u003eAneurysm of artery of upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.2\u003c/td\u003e\n              \u003ctd\u003eAneurysm of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.3\u003c/td\u003e\n              \u003ctd\u003eAneurysm of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.4\u003c/td\u003e\n              \u003ctd\u003eAneurysm of artery of lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.5\u003c/td\u003e\n              \u003ctd\u003eAneurysm of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.6\u003c/td\u003e\n              \u003ctd\u003eAneurysm of vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.8\u003c/td\u003e\n              \u003ctd\u003eAneurysm of other specified arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI72.9\u003c/td\u003e\n              \u003ctd\u003eAneurysm of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.00\u003c/td\u003e\n              \u003ctd\u003eRaynaud\u0027s syndrome without gangrene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.01\u003c/td\u003e\n              \u003ctd\u003eRaynaud\u0027s syndrome with gangrene\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.1\u003c/td\u003e\n              \u003ctd\u003eThromboangiitis obliterans [Buerger\u0027s disease]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.81\u003c/td\u003e\n              \u003ctd\u003eErythromelalgia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.89\u003c/td\u003e\n              \u003ctd\u003eOther specified peripheral vascular diseases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI73.9\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular disease, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.01\u003c/td\u003e\n              \u003ctd\u003eSaddle embolus of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.09\u003c/td\u003e\n              \u003ctd\u003eOther arterial embolism and thrombosis of abdominal aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.10\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of unspecified parts of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.11\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of thoracic aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.19\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of other parts of aorta\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.2\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of the upper extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.3\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of the lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.4\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of arteries of extremities, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.5\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.8\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of other arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI74.9\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of unspecified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.011\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.012\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.013\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of bilateral upper extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.019\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.021\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.022\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.023\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of bilateral lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.029\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.81\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI75.89\u003c/td\u003e\n              \u003ctd\u003eAtheroembolism of other site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.0\u003c/td\u003e\n              \u003ctd\u003eArteriovenous fistula, acquired\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.1\u003c/td\u003e\n              \u003ctd\u003eStricture of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.2\u003c/td\u003e\n              \u003ctd\u003eRupture of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.3\u003c/td\u003e\n              \u003ctd\u003eArterial fibromuscular dysplasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.4\u003c/td\u003e\n              \u003ctd\u003eCeliac artery compression syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.5\u003c/td\u003e\n              \u003ctd\u003eNecrosis of artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.6\u003c/td\u003e\n              \u003ctd\u003eArteritis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.70\u003c/td\u003e\n              \u003ctd\u003eDissection of unspecified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.71\u003c/td\u003e\n              \u003ctd\u003eDissection of carotid artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.72\u003c/td\u003e\n              \u003ctd\u003eDissection of iliac artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.73\u003c/td\u003e\n              \u003ctd\u003eDissection of renal artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.74\u003c/td\u003e\n              \u003ctd\u003eDissection of vertebral artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.75\u003c/td\u003e\n              \u003ctd\u003eDissection of other precerebral arteries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.76\u003c/td\u003e\n              \u003ctd\u003eDissection of artery of upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.77\u003c/td\u003e\n              \u003ctd\u003eDissection of artery of lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.79\u003c/td\u003e\n              \u003ctd\u003eDissection of other specified artery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.810\u003c/td\u003e\n              \u003ctd\u003eThoracic aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.811\u003c/td\u003e\n              \u003ctd\u003eAbdominal aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.812\u003c/td\u003e\n              \u003ctd\u003eThoracoabdominal aortic ectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.819\u003c/td\u003e\n              \u003ctd\u003eAortic ectasia, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.89\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of arteries and arterioles\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI77.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of arteries and arterioles, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.0\u003c/td\u003e\n              \u003ctd\u003eHereditary hemorrhagic telangiectasia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.1\u003c/td\u003e\n              \u003ctd\u003eNevus, non-neoplastic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.8\u003c/td\u003e\n              \u003ctd\u003eOther diseases of capillaries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI78.9\u003c/td\u003e\n              \u003ctd\u003eDisease of capillaries, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.0\u003c/td\u003e\n              \u003ctd\u003eAneurysm of aorta in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.1\u003c/td\u003e\n              \u003ctd\u003eAortitis in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI79.8\u003c/td\u003e\n              \u003ctd\u003eOther disorders of arteries, arterioles and capillaries in diseases classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.00\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.01\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.02\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.03\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.10\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.11\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.12\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.13\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.201\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.202\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.203\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.209\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.211\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.212\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.213\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.219\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.221\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.222\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.223\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.229\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.231\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.232\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.233\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.239\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.291\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.292\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.293\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.299\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.3\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of lower extremities, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.8\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI80.9\u003c/td\u003e\n              \u003ctd\u003ePhlebitis and thrombophlebitis of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI81\u003c/td\u003e\n              \u003ctd\u003ePortal vein thrombosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.0\u003c/td\u003e\n              \u003ctd\u003eBudd-Chiari syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.1\u003c/td\u003e\n              \u003ctd\u003eThrombophlebitis migrans\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.210\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.211\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.220\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of inferior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.221\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of inferior vena cava\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.290\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other thoracic veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.291\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other thoracic veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.3\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of renal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.401\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.402\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.403\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.409\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.411\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.412\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.413\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.419\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.421\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.422\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.423\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.429\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.431\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.432\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.433\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.439\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.441\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.442\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.443\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.449\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.491\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.492\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.493\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.499\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified deep vein of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y1\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y2\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y3\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Y9\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z1\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of right distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z2\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of left distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z3\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.4Z9\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.501\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.502\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.503\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.509\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.511\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.512\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.513\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of femoral vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.519\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified femoral vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.521\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.522\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.523\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of iliac vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.529\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified iliac vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.531\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.532\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.533\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of popliteal vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.539\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified popliteal vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.541\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.542\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.543\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of tibial vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.549\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified tibial vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.591\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.592\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.593\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.599\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified deep vein of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y1\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y2\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y3\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Y9\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z1\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of right distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z2\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of left distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z3\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.5Z9\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.601\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.602\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.603\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.609\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.611\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.612\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.613\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.619\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of superficial veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.621\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.622\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.623\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.629\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of deep veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.701\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.702\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.703\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.709\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.711\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.712\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.713\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.719\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of superficial veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.721\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of right upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.722\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of left upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.723\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of upper extremity, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.729\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of deep veins of unspecified upper extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.811\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.812\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.813\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of lower extremities, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.819\u003c/td\u003e\n              \u003ctd\u003eEmbolism and thrombosis of superficial veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.890\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of other specified veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.891\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of other specified veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.90\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.91\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of axillary vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of axillary vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.A29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified axillary vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of subclavian vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of subclavian vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.B29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified subclavian vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C11\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of right internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C12\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of left internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C13\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of internal jugular vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C19\u003c/td\u003e\n              \u003ctd\u003eAcute embolism and thrombosis of unspecified internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C21\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of right internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C22\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of left internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C23\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of internal jugular vein, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI82.C29\u003c/td\u003e\n              \u003ctd\u003eChronic embolism and thrombosis of unspecified internal jugular vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.001\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.002\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.003\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.004\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.005\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.008\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.009\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.011\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.012\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.013\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.014\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.015\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.018\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.019\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.021\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of thigh\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.022\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of calf\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.023\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of ankle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.024\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of heel and midfoot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.025\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer other part of foot\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.028\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer other part of lower leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.029\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with ulcer of unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.10\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.11\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.12\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.201\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.202\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.203\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.204\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.205\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.208\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.209\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.211\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.212\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.213\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.214\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.215\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.218\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.219\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.221\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of thigh and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.222\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of calf and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.223\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of ankle and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.224\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of heel and midfoot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.225\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer other part of foot and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.228\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.229\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with both ulcer of unspecified site and inflammation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.811\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.812\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.813\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of bilateral lower extremities with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.819\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.891\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of right lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.892\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of left lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.893\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of bilateral lower extremities with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.899\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of unspecified lower extremity with other complications\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.90\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.91\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.92\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI83.93\u003c/td\u003e\n              \u003ctd\u003eAsymptomatic varicose veins of bilateral lower extremities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.0\u003c/td\u003e\n              \u003ctd\u003eSublingual varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.1\u003c/td\u003e\n              \u003ctd\u003eScrotal varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.2\u003c/td\u003e\n              \u003ctd\u003ePelvic varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.3\u003c/td\u003e\n              \u003ctd\u003eVulval varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.4\u003c/td\u003e\n              \u003ctd\u003eGastric varices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI86.8\u003c/td\u003e\n              \u003ctd\u003eVaricose veins of other specified sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.001\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.002\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.003\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.009\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome without complications of unspecified extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.011\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.012\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.013\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.019\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.021\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.022\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.023\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.029\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.031\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.032\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.033\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.039\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with ulcer and inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.091\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.092\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.093\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.099\u003c/td\u003e\n              \u003ctd\u003ePostthrombotic syndrome with other complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.1\u003c/td\u003e\n              \u003ctd\u003eCompression of vein\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.2\u003c/td\u003e\n              \u003ctd\u003eVenous insufficiency (chronic) (peripheral)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.301\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.302\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.303\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.309\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) without complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.311\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.312\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.313\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.319\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.321\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.322\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.323\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.329\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.331\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.332\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.333\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.339\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.391\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of right lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.392\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of left lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.393\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of bilateral lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.399\u003c/td\u003e\n              \u003ctd\u003eChronic venous hypertension (idiopathic) with other complications of unspecified lower extremity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.8\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of veins\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI87.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of vein, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.0\u003c/td\u003e\n              \u003ctd\u003eNonspecific mesenteric lymphadenitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.1\u003c/td\u003e\n              \u003ctd\u003eChronic lymphadenitis, except mesenteric\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.8\u003c/td\u003e\n              \u003ctd\u003eOther nonspecific lymphadenitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI88.9\u003c/td\u003e\n              \u003ctd\u003eNonspecific lymphadenitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.0\u003c/td\u003e\n              \u003ctd\u003eLymphedema, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.1\u003c/td\u003e\n              \u003ctd\u003eLymphangitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.8\u003c/td\u003e\n              \u003ctd\u003eOther specified noninfective disorders of lymphatic vessels and lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI89.9\u003c/td\u003e\n              \u003ctd\u003eNoninfective disorder of lymphatic vessels and lymph nodes, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.0\u003c/td\u003e\n              \u003ctd\u003eIdiopathic hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.1\u003c/td\u003e\n              \u003ctd\u003eOrthostatic hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.89\u003c/td\u003e\n              \u003ctd\u003eOther hypotension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI95.9\u003c/td\u003e\n              \u003ctd\u003eHypotension, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI96\u003c/td\u003e\n              \u003ctd\u003eGangrene, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI99.8\u003c/td\u003e\n              \u003ctd\u003eOther disorder of circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eI99.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified disorder of circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ10.82\u003c/td\u003e\n              \u003ctd\u003eInfluenza due to other identified influenza virus with myocarditis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ30.5\u003c/td\u003e\n              \u003ctd\u003eAllergic rhinitis due to food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ85.0\u003c/td\u003e\n              \u003ctd\u003eGangrene and necrosis of lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eJ91.0\u003c/td\u003e\n              \u003ctd\u003eMalignant pleural effusion\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK31.7\u003c/td\u003e\n              \u003ctd\u003ePolyp of stomach and duodenum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.2\u003c/td\u003e\n              \u003ctd\u003eAllergic and dietetic gastroenteritis and colitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.21\u003c/td\u003e\n              \u003ctd\u003eFood protein-induced enterocolitis syndrome\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.22\u003c/td\u003e\n              \u003ctd\u003eFood protein-induced enteropathy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK52.29\u003c/td\u003e\n              \u003ctd\u003eOther allergic and dietetic gastroenteritis and colitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.0\u003c/td\u003e\n              \u003ctd\u003eAcute vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.011\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.012\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.019\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of small intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.021\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.022\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.029\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of small intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.031\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.032\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.039\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of large intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.041\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.042\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.049\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of large intestine, extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.051\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute (reversible) ischemia of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.052\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute (reversible) ischemia of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.059\u003c/td\u003e\n              \u003ctd\u003eAcute (reversible) ischemia of intestine, part and extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.061\u003c/td\u003e\n              \u003ctd\u003eFocal (segmental) acute infarction of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.062\u003c/td\u003e\n              \u003ctd\u003eDiffuse acute infarction of intestine, part unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.069\u003c/td\u003e\n              \u003ctd\u003eAcute infarction of intestine, part and extent unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.1\u003c/td\u003e\n              \u003ctd\u003eChronic vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.8\u003c/td\u003e\n              \u003ctd\u003eOther vascular disorders of intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK55.9\u003c/td\u003e\n              \u003ctd\u003eVascular disorder of intestine, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK63.5\u003c/td\u003e\n              \u003ctd\u003ePolyp of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.0\u003c/td\u003e\n              \u003ctd\u003eFirst degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.1\u003c/td\u003e\n              \u003ctd\u003eSecond degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.2\u003c/td\u003e\n              \u003ctd\u003eThird degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.3\u003c/td\u003e\n              \u003ctd\u003eFourth degree hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.4\u003c/td\u003e\n              \u003ctd\u003eResidual hemorrhoidal skin tags\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.5\u003c/td\u003e\n              \u003ctd\u003ePerianal venous thrombosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.8\u003c/td\u003e\n              \u003ctd\u003eOther hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK64.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified hemorrhoids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eK90.41\u003c/td\u003e\n              \u003ctd\u003eNon-celiac gluten sensitivity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.0\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of face, head and neck\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.1\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of trunk\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.2\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of upper limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.3\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of lower limb\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.8\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL04.9\u003c/td\u003e\n              \u003ctd\u003eAcute lymphadenitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.0\u003c/td\u003e\n              \u003ctd\u003eBesnier\u0027s prurigo\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.81\u003c/td\u003e\n              \u003ctd\u003eAtopic neurodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.82\u003c/td\u003e\n              \u003ctd\u003eFlexural eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.83\u003c/td\u003e\n              \u003ctd\u003eInfantile (acute) (chronic) eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.84\u003c/td\u003e\n              \u003ctd\u003eIntrinsic (allergic) eczema\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.89\u003c/td\u003e\n              \u003ctd\u003eOther atopic dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL20.9\u003c/td\u003e\n              \u003ctd\u003eAtopic dermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL22\u003c/td\u003e\n              \u003ctd\u003eDiaper dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.0\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to metals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.1\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to adhesives\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.2\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.3\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.4\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to dyes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.5\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.6\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to food in contact with the skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.7\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.81\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to animal (cat) (dog) dander\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.89\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL23.9\u003c/td\u003e\n              \u003ctd\u003eAllergic contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.0\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to detergents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.1\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to oils and greases\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.2\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to solvents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.3\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.4\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.5\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.6\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to food in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.7\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.81\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to metals\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.89\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL24.9\u003c/td\u003e\n              \u003ctd\u003eIrritant contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.0\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to cosmetics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.1\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to drugs in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.2\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to dyes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.3\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to other chemical products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.4\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to food in contact with skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.5\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to plants, except food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.8\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis due to other agents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL25.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified contact dermatitis, unspecified cause\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.0\u003c/td\u003e\n              \u003ctd\u003eGeneralized skin eruption due to drugs and medicaments taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.1\u003c/td\u003e\n              \u003ctd\u003eLocalized skin eruption due to drugs and medicaments taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.2\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to ingested food\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.8\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to other substances taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL27.9\u003c/td\u003e\n              \u003ctd\u003eDermatitis due to unspecified substance taken internally\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.0\u003c/td\u003e\n              \u003ctd\u003eNummular dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.2\u003c/td\u003e\n              \u003ctd\u003eCutaneous autosensitization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.8\u003c/td\u003e\n              \u003ctd\u003eOther specified dermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL30.9\u003c/td\u003e\n              \u003ctd\u003eDermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.0\u003c/td\u003e\n              \u003ctd\u003eAllergic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.1\u003c/td\u003e\n              \u003ctd\u003eIdiopathic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.2\u003c/td\u003e\n              \u003ctd\u003eUrticaria due to cold and heat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.3\u003c/td\u003e\n              \u003ctd\u003eDermatographic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.4\u003c/td\u003e\n              \u003ctd\u003eVibratory urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.5\u003c/td\u003e\n              \u003ctd\u003eCholinergic urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.6\u003c/td\u003e\n              \u003ctd\u003eContact urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.8\u003c/td\u003e\n              \u003ctd\u003eOther urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL50.9\u003c/td\u003e\n              \u003ctd\u003eUrticaria, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.0\u003c/td\u003e\n              \u003ctd\u003eDrug phototoxic response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.1\u003c/td\u003e\n              \u003ctd\u003eDrug photoallergic response\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.2\u003c/td\u003e\n              \u003ctd\u003ePhotocontact dermatitis [berloque dermatitis]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.3\u003c/td\u003e\n              \u003ctd\u003eSolar urticaria\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.4\u003c/td\u003e\n              \u003ctd\u003ePolymorphous light eruption\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.8\u003c/td\u003e\n              \u003ctd\u003eOther specified acute skin changes due to ultraviolet radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL56.9\u003c/td\u003e\n              \u003ctd\u003eAcute skin change due to ultraviolet radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL57.8\u003c/td\u003e\n              \u003ctd\u003eOther skin changes due to chronic exposure to nonionizing radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL57.9\u003c/td\u003e\n              \u003ctd\u003eSkin changes due to chronic exposure to nonionizing radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.0\u003c/td\u003e\n              \u003ctd\u003eAcute radiodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.1\u003c/td\u003e\n              \u003ctd\u003eChronic radiodermatitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL58.9\u003c/td\u003e\n              \u003ctd\u003eRadiodermatitis, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.0\u003c/td\u003e\n              \u003ctd\u003eErythema ab igne [dermatitis ab igne]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.8\u003c/td\u003e\n              \u003ctd\u003eOther specified disorders of the skin and subcutaneous tissue related to radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eL59.9\u003c/td\u003e\n              \u003ctd\u003eDisorder of the skin and subcutaneous tissue related to radiation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eM31.0\u003c/td\u003e\n              \u003ctd\u003eHypersensitivity angiitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eN26.2\u003c/td\u003e\n              \u003ctd\u003ePage kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.0\u003c/td\u003e\n              \u003ctd\u003eTachycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.1\u003c/td\u003e\n              \u003ctd\u003eBradycardia, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.2\u003c/td\u003e\n              \u003ctd\u003ePalpitations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormalities of heart beat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR00.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormalities of heart beat\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.0\u003c/td\u003e\n              \u003ctd\u003eBenign and innocent cardiac murmurs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.1\u003c/td\u003e\n              \u003ctd\u003eCardiac murmur, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR01.2\u003c/td\u003e\n              \u003ctd\u003eOther cardiac sounds\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR03.0\u003c/td\u003e\n              \u003ctd\u003eElevated blood-pressure reading, without diagnosis of hypertension\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR03.1\u003c/td\u003e\n              \u003ctd\u003eNonspecific low blood-pressure reading\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.2\u003c/td\u003e\n              \u003ctd\u003ePrecordial pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.82\u003c/td\u003e\n              \u003ctd\u003eIntercostal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.89\u003c/td\u003e\n              \u003ctd\u003eOther chest pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR07.9\u003c/td\u003e\n              \u003ctd\u003eChest pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR09.89\u003c/td\u003e\n              \u003ctd\u003eOther specified symptoms and signs involving the circulatory and respiratory systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.0\u003c/td\u003e\n              \u003ctd\u003eAcute abdomen\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.10\u003c/td\u003e\n              \u003ctd\u003eUpper abdominal pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.11\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.12\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.13\u003c/td\u003e\n              \u003ctd\u003eEpigastric pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.2\u003c/td\u003e\n              \u003ctd\u003ePelvic and perineal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.30\u003c/td\u003e\n              \u003ctd\u003eLower abdominal pain, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.31\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.32\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.33\u003c/td\u003e\n              \u003ctd\u003ePeriumbilical pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.811\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.812\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.813\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.814\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.815\u003c/td\u003e\n              \u003ctd\u003ePeriumbilic abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.816\u003c/td\u003e\n              \u003ctd\u003eEpigastric abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.817\u003c/td\u003e\n              \u003ctd\u003eGeneralized abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.819\u003c/td\u003e\n              \u003ctd\u003eAbdominal tenderness, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.821\u003c/td\u003e\n              \u003ctd\u003eRight upper quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.822\u003c/td\u003e\n              \u003ctd\u003eLeft upper quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.823\u003c/td\u003e\n              \u003ctd\u003eRight lower quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.824\u003c/td\u003e\n              \u003ctd\u003eLeft lower quadrant rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.825\u003c/td\u003e\n              \u003ctd\u003ePeriumbilic rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.826\u003c/td\u003e\n              \u003ctd\u003eEpigastric rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.827\u003c/td\u003e\n              \u003ctd\u003eGeneralized rebound abdominal tenderness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.829\u003c/td\u003e\n              \u003ctd\u003eRebound abdominal tenderness, unspecified site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.84\u003c/td\u003e\n              \u003ctd\u003eGeneralized abdominal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR10.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abdominal pain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.0\u003c/td\u003e\n              \u003ctd\u003eNausea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.10\u003c/td\u003e\n              \u003ctd\u003eVomiting, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.11\u003c/td\u003e\n              \u003ctd\u003eVomiting without nausea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.12\u003c/td\u003e\n              \u003ctd\u003eProjectile vomiting\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.14\u003c/td\u003e\n              \u003ctd\u003eBilious vomiting\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR11.2\u003c/td\u003e\n              \u003ctd\u003eNausea with vomiting, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR18.0\u003c/td\u003e\n              \u003ctd\u003eMalignant ascites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.700\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 0\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.701\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 1\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.702\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 2\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.703\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 3\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.704\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 4\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.705\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 5\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.706\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 6\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.707\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 7\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.708\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 8\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.709\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 9\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.710\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 10\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.711\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 11\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.712\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 12\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.713\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 13\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.714\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 14\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.715\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 15\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.716\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 16\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.717\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 17\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.718\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 18\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.719\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 19\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.720\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 20\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.721\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 21\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.722\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 22\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.723\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 23\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.724\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 24\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.725\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 25\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.726\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 26\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.727\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 27\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.728\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 28\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.729\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 29\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.730\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 30\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.731\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 31\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.732\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 32\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.733\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 33\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.734\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 34\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.735\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 35\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.736\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 36\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.737\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 37\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.738\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 38\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.739\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 39\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.740\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 40\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.741\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 41\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR29.742\u003c/td\u003e\n              \u003ctd\u003eNIHSS score 42\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR50.81\u003c/td\u003e\n              \u003ctd\u003eFever presenting with conditions classified elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR50.9\u003c/td\u003e\n              \u003ctd\u003eFever, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.0\u003c/td\u003e\n              \u003ctd\u003eNeoplastic (malignant) related fatigue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.1\u003c/td\u003e\n              \u003ctd\u003eWeakness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.81\u003c/td\u003e\n              \u003ctd\u003eOther malaise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.82\u003c/td\u003e\n              \u003ctd\u003eChronic fatigue, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR53.83\u003c/td\u003e\n              \u003ctd\u003eOther fatigue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR55\u003c/td\u003e\n              \u003ctd\u003eSyncope and collapse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.0\u003c/td\u003e\n              \u003ctd\u003eCardiogenic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.1\u003c/td\u003e\n              \u003ctd\u003eHypovolemic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.8\u003c/td\u003e\n              \u003ctd\u003eOther shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR57.9\u003c/td\u003e\n              \u003ctd\u003eShock, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR58\u003c/td\u003e\n              \u003ctd\u003eHemorrhage, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.0\u003c/td\u003e\n              \u003ctd\u003eLocalized enlarged lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.1\u003c/td\u003e\n              \u003ctd\u003eGeneralized enlarged lymph nodes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR59.9\u003c/td\u003e\n              \u003ctd\u003eEnlarged lymph nodes, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR65.21\u003c/td\u003e\n              \u003ctd\u003eSevere sepsis with septic shock\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.71\u003c/td\u003e\n              \u003ctd\u003eAbnormal lead level in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.79\u003c/td\u003e\n              \u003ctd\u003eFinding of abnormal level of heavy metals in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.89\u003c/td\u003e\n              \u003ctd\u003eFinding of other specified substances, not normally found in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR78.9\u003c/td\u003e\n              \u003ctd\u003eFinding of unspecified substance, not normally found in blood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of blood mineral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal coagulation profile\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.81\u003c/td\u003e\n              \u003ctd\u003eAbnormal blood-gas level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.82\u003c/td\u003e\n              \u003ctd\u003eElevated C-reactive protein (CRP)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.89\u003c/td\u003e\n              \u003ctd\u003eOther specified abnormal findings of blood chemistry\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR79.9\u003c/td\u003e\n              \u003ctd\u003eAbnormal finding of blood chemistry, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR83.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in cerebrospinal fluid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR84.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from respiratory organs and thorax\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.610\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.611\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.612\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.613\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.614\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.615\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.616\u003c/td\u003e\n              \u003ctd\u003eSatisfactory anal smear but lacking transformation zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.618\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.619\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.69\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR85.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from digestive organs and abdominal cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR86.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.610\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.611\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.612\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.613\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.614\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.615\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.616\u003c/td\u003e\n              \u003ctd\u003eSatisfactory cervical smear but lacking transformation zone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.618\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.619\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.620\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.621\u003c/td\u003e\n              \u003ctd\u003eAtypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.622\u003c/td\u003e\n              \u003ctd\u003eLow grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.623\u003c/td\u003e\n              \u003ctd\u003eHigh grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.624\u003c/td\u003e\n              \u003ctd\u003eCytologic evidence of malignancy on smear of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.625\u003c/td\u003e\n              \u003ctd\u003eUnsatisfactory cytologic smear of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.628\u003c/td\u003e\n              \u003ctd\u003eOther abnormal cytological findings on specimens from vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.629\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal cytological findings in specimens from vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.69\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR87.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR88.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings in other body fluids and substances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of enzymes in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of hormones in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal immunological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal microbiological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal cytological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal histological findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR89.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified abnormal finding in specimens from other organs, systems and tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR90.81\u003c/td\u003e\n              \u003ctd\u003eAbnormal echoencephalogram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR90.89\u003c/td\u003e\n              \u003ctd\u003eOther abnormal findings on diagnostic imaging of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR92.2\u003c/td\u003e\n              \u003ctd\u003eInconclusive mammogram\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR92.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal and inconclusive findings on diagnostic imaging of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.0\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of skull and head, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.1\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of heart and coronary circulation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of liver and biliary tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.3\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other parts of digestive tract\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.41\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.421\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of right kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.422\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of left kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.429\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of unspecified kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.49\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of other urinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of limbs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other parts of musculoskeletal system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other specified body structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.811\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of right testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.812\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of left testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.813\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of testicles, bilateral\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.819\u003c/td\u003e\n              \u003ctd\u003eAbnormal radiologic findings on diagnostic imaging of unspecified testicle\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.89\u003c/td\u003e\n              \u003ctd\u003eAbnormal findings on diagnostic imaging of other specified body structures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR93.9\u003c/td\u003e\n              \u003ctd\u003eDiagnostic imaging inconclusive due to excess body fat of patient\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.01\u003c/td\u003e\n              \u003ctd\u003eAbnormal electroencephalogram [EEG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.02\u003c/td\u003e\n              \u003ctd\u003eAbnormal brain scan\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.09\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of central nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.110\u003c/td\u003e\n              \u003ctd\u003eAbnormal electro-oculogram [EOG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.111\u003c/td\u003e\n              \u003ctd\u003eAbnormal electroretinogram [ERG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.112\u003c/td\u003e\n              \u003ctd\u003eAbnormal visually evoked potential [VEP]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.113\u003c/td\u003e\n              \u003ctd\u003eAbnormal oculomotor study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.118\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.120\u003c/td\u003e\n              \u003ctd\u003eAbnormal auditory function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.121\u003c/td\u003e\n              \u003ctd\u003eAbnormal vestibular function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.128\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of ear and other special senses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.130\u003c/td\u003e\n              \u003ctd\u003eAbnormal response to nerve stimulation, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.131\u003c/td\u003e\n              \u003ctd\u003eAbnormal electromyogram [EMG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.138\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other function studies of peripheral nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.2\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of pulmonary function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.30\u003c/td\u003e\n              \u003ctd\u003eAbnormal result of cardiovascular function study, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.31\u003c/td\u003e\n              \u003ctd\u003eAbnormal electrocardiogram [ECG] [EKG]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.39\u003c/td\u003e\n              \u003ctd\u003eAbnormal result of other cardiovascular function study\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.4\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of kidney function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.5\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of liver function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.6\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of thyroid function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.7\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of other endocrine function studies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR94.8\u003c/td\u003e\n              \u003ctd\u003eAbnormal results of function studies of other organs and systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.0\u003c/td\u003e\n              \u003ctd\u003eElevated carcinoembryonic antigen [CEA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.1\u003c/td\u003e\n              \u003ctd\u003eElevated cancer antigen 125 [CA 125]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.2\u003c/td\u003e\n              \u003ctd\u003eElevated prostate specific antigen [PSA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.20\u003c/td\u003e\n              \u003ctd\u003eElevated prostate specific antigen [PSA]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.21\u003c/td\u003e\n              \u003ctd\u003eRising PSA following treatment for malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eR97.8\u003c/td\u003e\n              \u003ctd\u003eOther abnormal tumor markers\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.00XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to unspecified food, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.01XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to peanuts, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.02XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to shellfish (crustaceans), sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.03XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other fish, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.04XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to fruits and vegetables, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.05XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to tree nuts and seeds, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.06XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to food additives, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.07XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to milk and dairy products, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.08XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to eggs, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XD\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.09XS\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic reaction due to other food products, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXA\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXD\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, subsequent encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.1XXS\u003c/td\u003e\n              \u003ctd\u003eOther adverse food reactions, not elsewhere classified, sequela\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.2XXA\u003c/td\u003e\n              \u003ctd\u003eAnaphylactic shock, unspecified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.40XA\u003c/td\u003e\n              \u003ctd\u003eAllergy, unspecified, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eT78.49XA\u003c/td\u003e\n              \u003ctd\u003eOther allergy, initial encounter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for general adult medical examination without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for general adult medical examination with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.110\u003c/td\u003e\n              \u003ctd\u003eHealth examination for newborn under 8 days old\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.111\u003c/td\u003e\n              \u003ctd\u003eHealth examination for newborn 8 to 28 days old\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.121\u003c/td\u003e\n              \u003ctd\u003eEncounter for routine child health examination with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.129\u003c/td\u003e\n              \u003ctd\u003eEncounter for routine child health examination without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of rapid growth in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for adolescent development state\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of potential donor of organ and tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for normal comparison and control in clinical research program\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.70\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of delayed growth in childhood without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for period of delayed growth in childhood with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ00.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for other general examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of eyes and vision without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of eyes and vision with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.10\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of ears and hearing without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.110\u003c/td\u003e\n              \u003ctd\u003eEncounter for hearing examination following failed hearing screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.118\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of ears and hearing with other abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for hearing conservation and treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.20\u003c/td\u003e\n              \u003ctd\u003eEncounter for dental examination and cleaning without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for dental examination and cleaning with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.30\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of blood pressure without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination of blood pressure with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.411\u003c/td\u003e\n              \u003ctd\u003eEncounter for gynecological examination (general) (routine) with abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.419\u003c/td\u003e\n              \u003ctd\u003eEncounter for gynecological examination (general) (routine) without abnormal findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural cardiovascular examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural respiratory examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for preprocedural laboratory examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.818\u003c/td\u003e\n              \u003ctd\u003eEncounter for other preprocedural examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for allergy testing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for blood typing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for antibody response examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ01.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified special examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for admission to educational institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for pre-employment examination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for admission to residential institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for recruitment to armed forces\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for driving license\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for participation in sport\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination for insurance purposes\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for disability determination\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for issue of other medical certificate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for paternity testing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for adoption services\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for blood-alcohol and blood-drug test\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other administrative examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ02.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for administrative examinations, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for observation for suspected toxic effect from ingested substance ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected problem with amniotic cavity and membrane ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected placental problem ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.73\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected fetal anomaly ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.74\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected problem with fetal growth ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.75\u003c/td\u003e\n              \u003ctd\u003eEncounter for suspected cervical shortening ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for other suspected maternal and fetal conditions ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ03.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for observation for other suspected diseases and conditions ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.41\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged adult rape\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged child rape\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged adult physical abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation following alleged child physical abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for other specified reasons\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation of victim following forced sexual exploitation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation of victim following forced labor exploitation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for other specified reasons\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ04.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for examination and observation for unspecified reason\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.0\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected cardiac condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.2\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected neurological condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.3\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected respiratory condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.41\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected genetic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.42\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected metabolic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.43\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected immunologic condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.5\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected gastrointestinal condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.6\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected genitourinary condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.71\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.72\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected musculoskeletal condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.73\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for suspected connective tissue condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.8\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for other specified suspected condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ05.9\u003c/td\u003e\n              \u003ctd\u003eObservation and evaluation of newborn for unspecified suspected condition ruled out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ08\u003c/td\u003e\n              \u003ctd\u003eEncounter for follow-up examination after completed treatment for malignant neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ09\u003c/td\u003e\n              \u003ctd\u003eEncounter for follow-up examination after completed treatment for conditions other than malignant neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.10\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of intestinal tract, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of colon\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.13\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of respiratory organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening mammogram for malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.39\u003c/td\u003e\n              \u003ctd\u003eEncounter for other screening for malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of cervix\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.72\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of vagina\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.73\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of other genitourinary organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm of other sites\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ12.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for malignant neoplasm, site unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for diabetes mellitus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for nutritional disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.220\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for lipoid disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.228\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other metabolic disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.29\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other suspected endocrine disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for eye and ear disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for cardiovascular disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.71\u003c/td\u003e\n              \u003ctd\u003eEncounter for nonprocreative screening for genetic disease carrier status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.79\u003c/td\u003e\n              \u003ctd\u003eEncounter for other screening for genetic and chromosomal anomalies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for upper gastrointestinal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for lower gastrointestinal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.818\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other digestive system disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.820\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for osteoporosis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.828\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other musculoskeletal disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for respiratory disorder NEC\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for dental disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.850\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for traumatic brain injury\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.858\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other nervous system disorders\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.88\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for disorder due to exposure to contaminants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening for other disorder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ13.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for screening, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for pregnancy test, result unknown\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for pregnancy test, result negative\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for childbirth instruction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ32.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for childcare instruction\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening of mother\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for chromosomal anomalies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for raised alphafetoprotein level\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for other antenatal screening follow-up\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.3\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for malformations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.4\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal growth retardation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for isoimmunization\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for hydrops fetalis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for nuchal translucency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for fetal screening for congenital cardiac abnormalities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.84\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal lung maturity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.85\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for Streptococcus B\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.86\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for cervical length\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.87\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for uncertain dates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.88\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for fetal macrosomia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified antenatal screening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.8A\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening for other genetic defects\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ36.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for antenatal screening, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ42.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for breast reconstruction following mastectomy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ42.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for other plastic and reconstructive surgery following medical procedure or healed injury\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ43.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for attention to other artificial openings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ43.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for attention to unspecified artificial opening\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.001\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified right artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.002\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified left artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.009\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.011\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete right artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.012\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete left artificial arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.019\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.021\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial right arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.022\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial left arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.029\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial arm, unspecified arm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.101\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified right artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.102\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified left artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.109\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.111\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete right artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.112\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete left artificial leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.119\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of complete artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.121\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial right leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.122\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial left leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.129\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of partial artificial leg, unspecified leg\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.30\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external breast prosthesis, unspecified breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external right breast prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.32\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of external left breast prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.8\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of other external prosthetic devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ44.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified external prosthetic device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.010\u003c/td\u003e\n              \u003ctd\u003eEncounter for checking and testing of cardiac pacemaker pulse generator [battery]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.018\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other part of cardiac pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of automatic implantable cardiac defibrillator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.09\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other cardiac device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of infusion pump\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of vascular access device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.31\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of implanted visual substitution device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.320\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of bone conduction device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.321\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of cochlear device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.328\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted hearing device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.41\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of cerebrospinal fluid drainage device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.42\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of neurostimulator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.49\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted nervous system device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of right breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of left breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.819\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of unspecified breast implant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment or removal of myringotomy device (stent) (tube)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of other implanted devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ45.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for adjustment and management of unspecified implanted device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of non-vascular catheter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of other specified devices\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ46.9\u003c/td\u003e\n              \u003ctd\u003eEncounter for fitting and adjustment of unspecified device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.1\u003c/td\u003e\n              \u003ctd\u003eAftercare following joint replacement surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for removal of internal fixation device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.31\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of shoulder joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.32\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of hip joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.33\u003c/td\u003e\n              \u003ctd\u003eAftercare following explantation of knee joint prosthesis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for orthopedic aftercare following surgical amputation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for orthopedic aftercare following scoliosis surgery\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ47.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other orthopedic aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.00\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of nonsurgical wound dressing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.01\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of surgical wound dressing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.02\u003c/td\u003e\n              \u003ctd\u003eEncounter for removal of sutures\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.03\u003c/td\u003e\n              \u003ctd\u003eEncounter for change or removal of drains\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for planned postprocedural wound closure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.21\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following heart transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.22\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following kidney transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.23\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following liver transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.24\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following lung transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.280\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following heart-lung transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.288\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following multiple organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.290\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following bone marrow transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.298\u003c/td\u003e\n              \u003ctd\u003eEncounter for aftercare following other organ transplant\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.3\u003c/td\u003e\n              \u003ctd\u003eAftercare following surgery for neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.810\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the sense organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.811\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the nervous system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.812\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.813\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the respiratory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.814\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the teeth or oral cavity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.815\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the digestive system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.816\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the genitourinary system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.817\u003c/td\u003e\n              \u003ctd\u003eEncounter for surgical aftercare following surgery on the skin and subcutaneous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ48.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified surgical aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic radiation therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic chemotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for antineoplastic immunotherapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.5\u003c/td\u003e\n              \u003ctd\u003eEncounter for palliative care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.6\u003c/td\u003e\n              \u003ctd\u003eEncounter for desensitization to allergens\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for therapeutic drug level monitoring\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ51.89\u003c/td\u003e\n              \u003ctd\u003eEncounter for other specified aftercare\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.0\u003c/td\u003e\n              \u003ctd\u003eIlliteracy and low-level literacy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.1\u003c/td\u003e\n              \u003ctd\u003eSchooling unavailable and unattainable\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.2\u003c/td\u003e\n              \u003ctd\u003eFailed school examinations\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.3\u003c/td\u003e\n              \u003ctd\u003eUnderachievement in school\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.4\u003c/td\u003e\n              \u003ctd\u003eEducational maladjustment and discord with teachers and classmates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to education and literacy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ55.9\u003c/td\u003e\n              \u003ctd\u003eProblems related to education and literacy, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.0\u003c/td\u003e\n              \u003ctd\u003eUnemployment, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.1\u003c/td\u003e\n              \u003ctd\u003eChange of job\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.2\u003c/td\u003e\n              \u003ctd\u003eThreat of job loss\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.3\u003c/td\u003e\n              \u003ctd\u003eStressful work schedule\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.4\u003c/td\u003e\n              \u003ctd\u003eDiscord with boss and workmates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.5\u003c/td\u003e\n              \u003ctd\u003eUncongenial work environment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.6\u003c/td\u003e\n              \u003ctd\u003eOther physical and mental strain related to work\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.81\u003c/td\u003e\n              \u003ctd\u003eSexual harassment on the job\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.82\u003c/td\u003e\n              \u003ctd\u003eMilitary deployment status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.89\u003c/td\u003e\n              \u003ctd\u003eOther problems related to employment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ56.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified problems related to employment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.0\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to noise\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.1\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to radiation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.2\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to dust\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.31\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to environmental tobacco smoke\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.39\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to other air contaminants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.4\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to toxic agents in agriculture\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.5\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to toxic agents in other industries\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.6\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to extreme temperature\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.7\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to vibration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.8\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to other risk factors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ57.9\u003c/td\u003e\n              \u003ctd\u003eOccupational exposure to unspecified risk factor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.0\u003c/td\u003e\n              \u003ctd\u003eHomelessness\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.1\u003c/td\u003e\n              \u003ctd\u003eInadequate housing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.2\u003c/td\u003e\n              \u003ctd\u003eDiscord with neighbors, lodgers and landlord\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.3\u003c/td\u003e\n              \u003ctd\u003eProblems related to living in residential institution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.4\u003c/td\u003e\n              \u003ctd\u003eLack of adequate food and safe drinking water\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.5\u003c/td\u003e\n              \u003ctd\u003eExtreme poverty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.6\u003c/td\u003e\n              \u003ctd\u003eLow income\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.7\u003c/td\u003e\n              \u003ctd\u003eInsufficient social insurance and welfare support\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to housing and economic circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ59.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to housing and economic circumstances, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.0\u003c/td\u003e\n              \u003ctd\u003eProblems of adjustment to life-cycle transitions\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.2\u003c/td\u003e\n              \u003ctd\u003eProblems related to living alone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.3\u003c/td\u003e\n              \u003ctd\u003eAcculturation difficulty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.4\u003c/td\u003e\n              \u003ctd\u003eSocial exclusion and rejection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.5\u003c/td\u003e\n              \u003ctd\u003eTarget of (perceived) adverse discrimination and persecution\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to social environment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ60.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to social environment, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.0\u003c/td\u003e\n              \u003ctd\u003eInadequate parental supervision and control\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.1\u003c/td\u003e\n              \u003ctd\u003eParental overprotection\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.21\u003c/td\u003e\n              \u003ctd\u003eChild in welfare custody\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.22\u003c/td\u003e\n              \u003ctd\u003eInstitutional upbringing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.29\u003c/td\u003e\n              \u003ctd\u003eOther upbringing away from parents\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.3\u003c/td\u003e\n              \u003ctd\u003eHostility towards and scapegoating of child\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.6\u003c/td\u003e\n              \u003ctd\u003eInappropriate (excessive) parental pressure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.810\u003c/td\u003e\n              \u003ctd\u003ePersonal history of physical and sexual abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.811\u003c/td\u003e\n              \u003ctd\u003ePersonal history of psychological abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.812\u003c/td\u003e\n              \u003ctd\u003ePersonal history of neglect in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.813\u003c/td\u003e\n              \u003ctd\u003ePersonal history of forced labor or sexual exploitation in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.819\u003c/td\u003e\n              \u003ctd\u003ePersonal history of unspecified abuse in childhood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.820\u003c/td\u003e\n              \u003ctd\u003eParent-biological child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.821\u003c/td\u003e\n              \u003ctd\u003eParent-adopted child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.822\u003c/td\u003e\n              \u003ctd\u003eParent-foster child conflict\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.890\u003c/td\u003e\n              \u003ctd\u003eParent-child estrangement NEC\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.891\u003c/td\u003e\n              \u003ctd\u003eSibling rivalry\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.898\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to upbringing\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ62.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to upbringing, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.0\u003c/td\u003e\n              \u003ctd\u003eProblems in relationship with spouse or partner\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.1\u003c/td\u003e\n              \u003ctd\u003eProblems in relationship with in-laws\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.31\u003c/td\u003e\n              \u003ctd\u003eAbsence of family member due to military deployment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.32\u003c/td\u003e\n              \u003ctd\u003eOther absence of family member\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.4\u003c/td\u003e\n              \u003ctd\u003eDisappearance and death of family member\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.5\u003c/td\u003e\n              \u003ctd\u003eDisruption of family by separation and divorce\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.6\u003c/td\u003e\n              \u003ctd\u003eDependent relative needing care at home\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.71\u003c/td\u003e\n              \u003ctd\u003eStress on family due to return of family member from military deployment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.72\u003c/td\u003e\n              \u003ctd\u003eAlcoholism and drug addiction in family\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.79\u003c/td\u003e\n              \u003ctd\u003eOther stressful life events affecting family and household\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.8\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to primary support group\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ63.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to primary support group, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.0\u003c/td\u003e\n              \u003ctd\u003eProblems related to unwanted pregnancy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.1\u003c/td\u003e\n              \u003ctd\u003eProblems related to multiparity\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ64.4\u003c/td\u003e\n              \u003ctd\u003eDiscord with counselors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.0\u003c/td\u003e\n              \u003ctd\u003eConviction in civil and criminal proceedings without imprisonment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.1\u003c/td\u003e\n              \u003ctd\u003eImprisonment and other incarceration\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.2\u003c/td\u003e\n              \u003ctd\u003eProblems related to release from prison\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.3\u003c/td\u003e\n              \u003ctd\u003eProblems related to other legal circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.4\u003c/td\u003e\n              \u003ctd\u003eVictim of crime and terrorism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.5\u003c/td\u003e\n              \u003ctd\u003eExposure to disaster, war and other hostilities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.8\u003c/td\u003e\n              \u003ctd\u003eOther specified problems related to psychosocial circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ65.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to unspecified psychosocial circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.010\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.011\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.020\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of non-parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.021\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of non-parental child abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.11\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of spousal or partner abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.12\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of spousal or partner abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.81\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for victim of other abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ69.82\u003c/td\u003e\n              \u003ctd\u003eEncounter for mental health services for perpetrator of other abuse\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.0\u003c/td\u003e\n              \u003ctd\u003eCounseling related to sexual attitude\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.1\u003c/td\u003e\n              \u003ctd\u003eCounseling related to patient\u0027s sexual behavior and orientation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.2\u003c/td\u003e\n              \u003ctd\u003eCounseling related to sexual behavior and orientation of third party\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.3\u003c/td\u003e\n              \u003ctd\u003eCounseling related to combined concerns regarding sexual attitude, behavior and orientation\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.8\u003c/td\u003e\n              \u003ctd\u003eOther sex counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ70.9\u003c/td\u003e\n              \u003ctd\u003eSex counseling, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.0\u003c/td\u003e\n              \u003ctd\u003ePerson encountering health services to consult on behalf of another person\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.1\u003c/td\u003e\n              \u003ctd\u003ePerson with feared health complaint in whom no diagnosis is made\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.2\u003c/td\u003e\n              \u003ctd\u003ePerson consulting for explanation of examination or test findings\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.3\u003c/td\u003e\n              \u003ctd\u003eDietary counseling and surveillance\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.41\u003c/td\u003e\n              \u003ctd\u003eAlcohol abuse counseling and surveillance of alcoholic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.42\u003c/td\u003e\n              \u003ctd\u003eCounseling for family member of alcoholic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.51\u003c/td\u003e\n              \u003ctd\u003eDrug abuse counseling and surveillance of drug abuser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.52\u003c/td\u003e\n              \u003ctd\u003eCounseling for family member of drug abuser\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.6\u003c/td\u003e\n              \u003ctd\u003eTobacco abuse counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.7\u003c/td\u003e\n              \u003ctd\u003eHuman immunodeficiency virus [HIV] counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.81\u003c/td\u003e\n              \u003ctd\u003eSpiritual or religious counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.82\u003c/td\u003e\n              \u003ctd\u003eExercise counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.83\u003c/td\u003e\n              \u003ctd\u003eEncounter for nonprocreative genetic counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.89\u003c/td\u003e\n              \u003ctd\u003eOther specified counseling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ71.9\u003c/td\u003e\n              \u003ctd\u003eCounseling, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.0\u003c/td\u003e\n              \u003ctd\u003eBurn-out\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.1\u003c/td\u003e\n              \u003ctd\u003eType A behavior pattern\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.2\u003c/td\u003e\n              \u003ctd\u003eLack of relaxation and leisure\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.3\u003c/td\u003e\n              \u003ctd\u003eStress, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.4\u003c/td\u003e\n              \u003ctd\u003eInadequate social skills, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.5\u003c/td\u003e\n              \u003ctd\u003eSocial role conflict, not elsewhere classified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.6\u003c/td\u003e\n              \u003ctd\u003eLimitation of activities due to disability\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.810\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, sleep-onset association type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.811\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, limit setting type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.812\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, combined type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.819\u003c/td\u003e\n              \u003ctd\u003eBehavioral insomnia of childhood, unspecified type\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.89\u003c/td\u003e\n              \u003ctd\u003eOther problems related to life management difficulty\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ73.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to life management difficulty, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.01\u003c/td\u003e\n              \u003ctd\u003eBed confinement status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.09\u003c/td\u003e\n              \u003ctd\u003eOther reduced mobility\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.1\u003c/td\u003e\n              \u003ctd\u003eNeed for assistance with personal care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.2\u003c/td\u003e\n              \u003ctd\u003eNeed for assistance at home and no other household member able to render care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.3\u003c/td\u003e\n              \u003ctd\u003eNeed for continuous supervision\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to care provider dependency\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ74.9\u003c/td\u003e\n              \u003ctd\u003eProblem related to care provider dependency, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.0\u003c/td\u003e\n              \u003ctd\u003eMedical services not available in home\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.1\u003c/td\u003e\n              \u003ctd\u003ePerson awaiting admission to adequate facility elsewhere\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.2\u003c/td\u003e\n              \u003ctd\u003eOther waiting period for investigation and treatment\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.3\u003c/td\u003e\n              \u003ctd\u003eUnavailability and inaccessibility of health-care facilities\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.4\u003c/td\u003e\n              \u003ctd\u003eUnavailability and inaccessibility of other helping agencies\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.5\u003c/td\u003e\n              \u003ctd\u003eHoliday relief care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.8\u003c/td\u003e\n              \u003ctd\u003eOther problems related to medical facilities and other health care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ75.9\u003c/td\u003e\n              \u003ctd\u003eUnspecified problem related to medical facilities and other health care\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.0\u003c/td\u003e\n              \u003ctd\u003eEncounter for issue of repeat prescription\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.1\u003c/td\u003e\n              \u003ctd\u003eEncounter for health supervision and care of foundling\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.2\u003c/td\u003e\n              \u003ctd\u003eEncounter for health supervision and care of other healthy infant and child\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.3\u003c/td\u003e\n              \u003ctd\u003eHealthy person accompanying sick person\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.4\u003c/td\u003e\n              \u003ctd\u003eOther boarder to healthcare facility\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.5\u003c/td\u003e\n              \u003ctd\u003eMalingerer [conscious simulation]\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.81\u003c/td\u003e\n              \u003ctd\u003eExpectant parent(s) prebirth pediatrician visit\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ76.89\u003c/td\u003e\n              \u003ctd\u003ePersons encountering health services in other specified circumstances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.01\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of anticoagulants\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.02\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of antithrombotics/antiplatelets\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.1\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of non-steroidal anti-inflammatories (NSAID)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.2\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of antibiotics\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.3\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of hormonal contraceptives\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.4\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of insulin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.51\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of inhaled steroids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.52\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of systemic steroids\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.810\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of selective estrogen receptor modulators (SERMs)\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.811\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of aromatase inhibitors\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.818\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of other agents affecting estrogen receptors and estrogen levels\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.82\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of aspirin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.83\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of bisphosphonates\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.84\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of oral hypoglycemic drugs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.891\u003c/td\u003e\n              \u003ctd\u003eLong term (current) use of opiate analgesic\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ79.899\u003c/td\u003e\n              \u003ctd\u003eOther long term (current) drug therapy\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.00\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified digestive organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.01\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of esophagus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.020\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.028\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of stomach\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.030\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.038\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of large intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.040\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of rectum\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.048\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.05\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of liver\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.060\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.068\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of small intestine\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.07\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of pancreas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.09\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other digestive organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.110\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.118\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of bronchus and lung\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.12\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of trachea\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.20\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified respiratory organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.21\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of larynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.22\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.230\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.238\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of thymus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.29\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other respiratory and intrathoracic organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.3\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.40\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified female genital organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.41\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.42\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other parts of uterus\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.43\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of ovary\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.44\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other female genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.45\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified male genital organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.46\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of prostate\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.47\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of testis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.48\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of epididymis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.49\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other male genital organs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.50\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified urinary tract organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.51\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of bladder\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.520\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant carcinoid tumor of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.528\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of kidney\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.53\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of renal pelvis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.54\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of ureter\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.59\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other urinary tract organ\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.6\u003c/td\u003e\n              \u003ctd\u003ePersonal history of leukemia\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.71\u003c/td\u003e\n              \u003ctd\u003ePersonal history of Hodgkin lymphoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.72\u003c/td\u003e\n              \u003ctd\u003ePersonal history of non-Hodgkin lymphomas\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.79\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.810\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of tongue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.818\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.819\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.820\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant melanoma of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.821\u003c/td\u003e\n              \u003ctd\u003ePersonal history of Merkel cell carcinoma\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.828\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other malignant neoplasm of skin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.830\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of bone\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.831\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of soft tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.840\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of eye\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.841\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of brain\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.848\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other parts of nervous tissue\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.850\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of thyroid\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.858\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other endocrine glands\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.89\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm of other organs and systems\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ85.9\u003c/td\u003e\n              \u003ctd\u003ePersonal history of malignant neoplasm, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.000\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of breast\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.001\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of cervix uteri\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.008\u003c/td\u003e\n              \u003ctd\u003ePersonal history of in-situ neoplasm of other site\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.010\u003c/td\u003e\n              \u003ctd\u003ePersonal history of colonic polyps\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.012\u003c/td\u003e\n              \u003ctd\u003ePersonal history of benign carcinoid tumor\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.018\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other benign neoplasm\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.03\u003c/td\u003e\n              \u003ctd\u003ePersonal history of neoplasm of uncertain behavior\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.711\u003c/td\u003e\n              \u003ctd\u003ePersonal history of pulmonary embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.718\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other venous thrombosis and embolism\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.72\u003c/td\u003e\n              \u003ctd\u003ePersonal history of thrombophlebitis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.73\u003c/td\u003e\n              \u003ctd\u003ePersonal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.74\u003c/td\u003e\n              \u003ctd\u003ePersonal history of sudden cardiac arrest\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ86.79\u003c/td\u003e\n              \u003ctd\u003ePersonal history of other diseases of the circulatory system\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ87.892\u003c/td\u003e\n              \u003ctd\u003ePersonal history of anaphylaxis\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.0\u003c/td\u003e\n              \u003ctd\u003eAllergy status to penicillin\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.1\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other antibiotic agents status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.2\u003c/td\u003e\n              \u003ctd\u003eAllergy status to sulfonamides status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.3\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other anti-infective agents status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.4\u003c/td\u003e\n              \u003ctd\u003eAllergy status to anesthetic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.5\u003c/td\u003e\n              \u003ctd\u003eAllergy status to narcotic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.6\u003c/td\u003e\n              \u003ctd\u003eAllergy status to analgesic agent status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.7\u003c/td\u003e\n              \u003ctd\u003eAllergy status to serum and vaccine status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.8\u003c/td\u003e\n              \u003ctd\u003eAllergy status to other drugs, medicaments and biological substances status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ88.9\u003c/td\u003e\n              \u003ctd\u003eAllergy status to unspecified drugs, medicaments and biological substances status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.010\u003c/td\u003e\n              \u003ctd\u003eAllergy to peanuts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.011\u003c/td\u003e\n              \u003ctd\u003eAllergy to milk products\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.012\u003c/td\u003e\n              \u003ctd\u003eAllergy to eggs\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.013\u003c/td\u003e\n              \u003ctd\u003eAllergy to seafood\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.018\u003c/td\u003e\n              \u003ctd\u003eAllergy to other foods\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.02\u003c/td\u003e\n              \u003ctd\u003eFood additives allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.030\u003c/td\u003e\n              \u003ctd\u003eBee allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.038\u003c/td\u003e\n              \u003ctd\u003eOther insect allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.040\u003c/td\u003e\n              \u003ctd\u003eLatex allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.041\u003c/td\u003e\n              \u003ctd\u003eRadiographic dye allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.048\u003c/td\u003e\n              \u003ctd\u003eOther nonmedicinal substance allergy status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ91.09\u003c/td\u003e\n              \u003ctd\u003eOther allergy status, other than to drugs and biological substances\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ94.1\u003c/td\u003e\n              \u003ctd\u003eHeart transplant status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ94.3\u003c/td\u003e\n              \u003ctd\u003eHeart and lungs transplant status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.0\u003c/td\u003e\n              \u003ctd\u003ePresence of cardiac pacemaker\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.1\u003c/td\u003e\n              \u003ctd\u003ePresence of aortocoronary bypass graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.2\u003c/td\u003e\n              \u003ctd\u003ePresence of prosthetic heart valve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.3\u003c/td\u003e\n              \u003ctd\u003ePresence of xenogenic heart valve\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.4\u003c/td\u003e\n              \u003ctd\u003ePresence of other heart-valve replacement\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.5\u003c/td\u003e\n              \u003ctd\u003ePresence of coronary angioplasty implant and graft\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.810\u003c/td\u003e\n              \u003ctd\u003ePresence of automatic (implantable) cardiac defibrillator\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.811\u003c/td\u003e\n              \u003ctd\u003ePresence of heart assist device\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.812\u003c/td\u003e\n              \u003ctd\u003ePresence of fully implantable artificial heart\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.818\u003c/td\u003e\n              \u003ctd\u003ePresence of other cardiac implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.820\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular angioplasty status with implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.828\u003c/td\u003e\n              \u003ctd\u003ePresence of other vascular implants and grafts\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ95.9\u003c/td\u003e\n              \u003ctd\u003ePresence of cardiac and vascular implant and graft, unspecified\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ98.61\u003c/td\u003e\n              \u003ctd\u003eCoronary angioplasty status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n            \u003ctr\u003e\n              \u003ctd\u003eZ98.62\u003c/td\u003e\n              \u003ctd\u003ePeripheral vascular angioplasty status\u003c/td\u003e\n              \u003ctd/\u003e\n            \u003c/tr\u003e\n          \u003c/table\u003e\n        \u003c/li\u003e\n      \u003c/ul\u003e\n    \u003c/div\u003e"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1182.311","version":"20191111","name":"Complications of Care","status":"active","date":"2019-11-11T01:00:18-05:00","publisher":"Change Healthcare Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"A36.81","display":"Diphtheritic cardiomyopathy"},{"code":"A38.1","display":"Scarlet fever with myocarditis"},{"code":"A39.50","display":"Meningococcal carditis, unspecified"},{"code":"A39.51","display":"Meningococcal endocarditis"},{"code":"A39.52","display":"Meningococcal myocarditis"},{"code":"A39.53","display":"Meningococcal pericarditis"},{"code":"B26.82","display":"Mumps myocarditis"},{"code":"B33.20","display":"Viral carditis, unspecified"},{"code":"B33.21","display":"Viral endocarditis"},{"code":"B33.22","display":"Viral myocarditis"},{"code":"B33.23","display":"Viral pericarditis"},{"code":"B33.24","display":"Viral cardiomyopathy"},{"code":"B37.6","display":"Candidal endocarditis"},{"code":"B44.81","display":"Allergic bronchopulmonary aspergillosis"},{"code":"B58.81","display":"Toxoplasma myocarditis"},{"code":"C00.0","display":"Malignant neoplasm of external upper lip"},{"code":"C00.1","display":"Malignant neoplasm of external lower lip"},{"code":"C00.2","display":"Malignant neoplasm of external lip, unspecified"},{"code":"C00.3","display":"Malignant neoplasm of upper lip, inner aspect"},{"code":"C00.4","display":"Malignant neoplasm of lower lip, inner aspect"},{"code":"C00.5","display":"Malignant neoplasm of lip, unspecified, inner aspect"},{"code":"C00.6","display":"Malignant neoplasm of commissure of lip, unspecified"},{"code":"C00.8","display":"Malignant neoplasm of overlapping sites of lip"},{"code":"C00.9","display":"Malignant neoplasm of lip, unspecified"},{"code":"C01","display":"Malignant neoplasm of base of tongue"},{"code":"C02.0","display":"Malignant neoplasm of dorsal surface of tongue"},{"code":"C02.1","display":"Malignant neoplasm of border of tongue"},{"code":"C02.2","display":"Malignant neoplasm of ventral surface of tongue"},{"code":"C02.3","display":"Malignant neoplasm of anterior two-thirds of tongue, part unspecified"},{"code":"C02.4","display":"Malignant neoplasm of lingual tonsil"},{"code":"C02.8","display":"Malignant neoplasm of overlapping sites of tongue"},{"code":"C02.9","display":"Malignant neoplasm of tongue, unspecified"},{"code":"C03.0","display":"Malignant neoplasm of upper gum"},{"code":"C03.1","display":"Malignant neoplasm of lower gum"},{"code":"C03.9","display":"Malignant neoplasm of gum, unspecified"},{"code":"C04.0","display":"Malignant neoplasm of anterior floor of mouth"},{"code":"C04.1","display":"Malignant neoplasm of lateral floor of mouth"},{"code":"C04.8","display":"Malignant neoplasm of overlapping sites of floor of mouth"},{"code":"C04.9","display":"Malignant neoplasm of floor of mouth, unspecified"},{"code":"C05.0","display":"Malignant neoplasm of hard palate"},{"code":"C05.1","display":"Malignant neoplasm of soft palate"},{"code":"C05.2","display":"Malignant neoplasm of uvula"},{"code":"C05.8","display":"Malignant neoplasm of overlapping sites of palate"},{"code":"C05.9","display":"Malignant neoplasm of palate, unspecified"},{"code":"C06.0","display":"Malignant neoplasm of cheek mucosa"},{"code":"C06.1","display":"Malignant neoplasm of vestibule of mouth"},{"code":"C06.2","display":"Malignant neoplasm of retromolar area"},{"code":"C06.80","display":"Malignant neoplasm of overlapping sites of unspecified parts of mouth"},{"code":"C06.89","display":"Malignant neoplasm of overlapping sites of other parts of mouth"},{"code":"C06.9","display":"Malignant neoplasm of mouth, unspecified"},{"code":"C07","display":"Malignant neoplasm of parotid gland"},{"code":"C08.0","display":"Malignant neoplasm of submandibular gland"},{"code":"C08.1","display":"Malignant neoplasm of sublingual gland"},{"code":"C08.9","display":"Malignant neoplasm of major salivary gland, unspecified"},{"code":"C09.0","display":"Malignant neoplasm of tonsillar fossa"},{"code":"C09.1","display":"Malignant neoplasm of tonsillar pillar (anterior) (posterior)"},{"code":"C09.8","display":"Malignant neoplasm of overlapping sites of tonsil"},{"code":"C09.9","display":"Malignant neoplasm of tonsil, unspecified"},{"code":"C10.0","display":"Malignant neoplasm of vallecula"},{"code":"C10.1","display":"Malignant neoplasm of anterior surface of epiglottis"},{"code":"C10.2","display":"Malignant neoplasm of lateral wall of oropharynx"},{"code":"C10.3","display":"Malignant neoplasm of posterior wall of oropharynx"},{"code":"C10.4","display":"Malignant neoplasm of branchial cleft"},{"code":"C10.8","display":"Malignant neoplasm of overlapping sites of oropharynx"},{"code":"C10.9","display":"Malignant neoplasm of oropharynx, unspecified"},{"code":"C11.0","display":"Malignant neoplasm of superior wall of nasopharynx"},{"code":"C11.1","display":"Malignant neoplasm of posterior wall of nasopharynx"},{"code":"C11.2","display":"Malignant neoplasm of lateral wall of nasopharynx"},{"code":"C11.3","display":"Malignant neoplasm of anterior wall of nasopharynx"},{"code":"C11.8","display":"Malignant neoplasm of overlapping sites of nasopharynx"},{"code":"C11.9","display":"Malignant neoplasm of nasopharynx, unspecified"},{"code":"C12","display":"Malignant neoplasm of pyriform sinus"},{"code":"C13.0","display":"Malignant neoplasm of postcricoid region"},{"code":"C13.1","display":"Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect"},{"code":"C13.2","display":"Malignant neoplasm of posterior wall of hypopharynx"},{"code":"C13.8","display":"Malignant neoplasm of overlapping sites of hypopharynx"},{"code":"C13.9","display":"Malignant neoplasm of hypopharynx, unspecified"},{"code":"C14.0","display":"Malignant neoplasm of pharynx, unspecified"},{"code":"C14.2","display":"Malignant neoplasm of Waldeyer\u0027s ring"},{"code":"C14.8","display":"Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx"},{"code":"C15.3","display":"Malignant neoplasm of upper third of esophagus"},{"code":"C15.4","display":"Malignant neoplasm of middle third of esophagus"},{"code":"C15.5","display":"Malignant neoplasm of lower third of esophagus"},{"code":"C15.8","display":"Malignant neoplasm of overlapping sites of esophagus"},{"code":"C15.9","display":"Malignant neoplasm of esophagus, unspecified"},{"code":"C16.0","display":"Malignant neoplasm of cardia"},{"code":"C16.1","display":"Malignant neoplasm of fundus of stomach"},{"code":"C16.2","display":"Malignant neoplasm of body of stomach"},{"code":"C16.3","display":"Malignant neoplasm of pyloric antrum"},{"code":"C16.4","display":"Malignant neoplasm of pylorus"},{"code":"C16.5","display":"Malignant neoplasm of lesser curvature of stomach, unspecified"},{"code":"C16.6","display":"Malignant neoplasm of greater curvature of stomach, unspecified"},{"code":"C16.8","display":"Malignant neoplasm of overlapping sites of stomach"},{"code":"C16.9","display":"Malignant neoplasm of stomach, unspecified"},{"code":"C17.0","display":"Malignant neoplasm of duodenum"},{"code":"C17.1","display":"Malignant neoplasm of jejunum"},{"code":"C17.2","display":"Malignant neoplasm of ileum"},{"code":"C17.3","display":"Meckel\u0027s diverticulum, malignant"},{"code":"C17.8","display":"Malignant neoplasm of overlapping sites of small intestine"},{"code":"C17.9","display":"Malignant neoplasm of small intestine, unspecified"},{"code":"C18.0","display":"Malignant neoplasm of cecum"},{"code":"C18.1","display":"Malignant neoplasm of appendix"},{"code":"C18.2","display":"Malignant neoplasm of ascending colon"},{"code":"C18.3","display":"Malignant neoplasm of hepatic flexure"},{"code":"C18.4","display":"Malignant neoplasm of transverse colon"},{"code":"C18.5","display":"Malignant neoplasm of splenic flexure"},{"code":"C18.6","display":"Malignant neoplasm of descending colon"},{"code":"C18.7","display":"Malignant neoplasm of sigmoid colon"},{"code":"C18.8","display":"Malignant neoplasm of overlapping sites of colon"},{"code":"C18.9","display":"Malignant neoplasm of colon, unspecified"},{"code":"C19","display":"Malignant neoplasm of rectosigmoid junction"},{"code":"C20","display":"Malignant neoplasm of rectum"},{"code":"C21.0","display":"Malignant neoplasm of anus, unspecified"},{"code":"C21.1","display":"Malignant neoplasm of anal canal"},{"code":"C21.2","display":"Malignant neoplasm of cloacogenic zone"},{"code":"C21.8","display":"Malignant neoplasm of overlapping sites of rectum, anus and anal canal"},{"code":"C22.0","display":"Liver cell carcinoma"},{"code":"C22.1","display":"Intrahepatic bile duct carcinoma"},{"code":"C22.2","display":"Hepatoblastoma"},{"code":"C22.3","display":"Angiosarcoma of liver"},{"code":"C22.4","display":"Other sarcomas of liver"},{"code":"C22.7","display":"Other specified carcinomas of liver"},{"code":"C22.8","display":"Malignant neoplasm of liver, primary, unspecified as to type"},{"code":"C22.9","display":"Malignant neoplasm of liver, not specified as primary or secondary"},{"code":"C23","display":"Malignant neoplasm of gallbladder"},{"code":"C24.0","display":"Malignant neoplasm of extrahepatic bile duct"},{"code":"C24.1","display":"Malignant neoplasm of ampulla of Vater"},{"code":"C24.8","display":"Malignant neoplasm of overlapping sites of biliary tract"},{"code":"C24.9","display":"Malignant neoplasm of biliary tract, unspecified"},{"code":"C25.0","display":"Malignant neoplasm of head of pancreas"},{"code":"C25.1","display":"Malignant neoplasm of body of pancreas"},{"code":"C25.2","display":"Malignant neoplasm of tail of pancreas"},{"code":"C25.3","display":"Malignant neoplasm of pancreatic duct"},{"code":"C25.4","display":"Malignant neoplasm of endocrine pancreas"},{"code":"C25.7","display":"Malignant neoplasm of other parts of pancreas"},{"code":"C25.8","display":"Malignant neoplasm of overlapping sites of pancreas"},{"code":"C25.9","display":"Malignant neoplasm of pancreas, unspecified"},{"code":"C26.0","display":"Malignant neoplasm of intestinal tract, part unspecified"},{"code":"C26.1","display":"Malignant neoplasm of spleen"},{"code":"C26.9","display":"Malignant neoplasm of ill-defined sites within the digestive system"},{"code":"C30.0","display":"Malignant neoplasm of nasal cavity"},{"code":"C30.1","display":"Malignant neoplasm of middle ear"},{"code":"C31.0","display":"Malignant neoplasm of maxillary sinus"},{"code":"C31.1","display":"Malignant neoplasm of ethmoidal sinus"},{"code":"C31.2","display":"Malignant neoplasm of frontal sinus"},{"code":"C31.3","display":"Malignant neoplasm of sphenoid sinus"},{"code":"C31.8","display":"Malignant neoplasm of overlapping sites of accessory sinuses"},{"code":"C31.9","display":"Malignant neoplasm of accessory sinus, unspecified"},{"code":"C32.0","display":"Malignant neoplasm of glottis"},{"code":"C32.1","display":"Malignant neoplasm of supraglottis"},{"code":"C32.2","display":"Malignant neoplasm of subglottis"},{"code":"C32.3","display":"Malignant neoplasm of laryngeal cartilage"},{"code":"C32.8","display":"Malignant neoplasm of overlapping sites of larynx"},{"code":"C32.9","display":"Malignant neoplasm of larynx, unspecified"},{"code":"C33","display":"Malignant neoplasm of trachea"},{"code":"C34.00","display":"Malignant neoplasm of unspecified main bronchus"},{"code":"C34.01","display":"Malignant neoplasm of right main bronchus"},{"code":"C34.02","display":"Malignant neoplasm of left main bronchus"},{"code":"C34.10","display":"Malignant neoplasm of upper lobe, unspecified bronchus or lung"},{"code":"C34.11","display":"Malignant neoplasm of upper lobe, right bronchus or lung"},{"code":"C34.12","display":"Malignant neoplasm of upper lobe, left bronchus or lung"},{"code":"C34.2","display":"Malignant neoplasm of middle lobe, bronchus or lung"},{"code":"C34.30","display":"Malignant neoplasm of lower lobe, unspecified bronchus or lung"},{"code":"C34.31","display":"Malignant neoplasm of lower lobe, right bronchus or lung"},{"code":"C34.32","display":"Malignant neoplasm of lower lobe, left bronchus or lung"},{"code":"C34.80","display":"Malignant neoplasm of overlapping sites of unspecified bronchus and lung"},{"code":"C34.81","display":"Malignant neoplasm of overlapping sites of right bronchus and lung"},{"code":"C34.82","display":"Malignant neoplasm of overlapping sites of left bronchus and lung"},{"code":"C34.90","display":"Malignant neoplasm of unspecified part of unspecified bronchus or lung"},{"code":"C34.91","display":"Malignant neoplasm of unspecified part of right bronchus or lung"},{"code":"C34.92","display":"Malignant neoplasm of unspecified part of left bronchus or lung"},{"code":"C37","display":"Malignant neoplasm of thymus"},{"code":"C38.0","display":"Malignant neoplasm of heart"},{"code":"C38.1","display":"Malignant neoplasm of anterior mediastinum"},{"code":"C38.2","display":"Malignant neoplasm of posterior mediastinum"},{"code":"C38.3","display":"Malignant neoplasm of mediastinum, part unspecified"},{"code":"C38.4","display":"Malignant neoplasm of pleura"},{"code":"C38.8","display":"Malignant neoplasm of overlapping sites of heart, mediastinum and pleura"},{"code":"C39.0","display":"Malignant neoplasm of upper respiratory tract, part unspecified"},{"code":"C39.9","display":"Malignant neoplasm of lower respiratory tract, part unspecified"},{"code":"C40.00","display":"Malignant neoplasm of scapula and long bones of unspecified upper limb"},{"code":"C40.01","display":"Malignant neoplasm of scapula and long bones of right upper limb"},{"code":"C40.02","display":"Malignant neoplasm of scapula and long bones of left upper limb"},{"code":"C40.10","display":"Malignant neoplasm of short bones of unspecified upper limb"},{"code":"C40.11","display":"Malignant neoplasm of short bones of right upper limb"},{"code":"C40.12","display":"Malignant neoplasm of short bones of left upper limb"},{"code":"C40.20","display":"Malignant neoplasm of long bones of unspecified lower limb"},{"code":"C40.21","display":"Malignant neoplasm of long bones of right lower limb"},{"code":"C40.22","display":"Malignant neoplasm of long bones of left lower limb"},{"code":"C40.30","display":"Malignant neoplasm of short bones of unspecified lower limb"},{"code":"C40.31","display":"Malignant neoplasm of short bones of right lower limb"},{"code":"C40.32","display":"Malignant neoplasm of short bones of left lower limb"},{"code":"C40.80","display":"Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb"},{"code":"C40.81","display":"Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb"},{"code":"C40.82","display":"Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb"},{"code":"C40.90","display":"Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb"},{"code":"C40.91","display":"Malignant neoplasm of unspecified bones and articular cartilage of right limb"},{"code":"C40.92","display":"Malignant neoplasm of unspecified bones and articular cartilage of left limb"},{"code":"C41.0","display":"Malignant neoplasm of bones of skull and face"},{"code":"C41.1","display":"Malignant neoplasm of mandible"},{"code":"C41.2","display":"Malignant neoplasm of vertebral column"},{"code":"C41.3","display":"Malignant neoplasm of ribs, sternum and clavicle"},{"code":"C41.4","display":"Malignant neoplasm of pelvic bones, sacrum and coccyx"},{"code":"C41.9","display":"Malignant neoplasm of bone and articular cartilage, unspecified"},{"code":"C43.0","display":"Malignant melanoma of lip"},{"code":"C43.10","display":"Malignant melanoma of unspecified eyelid, including canthus"},{"code":"C43.11","display":"Malignant melanoma of right eyelid, including canthus"},{"code":"C43.111","display":"Malignant melanoma of right upper eyelid, including canthus"},{"code":"C43.112","display":"Malignant melanoma of right lower eyelid, including canthus"},{"code":"C43.12","display":"Malignant melanoma of left eyelid, including canthus"},{"code":"C43.121","display":"Malignant melanoma of left upper eyelid, including canthus"},{"code":"C43.122","display":"Malignant melanoma of left lower eyelid, including canthus"},{"code":"C43.20","display":"Malignant melanoma of unspecified ear and external auricular canal"},{"code":"C43.21","display":"Malignant melanoma of right ear and external auricular canal"},{"code":"C43.22","display":"Malignant melanoma of left ear and external auricular canal"},{"code":"C43.30","display":"Malignant melanoma of unspecified part of face"},{"code":"C43.31","display":"Malignant melanoma of nose"},{"code":"C43.39","display":"Malignant melanoma of other parts of face"},{"code":"C43.4","display":"Malignant melanoma of scalp and neck"},{"code":"C43.51","display":"Malignant melanoma of anal skin"},{"code":"C43.52","display":"Malignant melanoma of skin of breast"},{"code":"C43.59","display":"Malignant melanoma of other part of trunk"},{"code":"C43.60","display":"Malignant melanoma of unspecified upper limb, including shoulder"},{"code":"C43.61","display":"Malignant melanoma of right upper limb, including shoulder"},{"code":"C43.62","display":"Malignant melanoma of left upper limb, including shoulder"},{"code":"C43.70","display":"Malignant melanoma of unspecified lower limb, including hip"},{"code":"C43.71","display":"Malignant melanoma of right lower limb, including hip"},{"code":"C43.72","display":"Malignant melanoma of left lower limb, including hip"},{"code":"C43.8","display":"Malignant melanoma of overlapping sites of skin"},{"code":"C43.9","display":"Malignant melanoma of skin, unspecified"},{"code":"C44.00","display":"Unspecified malignant neoplasm of skin of lip"},{"code":"C44.01","display":"Basal cell carcinoma of skin of lip"},{"code":"C44.02","display":"Squamous cell carcinoma of skin of lip"},{"code":"C44.09","display":"Other specified malignant neoplasm of skin of lip"},{"code":"C44.101","display":"Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus"},{"code":"C44.102","display":"Unspecified malignant neoplasm of skin of right eyelid, including canthus"},{"code":"C44.1021","display":"Unspecified malignant neoplasm of skin of right upper eyelid, including canthus"},{"code":"C44.1022","display":"Unspecified malignant neoplasm of skin of right lower eyelid, including canthus"},{"code":"C44.109","display":"Unspecified malignant neoplasm of skin of left eyelid, including canthus"},{"code":"C44.1091","display":"Unspecified malignant neoplasm of skin of left upper eyelid, including canthus"},{"code":"C44.1092","display":"Unspecified malignant neoplasm of skin of left lower eyelid, including canthus"},{"code":"C44.111","display":"Basal cell carcinoma of skin of unspecified eyelid, including canthus"},{"code":"C44.112","display":"Basal cell carcinoma of skin of right eyelid, including canthus"},{"code":"C44.1121","display":"Basal cell carcinoma of skin of right upper eyelid, including canthus"},{"code":"C44.1122","display":"Basal cell carcinoma of skin of right lower eyelid, including canthus"},{"code":"C44.119","display":"Basal cell carcinoma of skin of left eyelid, including canthus"},{"code":"C44.1191","display":"Basal cell carcinoma of skin of left upper eyelid, including canthus"},{"code":"C44.1192","display":"Basal cell carcinoma of skin of left lower eyelid, including canthus"},{"code":"C44.121","display":"Squamous cell carcinoma of skin of unspecified eyelid, including canthus"},{"code":"C44.122","display":"Squamous cell carcinoma of skin of right eyelid, including canthus"},{"code":"C44.1221","display":"Squamous cell carcinoma of skin of right upper eyelid, including canthus"},{"code":"C44.1222","display":"Squamous cell carcinoma of skin of right lower eyelid, including canthus"},{"code":"C44.129","display":"Squamous cell carcinoma of skin of left eyelid, including canthus"},{"code":"C44.1291","display":"Squamous cell carcinoma of skin of left upper eyelid, including canthus"},{"code":"C44.1292","display":"Squamous cell carcinoma of skin of left lower eyelid, including canthus"},{"code":"C44.131","display":"Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus"},{"code":"C44.1321","display":"Sebaceous cell carcinoma of skin of right upper eyelid, including canthus"},{"code":"C44.1322","display":"Sebaceous cell carcinoma of skin of right lower eyelid, including canthus"},{"code":"C44.1391","display":"Sebaceous cell carcinoma of skin of left upper eyelid, including canthus"},{"code":"C44.1392","display":"Sebaceous cell carcinoma of skin of left lower eyelid, including canthus"},{"code":"C44.191","display":"Other specified malignant neoplasm of skin of unspecified eyelid, including canthus"},{"code":"C44.192","display":"Other specified malignant neoplasm of skin of right eyelid, including canthus"},{"code":"C44.1921","display":"Other specified malignant neoplasm of skin of right upper eyelid, including canthus"},{"code":"C44.1922","display":"Other specified malignant neoplasm of skin of right lower eyelid, including canthus"},{"code":"C44.199","display":"Other specified malignant neoplasm of skin of left eyelid, including canthus"},{"code":"C44.1991","display":"Other specified malignant neoplasm of skin of left upper eyelid, including canthus"},{"code":"C44.1992","display":"Other specified malignant neoplasm of skin of left lower eyelid, including canthus"},{"code":"C44.201","display":"Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal"},{"code":"C44.202","display":"Unspecified malignant neoplasm of skin of right ear and external auricular canal"},{"code":"C44.209","display":"Unspecified malignant neoplasm of skin of left ear and external auricular canal"},{"code":"C44.211","display":"Basal cell carcinoma of skin of unspecified ear and external auricular canal"},{"code":"C44.212","display":"Basal cell carcinoma of skin of right ear and external auricular canal"},{"code":"C44.219","display":"Basal cell carcinoma of skin of left ear and external auricular canal"},{"code":"C44.221","display":"Squamous cell carcinoma of skin of unspecified ear and external auricular canal"},{"code":"C44.222","display":"Squamous cell carcinoma of skin of right ear and external auricular canal"},{"code":"C44.229","display":"Squamous cell carcinoma of skin of left ear and external auricular canal"},{"code":"C44.291","display":"Other specified malignant neoplasm of skin of unspecified ear and external auricular canal"},{"code":"C44.292","display":"Other specified malignant neoplasm of skin of right ear and external auricular canal"},{"code":"C44.299","display":"Other specified malignant neoplasm of skin of left ear and external auricular canal"},{"code":"C44.300","display":"Unspecified malignant neoplasm of skin of unspecified part of face"},{"code":"C44.301","display":"Unspecified malignant neoplasm of skin of nose"},{"code":"C44.309","display":"Unspecified malignant neoplasm of skin of other parts of face"},{"code":"C44.310","display":"Basal cell carcinoma of skin of unspecified parts of face"},{"code":"C44.311","display":"Basal cell carcinoma of skin of nose"},{"code":"C44.319","display":"Basal cell carcinoma of skin of other parts of face"},{"code":"C44.320","display":"Squamous cell carcinoma of skin of unspecified parts of face"},{"code":"C44.321","display":"Squamous cell carcinoma of skin of nose"},{"code":"C44.329","display":"Squamous cell carcinoma of skin of other parts of face"},{"code":"C44.390","display":"Other specified malignant neoplasm of skin of unspecified parts of face"},{"code":"C44.391","display":"Other specified malignant neoplasm of skin of nose"},{"code":"C44.399","display":"Other specified malignant neoplasm of skin of other parts of face"},{"code":"C44.40","display":"Unspecified malignant neoplasm of skin of scalp and neck"},{"code":"C44.41","display":"Basal cell carcinoma of skin of scalp and neck"},{"code":"C44.42","display":"Squamous cell carcinoma of skin of scalp and neck"},{"code":"C44.49","display":"Other specified malignant neoplasm of skin of scalp and neck"},{"code":"C44.500","display":"Unspecified malignant neoplasm of anal skin"},{"code":"C44.501","display":"Unspecified malignant neoplasm of skin of breast"},{"code":"C44.509","display":"Unspecified malignant neoplasm of skin of other part of trunk"},{"code":"C44.510","display":"Basal cell carcinoma of anal skin"},{"code":"C44.511","display":"Basal cell carcinoma of skin of breast"},{"code":"C44.519","display":"Basal cell carcinoma of skin of other part of trunk"},{"code":"C44.520","display":"Squamous cell carcinoma of anal skin"},{"code":"C44.521","display":"Squamous cell carcinoma of skin of breast"},{"code":"C44.529","display":"Squamous cell carcinoma of skin of other part of trunk"},{"code":"C44.590","display":"Other specified malignant neoplasm of anal skin"},{"code":"C44.591","display":"Other specified malignant neoplasm of skin of breast"},{"code":"C44.599","display":"Other specified malignant neoplasm of skin of other part of trunk"},{"code":"C44.601","display":"Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder"},{"code":"C44.602","display":"Unspecified malignant neoplasm of skin of right upper limb, including shoulder"},{"code":"C44.609","display":"Unspecified malignant neoplasm of skin of left upper limb, including shoulder"},{"code":"C44.611","display":"Basal cell carcinoma of skin of unspecified upper limb, including shoulder"},{"code":"C44.612","display":"Basal cell carcinoma of skin of right upper limb, including shoulder"},{"code":"C44.619","display":"Basal cell carcinoma of skin of left upper limb, including shoulder"},{"code":"C44.621","display":"Squamous cell carcinoma of skin of unspecified upper limb, including shoulder"},{"code":"C44.622","display":"Squamous cell carcinoma of skin of right upper limb, including shoulder"},{"code":"C44.629","display":"Squamous cell carcinoma of skin of left upper limb, including shoulder"},{"code":"C44.691","display":"Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder"},{"code":"C44.692","display":"Other specified malignant neoplasm of skin of right upper limb, including shoulder"},{"code":"C44.699","display":"Other specified malignant neoplasm of skin of left upper limb, including shoulder"},{"code":"C44.701","display":"Unspecified malignant neoplasm of skin of unspecified lower limb, including hip"},{"code":"C44.702","display":"Unspecified malignant neoplasm of skin of right lower limb, including hip"},{"code":"C44.709","display":"Unspecified malignant neoplasm of skin of left lower limb, including hip"},{"code":"C44.711","display":"Basal cell carcinoma of skin of unspecified lower limb, including hip"},{"code":"C44.712","display":"Basal cell carcinoma of skin of right lower limb, including hip"},{"code":"C44.719","display":"Basal cell carcinoma of skin of left lower limb, including hip"},{"code":"C44.721","display":"Squamous cell carcinoma of skin of unspecified lower limb, including hip"},{"code":"C44.722","display":"Squamous cell carcinoma of skin of right lower limb, including hip"},{"code":"C44.729","display":"Squamous cell carcinoma of skin of left lower limb, including hip"},{"code":"C44.791","display":"Other specified malignant neoplasm of skin of unspecified lower limb, including hip"},{"code":"C44.792","display":"Other specified malignant neoplasm of skin of right lower limb, including hip"},{"code":"C44.799","display":"Other specified malignant neoplasm of skin of left lower limb, including hip"},{"code":"C44.80","display":"Unspecified malignant neoplasm of overlapping sites of skin"},{"code":"C44.81","display":"Basal cell carcinoma of overlapping sites of skin"},{"code":"C44.82","display":"Squamous cell carcinoma of overlapping sites of skin"},{"code":"C44.89","display":"Other specified malignant neoplasm of overlapping sites of skin"},{"code":"C44.90","display":"Unspecified malignant neoplasm of skin, unspecified"},{"code":"C44.91","display":"Basal cell carcinoma of skin, unspecified"},{"code":"C44.92","display":"Squamous cell carcinoma of skin, unspecified"},{"code":"C44.99","display":"Other specified malignant neoplasm of skin, unspecified"},{"code":"C45.0","display":"Mesothelioma of pleura"},{"code":"C45.1","display":"Mesothelioma of peritoneum"},{"code":"C45.2","display":"Mesothelioma of pericardium"},{"code":"C45.7","display":"Mesothelioma of other sites"},{"code":"C45.9","display":"Mesothelioma, unspecified"},{"code":"C46.0","display":"Kaposi\u0027s sarcoma of skin"},{"code":"C46.1","display":"Kaposi\u0027s sarcoma of soft tissue"},{"code":"C46.2","display":"Kaposi\u0027s sarcoma of palate"},{"code":"C46.3","display":"Kaposi\u0027s sarcoma of lymph nodes"},{"code":"C46.4","display":"Kaposi\u0027s sarcoma of gastrointestinal sites"},{"code":"C46.50","display":"Kaposi\u0027s sarcoma of unspecified lung"},{"code":"C46.51","display":"Kaposi\u0027s sarcoma of right lung"},{"code":"C46.52","display":"Kaposi\u0027s sarcoma of left lung"},{"code":"C46.7","display":"Kaposi\u0027s sarcoma of other sites"},{"code":"C46.9","display":"Kaposi\u0027s sarcoma, unspecified"},{"code":"C47.0","display":"Malignant neoplasm of peripheral nerves of head, face and neck"},{"code":"C47.10","display":"Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder"},{"code":"C47.11","display":"Malignant neoplasm of peripheral nerves of right upper limb, including shoulder"},{"code":"C47.12","display":"Malignant neoplasm of peripheral nerves of left upper limb, including shoulder"},{"code":"C47.20","display":"Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip"},{"code":"C47.21","display":"Malignant neoplasm of peripheral nerves of right lower limb, including hip"},{"code":"C47.22","display":"Malignant neoplasm of peripheral nerves of left lower limb, including hip"},{"code":"C47.3","display":"Malignant neoplasm of peripheral nerves of thorax"},{"code":"C47.4","display":"Malignant neoplasm of peripheral nerves of abdomen"},{"code":"C47.5","display":"Malignant neoplasm of peripheral nerves of pelvis"},{"code":"C47.6","display":"Malignant neoplasm of peripheral nerves of trunk, unspecified"},{"code":"C47.8","display":"Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system"},{"code":"C47.9","display":"Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified"},{"code":"C48.0","display":"Malignant neoplasm of retroperitoneum"},{"code":"C48.1","display":"Malignant neoplasm of specified parts of peritoneum"},{"code":"C48.2","display":"Malignant neoplasm of peritoneum, unspecified"},{"code":"C48.8","display":"Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum"},{"code":"C49.0","display":"Malignant neoplasm of connective and soft tissue of head, face and neck"},{"code":"C49.10","display":"Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder"},{"code":"C49.11","display":"Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder"},{"code":"C49.12","display":"Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder"},{"code":"C49.20","display":"Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip"},{"code":"C49.21","display":"Malignant neoplasm of connective and soft tissue of right lower limb, including hip"},{"code":"C49.22","display":"Malignant neoplasm of connective and soft tissue of left lower limb, including hip"},{"code":"C49.3","display":"Malignant neoplasm of connective and soft tissue of thorax"},{"code":"C49.4","display":"Malignant neoplasm of connective and soft tissue of abdomen"},{"code":"C49.5","display":"Malignant neoplasm of connective and soft tissue of pelvis"},{"code":"C49.6","display":"Malignant neoplasm of connective and soft tissue of trunk, unspecified"},{"code":"C49.8","display":"Malignant neoplasm of overlapping sites of connective and soft tissue"},{"code":"C49.9","display":"Malignant neoplasm of connective and soft tissue, unspecified"},{"code":"C49.A0","display":"Gastrointestinal stromal tumor, unspecified site"},{"code":"C49.A1","display":"Gastrointestinal stromal tumor of esophagus"},{"code":"C49.A2","display":"Gastrointestinal stromal tumor of stomach"},{"code":"C49.A3","display":"Gastrointestinal stromal tumor of small intestine"},{"code":"C49.A4","display":"Gastrointestinal stromal tumor of large intestine"},{"code":"C49.A5","display":"Gastrointestinal stromal tumor of rectum"},{"code":"C49.A9","display":"Gastrointestinal stromal tumor of other sites"},{"code":"C4A.0","display":"Merkel cell carcinoma of lip"},{"code":"C4A.10","display":"Merkel cell carcinoma of unspecified eyelid, including canthus"},{"code":"C4A.11","display":"Merkel cell carcinoma of right eyelid, including canthus"},{"code":"C4A.111","display":"Merkel cell carcinoma of right upper eyelid, including canthus"},{"code":"C4A.112","display":"Merkel cell carcinoma of right lower eyelid, including canthus"},{"code":"C4A.12","display":"Merkel cell carcinoma of left eyelid, including canthus"},{"code":"C4A.121","display":"Merkel cell carcinoma of left upper eyelid, including canthus"},{"code":"C4A.122","display":"Merkel cell carcinoma of left lower eyelid, including canthus"},{"code":"C4A.20","display":"Merkel cell carcinoma of unspecified ear and external auricular canal"},{"code":"C4A.21","display":"Merkel cell carcinoma of right ear and external auricular canal"},{"code":"C4A.22","display":"Merkel cell carcinoma of left ear and external auricular canal"},{"code":"C4A.30","display":"Merkel cell carcinoma of unspecified part of face"},{"code":"C4A.31","display":"Merkel cell carcinoma of nose"},{"code":"C4A.39","display":"Merkel cell carcinoma of other parts of face"},{"code":"C4A.4","display":"Merkel cell carcinoma of scalp and neck"},{"code":"C4A.51","display":"Merkel cell carcinoma of anal skin"},{"code":"C4A.52","display":"Merkel cell carcinoma of skin of breast"},{"code":"C4A.59","display":"Merkel cell carcinoma of other part of trunk"},{"code":"C4A.60","display":"Merkel cell carcinoma of unspecified upper limb, including shoulder"},{"code":"C4A.61","display":"Merkel cell carcinoma of right upper limb, including shoulder"},{"code":"C4A.62","display":"Merkel cell carcinoma of left upper limb, including shoulder"},{"code":"C4A.70","display":"Merkel cell carcinoma of unspecified lower limb, including hip"},{"code":"C4A.71","display":"Merkel cell carcinoma of right lower limb, including hip"},{"code":"C4A.72","display":"Merkel cell carcinoma of left lower limb, including hip"},{"code":"C4A.8","display":"Merkel cell carcinoma of overlapping sites"},{"code":"C4A.9","display":"Merkel cell carcinoma, unspecified"},{"code":"C50.011","display":"Malignant neoplasm of nipple and areola, right female breast"},{"code":"C50.012","display":"Malignant neoplasm of nipple and areola, left female breast"},{"code":"C50.019","display":"Malignant neoplasm of nipple and areola, unspecified female breast"},{"code":"C50.021","display":"Malignant neoplasm of nipple and areola, right male breast"},{"code":"C50.022","display":"Malignant neoplasm of nipple and areola, left male breast"},{"code":"C50.029","display":"Malignant neoplasm of nipple and areola, unspecified male breast"},{"code":"C50.111","display":"Malignant neoplasm of central portion of right female breast"},{"code":"C50.112","display":"Malignant neoplasm of central portion of left female breast"},{"code":"C50.119","display":"Malignant neoplasm of central portion of unspecified female breast"},{"code":"C50.121","display":"Malignant neoplasm of central portion of right male breast"},{"code":"C50.122","display":"Malignant neoplasm of central portion of left male breast"},{"code":"C50.129","display":"Malignant neoplasm of central portion of unspecified male breast"},{"code":"C50.211","display":"Malignant neoplasm of upper-inner quadrant of right female breast"},{"code":"C50.212","display":"Malignant neoplasm of upper-inner quadrant of left female breast"},{"code":"C50.219","display":"Malignant neoplasm of upper-inner quadrant of unspecified female breast"},{"code":"C50.221","display":"Malignant neoplasm of upper-inner quadrant of right male breast"},{"code":"C50.222","display":"Malignant neoplasm of upper-inner quadrant of left male breast"},{"code":"C50.229","display":"Malignant neoplasm of upper-inner quadrant of unspecified male breast"},{"code":"C50.311","display":"Malignant neoplasm of lower-inner quadrant of right female breast"},{"code":"C50.312","display":"Malignant neoplasm of lower-inner quadrant of left female breast"},{"code":"C50.319","display":"Malignant neoplasm of lower-inner quadrant of unspecified female breast"},{"code":"C50.321","display":"Malignant neoplasm of lower-inner quadrant of right male breast"},{"code":"C50.322","display":"Malignant neoplasm of lower-inner quadrant of left male breast"},{"code":"C50.329","display":"Malignant neoplasm of lower-inner quadrant of unspecified male breast"},{"code":"C50.411","display":"Malignant neoplasm of upper-outer quadrant of right female breast"},{"code":"C50.412","display":"Malignant neoplasm of upper-outer quadrant of left female breast"},{"code":"C50.419","display":"Malignant neoplasm of upper-outer quadrant of unspecified female breast"},{"code":"C50.421","display":"Malignant neoplasm of upper-outer quadrant of right male breast"},{"code":"C50.422","display":"Malignant neoplasm of upper-outer quadrant of left male breast"},{"code":"C50.429","display":"Malignant neoplasm of upper-outer quadrant of unspecified male breast"},{"code":"C50.511","display":"Malignant neoplasm of lower-outer quadrant of right female breast"},{"code":"C50.512","display":"Malignant neoplasm of lower-outer quadrant of left female breast"},{"code":"C50.519","display":"Malignant neoplasm of lower-outer quadrant of unspecified female breast"},{"code":"C50.521","display":"Malignant neoplasm of lower-outer quadrant of right male breast"},{"code":"C50.522","display":"Malignant neoplasm of lower-outer quadrant of left male breast"},{"code":"C50.529","display":"Malignant neoplasm of lower-outer quadrant of unspecified male breast"},{"code":"C50.611","display":"Malignant neoplasm of axillary tail of right female breast"},{"code":"C50.612","display":"Malignant neoplasm of axillary tail of left female breast"},{"code":"C50.619","display":"Malignant neoplasm of axillary tail of unspecified female breast"},{"code":"C50.621","display":"Malignant neoplasm of axillary tail of right male breast"},{"code":"C50.622","display":"Malignant neoplasm of axillary tail of left male breast"},{"code":"C50.629","display":"Malignant neoplasm of axillary tail of unspecified male breast"},{"code":"C50.811","display":"Malignant neoplasm of overlapping sites of right female breast"},{"code":"C50.812","display":"Malignant neoplasm of overlapping sites of left female breast"},{"code":"C50.819","display":"Malignant neoplasm of overlapping sites of unspecified female breast"},{"code":"C50.821","display":"Malignant neoplasm of overlapping sites of right male breast"},{"code":"C50.822","display":"Malignant neoplasm of overlapping sites of left male breast"},{"code":"C50.829","display":"Malignant neoplasm of overlapping sites of unspecified male breast"},{"code":"C50.911","display":"Malignant neoplasm of unspecified site of right female breast"},{"code":"C50.912","display":"Malignant neoplasm of unspecified site of left female breast"},{"code":"C50.919","display":"Malignant neoplasm of unspecified site of unspecified female breast"},{"code":"C50.921","display":"Malignant neoplasm of unspecified site of right male breast"},{"code":"C50.922","display":"Malignant neoplasm of unspecified site of left male breast"},{"code":"C50.929","display":"Malignant neoplasm of unspecified site of unspecified male breast"},{"code":"C51.0","display":"Malignant neoplasm of labium majus"},{"code":"C51.1","display":"Malignant neoplasm of labium minus"},{"code":"C51.2","display":"Malignant neoplasm of clitoris"},{"code":"C51.8","display":"Malignant neoplasm of overlapping sites of vulva"},{"code":"C51.9","display":"Malignant neoplasm of vulva, unspecified"},{"code":"C52","display":"Malignant neoplasm of vagina"},{"code":"C53.0","display":"Malignant neoplasm of endocervix"},{"code":"C53.1","display":"Malignant neoplasm of exocervix"},{"code":"C53.8","display":"Malignant neoplasm of overlapping sites of cervix uteri"},{"code":"C53.9","display":"Malignant neoplasm of cervix uteri, unspecified"},{"code":"C54.0","display":"Malignant neoplasm of isthmus uteri"},{"code":"C54.1","display":"Malignant neoplasm of endometrium"},{"code":"C54.2","display":"Malignant neoplasm of myometrium"},{"code":"C54.3","display":"Malignant neoplasm of fundus uteri"},{"code":"C54.8","display":"Malignant neoplasm of overlapping sites of corpus uteri"},{"code":"C54.9","display":"Malignant neoplasm of corpus uteri, unspecified"},{"code":"C55","display":"Malignant neoplasm of uterus, part unspecified"},{"code":"C56.1","display":"Malignant neoplasm of right ovary"},{"code":"C56.2","display":"Malignant neoplasm of left ovary"},{"code":"C56.9","display":"Malignant neoplasm of unspecified ovary"},{"code":"C57.00","display":"Malignant neoplasm of unspecified fallopian tube"},{"code":"C57.01","display":"Malignant neoplasm of right fallopian tube"},{"code":"C57.02","display":"Malignant neoplasm of left fallopian tube"},{"code":"C57.10","display":"Malignant neoplasm of unspecified broad ligament"},{"code":"C57.11","display":"Malignant neoplasm of right broad ligament"},{"code":"C57.12","display":"Malignant neoplasm of left broad ligament"},{"code":"C57.20","display":"Malignant neoplasm of unspecified round ligament"},{"code":"C57.21","display":"Malignant neoplasm of right round ligament"},{"code":"C57.22","display":"Malignant neoplasm of left round ligament"},{"code":"C57.3","display":"Malignant neoplasm of parametrium"},{"code":"C57.4","display":"Malignant neoplasm of uterine adnexa, unspecified"},{"code":"C57.7","display":"Malignant neoplasm of other specified female genital organs"},{"code":"C57.8","display":"Malignant neoplasm of overlapping sites of female genital organs"},{"code":"C57.9","display":"Malignant neoplasm of female genital organ, unspecified"},{"code":"C58","display":"Malignant neoplasm of placenta"},{"code":"C60.0","display":"Malignant neoplasm of prepuce"},{"code":"C60.1","display":"Malignant neoplasm of glans penis"},{"code":"C60.2","display":"Malignant neoplasm of body of penis"},{"code":"C60.8","display":"Malignant neoplasm of overlapping sites of penis"},{"code":"C60.9","display":"Malignant neoplasm of penis, unspecified"},{"code":"C61","display":"Malignant neoplasm of prostate"},{"code":"C62.00","display":"Malignant neoplasm of unspecified undescended testis"},{"code":"C62.01","display":"Malignant neoplasm of undescended right testis"},{"code":"C62.02","display":"Malignant neoplasm of undescended left testis"},{"code":"C62.10","display":"Malignant neoplasm of unspecified descended testis"},{"code":"C62.11","display":"Malignant neoplasm of descended right testis"},{"code":"C62.12","display":"Malignant neoplasm of descended left testis"},{"code":"C62.90","display":"Malignant neoplasm of unspecified testis, unspecified whether descended or undescended"},{"code":"C62.91","display":"Malignant neoplasm of right testis, unspecified whether descended or undescended"},{"code":"C62.92","display":"Malignant neoplasm of left testis, unspecified whether descended or undescended"},{"code":"C63.00","display":"Malignant neoplasm of unspecified epididymis"},{"code":"C63.01","display":"Malignant neoplasm of right epididymis"},{"code":"C63.02","display":"Malignant neoplasm of left epididymis"},{"code":"C63.10","display":"Malignant neoplasm of unspecified spermatic cord"},{"code":"C63.11","display":"Malignant neoplasm of right spermatic cord"},{"code":"C63.12","display":"Malignant neoplasm of left spermatic cord"},{"code":"C63.2","display":"Malignant neoplasm of scrotum"},{"code":"C63.7","display":"Malignant neoplasm of other specified male genital organs"},{"code":"C63.8","display":"Malignant neoplasm of overlapping sites of male genital organs"},{"code":"C63.9","display":"Malignant neoplasm of male genital organ, unspecified"},{"code":"C64.1","display":"Malignant neoplasm of right kidney, except renal pelvis"},{"code":"C64.2","display":"Malignant neoplasm of left kidney, except renal pelvis"},{"code":"C64.9","display":"Malignant neoplasm of unspecified kidney, except renal pelvis"},{"code":"C65.1","display":"Malignant neoplasm of right renal pelvis"},{"code":"C65.2","display":"Malignant neoplasm of left renal pelvis"},{"code":"C65.9","display":"Malignant neoplasm of unspecified renal pelvis"},{"code":"C66.1","display":"Malignant neoplasm of right ureter"},{"code":"C66.2","display":"Malignant neoplasm of left ureter"},{"code":"C66.9","display":"Malignant neoplasm of unspecified ureter"},{"code":"C67.0","display":"Malignant neoplasm of trigone of bladder"},{"code":"C67.1","display":"Malignant neoplasm of dome of bladder"},{"code":"C67.2","display":"Malignant neoplasm of lateral wall of bladder"},{"code":"C67.3","display":"Malignant neoplasm of anterior wall of bladder"},{"code":"C67.4","display":"Malignant neoplasm of posterior wall of bladder"},{"code":"C67.5","display":"Malignant neoplasm of bladder neck"},{"code":"C67.6","display":"Malignant neoplasm of ureteric orifice"},{"code":"C67.7","display":"Malignant neoplasm of urachus"},{"code":"C67.8","display":"Malignant neoplasm of overlapping sites of bladder"},{"code":"C67.9","display":"Malignant neoplasm of bladder, unspecified"},{"code":"C68.0","display":"Malignant neoplasm of urethra"},{"code":"C68.1","display":"Malignant neoplasm of paraurethral glands"},{"code":"C68.8","display":"Malignant neoplasm of overlapping sites of urinary organs"},{"code":"C68.9","display":"Malignant neoplasm of urinary organ, unspecified"},{"code":"C69.00","display":"Malignant neoplasm of unspecified conjunctiva"},{"code":"C69.01","display":"Malignant neoplasm of right conjunctiva"},{"code":"C69.02","display":"Malignant neoplasm of left conjunctiva"},{"code":"C69.10","display":"Malignant neoplasm of unspecified cornea"},{"code":"C69.11","display":"Malignant neoplasm of right cornea"},{"code":"C69.12","display":"Malignant neoplasm of left cornea"},{"code":"C69.20","display":"Malignant neoplasm of unspecified retina"},{"code":"C69.21","display":"Malignant neoplasm of right retina"},{"code":"C69.22","display":"Malignant neoplasm of left retina"},{"code":"C69.30","display":"Malignant neoplasm of unspecified choroid"},{"code":"C69.31","display":"Malignant neoplasm of right choroid"},{"code":"C69.32","display":"Malignant neoplasm of left choroid"},{"code":"C69.40","display":"Malignant neoplasm of unspecified ciliary body"},{"code":"C69.41","display":"Malignant neoplasm of right ciliary body"},{"code":"C69.42","display":"Malignant neoplasm of left ciliary body"},{"code":"C69.50","display":"Malignant neoplasm of unspecified lacrimal gland and duct"},{"code":"C69.51","display":"Malignant neoplasm of right lacrimal gland and duct"},{"code":"C69.52","display":"Malignant neoplasm of left lacrimal gland and duct"},{"code":"C69.60","display":"Malignant neoplasm of unspecified orbit"},{"code":"C69.61","display":"Malignant neoplasm of right orbit"},{"code":"C69.62","display":"Malignant neoplasm of left orbit"},{"code":"C69.80","display":"Malignant neoplasm of overlapping sites of unspecified eye and adnexa"},{"code":"C69.81","display":"Malignant neoplasm of overlapping sites of right eye and adnexa"},{"code":"C69.82","display":"Malignant neoplasm of overlapping sites of left eye and adnexa"},{"code":"C69.90","display":"Malignant neoplasm of unspecified site of unspecified eye"},{"code":"C69.91","display":"Malignant neoplasm of unspecified site of right eye"},{"code":"C69.92","display":"Malignant neoplasm of unspecified site of left eye"},{"code":"C70.0","display":"Malignant neoplasm of cerebral meninges"},{"code":"C70.1","display":"Malignant neoplasm of spinal meninges"},{"code":"C70.9","display":"Malignant neoplasm of meninges, unspecified"},{"code":"C71.0","display":"Malignant neoplasm of cerebrum, except lobes and ventricles"},{"code":"C71.1","display":"Malignant neoplasm of frontal lobe"},{"code":"C71.2","display":"Malignant neoplasm of temporal lobe"},{"code":"C71.3","display":"Malignant neoplasm of parietal lobe"},{"code":"C71.4","display":"Malignant neoplasm of occipital lobe"},{"code":"C71.5","display":"Malignant neoplasm of cerebral ventricle"},{"code":"C71.6","display":"Malignant neoplasm of cerebellum"},{"code":"C71.7","display":"Malignant neoplasm of brain stem"},{"code":"C71.8","display":"Malignant neoplasm of overlapping sites of brain"},{"code":"C71.9","display":"Malignant neoplasm of brain, unspecified"},{"code":"C72.0","display":"Malignant neoplasm of spinal cord"},{"code":"C72.1","display":"Malignant neoplasm of cauda equina"},{"code":"C72.20","display":"Malignant neoplasm of unspecified olfactory nerve"},{"code":"C72.21","display":"Malignant neoplasm of right olfactory nerve"},{"code":"C72.22","display":"Malignant neoplasm of left olfactory nerve"},{"code":"C72.30","display":"Malignant neoplasm of unspecified optic nerve"},{"code":"C72.31","display":"Malignant neoplasm of right optic nerve"},{"code":"C72.32","display":"Malignant neoplasm of left optic nerve"},{"code":"C72.40","display":"Malignant neoplasm of unspecified acoustic nerve"},{"code":"C72.41","display":"Malignant neoplasm of right acoustic nerve"},{"code":"C72.42","display":"Malignant neoplasm of left acoustic nerve"},{"code":"C72.50","display":"Malignant neoplasm of unspecified cranial nerve"},{"code":"C72.59","display":"Malignant neoplasm of other cranial nerves"},{"code":"C72.9","display":"Malignant neoplasm of central nervous system, unspecified"},{"code":"C73","display":"Malignant neoplasm of thyroid gland"},{"code":"C74.00","display":"Malignant neoplasm of cortex of unspecified adrenal gland"},{"code":"C74.01","display":"Malignant neoplasm of cortex of right adrenal gland"},{"code":"C74.02","display":"Malignant neoplasm of cortex of left adrenal gland"},{"code":"C74.10","display":"Malignant neoplasm of medulla of unspecified adrenal gland"},{"code":"C74.11","display":"Malignant neoplasm of medulla of right adrenal gland"},{"code":"C74.12","display":"Malignant neoplasm of medulla of left adrenal gland"},{"code":"C74.90","display":"Malignant neoplasm of unspecified part of unspecified adrenal gland"},{"code":"C74.91","display":"Malignant neoplasm of unspecified part of right adrenal gland"},{"code":"C74.92","display":"Malignant neoplasm of unspecified part of left adrenal gland"},{"code":"C75.0","display":"Malignant neoplasm of parathyroid gland"},{"code":"C75.1","display":"Malignant neoplasm of pituitary gland"},{"code":"C75.2","display":"Malignant neoplasm of craniopharyngeal duct"},{"code":"C75.3","display":"Malignant neoplasm of pineal gland"},{"code":"C75.4","display":"Malignant neoplasm of carotid body"},{"code":"C75.5","display":"Malignant neoplasm of aortic body and other paraganglia"},{"code":"C75.8","display":"Malignant neoplasm with pluriglandular involvement, unspecified"},{"code":"C75.9","display":"Malignant neoplasm of endocrine gland, unspecified"},{"code":"C76.0","display":"Malignant neoplasm of head, face and neck"},{"code":"C76.1","display":"Malignant neoplasm of thorax"},{"code":"C76.2","display":"Malignant neoplasm of abdomen"},{"code":"C76.3","display":"Malignant neoplasm of pelvis"},{"code":"C76.40","display":"Malignant neoplasm of unspecified upper limb"},{"code":"C76.41","display":"Malignant neoplasm of right upper limb"},{"code":"C76.42","display":"Malignant neoplasm of left upper limb"},{"code":"C76.50","display":"Malignant neoplasm of unspecified lower limb"},{"code":"C76.51","display":"Malignant neoplasm of right lower limb"},{"code":"C76.52","display":"Malignant neoplasm of left lower limb"},{"code":"C76.8","display":"Malignant neoplasm of other specified ill-defined sites"},{"code":"C77.0","display":"Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck"},{"code":"C77.1","display":"Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes"},{"code":"C77.2","display":"Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes"},{"code":"C77.3","display":"Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes"},{"code":"C77.4","display":"Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes"},{"code":"C77.5","display":"Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes"},{"code":"C77.8","display":"Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions"},{"code":"C77.9","display":"Secondary and unspecified malignant neoplasm of lymph node, unspecified"},{"code":"C78.00","display":"Secondary malignant neoplasm of unspecified lung"},{"code":"C78.01","display":"Secondary malignant neoplasm of right lung"},{"code":"C78.02","display":"Secondary malignant neoplasm of left lung"},{"code":"C78.1","display":"Secondary malignant neoplasm of mediastinum"},{"code":"C78.2","display":"Secondary malignant neoplasm of pleura"},{"code":"C78.30","display":"Secondary malignant neoplasm of unspecified respiratory organ"},{"code":"C78.39","display":"Secondary malignant neoplasm of other respiratory organs"},{"code":"C78.4","display":"Secondary malignant neoplasm of small intestine"},{"code":"C78.5","display":"Secondary malignant neoplasm of large intestine and rectum"},{"code":"C78.6","display":"Secondary malignant neoplasm of retroperitoneum and peritoneum"},{"code":"C78.7","display":"Secondary malignant neoplasm of liver and intrahepatic bile duct"},{"code":"C78.80","display":"Secondary malignant neoplasm of unspecified digestive organ"},{"code":"C78.89","display":"Secondary malignant neoplasm of other digestive organs"},{"code":"C79.00","display":"Secondary malignant neoplasm of unspecified kidney and renal pelvis"},{"code":"C79.01","display":"Secondary malignant neoplasm of right kidney and renal pelvis"},{"code":"C79.02","display":"Secondary malignant neoplasm of left kidney and renal pelvis"},{"code":"C79.10","display":"Secondary malignant neoplasm of unspecified urinary organs"},{"code":"C79.11","display":"Secondary malignant neoplasm of bladder"},{"code":"C79.19","display":"Secondary malignant neoplasm of other urinary organs"},{"code":"C79.2","display":"Secondary malignant neoplasm of skin"},{"code":"C79.31","display":"Secondary malignant neoplasm of brain"},{"code":"C79.32","display":"Secondary malignant neoplasm of cerebral meninges"},{"code":"C79.40","display":"Secondary malignant neoplasm of unspecified part of nervous system"},{"code":"C79.49","display":"Secondary malignant neoplasm of other parts of nervous system"},{"code":"C79.51","display":"Secondary malignant neoplasm of bone"},{"code":"C79.52","display":"Secondary malignant neoplasm of bone marrow"},{"code":"C79.60","display":"Secondary malignant neoplasm of unspecified ovary"},{"code":"C79.61","display":"Secondary malignant neoplasm of right ovary"},{"code":"C79.62","display":"Secondary malignant neoplasm of left ovary"},{"code":"C79.70","display":"Secondary malignant neoplasm of unspecified adrenal gland"},{"code":"C79.71","display":"Secondary malignant neoplasm of right adrenal gland"},{"code":"C79.72","display":"Secondary malignant neoplasm of left adrenal gland"},{"code":"C79.81","display":"Secondary malignant neoplasm of breast"},{"code":"C79.82","display":"Secondary malignant neoplasm of genital organs"},{"code":"C79.89","display":"Secondary malignant neoplasm of other specified sites"},{"code":"C79.9","display":"Secondary malignant neoplasm of unspecified site"},{"code":"C7A.00","display":"Malignant carcinoid tumor of unspecified site"},{"code":"C7A.010","display":"Malignant carcinoid tumor of the duodenum"},{"code":"C7A.011","display":"Malignant carcinoid tumor of the jejunum"},{"code":"C7A.012","display":"Malignant carcinoid tumor of the ileum"},{"code":"C7A.019","display":"Malignant carcinoid tumor of the small intestine, unspecified portion"},{"code":"C7A.020","display":"Malignant carcinoid tumor of the appendix"},{"code":"C7A.021","display":"Malignant carcinoid tumor of the cecum"},{"code":"C7A.022","display":"Malignant carcinoid tumor of the ascending colon"},{"code":"C7A.023","display":"Malignant carcinoid tumor of the transverse colon"},{"code":"C7A.024","display":"Malignant carcinoid tumor of the descending colon"},{"code":"C7A.025","display":"Malignant carcinoid tumor of the sigmoid colon"},{"code":"C7A.026","display":"Malignant carcinoid tumor of the rectum"},{"code":"C7A.029","display":"Malignant carcinoid tumor of the large intestine, unspecified portion"},{"code":"C7A.090","display":"Malignant carcinoid tumor of the bronchus and lung"},{"code":"C7A.091","display":"Malignant carcinoid tumor of the thymus"},{"code":"C7A.092","display":"Malignant carcinoid tumor of the stomach"},{"code":"C7A.093","display":"Malignant carcinoid tumor of the kidney"},{"code":"C7A.094","display":"Malignant carcinoid tumor of the foregut, unspecified"},{"code":"C7A.095","display":"Malignant carcinoid tumor of the midgut, unspecified"},{"code":"C7A.096","display":"Malignant carcinoid tumor of the hindgut, unspecified"},{"code":"C7A.098","display":"Malignant carcinoid tumors of other sites"},{"code":"C7A.1","display":"Malignant poorly differentiated neuroendocrine tumors"},{"code":"C7A.8","display":"Other malignant neuroendocrine tumors"},{"code":"C7B.00","display":"Secondary carcinoid tumors, unspecified site"},{"code":"C7B.01","display":"Secondary carcinoid tumors of distant lymph nodes"},{"code":"C7B.02","display":"Secondary carcinoid tumors of liver"},{"code":"C7B.03","display":"Secondary carcinoid tumors of bone"},{"code":"C7B.04","display":"Secondary carcinoid tumors of peritoneum"},{"code":"C7B.09","display":"Secondary carcinoid tumors of other sites"},{"code":"C7B.1","display":"Secondary Merkel cell carcinoma"},{"code":"C7B.8","display":"Other secondary neuroendocrine tumors"},{"code":"C80.0","display":"Disseminated malignant neoplasm, unspecified"},{"code":"C80.1","display":"Malignant (primary) neoplasm, unspecified"},{"code":"C80.2","display":"Malignant neoplasm associated with transplanted organ"},{"code":"C81.00","display":"Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site"},{"code":"C81.01","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.02","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.03","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.04","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.05","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.06","display":"Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.07","display":"Nodular lymphocyte predominant Hodgkin lymphoma, spleen"},{"code":"C81.08","display":"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.09","display":"Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.10","display":"Nodular sclerosis Hodgkin lymphoma, unspecified site"},{"code":"C81.11","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.12","display":"Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.13","display":"Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.14","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.15","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.16","display":"Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.17","display":"Nodular sclerosis Hodgkin lymphoma, spleen"},{"code":"C81.18","display":"Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.19","display":"Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.20","display":"Mixed cellularity Hodgkin lymphoma, unspecified site"},{"code":"C81.21","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.22","display":"Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.23","display":"Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.24","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.25","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.26","display":"Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.27","display":"Mixed cellularity Hodgkin lymphoma, spleen"},{"code":"C81.28","display":"Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.29","display":"Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.30","display":"Lymphocyte depleted Hodgkin lymphoma, unspecified site"},{"code":"C81.31","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.32","display":"Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.33","display":"Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.34","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.35","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.36","display":"Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.37","display":"Lymphocyte depleted Hodgkin lymphoma, spleen"},{"code":"C81.38","display":"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.39","display":"Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.40","display":"Lymphocyte-rich Hodgkin lymphoma, unspecified site"},{"code":"C81.41","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.42","display":"Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.43","display":"Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.44","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.45","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.46","display":"Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.47","display":"Lymphocyte-rich Hodgkin lymphoma, spleen"},{"code":"C81.48","display":"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.49","display":"Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.70","display":"Other Hodgkin lymphoma, unspecified site"},{"code":"C81.71","display":"Other Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C81.72","display":"Other Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C81.73","display":"Other Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C81.74","display":"Other Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C81.75","display":"Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C81.76","display":"Other Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C81.77","display":"Other Hodgkin lymphoma, spleen"},{"code":"C81.78","display":"Other Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C81.79","display":"Other Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C81.90","display":"Hodgkin lymphoma, unspecified, unspecified site"},{"code":"C81.91","display":"Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C81.92","display":"Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C81.93","display":"Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C81.94","display":"Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C81.95","display":"Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C81.96","display":"Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C81.97","display":"Hodgkin lymphoma, unspecified, spleen"},{"code":"C81.98","display":"Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C81.99","display":"Hodgkin lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C82.00","display":"Follicular lymphoma grade I, unspecified site"},{"code":"C82.01","display":"Follicular lymphoma grade I, lymph nodes of head, face, and neck"},{"code":"C82.02","display":"Follicular lymphoma grade I, intrathoracic lymph nodes"},{"code":"C82.03","display":"Follicular lymphoma grade I, intra-abdominal lymph nodes"},{"code":"C82.04","display":"Follicular lymphoma grade I, lymph nodes of axilla and upper limb"},{"code":"C82.05","display":"Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb"},{"code":"C82.06","display":"Follicular lymphoma grade I, intrapelvic lymph nodes"},{"code":"C82.07","display":"Follicular lymphoma grade I, spleen"},{"code":"C82.08","display":"Follicular lymphoma grade I, lymph nodes of multiple sites"},{"code":"C82.09","display":"Follicular lymphoma grade I, extranodal and solid organ sites"},{"code":"C82.10","display":"Follicular lymphoma grade II, unspecified site"},{"code":"C82.11","display":"Follicular lymphoma grade II, lymph nodes of head, face, and neck"},{"code":"C82.12","display":"Follicular lymphoma grade II, intrathoracic lymph nodes"},{"code":"C82.13","display":"Follicular lymphoma grade II, intra-abdominal lymph nodes"},{"code":"C82.14","display":"Follicular lymphoma grade II, lymph nodes of axilla and upper limb"},{"code":"C82.15","display":"Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb"},{"code":"C82.16","display":"Follicular lymphoma grade II, intrapelvic lymph nodes"},{"code":"C82.17","display":"Follicular lymphoma grade II, spleen"},{"code":"C82.18","display":"Follicular lymphoma grade II, lymph nodes of multiple sites"},{"code":"C82.19","display":"Follicular lymphoma grade II, extranodal and solid organ sites"},{"code":"C82.20","display":"Follicular lymphoma grade III, unspecified, unspecified site"},{"code":"C82.21","display":"Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck"},{"code":"C82.22","display":"Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes"},{"code":"C82.23","display":"Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes"},{"code":"C82.24","display":"Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb"},{"code":"C82.25","display":"Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C82.26","display":"Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes"},{"code":"C82.27","display":"Follicular lymphoma grade III, unspecified, spleen"},{"code":"C82.28","display":"Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites"},{"code":"C82.29","display":"Follicular lymphoma grade III, unspecified, extranodal and solid organ sites"},{"code":"C82.30","display":"Follicular lymphoma grade IIIa, unspecified site"},{"code":"C82.31","display":"Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck"},{"code":"C82.32","display":"Follicular lymphoma grade IIIa, intrathoracic lymph nodes"},{"code":"C82.33","display":"Follicular lymphoma grade IIIa, intra-abdominal lymph nodes"},{"code":"C82.34","display":"Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb"},{"code":"C82.35","display":"Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb"},{"code":"C82.36","display":"Follicular lymphoma grade IIIa, intrapelvic lymph nodes"},{"code":"C82.37","display":"Follicular lymphoma grade IIIa, spleen"},{"code":"C82.38","display":"Follicular lymphoma grade IIIa, lymph nodes of multiple sites"},{"code":"C82.39","display":"Follicular lymphoma grade IIIa, extranodal and solid organ sites"},{"code":"C82.40","display":"Follicular lymphoma grade IIIb, unspecified site"},{"code":"C82.41","display":"Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck"},{"code":"C82.42","display":"Follicular lymphoma grade IIIb, intrathoracic lymph nodes"},{"code":"C82.43","display":"Follicular lymphoma grade IIIb, intra-abdominal lymph nodes"},{"code":"C82.44","display":"Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb"},{"code":"C82.45","display":"Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb"},{"code":"C82.46","display":"Follicular lymphoma grade IIIb, intrapelvic lymph nodes"},{"code":"C82.47","display":"Follicular lymphoma grade IIIb, spleen"},{"code":"C82.48","display":"Follicular lymphoma grade IIIb, lymph nodes of multiple sites"},{"code":"C82.49","display":"Follicular lymphoma grade IIIb, extranodal and solid organ sites"},{"code":"C82.50","display":"Diffuse follicle center lymphoma, unspecified site"},{"code":"C82.51","display":"Diffuse follicle center lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.52","display":"Diffuse follicle center lymphoma, intrathoracic lymph nodes"},{"code":"C82.53","display":"Diffuse follicle center lymphoma, intra-abdominal lymph nodes"},{"code":"C82.54","display":"Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.55","display":"Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.56","display":"Diffuse follicle center lymphoma, intrapelvic lymph nodes"},{"code":"C82.57","display":"Diffuse follicle center lymphoma, spleen"},{"code":"C82.58","display":"Diffuse follicle center lymphoma, lymph nodes of multiple sites"},{"code":"C82.59","display":"Diffuse follicle center lymphoma, extranodal and solid organ sites"},{"code":"C82.60","display":"Cutaneous follicle center lymphoma, unspecified site"},{"code":"C82.61","display":"Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.62","display":"Cutaneous follicle center lymphoma, intrathoracic lymph nodes"},{"code":"C82.63","display":"Cutaneous follicle center lymphoma, intra-abdominal lymph nodes"},{"code":"C82.64","display":"Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.65","display":"Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.66","display":"Cutaneous follicle center lymphoma, intrapelvic lymph nodes"},{"code":"C82.67","display":"Cutaneous follicle center lymphoma, spleen"},{"code":"C82.68","display":"Cutaneous follicle center lymphoma, lymph nodes of multiple sites"},{"code":"C82.69","display":"Cutaneous follicle center lymphoma, extranodal and solid organ sites"},{"code":"C82.80","display":"Other types of follicular lymphoma, unspecified site"},{"code":"C82.81","display":"Other types of follicular lymphoma, lymph nodes of head, face, and neck"},{"code":"C82.82","display":"Other types of follicular lymphoma, intrathoracic lymph nodes"},{"code":"C82.83","display":"Other types of follicular lymphoma, intra-abdominal lymph nodes"},{"code":"C82.84","display":"Other types of follicular lymphoma, lymph nodes of axilla and upper limb"},{"code":"C82.85","display":"Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C82.86","display":"Other types of follicular lymphoma, intrapelvic lymph nodes"},{"code":"C82.87","display":"Other types of follicular lymphoma, spleen"},{"code":"C82.88","display":"Other types of follicular lymphoma, lymph nodes of multiple sites"},{"code":"C82.89","display":"Other types of follicular lymphoma, extranodal and solid organ sites"},{"code":"C82.90","display":"Follicular lymphoma, unspecified, unspecified site"},{"code":"C82.91","display":"Follicular lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C82.92","display":"Follicular lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C82.93","display":"Follicular lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C82.94","display":"Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C82.95","display":"Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C82.96","display":"Follicular lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C82.97","display":"Follicular lymphoma, unspecified, spleen"},{"code":"C82.98","display":"Follicular lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C82.99","display":"Follicular lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C83.00","display":"Small cell B-cell lymphoma, unspecified site"},{"code":"C83.01","display":"Small cell B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.02","display":"Small cell B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C83.03","display":"Small cell B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C83.04","display":"Small cell B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.05","display":"Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.06","display":"Small cell B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C83.07","display":"Small cell B-cell lymphoma, spleen"},{"code":"C83.08","display":"Small cell B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C83.09","display":"Small cell B-cell lymphoma, extranodal and solid organ sites"},{"code":"C83.10","display":"Mantle cell lymphoma, unspecified site"},{"code":"C83.11","display":"Mantle cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.12","display":"Mantle cell lymphoma, intrathoracic lymph nodes"},{"code":"C83.13","display":"Mantle cell lymphoma, intra-abdominal lymph nodes"},{"code":"C83.14","display":"Mantle cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.15","display":"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.16","display":"Mantle cell lymphoma, intrapelvic lymph nodes"},{"code":"C83.17","display":"Mantle cell lymphoma, spleen"},{"code":"C83.18","display":"Mantle cell lymphoma, lymph nodes of multiple sites"},{"code":"C83.19","display":"Mantle cell lymphoma, extranodal and solid organ sites"},{"code":"C83.30","display":"Diffuse large B-cell lymphoma, unspecified site"},{"code":"C83.31","display":"Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.32","display":"Diffuse large B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C83.33","display":"Diffuse large B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C83.34","display":"Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.35","display":"Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.36","display":"Diffuse large B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C83.37","display":"Diffuse large B-cell lymphoma, spleen"},{"code":"C83.38","display":"Diffuse large B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C83.39","display":"Diffuse large B-cell lymphoma, extranodal and solid organ sites"},{"code":"C83.50","display":"Lymphoblastic (diffuse) lymphoma, unspecified site"},{"code":"C83.51","display":"Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.52","display":"Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes"},{"code":"C83.53","display":"Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes"},{"code":"C83.54","display":"Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.55","display":"Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.56","display":"Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes"},{"code":"C83.57","display":"Lymphoblastic (diffuse) lymphoma, spleen"},{"code":"C83.58","display":"Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites"},{"code":"C83.59","display":"Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites"},{"code":"C83.70","display":"Burkitt lymphoma, unspecified site"},{"code":"C83.71","display":"Burkitt lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.72","display":"Burkitt lymphoma, intrathoracic lymph nodes"},{"code":"C83.73","display":"Burkitt lymphoma, intra-abdominal lymph nodes"},{"code":"C83.74","display":"Burkitt lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.75","display":"Burkitt lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.76","display":"Burkitt lymphoma, intrapelvic lymph nodes"},{"code":"C83.77","display":"Burkitt lymphoma, spleen"},{"code":"C83.78","display":"Burkitt lymphoma, lymph nodes of multiple sites"},{"code":"C83.79","display":"Burkitt lymphoma, extranodal and solid organ sites"},{"code":"C83.80","display":"Other non-follicular lymphoma, unspecified site"},{"code":"C83.81","display":"Other non-follicular lymphoma, lymph nodes of head, face, and neck"},{"code":"C83.82","display":"Other non-follicular lymphoma, intrathoracic lymph nodes"},{"code":"C83.83","display":"Other non-follicular lymphoma, intra-abdominal lymph nodes"},{"code":"C83.84","display":"Other non-follicular lymphoma, lymph nodes of axilla and upper limb"},{"code":"C83.85","display":"Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C83.86","display":"Other non-follicular lymphoma, intrapelvic lymph nodes"},{"code":"C83.87","display":"Other non-follicular lymphoma, spleen"},{"code":"C83.88","display":"Other non-follicular lymphoma, lymph nodes of multiple sites"},{"code":"C83.89","display":"Other non-follicular lymphoma, extranodal and solid organ sites"},{"code":"C83.90","display":"Non-follicular (diffuse) lymphoma, unspecified, unspecified site"},{"code":"C83.91","display":"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C83.92","display":"Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C83.93","display":"Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C83.94","display":"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C83.95","display":"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C83.96","display":"Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C83.97","display":"Non-follicular (diffuse) lymphoma, unspecified, spleen"},{"code":"C83.98","display":"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C83.99","display":"Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C84.00","display":"Mycosis fungoides, unspecified site"},{"code":"C84.01","display":"Mycosis fungoides, lymph nodes of head, face, and neck"},{"code":"C84.02","display":"Mycosis fungoides, intrathoracic lymph nodes"},{"code":"C84.03","display":"Mycosis fungoides, intra-abdominal lymph nodes"},{"code":"C84.04","display":"Mycosis fungoides, lymph nodes of axilla and upper limb"},{"code":"C84.05","display":"Mycosis fungoides, lymph nodes of inguinal region and lower limb"},{"code":"C84.06","display":"Mycosis fungoides, intrapelvic lymph nodes"},{"code":"C84.07","display":"Mycosis fungoides, spleen"},{"code":"C84.08","display":"Mycosis fungoides, lymph nodes of multiple sites"},{"code":"C84.09","display":"Mycosis fungoides, extranodal and solid organ sites"},{"code":"C84.10","display":"Sézary disease, unspecified site"},{"code":"C84.11","display":"Sézary disease, lymph nodes of head, face, and neck"},{"code":"C84.12","display":"Sézary disease, intrathoracic lymph nodes"},{"code":"C84.13","display":"Sézary disease, intra-abdominal lymph nodes"},{"code":"C84.14","display":"Sézary disease, lymph nodes of axilla and upper limb"},{"code":"C84.15","display":"Sézary disease, lymph nodes of inguinal region and lower limb"},{"code":"C84.16","display":"Sézary disease, intrapelvic lymph nodes"},{"code":"C84.17","display":"Sézary disease, spleen"},{"code":"C84.18","display":"Sézary disease, lymph nodes of multiple sites"},{"code":"C84.19","display":"Sézary disease, extranodal and solid organ sites"},{"code":"C84.40","display":"Peripheral T-cell lymphoma, not classified, unspecified site"},{"code":"C84.41","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck"},{"code":"C84.42","display":"Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes"},{"code":"C84.43","display":"Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes"},{"code":"C84.44","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb"},{"code":"C84.45","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb"},{"code":"C84.46","display":"Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes"},{"code":"C84.47","display":"Peripheral T-cell lymphoma, not classified, spleen"},{"code":"C84.48","display":"Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites"},{"code":"C84.49","display":"Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites"},{"code":"C84.60","display":"Anaplastic large cell lymphoma, ALK-positive, unspecified site"},{"code":"C84.61","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck"},{"code":"C84.62","display":"Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes"},{"code":"C84.63","display":"Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes"},{"code":"C84.64","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb"},{"code":"C84.65","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb"},{"code":"C84.66","display":"Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes"},{"code":"C84.67","display":"Anaplastic large cell lymphoma, ALK-positive, spleen"},{"code":"C84.68","display":"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites"},{"code":"C84.69","display":"Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites"},{"code":"C84.70","display":"Anaplastic large cell lymphoma, ALK-negative, unspecified site"},{"code":"C84.71","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck"},{"code":"C84.72","display":"Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes"},{"code":"C84.73","display":"Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes"},{"code":"C84.74","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb"},{"code":"C84.75","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb"},{"code":"C84.76","display":"Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes"},{"code":"C84.77","display":"Anaplastic large cell lymphoma, ALK-negative, spleen"},{"code":"C84.78","display":"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites"},{"code":"C84.79","display":"Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites"},{"code":"C84.90","display":"Mature T/NK-cell lymphomas, unspecified, unspecified site"},{"code":"C84.91","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck"},{"code":"C84.92","display":"Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes"},{"code":"C84.93","display":"Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes"},{"code":"C84.94","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb"},{"code":"C84.95","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C84.96","display":"Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes"},{"code":"C84.97","display":"Mature T/NK-cell lymphomas, unspecified, spleen"},{"code":"C84.98","display":"Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites"},{"code":"C84.99","display":"Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites"},{"code":"C84.A0","display":"Cutaneous T-cell lymphoma, unspecified, unspecified site"},{"code":"C84.A1","display":"Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck"},{"code":"C84.A2","display":"Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C84.A3","display":"Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C84.A4","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C84.A5","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C84.A6","display":"Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C84.A7","display":"Cutaneous T-cell lymphoma, unspecified, spleen"},{"code":"C84.A8","display":"Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C84.A9","display":"Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C84.Z0","display":"Other mature T/NK-cell lymphomas, unspecified site"},{"code":"C84.Z1","display":"Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck"},{"code":"C84.Z2","display":"Other mature T/NK-cell lymphomas, intrathoracic lymph nodes"},{"code":"C84.Z3","display":"Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes"},{"code":"C84.Z4","display":"Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb"},{"code":"C84.Z5","display":"Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb"},{"code":"C84.Z6","display":"Other mature T/NK-cell lymphomas, intrapelvic lymph nodes"},{"code":"C84.Z7","display":"Other mature T/NK-cell lymphomas, spleen"},{"code":"C84.Z8","display":"Other mature T/NK-cell lymphomas, lymph nodes of multiple sites"},{"code":"C84.Z9","display":"Other mature T/NK-cell lymphomas, extranodal and solid organ sites"},{"code":"C85.10","display":"Unspecified B-cell lymphoma, unspecified site"},{"code":"C85.11","display":"Unspecified B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.12","display":"Unspecified B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C85.13","display":"Unspecified B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C85.14","display":"Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.15","display":"Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.16","display":"Unspecified B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C85.17","display":"Unspecified B-cell lymphoma, spleen"},{"code":"C85.18","display":"Unspecified B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C85.19","display":"Unspecified B-cell lymphoma, extranodal and solid organ sites"},{"code":"C85.20","display":"Mediastinal (thymic) large B-cell lymphoma, unspecified site"},{"code":"C85.21","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.22","display":"Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes"},{"code":"C85.23","display":"Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes"},{"code":"C85.24","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.25","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.26","display":"Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes"},{"code":"C85.27","display":"Mediastinal (thymic) large B-cell lymphoma, spleen"},{"code":"C85.28","display":"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites"},{"code":"C85.29","display":"Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites"},{"code":"C85.80","display":"Other specified types of non-Hodgkin lymphoma, unspecified site"},{"code":"C85.81","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck"},{"code":"C85.82","display":"Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes"},{"code":"C85.83","display":"Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes"},{"code":"C85.84","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb"},{"code":"C85.85","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb"},{"code":"C85.86","display":"Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes"},{"code":"C85.87","display":"Other specified types of non-Hodgkin lymphoma, spleen"},{"code":"C85.88","display":"Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites"},{"code":"C85.89","display":"Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites"},{"code":"C85.90","display":"Non-Hodgkin lymphoma, unspecified, unspecified site"},{"code":"C85.91","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck"},{"code":"C85.92","display":"Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes"},{"code":"C85.93","display":"Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes"},{"code":"C85.94","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb"},{"code":"C85.95","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb"},{"code":"C85.96","display":"Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes"},{"code":"C85.97","display":"Non-Hodgkin lymphoma, unspecified, spleen"},{"code":"C85.98","display":"Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites"},{"code":"C85.99","display":"Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites"},{"code":"C86.0","display":"Extranodal NK/T-cell lymphoma, nasal type"},{"code":"C86.1","display":"Hepatosplenic T-cell lymphoma"},{"code":"C86.2","display":"Enteropathy-type (intestinal) T-cell lymphoma"},{"code":"C86.3","display":"Subcutaneous panniculitis-like T-cell lymphoma"},{"code":"C86.4","display":"Blastic NK-cell lymphoma"},{"code":"C86.5","display":"Angioimmunoblastic T-cell lymphoma"},{"code":"C86.6","display":"Primary cutaneous CD30-positive T-cell proliferations"},{"code":"C88.0","display":"Waldenström macroglobulinemia"},{"code":"C88.2","display":"Heavy chain disease"},{"code":"C88.3","display":"Immunoproliferative small intestinal disease"},{"code":"C88.4","display":"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]"},{"code":"C88.8","display":"Other malignant immunoproliferative diseases"},{"code":"C88.9","display":"Malignant immunoproliferative disease, unspecified"},{"code":"C90.00","display":"Multiple myeloma not having achieved remission"},{"code":"C90.01","display":"Multiple myeloma in remission"},{"code":"C90.02","display":"Multiple myeloma in relapse"},{"code":"C90.10","display":"Plasma cell leukemia not having achieved remission"},{"code":"C90.11","display":"Plasma cell leukemia in remission"},{"code":"C90.12","display":"Plasma cell leukemia in relapse"},{"code":"C90.20","display":"Extramedullary plasmacytoma not having achieved remission"},{"code":"C90.21","display":"Extramedullary plasmacytoma in remission"},{"code":"C90.22","display":"Extramedullary plasmacytoma in relapse"},{"code":"C90.30","display":"Solitary plasmacytoma not having achieved remission"},{"code":"C90.31","display":"Solitary plasmacytoma in remission"},{"code":"C90.32","display":"Solitary plasmacytoma in relapse"},{"code":"C91.00","display":"Acute lymphoblastic leukemia not having achieved remission"},{"code":"C91.01","display":"Acute lymphoblastic leukemia, in remission"},{"code":"C91.02","display":"Acute lymphoblastic leukemia, in relapse"},{"code":"C91.10","display":"Chronic lymphocytic leukemia of B-cell type not having achieved remission"},{"code":"C91.11","display":"Chronic lymphocytic leukemia of B-cell type in remission"},{"code":"C91.12","display":"Chronic lymphocytic leukemia of B-cell type in relapse"},{"code":"C91.30","display":"Prolymphocytic leukemia of B-cell type not having achieved remission"},{"code":"C91.31","display":"Prolymphocytic leukemia of B-cell type, in remission"},{"code":"C91.32","display":"Prolymphocytic leukemia of B-cell type, in relapse"},{"code":"C91.40","display":"Hairy cell leukemia not having achieved remission"},{"code":"C91.41","display":"Hairy cell leukemia, in remission"},{"code":"C91.42","display":"Hairy cell leukemia, in relapse"},{"code":"C91.50","display":"Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission"},{"code":"C91.51","display":"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission"},{"code":"C91.52","display":"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse"},{"code":"C91.60","display":"Prolymphocytic leukemia of T-cell type not having achieved remission"},{"code":"C91.61","display":"Prolymphocytic leukemia of T-cell type, in remission"},{"code":"C91.62","display":"Prolymphocytic leukemia of T-cell type, in relapse"},{"code":"C91.90","display":"Lymphoid leukemia, unspecified not having achieved remission"},{"code":"C91.91","display":"Lymphoid leukemia, unspecified, in remission"},{"code":"C91.92","display":"Lymphoid leukemia, unspecified, in relapse"},{"code":"C91.A0","display":"Mature B-cell leukemia Burkitt-type not having achieved remission"},{"code":"C91.A1","display":"Mature B-cell leukemia Burkitt-type, in remission"},{"code":"C91.A2","display":"Mature B-cell leukemia Burkitt-type, in relapse"},{"code":"C91.Z0","display":"Other lymphoid leukemia not having achieved remission"},{"code":"C91.Z1","display":"Other lymphoid leukemia, in remission"},{"code":"C91.Z2","display":"Other lymphoid leukemia, in relapse"},{"code":"C92.00","display":"Acute myeloblastic leukemia, not having achieved remission"},{"code":"C92.01","display":"Acute myeloblastic leukemia, in remission"},{"code":"C92.02","display":"Acute myeloblastic leukemia, in relapse"},{"code":"C92.10","display":"Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission"},{"code":"C92.11","display":"Chronic myeloid leukemia, BCR/ABL-positive, in remission"},{"code":"C92.12","display":"Chronic myeloid leukemia, BCR/ABL-positive, in relapse"},{"code":"C92.20","display":"Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission"},{"code":"C92.21","display":"Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission"},{"code":"C92.22","display":"Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse"},{"code":"C92.30","display":"Myeloid sarcoma, not having achieved remission"},{"code":"C92.31","display":"Myeloid sarcoma, in remission"},{"code":"C92.32","display":"Myeloid sarcoma, in relapse"},{"code":"C92.40","display":"Acute promyelocytic leukemia, not having achieved remission"},{"code":"C92.41","display":"Acute promyelocytic leukemia, in remission"},{"code":"C92.42","display":"Acute promyelocytic leukemia, in relapse"},{"code":"C92.50","display":"Acute myelomonocytic leukemia, not having achieved remission"},{"code":"C92.51","display":"Acute myelomonocytic leukemia, in remission"},{"code":"C92.52","display":"Acute myelomonocytic leukemia, in relapse"},{"code":"C92.60","display":"Acute myeloid leukemia with 11q23-abnormality not having achieved remission"},{"code":"C92.61","display":"Acute myeloid leukemia with 11q23-abnormality in remission"},{"code":"C92.62","display":"Acute myeloid leukemia with 11q23-abnormality in relapse"},{"code":"C92.90","display":"Myeloid leukemia, unspecified, not having achieved remission"},{"code":"C92.91","display":"Myeloid leukemia, unspecified in remission"},{"code":"C92.92","display":"Myeloid leukemia, unspecified in relapse"},{"code":"C92.A0","display":"Acute myeloid leukemia with multilineage dysplasia, not having achieved remission"},{"code":"C92.A1","display":"Acute myeloid leukemia with multilineage dysplasia, in remission"},{"code":"C92.A2","display":"Acute myeloid leukemia with multilineage dysplasia, in relapse"},{"code":"C92.Z0","display":"Other myeloid leukemia not having achieved remission"},{"code":"C92.Z1","display":"Other myeloid leukemia, in remission"},{"code":"C92.Z2","display":"Other myeloid leukemia, in relapse"},{"code":"C93.00","display":"Acute monoblastic/monocytic leukemia, not having achieved remission"},{"code":"C93.01","display":"Acute monoblastic/monocytic leukemia, in remission"},{"code":"C93.02","display":"Acute monoblastic/monocytic leukemia, in relapse"},{"code":"C93.10","display":"Chronic myelomonocytic leukemia not having achieved remission"},{"code":"C93.11","display":"Chronic myelomonocytic leukemia, in remission"},{"code":"C93.12","display":"Chronic myelomonocytic leukemia, in relapse"},{"code":"C93.30","display":"Juvenile myelomonocytic leukemia, not having achieved remission"},{"code":"C93.31","display":"Juvenile myelomonocytic leukemia, in remission"},{"code":"C93.32","display":"Juvenile myelomonocytic leukemia, in relapse"},{"code":"C93.90","display":"Monocytic leukemia, unspecified, not having achieved remission"},{"code":"C93.91","display":"Monocytic leukemia, unspecified in remission"},{"code":"C93.92","display":"Monocytic leukemia, unspecified in relapse"},{"code":"C93.Z0","display":"Other monocytic leukemia, not having achieved remission"},{"code":"C93.Z1","display":"Other monocytic leukemia, in remission"},{"code":"C93.Z2","display":"Other monocytic leukemia, in relapse"},{"code":"C94.00","display":"Acute erythroid leukemia, not having achieved remission"},{"code":"C94.01","display":"Acute erythroid leukemia, in remission"},{"code":"C94.02","display":"Acute erythroid leukemia, in relapse"},{"code":"C94.20","display":"Acute megakaryoblastic leukemia not having achieved remission"},{"code":"C94.21","display":"Acute megakaryoblastic leukemia, in remission"},{"code":"C94.22","display":"Acute megakaryoblastic leukemia, in relapse"},{"code":"C94.30","display":"Mast cell leukemia not having achieved remission"},{"code":"C94.31","display":"Mast cell leukemia, in remission"},{"code":"C94.32","display":"Mast cell leukemia, in relapse"},{"code":"C94.40","display":"Acute panmyelosis with myelofibrosis not having achieved remission"},{"code":"C94.41","display":"Acute panmyelosis with myelofibrosis, in remission"},{"code":"C94.42","display":"Acute panmyelosis with myelofibrosis, in relapse"},{"code":"C94.6","display":"Myelodysplastic disease, not classified"},{"code":"C94.80","display":"Other specified leukemias not having achieved remission"},{"code":"C94.81","display":"Other specified leukemias, in remission"},{"code":"C94.82","display":"Other specified leukemias, in relapse"},{"code":"C95.00","display":"Acute leukemia of unspecified cell type not having achieved remission"},{"code":"C95.01","display":"Acute leukemia of unspecified cell type, in remission"},{"code":"C95.02","display":"Acute leukemia of unspecified cell type, in relapse"},{"code":"C95.10","display":"Chronic leukemia of unspecified cell type not having achieved remission"},{"code":"C95.11","display":"Chronic leukemia of unspecified cell type, in remission"},{"code":"C95.12","display":"Chronic leukemia of unspecified cell type, in relapse"},{"code":"C95.90","display":"Leukemia, unspecified not having achieved remission"},{"code":"C95.91","display":"Leukemia, unspecified, in remission"},{"code":"C95.92","display":"Leukemia, unspecified, in relapse"},{"code":"C96.0","display":"Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis"},{"code":"C96.2","display":"Malignant mast cell neoplasm"},{"code":"C96.20","display":"Malignant mast cell neoplasm, unspecified"},{"code":"C96.21","display":"Aggressive systemic mastocytosis"},{"code":"C96.22","display":"Mast cell sarcoma"},{"code":"C96.29","display":"Other malignant mast cell neoplasm"},{"code":"C96.4","display":"Sarcoma of dendritic cells (accessory cells)"},{"code":"C96.5","display":"Multifocal and unisystemic Langerhans-cell histiocytosis"},{"code":"C96.6","display":"Unifocal Langerhans-cell histiocytosis"},{"code":"C96.9","display":"Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified"},{"code":"C96.A","display":"Histiocytic sarcoma"},{"code":"C96.Z","display":"Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue"},{"code":"D00.00","display":"Carcinoma in situ of oral cavity, unspecified site"},{"code":"D00.01","display":"Carcinoma in situ of labial mucosa and vermilion border"},{"code":"D00.02","display":"Carcinoma in situ of buccal mucosa"},{"code":"D00.03","display":"Carcinoma in situ of gingiva and edentulous alveolar ridge"},{"code":"D00.04","display":"Carcinoma in situ of soft palate"},{"code":"D00.05","display":"Carcinoma in situ of hard palate"},{"code":"D00.06","display":"Carcinoma in situ of floor of mouth"},{"code":"D00.07","display":"Carcinoma in situ of tongue"},{"code":"D00.08","display":"Carcinoma in situ of pharynx"},{"code":"D00.1","display":"Carcinoma in situ of esophagus"},{"code":"D00.2","display":"Carcinoma in situ of stomach"},{"code":"D01.0","display":"Carcinoma in situ of colon"},{"code":"D01.1","display":"Carcinoma in situ of rectosigmoid junction"},{"code":"D01.2","display":"Carcinoma in situ of rectum"},{"code":"D01.3","display":"Carcinoma in situ of anus and anal canal"},{"code":"D01.40","display":"Carcinoma in situ of unspecified part of intestine"},{"code":"D01.49","display":"Carcinoma in situ of other parts of intestine"},{"code":"D01.5","display":"Carcinoma in situ of liver, gallbladder and bile ducts"},{"code":"D01.7","display":"Carcinoma in situ of other specified digestive organs"},{"code":"D01.9","display":"Carcinoma in situ of digestive organ, unspecified"},{"code":"D02.0","display":"Carcinoma in situ of larynx"},{"code":"D02.1","display":"Carcinoma in situ of trachea"},{"code":"D02.20","display":"Carcinoma in situ of unspecified bronchus and lung"},{"code":"D02.21","display":"Carcinoma in situ of right bronchus and lung"},{"code":"D02.22","display":"Carcinoma in situ of left bronchus and lung"},{"code":"D02.3","display":"Carcinoma in situ of other parts of respiratory system"},{"code":"D02.4","display":"Carcinoma in situ of respiratory system, unspecified"},{"code":"D03.0","display":"Melanoma in situ of lip"},{"code":"D03.10","display":"Melanoma in situ of unspecified eyelid, including canthus"},{"code":"D03.11","display":"Melanoma in situ of right eyelid, including canthus"},{"code":"D03.111","display":"Melanoma in situ of right upper eyelid, including canthus"},{"code":"D03.112","display":"Melanoma in situ of right lower eyelid, including canthus"},{"code":"D03.12","display":"Melanoma in situ of left eyelid, including canthus"},{"code":"D03.121","display":"Melanoma in situ of left upper eyelid, including canthus"},{"code":"D03.122","display":"Melanoma in situ of left lower eyelid, including canthus"},{"code":"D03.20","display":"Melanoma in situ of unspecified ear and external auricular canal"},{"code":"D03.21","display":"Melanoma in situ of right ear and external auricular canal"},{"code":"D03.22","display":"Melanoma in situ of left ear and external auricular canal"},{"code":"D03.30","display":"Melanoma in situ of unspecified part of face"},{"code":"D03.39","display":"Melanoma in situ of other parts of face"},{"code":"D03.4","display":"Melanoma in situ of scalp and neck"},{"code":"D03.51","display":"Melanoma in situ of anal skin"},{"code":"D03.52","display":"Melanoma in situ of breast (skin) (soft tissue)"},{"code":"D03.59","display":"Melanoma in situ of other part of trunk"},{"code":"D03.60","display":"Melanoma in situ of unspecified upper limb, including shoulder"},{"code":"D03.61","display":"Melanoma in situ of right upper limb, including shoulder"},{"code":"D03.62","display":"Melanoma in situ of left upper limb, including shoulder"},{"code":"D03.70","display":"Melanoma in situ of unspecified lower limb, including hip"},{"code":"D03.71","display":"Melanoma in situ of right lower limb, including hip"},{"code":"D03.72","display":"Melanoma in situ of left lower limb, including hip"},{"code":"D03.8","display":"Melanoma in situ of other sites"},{"code":"D03.9","display":"Melanoma in situ, unspecified"},{"code":"D04.0","display":"Carcinoma in situ of skin of lip"},{"code":"D04.10","display":"Carcinoma in situ of skin of unspecified eyelid, including canthus"},{"code":"D04.11","display":"Carcinoma in situ of skin of right eyelid, including canthus"},{"code":"D04.111","display":"Carcinoma in situ of skin of right upper eyelid, including canthus"},{"code":"D04.112","display":"Carcinoma in situ of skin of right lower eyelid, including canthus"},{"code":"D04.12","display":"Carcinoma in situ of skin of left eyelid, including canthus"},{"code":"D04.121","display":"Carcinoma in situ of skin of left upper eyelid, including canthus"},{"code":"D04.122","display":"Carcinoma in situ of skin of left lower eyelid, including canthus"},{"code":"D04.20","display":"Carcinoma in situ of skin of unspecified ear and external auricular canal"},{"code":"D04.21","display":"Carcinoma in situ of skin of right ear and external auricular canal"},{"code":"D04.22","display":"Carcinoma in situ of skin of left ear and external auricular canal"},{"code":"D04.30","display":"Carcinoma in situ of skin of unspecified part of face"},{"code":"D04.39","display":"Carcinoma in situ of skin of other parts of face"},{"code":"D04.4","display":"Carcinoma in situ of skin of scalp and neck"},{"code":"D04.5","display":"Carcinoma in situ of skin of trunk"},{"code":"D04.60","display":"Carcinoma in situ of skin of unspecified upper limb, including shoulder"},{"code":"D04.61","display":"Carcinoma in situ of skin of right upper limb, including shoulder"},{"code":"D04.62","display":"Carcinoma in situ of skin of left upper limb, including shoulder"},{"code":"D04.70","display":"Carcinoma in situ of skin of unspecified lower limb, including hip"},{"code":"D04.71","display":"Carcinoma in situ of skin of right lower limb, including hip"},{"code":"D04.72","display":"Carcinoma in situ of skin of left lower limb, including hip"},{"code":"D04.8","display":"Carcinoma in situ of skin of other sites"},{"code":"D04.9","display":"Carcinoma in situ of skin, unspecified"},{"code":"D05.00","display":"Lobular carcinoma in situ of unspecified breast"},{"code":"D05.01","display":"Lobular carcinoma in situ of right breast"},{"code":"D05.02","display":"Lobular carcinoma in situ of left breast"},{"code":"D05.10","display":"Intraductal carcinoma in situ of unspecified breast"},{"code":"D05.11","display":"Intraductal carcinoma in situ of right breast"},{"code":"D05.12","display":"Intraductal carcinoma in situ of left breast"},{"code":"D05.80","display":"Other specified type of carcinoma in situ of unspecified breast"},{"code":"D05.81","display":"Other specified type of carcinoma in situ of right breast"},{"code":"D05.82","display":"Other specified type of carcinoma in situ of left breast"},{"code":"D05.90","display":"Unspecified type of carcinoma in situ of unspecified breast"},{"code":"D05.91","display":"Unspecified type of carcinoma in situ of right breast"},{"code":"D05.92","display":"Unspecified type of carcinoma in situ of left breast"},{"code":"D06.0","display":"Carcinoma in situ of endocervix"},{"code":"D06.1","display":"Carcinoma in situ of exocervix"},{"code":"D06.7","display":"Carcinoma in situ of other parts of cervix"},{"code":"D06.9","display":"Carcinoma in situ of cervix, unspecified"},{"code":"D07.0","display":"Carcinoma in situ of endometrium"},{"code":"D07.1","display":"Carcinoma in situ of vulva"},{"code":"D07.2","display":"Carcinoma in situ of vagina"},{"code":"D07.30","display":"Carcinoma in situ of unspecified female genital organs"},{"code":"D07.39","display":"Carcinoma in situ of other female genital organs"},{"code":"D07.4","display":"Carcinoma in situ of penis"},{"code":"D07.5","display":"Carcinoma in situ of prostate"},{"code":"D07.60","display":"Carcinoma in situ of unspecified male genital organs"},{"code":"D07.61","display":"Carcinoma in situ of scrotum"},{"code":"D07.69","display":"Carcinoma in situ of other male genital organs"},{"code":"D09.0","display":"Carcinoma in situ of bladder"},{"code":"D09.10","display":"Carcinoma in situ of unspecified urinary organ"},{"code":"D09.19","display":"Carcinoma in situ of other urinary organs"},{"code":"D09.20","display":"Carcinoma in situ of unspecified eye"},{"code":"D09.21","display":"Carcinoma in situ of right eye"},{"code":"D09.22","display":"Carcinoma in situ of left eye"},{"code":"D09.3","display":"Carcinoma in situ of thyroid and other endocrine glands"},{"code":"D09.8","display":"Carcinoma in situ of other specified sites"},{"code":"D09.9","display":"Carcinoma in situ, unspecified"},{"code":"D10.0","display":"Benign neoplasm of lip"},{"code":"D10.1","display":"Benign neoplasm of tongue"},{"code":"D10.2","display":"Benign neoplasm of floor of mouth"},{"code":"D10.30","display":"Benign neoplasm of unspecified part of mouth"},{"code":"D10.39","display":"Benign neoplasm of other parts of mouth"},{"code":"D10.4","display":"Benign neoplasm of tonsil"},{"code":"D10.5","display":"Benign neoplasm of other parts of oropharynx"},{"code":"D10.6","display":"Benign neoplasm of nasopharynx"},{"code":"D10.7","display":"Benign neoplasm of hypopharynx"},{"code":"D10.9","display":"Benign neoplasm of pharynx, unspecified"},{"code":"D11.0","display":"Benign neoplasm of parotid gland"},{"code":"D11.7","display":"Benign neoplasm of other major salivary glands"},{"code":"D11.9","display":"Benign neoplasm of major salivary gland, unspecified"},{"code":"D12.0","display":"Benign neoplasm of cecum"},{"code":"D12.1","display":"Benign neoplasm of appendix"},{"code":"D12.2","display":"Benign neoplasm of ascending colon"},{"code":"D12.3","display":"Benign neoplasm of transverse colon"},{"code":"D12.4","display":"Benign neoplasm of descending colon"},{"code":"D12.5","display":"Benign neoplasm of sigmoid colon"},{"code":"D12.6","display":"Benign neoplasm of colon, unspecified"},{"code":"D12.7","display":"Benign neoplasm of rectosigmoid junction"},{"code":"D12.8","display":"Benign neoplasm of rectum"},{"code":"D12.9","display":"Benign neoplasm of anus and anal canal"},{"code":"D13.0","display":"Benign neoplasm of esophagus"},{"code":"D13.1","display":"Benign neoplasm of stomach"},{"code":"D13.2","display":"Benign neoplasm of duodenum"},{"code":"D13.30","display":"Benign neoplasm of unspecified part of small intestine"},{"code":"D13.39","display":"Benign neoplasm of other parts of small intestine"},{"code":"D13.4","display":"Benign neoplasm of liver"},{"code":"D13.5","display":"Benign neoplasm of extrahepatic bile ducts"},{"code":"D13.6","display":"Benign neoplasm of pancreas"},{"code":"D13.7","display":"Benign neoplasm of endocrine pancreas"},{"code":"D13.9","display":"Benign neoplasm of ill-defined sites within the digestive system"},{"code":"D14.0","display":"Benign neoplasm of middle ear, nasal cavity and accessory sinuses"},{"code":"D14.1","display":"Benign neoplasm of larynx"},{"code":"D14.2","display":"Benign neoplasm of trachea"},{"code":"D14.30","display":"Benign neoplasm of unspecified bronchus and lung"},{"code":"D14.31","display":"Benign neoplasm of right bronchus and lung"},{"code":"D14.32","display":"Benign neoplasm of left bronchus and lung"},{"code":"D14.4","display":"Benign neoplasm of respiratory system, unspecified"},{"code":"D15.0","display":"Benign neoplasm of thymus"},{"code":"D15.1","display":"Benign neoplasm of heart"},{"code":"D15.2","display":"Benign neoplasm of mediastinum"},{"code":"D15.7","display":"Benign neoplasm of other specified intrathoracic organs"},{"code":"D15.9","display":"Benign neoplasm of intrathoracic organ, unspecified"},{"code":"D16.00","display":"Benign neoplasm of scapula and long bones of unspecified upper limb"},{"code":"D16.01","display":"Benign neoplasm of scapula and long bones of right upper limb"},{"code":"D16.02","display":"Benign neoplasm of scapula and long bones of left upper limb"},{"code":"D16.10","display":"Benign neoplasm of short bones of unspecified upper limb"},{"code":"D16.11","display":"Benign neoplasm of short bones of right upper limb"},{"code":"D16.12","display":"Benign neoplasm of short bones of left upper limb"},{"code":"D16.20","display":"Benign neoplasm of long bones of unspecified lower limb"},{"code":"D16.21","display":"Benign neoplasm of long bones of right lower limb"},{"code":"D16.22","display":"Benign neoplasm of long bones of left lower limb"},{"code":"D16.30","display":"Benign neoplasm of short bones of unspecified lower limb"},{"code":"D16.31","display":"Benign neoplasm of short bones of right lower limb"},{"code":"D16.32","display":"Benign neoplasm of short bones of left lower limb"},{"code":"D16.4","display":"Benign neoplasm of bones of skull and face"},{"code":"D16.5","display":"Benign neoplasm of lower jaw bone"},{"code":"D16.6","display":"Benign neoplasm of vertebral column"},{"code":"D16.7","display":"Benign neoplasm of ribs, sternum and clavicle"},{"code":"D16.8","display":"Benign neoplasm of pelvic bones, sacrum and coccyx"},{"code":"D16.9","display":"Benign neoplasm of bone and articular cartilage, unspecified"},{"code":"D17.0","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck"},{"code":"D17.1","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk"},{"code":"D17.20","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified limb"},{"code":"D17.21","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of right arm"},{"code":"D17.22","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of left arm"},{"code":"D17.23","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of right leg"},{"code":"D17.24","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of left leg"},{"code":"D17.30","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of unspecified sites"},{"code":"D17.39","display":"Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites"},{"code":"D17.4","display":"Benign lipomatous neoplasm of intrathoracic organs"},{"code":"D17.5","display":"Benign lipomatous neoplasm of intra-abdominal organs"},{"code":"D17.6","display":"Benign lipomatous neoplasm of spermatic cord"},{"code":"D17.71","display":"Benign lipomatous neoplasm of kidney"},{"code":"D17.72","display":"Benign lipomatous neoplasm of other genitourinary organ"},{"code":"D17.79","display":"Benign lipomatous neoplasm of other sites"},{"code":"D17.9","display":"Benign lipomatous neoplasm, unspecified"},{"code":"D18.00","display":"Hemangioma unspecified site"},{"code":"D18.01","display":"Hemangioma of skin and subcutaneous tissue"},{"code":"D18.02","display":"Hemangioma of intracranial structures"},{"code":"D18.03","display":"Hemangioma of intra-abdominal structures"},{"code":"D18.09","display":"Hemangioma of other sites"},{"code":"D18.1","display":"Lymphangioma, any site"},{"code":"D19.0","display":"Benign neoplasm of mesothelial tissue of pleura"},{"code":"D19.1","display":"Benign neoplasm of mesothelial tissue of peritoneum"},{"code":"D19.7","display":"Benign neoplasm of mesothelial tissue of other sites"},{"code":"D19.9","display":"Benign neoplasm of mesothelial tissue, unspecified"},{"code":"D20.0","display":"Benign neoplasm of soft tissue of retroperitoneum"},{"code":"D20.1","display":"Benign neoplasm of soft tissue of peritoneum"},{"code":"D21.0","display":"Benign neoplasm of connective and other soft tissue of head, face and neck"},{"code":"D21.10","display":"Benign neoplasm of connective and other soft tissue of unspecified upper limb, including shoulder"},{"code":"D21.11","display":"Benign neoplasm of connective and other soft tissue of right upper limb, including shoulder"},{"code":"D21.12","display":"Benign neoplasm of connective and other soft tissue of left upper limb, including shoulder"},{"code":"D21.20","display":"Benign neoplasm of connective and other soft tissue of unspecified lower limb, including hip"},{"code":"D21.21","display":"Benign neoplasm of connective and other soft tissue of right lower limb, including hip"},{"code":"D21.22","display":"Benign neoplasm of connective and other soft tissue of left lower limb, including hip"},{"code":"D21.3","display":"Benign neoplasm of connective and other soft tissue of thorax"},{"code":"D21.4","display":"Benign neoplasm of connective and other soft tissue of abdomen"},{"code":"D21.5","display":"Benign neoplasm of connective and other soft tissue of pelvis"},{"code":"D21.6","display":"Benign neoplasm of connective and other soft tissue of trunk, unspecified"},{"code":"D21.9","display":"Benign neoplasm of connective and other soft tissue, unspecified"},{"code":"D22.0","display":"Melanocytic nevi of lip"},{"code":"D22.10","display":"Melanocytic nevi of unspecified eyelid, including canthus"},{"code":"D22.11","display":"Melanocytic nevi of right eyelid, including canthus"},{"code":"D22.111","display":"Melanocytic nevi of right upper eyelid, including canthus"},{"code":"D22.112","display":"Melanocytic nevi of right lower eyelid, including canthus"},{"code":"D22.12","display":"Melanocytic nevi of left eyelid, including canthus"},{"code":"D22.121","display":"Melanocytic nevi of left upper eyelid, including canthus"},{"code":"D22.122","display":"Melanocytic nevi of left lower eyelid, including canthus"},{"code":"D22.20","display":"Melanocytic nevi of unspecified ear and external auricular canal"},{"code":"D22.21","display":"Melanocytic nevi of right ear and external auricular canal"},{"code":"D22.22","display":"Melanocytic nevi of left ear and external auricular canal"},{"code":"D22.30","display":"Melanocytic nevi of unspecified part of face"},{"code":"D22.39","display":"Melanocytic nevi of other parts of face"},{"code":"D22.4","display":"Melanocytic nevi of scalp and neck"},{"code":"D22.5","display":"Melanocytic nevi of trunk"},{"code":"D22.60","display":"Melanocytic nevi of unspecified upper limb, including shoulder"},{"code":"D22.61","display":"Melanocytic nevi of right upper limb, including shoulder"},{"code":"D22.62","display":"Melanocytic nevi of left upper limb, including shoulder"},{"code":"D22.70","display":"Melanocytic nevi of unspecified lower limb, including hip"},{"code":"D22.71","display":"Melanocytic nevi of right lower limb, including hip"},{"code":"D22.72","display":"Melanocytic nevi of left lower limb, including hip"},{"code":"D22.9","display":"Melanocytic nevi, unspecified"},{"code":"D23.0","display":"Other benign neoplasm of skin of lip"},{"code":"D23.10","display":"Other benign neoplasm of skin of unspecified eyelid, including canthus"},{"code":"D23.11","display":"Other benign neoplasm of skin of right eyelid, including canthus"},{"code":"D23.111","display":"Other benign neoplasm of skin of right upper eyelid, including canthus"},{"code":"D23.112","display":"Other benign neoplasm of skin of right lower eyelid, including canthus"},{"code":"D23.12","display":"Other benign neoplasm of skin of left eyelid, including canthus"},{"code":"D23.121","display":"Other benign neoplasm of skin of left upper eyelid, including canthus"},{"code":"D23.122","display":"Other benign neoplasm of skin of left lower eyelid, including canthus"},{"code":"D23.20","display":"Other benign neoplasm of skin of unspecified ear and external auricular canal"},{"code":"D23.21","display":"Other benign neoplasm of skin of right ear and external auricular canal"},{"code":"D23.22","display":"Other benign neoplasm of skin of left ear and external auricular canal"},{"code":"D23.30","display":"Other benign neoplasm of skin of unspecified part of face"},{"code":"D23.39","display":"Other benign neoplasm of skin of other parts of face"},{"code":"D23.4","display":"Other benign neoplasm of skin of scalp and neck"},{"code":"D23.5","display":"Other benign neoplasm of skin of trunk"},{"code":"D23.60","display":"Other benign neoplasm of skin of unspecified upper limb, including shoulder"},{"code":"D23.61","display":"Other benign neoplasm of skin of right upper limb, including shoulder"},{"code":"D23.62","display":"Other benign neoplasm of skin of left upper limb, including shoulder"},{"code":"D23.70","display":"Other benign neoplasm of skin of unspecified lower limb, including hip"},{"code":"D23.71","display":"Other benign neoplasm of skin of right lower limb, including hip"},{"code":"D23.72","display":"Other benign neoplasm of skin of left lower limb, including hip"},{"code":"D23.9","display":"Other benign neoplasm of skin, unspecified"},{"code":"D24.1","display":"Benign neoplasm of right breast"},{"code":"D24.2","display":"Benign neoplasm of left breast"},{"code":"D24.9","display":"Benign neoplasm of unspecified breast"},{"code":"D25.0","display":"Submucous leiomyoma of uterus"},{"code":"D25.1","display":"Intramural leiomyoma of uterus"},{"code":"D25.2","display":"Subserosal leiomyoma of uterus"},{"code":"D25.9","display":"Leiomyoma of uterus, unspecified"},{"code":"D26.0","display":"Other benign neoplasm of cervix uteri"},{"code":"D26.1","display":"Other benign neoplasm of corpus uteri"},{"code":"D26.7","display":"Other benign neoplasm of other parts of uterus"},{"code":"D26.9","display":"Other benign neoplasm of uterus, unspecified"},{"code":"D27.0","display":"Benign neoplasm of right ovary"},{"code":"D27.1","display":"Benign neoplasm of left ovary"},{"code":"D27.9","display":"Benign neoplasm of unspecified ovary"},{"code":"D28.0","display":"Benign neoplasm of vulva"},{"code":"D28.1","display":"Benign neoplasm of vagina"},{"code":"D28.2","display":"Benign neoplasm of uterine tubes and ligaments"},{"code":"D28.7","display":"Benign neoplasm of other specified female genital organs"},{"code":"D28.9","display":"Benign neoplasm of female genital organ, unspecified"},{"code":"D29.0","display":"Benign neoplasm of penis"},{"code":"D29.1","display":"Benign neoplasm of prostate"},{"code":"D29.20","display":"Benign neoplasm of unspecified testis"},{"code":"D29.21","display":"Benign neoplasm of right testis"},{"code":"D29.22","display":"Benign neoplasm of left testis"},{"code":"D29.30","display":"Benign neoplasm of unspecified epididymis"},{"code":"D29.31","display":"Benign neoplasm of right epididymis"},{"code":"D29.32","display":"Benign neoplasm of left epididymis"},{"code":"D29.4","display":"Benign neoplasm of scrotum"},{"code":"D29.8","display":"Benign neoplasm of other specified male genital organs"},{"code":"D29.9","display":"Benign neoplasm of male genital organ, unspecified"},{"code":"D30.00","display":"Benign neoplasm of unspecified kidney"},{"code":"D30.01","display":"Benign neoplasm of right kidney"},{"code":"D30.02","display":"Benign neoplasm of left kidney"},{"code":"D30.10","display":"Benign neoplasm of unspecified renal pelvis"},{"code":"D30.11","display":"Benign neoplasm of right renal pelvis"},{"code":"D30.12","display":"Benign neoplasm of left renal pelvis"},{"code":"D30.20","display":"Benign neoplasm of unspecified ureter"},{"code":"D30.21","display":"Benign neoplasm of right ureter"},{"code":"D30.22","display":"Benign neoplasm of left ureter"},{"code":"D30.3","display":"Benign neoplasm of bladder"},{"code":"D30.4","display":"Benign neoplasm of urethra"},{"code":"D30.8","display":"Benign neoplasm of other specified urinary organs"},{"code":"D30.9","display":"Benign neoplasm of urinary organ, unspecified"},{"code":"D31.00","display":"Benign neoplasm of unspecified conjunctiva"},{"code":"D31.01","display":"Benign neoplasm of right conjunctiva"},{"code":"D31.02","display":"Benign neoplasm of left conjunctiva"},{"code":"D31.10","display":"Benign neoplasm of unspecified cornea"},{"code":"D31.11","display":"Benign neoplasm of right cornea"},{"code":"D31.12","display":"Benign neoplasm of left cornea"},{"code":"D31.20","display":"Benign neoplasm of unspecified retina"},{"code":"D31.21","display":"Benign neoplasm of right retina"},{"code":"D31.22","display":"Benign neoplasm of left retina"},{"code":"D31.30","display":"Benign neoplasm of unspecified choroid"},{"code":"D31.31","display":"Benign neoplasm of right choroid"},{"code":"D31.32","display":"Benign neoplasm of left choroid"},{"code":"D31.40","display":"Benign neoplasm of unspecified ciliary body"},{"code":"D31.41","display":"Benign neoplasm of right ciliary body"},{"code":"D31.42","display":"Benign neoplasm of left ciliary body"},{"code":"D31.50","display":"Benign neoplasm of unspecified lacrimal gland and duct"},{"code":"D31.51","display":"Benign neoplasm of right lacrimal gland and duct"},{"code":"D31.52","display":"Benign neoplasm of left lacrimal gland and duct"},{"code":"D31.60","display":"Benign neoplasm of unspecified site of unspecified orbit"},{"code":"D31.61","display":"Benign neoplasm of unspecified site of right orbit"},{"code":"D31.62","display":"Benign neoplasm of unspecified site of left orbit"},{"code":"D31.90","display":"Benign neoplasm of unspecified part of unspecified eye"},{"code":"D31.91","display":"Benign neoplasm of unspecified part of right eye"},{"code":"D31.92","display":"Benign neoplasm of unspecified part of left eye"},{"code":"D32.0","display":"Benign neoplasm of cerebral meninges"},{"code":"D32.1","display":"Benign neoplasm of spinal meninges"},{"code":"D32.9","display":"Benign neoplasm of meninges, unspecified"},{"code":"D33.0","display":"Benign neoplasm of brain, supratentorial"},{"code":"D33.1","display":"Benign neoplasm of brain, infratentorial"},{"code":"D33.2","display":"Benign neoplasm of brain, unspecified"},{"code":"D33.3","display":"Benign neoplasm of cranial nerves"},{"code":"D33.4","display":"Benign neoplasm of spinal cord"},{"code":"D33.7","display":"Benign neoplasm of other specified parts of central nervous system"},{"code":"D33.9","display":"Benign neoplasm of central nervous system, unspecified"},{"code":"D34","display":"Benign neoplasm of thyroid gland"},{"code":"D35.00","display":"Benign neoplasm of unspecified adrenal gland"},{"code":"D35.01","display":"Benign neoplasm of right adrenal gland"},{"code":"D35.02","display":"Benign neoplasm of left adrenal gland"},{"code":"D35.1","display":"Benign neoplasm of parathyroid gland"},{"code":"D35.2","display":"Benign neoplasm of pituitary gland"},{"code":"D35.3","display":"Benign neoplasm of craniopharyngeal duct"},{"code":"D35.4","display":"Benign neoplasm of pineal gland"},{"code":"D35.5","display":"Benign neoplasm of carotid body"},{"code":"D35.6","display":"Benign neoplasm of aortic body and other paraganglia"},{"code":"D35.7","display":"Benign neoplasm of other specified endocrine glands"},{"code":"D35.9","display":"Benign neoplasm of endocrine gland, unspecified"},{"code":"D36.0","display":"Benign neoplasm of lymph nodes"},{"code":"D36.10","display":"Benign neoplasm of peripheral nerves and autonomic nervous system, unspecified"},{"code":"D36.11","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of face, head, and neck"},{"code":"D36.12","display":"Benign neoplasm of peripheral nerves and autonomic nervous system, upper limb, including shoulder"},{"code":"D36.13","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of lower limb, including hip"},{"code":"D36.14","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of thorax"},{"code":"D36.15","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of abdomen"},{"code":"D36.16","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of pelvis"},{"code":"D36.17","display":"Benign neoplasm of peripheral nerves and autonomic nervous system of trunk, unspecified"},{"code":"D36.7","display":"Benign neoplasm of other specified sites"},{"code":"D36.9","display":"Benign neoplasm, unspecified site"},{"code":"D37.01","display":"Neoplasm of uncertain behavior of lip"},{"code":"D37.02","display":"Neoplasm of uncertain behavior of tongue"},{"code":"D37.030","display":"Neoplasm of uncertain behavior of the parotid salivary glands"},{"code":"D37.031","display":"Neoplasm of uncertain behavior of the sublingual salivary glands"},{"code":"D37.032","display":"Neoplasm of uncertain behavior of the submandibular salivary glands"},{"code":"D37.039","display":"Neoplasm of uncertain behavior of the major salivary glands, unspecified"},{"code":"D37.04","display":"Neoplasm of uncertain behavior of the minor salivary glands"},{"code":"D37.05","display":"Neoplasm of uncertain behavior of pharynx"},{"code":"D37.09","display":"Neoplasm of uncertain behavior of other specified sites of the oral cavity"},{"code":"D37.1","display":"Neoplasm of uncertain behavior of stomach"},{"code":"D37.2","display":"Neoplasm of uncertain behavior of small intestine"},{"code":"D37.3","display":"Neoplasm of uncertain behavior of appendix"},{"code":"D37.4","display":"Neoplasm of uncertain behavior of colon"},{"code":"D37.5","display":"Neoplasm of uncertain behavior of rectum"},{"code":"D37.6","display":"Neoplasm of uncertain behavior of liver, gallbladder and bile ducts"},{"code":"D37.8","display":"Neoplasm of uncertain behavior of other specified digestive organs"},{"code":"D37.9","display":"Neoplasm of uncertain behavior of digestive organ, unspecified"},{"code":"D38.0","display":"Neoplasm of uncertain behavior of larynx"},{"code":"D38.1","display":"Neoplasm of uncertain behavior of trachea, bronchus and lung"},{"code":"D38.2","display":"Neoplasm of uncertain behavior of pleura"},{"code":"D38.3","display":"Neoplasm of uncertain behavior of mediastinum"},{"code":"D38.4","display":"Neoplasm of uncertain behavior of thymus"},{"code":"D38.5","display":"Neoplasm of uncertain behavior of other respiratory organs"},{"code":"D38.6","display":"Neoplasm of uncertain behavior of respiratory organ, unspecified"},{"code":"D39.0","display":"Neoplasm of uncertain behavior of uterus"},{"code":"D39.10","display":"Neoplasm of uncertain behavior of unspecified ovary"},{"code":"D39.11","display":"Neoplasm of uncertain behavior of right ovary"},{"code":"D39.12","display":"Neoplasm of uncertain behavior of left ovary"},{"code":"D39.2","display":"Neoplasm of uncertain behavior of placenta"},{"code":"D39.8","display":"Neoplasm of uncertain behavior of other specified female genital organs"},{"code":"D39.9","display":"Neoplasm of uncertain behavior of female genital organ, unspecified"},{"code":"D3A.00","display":"Benign carcinoid tumor of unspecified site"},{"code":"D3A.010","display":"Benign carcinoid tumor of the duodenum"},{"code":"D3A.011","display":"Benign carcinoid tumor of the jejunum"},{"code":"D3A.012","display":"Benign carcinoid tumor of the ileum"},{"code":"D3A.019","display":"Benign carcinoid tumor of the small intestine, unspecified portion"},{"code":"D3A.020","display":"Benign carcinoid tumor of the appendix"},{"code":"D3A.021","display":"Benign carcinoid tumor of the cecum"},{"code":"D3A.022","display":"Benign carcinoid tumor of the ascending colon"},{"code":"D3A.023","display":"Benign carcinoid tumor of the transverse colon"},{"code":"D3A.024","display":"Benign carcinoid tumor of the descending colon"},{"code":"D3A.025","display":"Benign carcinoid tumor of the sigmoid colon"},{"code":"D3A.026","display":"Benign carcinoid tumor of the rectum"},{"code":"D3A.029","display":"Benign carcinoid tumor of the large intestine, unspecified portion"},{"code":"D3A.090","display":"Benign carcinoid tumor of the bronchus and lung"},{"code":"D3A.091","display":"Benign carcinoid tumor of the thymus"},{"code":"D3A.092","display":"Benign carcinoid tumor of the stomach"},{"code":"D3A.093","display":"Benign carcinoid tumor of the kidney"},{"code":"D3A.094","display":"Benign carcinoid tumor of the foregut, unspecified"},{"code":"D3A.095","display":"Benign carcinoid tumor of the midgut, unspecified"},{"code":"D3A.096","display":"Benign carcinoid tumor of the hindgut, unspecified"},{"code":"D3A.098","display":"Benign carcinoid tumors of other sites"},{"code":"D3A.8","display":"Other benign neuroendocrine tumors"},{"code":"D40.0","display":"Neoplasm of uncertain behavior of prostate"},{"code":"D40.10","display":"Neoplasm of uncertain behavior of unspecified testis"},{"code":"D40.11","display":"Neoplasm of uncertain behavior of right testis"},{"code":"D40.12","display":"Neoplasm of uncertain behavior of left testis"},{"code":"D40.8","display":"Neoplasm of uncertain behavior of other specified male genital organs"},{"code":"D40.9","display":"Neoplasm of uncertain behavior of male genital organ, unspecified"},{"code":"D41.00","display":"Neoplasm of uncertain behavior of unspecified kidney"},{"code":"D41.01","display":"Neoplasm of uncertain behavior of right kidney"},{"code":"D41.02","display":"Neoplasm of uncertain behavior of left kidney"},{"code":"D41.10","display":"Neoplasm of uncertain behavior of unspecified renal pelvis"},{"code":"D41.11","display":"Neoplasm of uncertain behavior of right renal pelvis"},{"code":"D41.12","display":"Neoplasm of uncertain behavior of left renal pelvis"},{"code":"D41.20","display":"Neoplasm of uncertain behavior of unspecified ureter"},{"code":"D41.21","display":"Neoplasm of uncertain behavior of right ureter"},{"code":"D41.22","display":"Neoplasm of uncertain behavior of left ureter"},{"code":"D41.3","display":"Neoplasm of uncertain behavior of urethra"},{"code":"D41.4","display":"Neoplasm of uncertain behavior of bladder"},{"code":"D41.8","display":"Neoplasm of uncertain behavior of other specified urinary organs"},{"code":"D41.9","display":"Neoplasm of uncertain behavior of unspecified urinary organ"},{"code":"D42.0","display":"Neoplasm of uncertain behavior of cerebral meninges"},{"code":"D42.1","display":"Neoplasm of uncertain behavior of spinal meninges"},{"code":"D42.9","display":"Neoplasm of uncertain behavior of meninges, unspecified"},{"code":"D43.0","display":"Neoplasm of uncertain behavior of brain, supratentorial"},{"code":"D43.1","display":"Neoplasm of uncertain behavior of brain, infratentorial"},{"code":"D43.2","display":"Neoplasm of uncertain behavior of brain, unspecified"},{"code":"D43.3","display":"Neoplasm of uncertain behavior of cranial nerves"},{"code":"D43.4","display":"Neoplasm of uncertain behavior of spinal cord"},{"code":"D43.8","display":"Neoplasm of uncertain behavior of other specified parts of central nervous system"},{"code":"D43.9","display":"Neoplasm of uncertain behavior of central nervous system, unspecified"},{"code":"D44.0","display":"Neoplasm of uncertain behavior of thyroid gland"},{"code":"D44.10","display":"Neoplasm of uncertain behavior of unspecified adrenal gland"},{"code":"D44.11","display":"Neoplasm of uncertain behavior of right adrenal gland"},{"code":"D44.12","display":"Neoplasm of uncertain behavior of left adrenal gland"},{"code":"D44.2","display":"Neoplasm of uncertain behavior of parathyroid gland"},{"code":"D44.3","display":"Neoplasm of uncertain behavior of pituitary gland"},{"code":"D44.4","display":"Neoplasm of uncertain behavior of craniopharyngeal duct"},{"code":"D44.5","display":"Neoplasm of uncertain behavior of pineal gland"},{"code":"D44.6","display":"Neoplasm of uncertain behavior of carotid body"},{"code":"D44.7","display":"Neoplasm of uncertain behavior of aortic body and other paraganglia"},{"code":"D44.9","display":"Neoplasm of uncertain behavior of unspecified endocrine gland"},{"code":"D45","display":"Polycythemia vera"},{"code":"D46.0","display":"Refractory anemia without ring sideroblasts, so stated"},{"code":"D46.1","display":"Refractory anemia with ring sideroblasts"},{"code":"D46.20","display":"Refractory anemia with excess of blasts, unspecified"},{"code":"D46.21","display":"Refractory anemia with excess of blasts 1"},{"code":"D46.22","display":"Refractory anemia with excess of blasts 2"},{"code":"D46.4","display":"Refractory anemia, unspecified"},{"code":"D46.9","display":"Myelodysplastic syndrome, unspecified"},{"code":"D46.A","display":"Refractory cytopenia with multilineage dysplasia"},{"code":"D46.B","display":"Refractory cytopenia with multilineage dysplasia and ring sideroblasts"},{"code":"D46.C","display":"Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality"},{"code":"D46.Z","display":"Other myelodysplastic syndromes"},{"code":"D47.0","display":"Mast cell neoplasms of uncertain behavior"},{"code":"D47.01","display":"Cutaneous mastocytosis"},{"code":"D47.02","display":"Systemic mastocytosis"},{"code":"D47.09","display":"Other mast cell neoplasms of uncertain behavior"},{"code":"D47.1","display":"Chronic myeloproliferative disease"},{"code":"D47.2","display":"Monoclonal gammopathy"},{"code":"D47.3","display":"Essential (hemorrhagic) thrombocythemia"},{"code":"D47.4","display":"Osteomyelofibrosis"},{"code":"D47.9","display":"Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified"},{"code":"D47.Z1","display":"Post-transplant lymphoproliferative disorder (PTLD)"},{"code":"D47.Z2","display":"Castleman disease"},{"code":"D47.Z9","display":"Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue"},{"code":"D48.0","display":"Neoplasm of uncertain behavior of bone and articular cartilage"},{"code":"D48.1","display":"Neoplasm of uncertain behavior of connective and other soft tissue"},{"code":"D48.2","display":"Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system"},{"code":"D48.3","display":"Neoplasm of uncertain behavior of retroperitoneum"},{"code":"D48.4","display":"Neoplasm of uncertain behavior of peritoneum"},{"code":"D48.5","display":"Neoplasm of uncertain behavior of skin"},{"code":"D48.60","display":"Neoplasm of uncertain behavior of unspecified breast"},{"code":"D48.61","display":"Neoplasm of uncertain behavior of right breast"},{"code":"D48.62","display":"Neoplasm of uncertain behavior of left breast"},{"code":"D48.7","display":"Neoplasm of uncertain behavior of other specified sites"},{"code":"D48.9","display":"Neoplasm of uncertain behavior, unspecified"},{"code":"D49.0","display":"Neoplasm of unspecified behavior of digestive system"},{"code":"D49.1","display":"Neoplasm of unspecified behavior of respiratory system"},{"code":"D49.2","display":"Neoplasm of unspecified behavior of bone, soft tissue, and skin"},{"code":"D49.3","display":"Neoplasm of unspecified behavior of breast"},{"code":"D49.4","display":"Neoplasm of unspecified behavior of bladder"},{"code":"D49.5","display":"Neoplasm of unspecified behavior of other genitourinary organs"},{"code":"D49.511","display":"Neoplasm of unspecified behavior of right kidney"},{"code":"D49.512","display":"Neoplasm of unspecified behavior of left kidney"},{"code":"D49.519","display":"Neoplasm of unspecified behavior of unspecified kidney"},{"code":"D49.59","display":"Neoplasm of unspecified behavior of other genitourinary organ"},{"code":"D49.6","display":"Neoplasm of unspecified behavior of brain"},{"code":"D49.7","display":"Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system"},{"code":"D49.81","display":"Neoplasm of unspecified behavior of retina and choroid"},{"code":"D49.89","display":"Neoplasm of unspecified behavior of other specified sites"},{"code":"D49.9","display":"Neoplasm of unspecified behavior of unspecified site"},{"code":"E31.22","display":"Multiple endocrine neoplasia [MEN] type IIA"},{"code":"E31.23","display":"Multiple endocrine neoplasia [MEN] type IIB"},{"code":"G43.601","display":"Persistent migraine aura with cerebral infarction, not intractable, with status migrainosus"},{"code":"G43.609","display":"Persistent migraine aura with cerebral infarction, not intractable, without status migrainosus"},{"code":"G43.611","display":"Persistent migraine aura with cerebral infarction, intractable, with status migrainosus"},{"code":"G43.619","display":"Persistent migraine aura with cerebral infarction, intractable, without status migrainosus"},{"code":"G45.0","display":"Vertebro-basilar artery syndrome"},{"code":"G45.1","display":"Carotid artery syndrome (hemispheric)"},{"code":"G45.2","display":"Multiple and bilateral precerebral artery syndromes"},{"code":"G45.3","display":"Amaurosis fugax"},{"code":"G45.4","display":"Transient global amnesia"},{"code":"G45.8","display":"Other transient cerebral ischemic attacks and related syndromes"},{"code":"G45.9","display":"Transient cerebral ischemic attack, unspecified"},{"code":"G46.0","display":"Middle cerebral artery syndrome"},{"code":"G46.1","display":"Anterior cerebral artery syndrome"},{"code":"G46.2","display":"Posterior cerebral artery syndrome"},{"code":"G46.3","display":"Brain stem stroke syndrome"},{"code":"G46.4","display":"Cerebellar stroke syndrome"},{"code":"G46.5","display":"Pure motor lacunar syndrome"},{"code":"G46.6","display":"Pure sensory lacunar syndrome"},{"code":"G46.7","display":"Other lacunar syndromes"},{"code":"G46.8","display":"Other vascular syndromes of brain in cerebrovascular diseases"},{"code":"G93.3","display":"Postviral fatigue syndrome"},{"code":"I01.0","display":"Acute rheumatic pericarditis"},{"code":"I01.1","display":"Acute rheumatic endocarditis"},{"code":"I01.2","display":"Acute rheumatic myocarditis"},{"code":"I01.8","display":"Other acute rheumatic heart disease"},{"code":"I01.9","display":"Acute rheumatic heart disease, unspecified"},{"code":"I02.0","display":"Rheumatic chorea with heart involvement"},{"code":"I05.0","display":"Rheumatic mitral stenosis"},{"code":"I05.1","display":"Rheumatic mitral insufficiency"},{"code":"I05.2","display":"Rheumatic mitral stenosis with insufficiency"},{"code":"I05.8","display":"Other rheumatic mitral valve diseases"},{"code":"I05.9","display":"Rheumatic mitral valve disease, unspecified"},{"code":"I06.0","display":"Rheumatic aortic stenosis"},{"code":"I06.1","display":"Rheumatic aortic insufficiency"},{"code":"I06.2","display":"Rheumatic aortic stenosis with insufficiency"},{"code":"I06.8","display":"Other rheumatic aortic valve diseases"},{"code":"I06.9","display":"Rheumatic aortic valve disease, unspecified"},{"code":"I07.0","display":"Rheumatic tricuspid stenosis"},{"code":"I07.1","display":"Rheumatic tricuspid insufficiency"},{"code":"I07.2","display":"Rheumatic tricuspid stenosis and insufficiency"},{"code":"I07.8","display":"Other rheumatic tricuspid valve diseases"},{"code":"I07.9","display":"Rheumatic tricuspid valve disease, unspecified"},{"code":"I08.0","display":"Rheumatic disorders of both mitral and aortic valves"},{"code":"I08.1","display":"Rheumatic disorders of both mitral and tricuspid valves"},{"code":"I08.2","display":"Rheumatic disorders of both aortic and tricuspid valves"},{"code":"I08.3","display":"Combined rheumatic disorders of mitral, aortic and tricuspid valves"},{"code":"I08.8","display":"Other rheumatic multiple valve diseases"},{"code":"I08.9","display":"Rheumatic multiple valve disease, unspecified"},{"code":"I09.0","display":"Rheumatic myocarditis"},{"code":"I09.1","display":"Rheumatic diseases of endocardium, valve unspecified"},{"code":"I09.2","display":"Chronic rheumatic pericarditis"},{"code":"I09.81","display":"Rheumatic heart failure"},{"code":"I09.89","display":"Other specified rheumatic heart diseases"},{"code":"I09.9","display":"Rheumatic heart disease, unspecified"},{"code":"I10","display":"Essential (primary) hypertension"},{"code":"I11.0","display":"Hypertensive heart disease with heart failure"},{"code":"I11.9","display":"Hypertensive heart disease without heart failure"},{"code":"I12.0","display":"Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease"},{"code":"I12.9","display":"Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"},{"code":"I13.0","display":"Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"},{"code":"I13.10","display":"Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease"},{"code":"I13.11","display":"Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease"},{"code":"I13.2","display":"Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease"},{"code":"I15.0","display":"Renovascular hypertension"},{"code":"I15.1","display":"Hypertension secondary to other renal disorders"},{"code":"I15.2","display":"Hypertension secondary to endocrine disorders"},{"code":"I15.8","display":"Other secondary hypertension"},{"code":"I15.9","display":"Secondary hypertension, unspecified"},{"code":"I16.0","display":"Hypertensive urgency"},{"code":"I16.1","display":"Hypertensive emergency"},{"code":"I16.9","display":"Hypertensive crisis, unspecified"},{"code":"I20.0","display":"Unstable angina"},{"code":"I20.1","display":"Angina pectoris with documented spasm"},{"code":"I20.8","display":"Other forms of angina pectoris"},{"code":"I20.9","display":"Angina pectoris, unspecified"},{"code":"I21.01","display":"ST elevation (STEMI) myocardial infarction involving left main coronary artery"},{"code":"I21.02","display":"ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery"},{"code":"I21.09","display":"ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall"},{"code":"I21.11","display":"ST elevation (STEMI) myocardial infarction involving right coronary artery"},{"code":"I21.19","display":"ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall"},{"code":"I21.21","display":"ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery"},{"code":"I21.29","display":"ST elevation (STEMI) myocardial infarction involving other sites"},{"code":"I21.3","display":"ST elevation (STEMI) myocardial infarction of unspecified site"},{"code":"I21.4","display":"Non-ST elevation (NSTEMI) myocardial infarction"},{"code":"I21.9","display":"Acute myocardial infarction, unspecified"},{"code":"I21.A1","display":"Myocardial infarction type 2"},{"code":"I21.A9","display":"Other myocardial infarction type"},{"code":"I22.0","display":"Subsequent ST elevation (STEMI) myocardial infarction of anterior wall"},{"code":"I22.1","display":"Subsequent ST elevation (STEMI) myocardial infarction of inferior wall"},{"code":"I22.2","display":"Subsequent non-ST elevation (NSTEMI) myocardial infarction"},{"code":"I22.8","display":"Subsequent ST elevation (STEMI) myocardial infarction of other sites"},{"code":"I22.9","display":"Subsequent ST elevation (STEMI) myocardial infarction of unspecified site"},{"code":"I23.0","display":"Hemopericardium as current complication following acute myocardial infarction"},{"code":"I23.1","display":"Atrial septal defect as current complication following acute myocardial infarction"},{"code":"I23.2","display":"Ventricular septal defect as current complication following acute myocardial infarction"},{"code":"I23.3","display":"Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction"},{"code":"I23.4","display":"Rupture of chordae tendineae as current complication following acute myocardial infarction"},{"code":"I23.5","display":"Rupture of papillary muscle as current complication following acute myocardial infarction"},{"code":"I23.6","display":"Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction"},{"code":"I23.7","display":"Postinfarction angina"},{"code":"I23.8","display":"Other current complications following acute myocardial infarction"},{"code":"I24.0","display":"Acute coronary thrombosis not resulting in myocardial infarction"},{"code":"I24.1","display":"Dressler\u0027s syndrome"},{"code":"I24.8","display":"Other forms of acute ischemic heart disease"},{"code":"I24.9","display":"Acute ischemic heart disease, unspecified"},{"code":"I25.10","display":"Atherosclerotic heart disease of native coronary artery without angina pectoris"},{"code":"I25.110","display":"Atherosclerotic heart disease of native coronary artery with unstable angina pectoris"},{"code":"I25.111","display":"Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm"},{"code":"I25.118","display":"Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris"},{"code":"I25.119","display":"Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris"},{"code":"I25.2","display":"Old myocardial infarction"},{"code":"I25.3","display":"Aneurysm of heart"},{"code":"I25.41","display":"Coronary artery aneurysm"},{"code":"I25.42","display":"Coronary artery dissection"},{"code":"I25.5","display":"Ischemic cardiomyopathy"},{"code":"I25.6","display":"Silent myocardial ischemia"},{"code":"I25.750","display":"Atherosclerosis of native coronary artery of transplanted heart with unstable angina"},{"code":"I25.751","display":"Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm"},{"code":"I25.758","display":"Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris"},{"code":"I25.759","display":"Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris"},{"code":"I25.811","display":"Atherosclerosis of native coronary artery of transplanted heart without angina pectoris"},{"code":"I25.82","display":"Chronic total occlusion of coronary artery"},{"code":"I25.83","display":"Coronary atherosclerosis due to lipid rich plaque"},{"code":"I25.84","display":"Coronary atherosclerosis due to calcified coronary lesion"},{"code":"I25.89","display":"Other forms of chronic ischemic heart disease"},{"code":"I25.9","display":"Chronic ischemic heart disease, unspecified"},{"code":"I26.01","display":"Septic pulmonary embolism with acute cor pulmonale"},{"code":"I26.02","display":"Saddle embolus of pulmonary artery with acute cor pulmonale"},{"code":"I26.09","display":"Other pulmonary embolism with acute cor pulmonale"},{"code":"I26.90","display":"Septic pulmonary embolism without acute cor pulmonale"},{"code":"I26.92","display":"Saddle embolus of pulmonary artery without acute cor pulmonale"},{"code":"I26.99","display":"Other pulmonary embolism without acute cor pulmonale"},{"code":"I27.0","display":"Primary pulmonary hypertension"},{"code":"I27.1","display":"Kyphoscoliotic heart disease"},{"code":"I27.2","display":"Other secondary pulmonary hypertension"},{"code":"I27.20","display":"Pulmonary hypertension, unspecified"},{"code":"I27.21","display":"Secondary pulmonary arterial hypertension"},{"code":"I27.22","display":"Pulmonary hypertension due to left heart disease"},{"code":"I27.23","display":"Pulmonary hypertension due to lung diseases and hypoxia"},{"code":"I27.24","display":"Chronic thromboembolic pulmonary hypertension"},{"code":"I27.29","display":"Other secondary pulmonary hypertension"},{"code":"I27.81","display":"Cor pulmonale (chronic)"},{"code":"I27.82","display":"Chronic pulmonary embolism"},{"code":"I27.83","display":"Eisenmenger\u0027s syndrome"},{"code":"I27.89","display":"Other specified pulmonary heart diseases"},{"code":"I27.9","display":"Pulmonary heart disease, unspecified"},{"code":"I28.0","display":"Arteriovenous fistula of pulmonary vessels"},{"code":"I28.1","display":"Aneurysm of pulmonary artery"},{"code":"I28.8","display":"Other diseases of pulmonary vessels"},{"code":"I28.9","display":"Disease of pulmonary vessels, unspecified"},{"code":"I30.0","display":"Acute nonspecific idiopathic pericarditis"},{"code":"I30.1","display":"Infective pericarditis"},{"code":"I30.8","display":"Other forms of acute pericarditis"},{"code":"I30.9","display":"Acute pericarditis, unspecified"},{"code":"I31.0","display":"Chronic adhesive pericarditis"},{"code":"I31.1","display":"Chronic constrictive pericarditis"},{"code":"I31.2","display":"Hemopericardium, not elsewhere classified"},{"code":"I31.3","display":"Pericardial effusion (noninflammatory)"},{"code":"I31.4","display":"Cardiac tamponade"},{"code":"I31.8","display":"Other specified diseases of pericardium"},{"code":"I31.9","display":"Disease of pericardium, unspecified"},{"code":"I32","display":"Pericarditis in diseases classified elsewhere"},{"code":"I33.0","display":"Acute and subacute infective endocarditis"},{"code":"I33.9","display":"Acute and subacute endocarditis, unspecified"},{"code":"I34.0","display":"Nonrheumatic mitral (valve) insufficiency"},{"code":"I34.1","display":"Nonrheumatic mitral (valve) prolapse"},{"code":"I34.2","display":"Nonrheumatic mitral (valve) stenosis"},{"code":"I34.8","display":"Other nonrheumatic mitral valve disorders"},{"code":"I34.9","display":"Nonrheumatic mitral valve disorder, unspecified"},{"code":"I35.0","display":"Nonrheumatic aortic (valve) stenosis"},{"code":"I35.1","display":"Nonrheumatic aortic (valve) insufficiency"},{"code":"I35.2","display":"Nonrheumatic aortic (valve) stenosis with insufficiency"},{"code":"I35.8","display":"Other nonrheumatic aortic valve disorders"},{"code":"I35.9","display":"Nonrheumatic aortic valve disorder, unspecified"},{"code":"I36.0","display":"Nonrheumatic tricuspid (valve) stenosis"},{"code":"I36.1","display":"Nonrheumatic tricuspid (valve) insufficiency"},{"code":"I36.2","display":"Nonrheumatic tricuspid (valve) stenosis with insufficiency"},{"code":"I36.8","display":"Other nonrheumatic tricuspid valve disorders"},{"code":"I36.9","display":"Nonrheumatic tricuspid valve disorder, unspecified"},{"code":"I37.0","display":"Nonrheumatic pulmonary valve stenosis"},{"code":"I37.1","display":"Nonrheumatic pulmonary valve insufficiency"},{"code":"I37.2","display":"Nonrheumatic pulmonary valve stenosis with insufficiency"},{"code":"I37.8","display":"Other nonrheumatic pulmonary valve disorders"},{"code":"I37.9","display":"Nonrheumatic pulmonary valve disorder, unspecified"},{"code":"I38","display":"Endocarditis, valve unspecified"},{"code":"I39","display":"Endocarditis and heart valve disorders in diseases classified elsewhere"},{"code":"I40.0","display":"Infective myocarditis"},{"code":"I40.1","display":"Isolated myocarditis"},{"code":"I40.8","display":"Other acute myocarditis"},{"code":"I40.9","display":"Acute myocarditis, unspecified"},{"code":"I41","display":"Myocarditis in diseases classified elsewhere"},{"code":"I42.0","display":"Dilated cardiomyopathy"},{"code":"I42.1","display":"Obstructive hypertrophic cardiomyopathy"},{"code":"I42.2","display":"Other hypertrophic cardiomyopathy"},{"code":"I42.3","display":"Endomyocardial (eosinophilic) disease"},{"code":"I42.4","display":"Endocardial fibroelastosis"},{"code":"I42.5","display":"Other restrictive cardiomyopathy"},{"code":"I42.7","display":"Cardiomyopathy due to drug and external agent"},{"code":"I42.8","display":"Other cardiomyopathies"},{"code":"I42.9","display":"Cardiomyopathy, unspecified"},{"code":"I43","display":"Cardiomyopathy in diseases classified elsewhere"},{"code":"I44.0","display":"Atrioventricular block, first degree"},{"code":"I44.1","display":"Atrioventricular block, second degree"},{"code":"I44.2","display":"Atrioventricular block, complete"},{"code":"I44.30","display":"Unspecified atrioventricular block"},{"code":"I44.39","display":"Other atrioventricular block"},{"code":"I44.4","display":"Left anterior fascicular block"},{"code":"I44.5","display":"Left posterior fascicular block"},{"code":"I44.60","display":"Unspecified fascicular block"},{"code":"I44.69","display":"Other fascicular block"},{"code":"I44.7","display":"Left bundle-branch block, unspecified"},{"code":"I45.0","display":"Right fascicular block"},{"code":"I45.10","display":"Unspecified right bundle-branch block"},{"code":"I45.19","display":"Other right bundle-branch block"},{"code":"I45.2","display":"Bifascicular block"},{"code":"I45.3","display":"Trifascicular block"},{"code":"I45.4","display":"Nonspecific intraventricular block"},{"code":"I45.5","display":"Other specified heart block"},{"code":"I45.6","display":"Pre-excitation syndrome"},{"code":"I45.81","display":"Long QT syndrome"},{"code":"I45.89","display":"Other specified conduction disorders"},{"code":"I45.9","display":"Conduction disorder, unspecified"},{"code":"I46.2","display":"Cardiac arrest due to underlying cardiac condition"},{"code":"I46.8","display":"Cardiac arrest due to other underlying condition"},{"code":"I46.9","display":"Cardiac arrest, cause unspecified"},{"code":"I47.0","display":"Re-entry ventricular arrhythmia"},{"code":"I47.1","display":"Supraventricular tachycardia"},{"code":"I47.2","display":"Ventricular tachycardia"},{"code":"I47.9","display":"Paroxysmal tachycardia, unspecified"},{"code":"I48.0","display":"Paroxysmal atrial fibrillation"},{"code":"I48.1","display":"Persistent atrial fibrillation"},{"code":"I48.2","display":"Chronic atrial fibrillation"},{"code":"I48.3","display":"Typical atrial flutter"},{"code":"I48.4","display":"Atypical atrial flutter"},{"code":"I48.91","display":"Unspecified atrial fibrillation"},{"code":"I48.92","display":"Unspecified atrial flutter"},{"code":"I49.01","display":"Ventricular fibrillation"},{"code":"I49.02","display":"Ventricular flutter"},{"code":"I49.1","display":"Atrial premature depolarization"},{"code":"I49.2","display":"Junctional premature depolarization"},{"code":"I49.3","display":"Ventricular premature depolarization"},{"code":"I49.40","display":"Unspecified premature depolarization"},{"code":"I49.49","display":"Other premature depolarization"},{"code":"I49.5","display":"Sick sinus syndrome"},{"code":"I49.8","display":"Other specified cardiac arrhythmias"},{"code":"I49.9","display":"Cardiac arrhythmia, unspecified"},{"code":"I50.1","display":"Left ventricular failure, unspecified"},{"code":"I50.20","display":"Unspecified systolic (congestive) heart failure"},{"code":"I50.21","display":"Acute systolic (congestive) heart failure"},{"code":"I50.22","display":"Chronic systolic (congestive) heart failure"},{"code":"I50.23","display":"Acute on chronic systolic (congestive) heart failure"},{"code":"I50.30","display":"Unspecified diastolic (congestive) heart failure"},{"code":"I50.31","display":"Acute diastolic (congestive) heart failure"},{"code":"I50.32","display":"Chronic diastolic (congestive) heart failure"},{"code":"I50.33","display":"Acute on chronic diastolic (congestive) heart failure"},{"code":"I50.40","display":"Unspecified combined systolic (congestive) and diastolic (congestive) heart failure"},{"code":"I50.41","display":"Acute combined systolic (congestive) and diastolic (congestive) heart failure"},{"code":"I50.42","display":"Chronic combined systolic (congestive) and diastolic (congestive) heart failure"},{"code":"I50.43","display":"Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure"},{"code":"I50.810","display":"Right heart failure, unspecified"},{"code":"I50.811","display":"Acute right heart failure"},{"code":"I50.812","display":"Chronic right heart failure"},{"code":"I50.813","display":"Acute on chronic right heart failure"},{"code":"I50.814","display":"Right heart failure due to left heart failure"},{"code":"I50.82","display":"Biventricular heart failure"},{"code":"I50.83","display":"High output heart failure"},{"code":"I50.84","display":"End stage heart failure"},{"code":"I50.89","display":"Other heart failure"},{"code":"I50.9","display":"Heart failure, unspecified"},{"code":"I51.0","display":"Cardiac septal defect, acquired"},{"code":"I51.1","display":"Rupture of chordae tendineae, not elsewhere classified"},{"code":"I51.2","display":"Rupture of papillary muscle, not elsewhere classified"},{"code":"I51.3","display":"Intracardiac thrombosis, not elsewhere classified"},{"code":"I51.4","display":"Myocarditis, unspecified"},{"code":"I51.5","display":"Myocardial degeneration"},{"code":"I51.7","display":"Cardiomegaly"},{"code":"I51.81","display":"Takotsubo syndrome"},{"code":"I51.89","display":"Other ill-defined heart diseases"},{"code":"I51.9","display":"Heart disease, unspecified"},{"code":"I52","display":"Other heart disorders in diseases classified elsewhere"},{"code":"I60.00","display":"Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation"},{"code":"I60.01","display":"Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation"},{"code":"I60.02","display":"Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation"},{"code":"I60.10","display":"Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery"},{"code":"I60.11","display":"Nontraumatic subarachnoid hemorrhage from right middle cerebral artery"},{"code":"I60.12","display":"Nontraumatic subarachnoid hemorrhage from left middle cerebral artery"},{"code":"I60.2","display":"Nontraumatic subarachnoid hemorrhage from anterior communicating artery"},{"code":"I60.30","display":"Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery"},{"code":"I60.31","display":"Nontraumatic subarachnoid hemorrhage from right posterior communicating artery"},{"code":"I60.32","display":"Nontraumatic subarachnoid hemorrhage from left posterior communicating artery"},{"code":"I60.4","display":"Nontraumatic subarachnoid hemorrhage from basilar artery"},{"code":"I60.50","display":"Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery"},{"code":"I60.51","display":"Nontraumatic subarachnoid hemorrhage from right vertebral artery"},{"code":"I60.52","display":"Nontraumatic subarachnoid hemorrhage from left vertebral artery"},{"code":"I60.6","display":"Nontraumatic subarachnoid hemorrhage from other intracranial arteries"},{"code":"I60.7","display":"Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery"},{"code":"I60.8","display":"Other nontraumatic subarachnoid hemorrhage"},{"code":"I60.9","display":"Nontraumatic subarachnoid hemorrhage, unspecified"},{"code":"I61.0","display":"Nontraumatic intracerebral hemorrhage in hemisphere, subcortical"},{"code":"I61.1","display":"Nontraumatic intracerebral hemorrhage in hemisphere, cortical"},{"code":"I61.2","display":"Nontraumatic intracerebral hemorrhage in hemisphere, unspecified"},{"code":"I61.3","display":"Nontraumatic intracerebral hemorrhage in brain stem"},{"code":"I61.4","display":"Nontraumatic intracerebral hemorrhage in cerebellum"},{"code":"I61.5","display":"Nontraumatic intracerebral hemorrhage, intraventricular"},{"code":"I61.6","display":"Nontraumatic intracerebral hemorrhage, multiple localized"},{"code":"I61.8","display":"Other nontraumatic intracerebral hemorrhage"},{"code":"I61.9","display":"Nontraumatic intracerebral hemorrhage, unspecified"},{"code":"I62.00","display":"Nontraumatic subdural hemorrhage, unspecified"},{"code":"I62.01","display":"Nontraumatic acute subdural hemorrhage"},{"code":"I62.02","display":"Nontraumatic subacute subdural hemorrhage"},{"code":"I62.03","display":"Nontraumatic chronic subdural hemorrhage"},{"code":"I62.1","display":"Nontraumatic extradural hemorrhage"},{"code":"I62.9","display":"Nontraumatic intracranial hemorrhage, unspecified"},{"code":"I63.00","display":"Cerebral infarction due to thrombosis of unspecified precerebral artery"},{"code":"I63.011","display":"Cerebral infarction due to thrombosis of right vertebral artery"},{"code":"I63.012","display":"Cerebral infarction due to thrombosis of left vertebral artery"},{"code":"I63.013","display":"Cerebral infarction due to thrombosis of bilateral vertebral arteries"},{"code":"I63.019","display":"Cerebral infarction due to thrombosis of unspecified vertebral artery"},{"code":"I63.02","display":"Cerebral infarction due to thrombosis of basilar artery"},{"code":"I63.031","display":"Cerebral infarction due to thrombosis of right carotid artery"},{"code":"I63.032","display":"Cerebral infarction due to thrombosis of left carotid artery"},{"code":"I63.033","display":"Cerebral infarction due to thrombosis of bilateral carotid arteries"},{"code":"I63.039","display":"Cerebral infarction due to thrombosis of unspecified carotid artery"},{"code":"I63.09","display":"Cerebral infarction due to thrombosis of other precerebral artery"},{"code":"I63.10","display":"Cerebral infarction due to embolism of unspecified precerebral artery"},{"code":"I63.111","display":"Cerebral infarction due to embolism of right vertebral artery"},{"code":"I63.112","display":"Cerebral infarction due to embolism of left vertebral artery"},{"code":"I63.113","display":"Cerebral infarction due to embolism of bilateral vertebral arteries"},{"code":"I63.119","display":"Cerebral infarction due to embolism of unspecified vertebral artery"},{"code":"I63.12","display":"Cerebral infarction due to embolism of basilar artery"},{"code":"I63.131","display":"Cerebral infarction due to embolism of right carotid artery"},{"code":"I63.132","display":"Cerebral infarction due to embolism of left carotid artery"},{"code":"I63.133","display":"Cerebral infarction due to embolism of bilateral carotid arteries"},{"code":"I63.139","display":"Cerebral infarction due to embolism of unspecified carotid artery"},{"code":"I63.19","display":"Cerebral infarction due to embolism of other precerebral artery"},{"code":"I63.20","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries"},{"code":"I63.211","display":"Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery"},{"code":"I63.212","display":"Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery"},{"code":"I63.213","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries"},{"code":"I63.219","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery"},{"code":"I63.22","display":"Cerebral infarction due to unspecified occlusion or stenosis of basilar artery"},{"code":"I63.231","display":"Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries"},{"code":"I63.232","display":"Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries"},{"code":"I63.233","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries"},{"code":"I63.239","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery"},{"code":"I63.29","display":"Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries"},{"code":"I63.30","display":"Cerebral infarction due to thrombosis of unspecified cerebral artery"},{"code":"I63.311","display":"Cerebral infarction due to thrombosis of right middle cerebral artery"},{"code":"I63.312","display":"Cerebral infarction due to thrombosis of left middle cerebral artery"},{"code":"I63.313","display":"Cerebral infarction due to thrombosis of bilateral middle cerebral arteries"},{"code":"I63.319","display":"Cerebral infarction due to thrombosis of unspecified middle cerebral artery"},{"code":"I63.321","display":"Cerebral infarction due to thrombosis of right anterior cerebral artery"},{"code":"I63.322","display":"Cerebral infarction due to thrombosis of left anterior cerebral artery"},{"code":"I63.323","display":"Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries"},{"code":"I63.329","display":"Cerebral infarction due to thrombosis of unspecified anterior cerebral artery"},{"code":"I63.331","display":"Cerebral infarction due to thrombosis of right posterior cerebral artery"},{"code":"I63.332","display":"Cerebral infarction due to thrombosis of left posterior cerebral artery"},{"code":"I63.333","display":"Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries"},{"code":"I63.339","display":"Cerebral infarction due to thrombosis of unspecified posterior cerebral artery"},{"code":"I63.341","display":"Cerebral infarction due to thrombosis of right cerebellar artery"},{"code":"I63.342","display":"Cerebral infarction due to thrombosis of left cerebellar artery"},{"code":"I63.343","display":"Cerebral infarction due to thrombosis of bilateral cerebellar arteries"},{"code":"I63.349","display":"Cerebral infarction due to thrombosis of unspecified cerebellar artery"},{"code":"I63.39","display":"Cerebral infarction due to thrombosis of other cerebral artery"},{"code":"I63.40","display":"Cerebral infarction due to embolism of unspecified cerebral artery"},{"code":"I63.411","display":"Cerebral infarction due to embolism of right middle cerebral artery"},{"code":"I63.412","display":"Cerebral infarction due to embolism of left middle cerebral artery"},{"code":"I63.413","display":"Cerebral infarction due to embolism of bilateral middle cerebral arteries"},{"code":"I63.419","display":"Cerebral infarction due to embolism of unspecified middle cerebral artery"},{"code":"I63.421","display":"Cerebral infarction due to embolism of right anterior cerebral artery"},{"code":"I63.422","display":"Cerebral infarction due to embolism of left anterior cerebral artery"},{"code":"I63.423","display":"Cerebral infarction due to embolism of bilateral anterior cerebral arteries"},{"code":"I63.429","display":"Cerebral infarction due to embolism of unspecified anterior cerebral artery"},{"code":"I63.431","display":"Cerebral infarction due to embolism of right posterior cerebral artery"},{"code":"I63.432","display":"Cerebral infarction due to embolism of left posterior cerebral artery"},{"code":"I63.433","display":"Cerebral infarction due to embolism of bilateral posterior cerebral arteries"},{"code":"I63.439","display":"Cerebral infarction due to embolism of unspecified posterior cerebral artery"},{"code":"I63.441","display":"Cerebral infarction due to embolism of right cerebellar artery"},{"code":"I63.442","display":"Cerebral infarction due to embolism of left cerebellar artery"},{"code":"I63.443","display":"Cerebral infarction due to embolism of bilateral cerebellar arteries"},{"code":"I63.449","display":"Cerebral infarction due to embolism of unspecified cerebellar artery"},{"code":"I63.49","display":"Cerebral infarction due to embolism of other cerebral artery"},{"code":"I63.50","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery"},{"code":"I63.511","display":"Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery"},{"code":"I63.512","display":"Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery"},{"code":"I63.513","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries"},{"code":"I63.519","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery"},{"code":"I63.521","display":"Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery"},{"code":"I63.522","display":"Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery"},{"code":"I63.523","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries"},{"code":"I63.529","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery"},{"code":"I63.531","display":"Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery"},{"code":"I63.532","display":"Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery"},{"code":"I63.533","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries"},{"code":"I63.539","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery"},{"code":"I63.541","display":"Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery"},{"code":"I63.542","display":"Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery"},{"code":"I63.543","display":"Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries"},{"code":"I63.549","display":"Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery"},{"code":"I63.59","display":"Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery"},{"code":"I63.6","display":"Cerebral infarction due to cerebral venous thrombosis, nonpyogenic"},{"code":"I63.8","display":"Other cerebral infarction"},{"code":"I63.81","display":"Other cerebral infarction due to occlusion or stenosis of small artery"},{"code":"I63.89","display":"Other cerebral infarction"},{"code":"I63.9","display":"Cerebral infarction, unspecified"},{"code":"I65.01","display":"Occlusion and stenosis of right vertebral artery"},{"code":"I65.02","display":"Occlusion and stenosis of left vertebral artery"},{"code":"I65.03","display":"Occlusion and stenosis of bilateral vertebral arteries"},{"code":"I65.09","display":"Occlusion and stenosis of unspecified vertebral artery"},{"code":"I65.1","display":"Occlusion and stenosis of basilar artery"},{"code":"I65.21","display":"Occlusion and stenosis of right carotid artery"},{"code":"I65.22","display":"Occlusion and stenosis of left carotid artery"},{"code":"I65.23","display":"Occlusion and stenosis of bilateral carotid arteries"},{"code":"I65.29","display":"Occlusion and stenosis of unspecified carotid artery"},{"code":"I65.8","display":"Occlusion and stenosis of other precerebral arteries"},{"code":"I65.9","display":"Occlusion and stenosis of unspecified precerebral artery"},{"code":"I66.01","display":"Occlusion and stenosis of right middle cerebral artery"},{"code":"I66.02","display":"Occlusion and stenosis of left middle cerebral artery"},{"code":"I66.03","display":"Occlusion and stenosis of bilateral middle cerebral arteries"},{"code":"I66.09","display":"Occlusion and stenosis of unspecified middle cerebral artery"},{"code":"I66.11","display":"Occlusion and stenosis of right anterior cerebral artery"},{"code":"I66.12","display":"Occlusion and stenosis of left anterior cerebral artery"},{"code":"I66.13","display":"Occlusion and stenosis of bilateral anterior cerebral arteries"},{"code":"I66.19","display":"Occlusion and stenosis of unspecified anterior cerebral artery"},{"code":"I66.21","display":"Occlusion and stenosis of right posterior cerebral artery"},{"code":"I66.22","display":"Occlusion and stenosis of left posterior cerebral artery"},{"code":"I66.23","display":"Occlusion and stenosis of bilateral posterior cerebral arteries"},{"code":"I66.29","display":"Occlusion and stenosis of unspecified posterior cerebral artery"},{"code":"I66.3","display":"Occlusion and stenosis of cerebellar arteries"},{"code":"I66.8","display":"Occlusion and stenosis of other cerebral arteries"},{"code":"I66.9","display":"Occlusion and stenosis of unspecified cerebral artery"},{"code":"I67.0","display":"Dissection of cerebral arteries, nonruptured"},{"code":"I67.1","display":"Cerebral aneurysm, nonruptured"},{"code":"I67.2","display":"Cerebral atherosclerosis"},{"code":"I67.4","display":"Hypertensive encephalopathy"},{"code":"I67.5","display":"Moyamoya disease"},{"code":"I67.6","display":"Nonpyogenic thrombosis of intracranial venous system"},{"code":"I67.7","display":"Cerebral arteritis, not elsewhere classified"},{"code":"I67.81","display":"Acute cerebrovascular insufficiency"},{"code":"I67.82","display":"Cerebral ischemia"},{"code":"I67.83","display":"Posterior reversible encephalopathy syndrome"},{"code":"I67.841","display":"Reversible cerebrovascular vasoconstriction syndrome"},{"code":"I67.848","display":"Other cerebrovascular vasospasm and vasoconstriction"},{"code":"I67.850","display":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy"},{"code":"I67.858","display":"Other hereditary cerebrovascular disease"},{"code":"I67.89","display":"Other cerebrovascular disease"},{"code":"I67.9","display":"Cerebrovascular disease, unspecified"},{"code":"I68.0","display":"Cerebral amyloid angiopathy"},{"code":"I68.2","display":"Cerebral arteritis in other diseases classified elsewhere"},{"code":"I68.8","display":"Other cerebrovascular disorders in diseases classified elsewhere"},{"code":"I69.00","display":"Unspecified sequelae of nontraumatic subarachnoid hemorrhage"},{"code":"I69.01","display":"Cognitive deficits following nontraumatic subarachnoid hemorrhage"},{"code":"I69.010","display":"Attention and concentration deficit following nontraumatic subarachnoid hemorrhage"},{"code":"I69.011","display":"Memory deficit following nontraumatic subarachnoid hemorrhage"},{"code":"I69.012","display":"Visuospatial deficit and spatial neglect following nontraumatic subarachnoid hemorrhage"},{"code":"I69.013","display":"Psychomotor deficit following nontraumatic subarachnoid hemorrhage"},{"code":"I69.014","display":"Frontal lobe and executive function deficit following nontraumatic subarachnoid hemorrhage"},{"code":"I69.015","display":"Cognitive social or emotional deficit following nontraumatic subarachnoid hemorrhage"},{"code":"I69.018","display":"Other symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage"},{"code":"I69.019","display":"Unspecified symptoms and signs involving cognitive functions following nontraumatic subarachnoid hemorrhage"},{"code":"I69.020","display":"Aphasia following nontraumatic subarachnoid hemorrhage"},{"code":"I69.021","display":"Dysphasia following nontraumatic subarachnoid hemorrhage"},{"code":"I69.022","display":"Dysarthria following nontraumatic subarachnoid hemorrhage"},{"code":"I69.023","display":"Fluency disorder following nontraumatic subarachnoid hemorrhage"},{"code":"I69.028","display":"Other speech and language deficits following nontraumatic subarachnoid hemorrhage"},{"code":"I69.031","display":"Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right dominant side"},{"code":"I69.032","display":"Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left dominant side"},{"code":"I69.033","display":"Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"},{"code":"I69.034","display":"Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"},{"code":"I69.039","display":"Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage affecting unspecified side"},{"code":"I69.041","display":"Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right dominant side"},{"code":"I69.042","display":"Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left dominant side"},{"code":"I69.043","display":"Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"},{"code":"I69.044","display":"Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"},{"code":"I69.049","display":"Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage affecting unspecified side"},{"code":"I69.051","display":"Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right dominant side"},{"code":"I69.052","display":"Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left dominant side"},{"code":"I69.053","display":"Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"},{"code":"I69.054","display":"Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"},{"code":"I69.059","display":"Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage affecting unspecified side"},{"code":"I69.061","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right dominant side"},{"code":"I69.062","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left dominant side"},{"code":"I69.063","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting right non-dominant side"},{"code":"I69.064","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting left non-dominant side"},{"code":"I69.065","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage, bilateral"},{"code":"I69.069","display":"Other paralytic syndrome following nontraumatic subarachnoid hemorrhage affecting unspecified side"},{"code":"I69.090","display":"Apraxia following nontraumatic subarachnoid hemorrhage"},{"code":"I69.091","display":"Dysphagia following nontraumatic subarachnoid hemorrhage"},{"code":"I69.092","display":"Facial weakness following nontraumatic subarachnoid hemorrhage"},{"code":"I69.093","display":"Ataxia following nontraumatic subarachnoid hemorrhage"},{"code":"I69.098","display":"Other sequelae following nontraumatic subarachnoid hemorrhage"},{"code":"I69.10","display":"Unspecified sequelae of nontraumatic intracerebral hemorrhage"},{"code":"I69.11","display":"Cognitive deficits following nontraumatic intracerebral hemorrhage"},{"code":"I69.110","display":"Attention and concentration deficit following nontraumatic intracerebral hemorrhage"},{"code":"I69.111","display":"Memory deficit following nontraumatic intracerebral hemorrhage"},{"code":"I69.112","display":"Visuospatial deficit and spatial neglect following nontraumatic intracerebral hemorrhage"},{"code":"I69.113","display":"Psychomotor deficit following nontraumatic intracerebral hemorrhage"},{"code":"I69.114","display":"Frontal lobe and executive function deficit following nontraumatic intracerebral hemorrhage"},{"code":"I69.115","display":"Cognitive social or emotional deficit following nontraumatic intracerebral hemorrhage"},{"code":"I69.118","display":"Other symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage"},{"code":"I69.119","display":"Unspecified symptoms and signs involving cognitive functions following nontraumatic intracerebral hemorrhage"},{"code":"I69.120","display":"Aphasia following nontraumatic intracerebral hemorrhage"},{"code":"I69.121","display":"Dysphasia following nontraumatic intracerebral hemorrhage"},{"code":"I69.122","display":"Dysarthria following nontraumatic intracerebral hemorrhage"},{"code":"I69.123","display":"Fluency disorder following nontraumatic intracerebral hemorrhage"},{"code":"I69.128","display":"Other speech and language deficits following nontraumatic intracerebral hemorrhage"},{"code":"I69.131","display":"Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right dominant side"},{"code":"I69.132","display":"Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left dominant side"},{"code":"I69.133","display":"Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side"},{"code":"I69.134","display":"Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side"},{"code":"I69.139","display":"Monoplegia of upper limb following nontraumatic intracerebral hemorrhage affecting unspecified side"},{"code":"I69.141","display":"Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right dominant side"},{"code":"I69.142","display":"Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left dominant side"},{"code":"I69.143","display":"Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting right non-dominant side"},{"code":"I69.144","display":"Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting left non-dominant side"},{"code":"I69.149","display":"Monoplegia of lower limb following nontraumatic intracerebral hemorrhage affecting unspecified side"},{"code":"I69.151","display":"Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right dominant side"},{"code":"I69.152","display":"Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left dominant side"},{"code":"I69.153","display":"Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting right non-dominant side"},{"code":"I69.154","display":"Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting left non-dominant side"},{"code":"I69.159","display":"Hemiplegia and hemiparesis following nontraumatic intracerebral hemorrhage affecting unspecified side"},{"code":"I69.161","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right dominant side"},{"code":"I69.162","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left dominant side"},{"code":"I69.163","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting right non-dominant side"},{"code":"I69.164","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting left non-dominant side"},{"code":"I69.165","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage, bilateral"},{"code":"I69.169","display":"Other paralytic syndrome following nontraumatic intracerebral hemorrhage affecting unspecified side"},{"code":"I69.190","display":"Apraxia following nontraumatic intracerebral hemorrhage"},{"code":"I69.191","display":"Dysphagia following nontraumatic intracerebral hemorrhage"},{"code":"I69.192","display":"Facial weakness following nontraumatic intracerebral hemorrhage"},{"code":"I69.193","display":"Ataxia following nontraumatic intracerebral hemorrhage"},{"code":"I69.198","display":"Other sequelae of nontraumatic intracerebral hemorrhage"},{"code":"I69.20","display":"Unspecified sequelae of other nontraumatic intracranial hemorrhage"},{"code":"I69.21","display":"Cognitive deficits following other nontraumatic intracranial hemorrhage"},{"code":"I69.210","display":"Attention and concentration deficit following other nontraumatic intracranial hemorrhage"},{"code":"I69.211","display":"Memory deficit following other nontraumatic intracranial hemorrhage"},{"code":"I69.212","display":"Visuospatial deficit and spatial neglect following other nontraumatic intracranial hemorrhage"},{"code":"I69.213","display":"Psychomotor deficit following other nontraumatic intracranial hemorrhage"},{"code":"I69.214","display":"Frontal lobe and executive function deficit following other nontraumatic intracranial hemorrhage"},{"code":"I69.215","display":"Cognitive social or emotional deficit following other nontraumatic intracranial hemorrhage"},{"code":"I69.218","display":"Other symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage"},{"code":"I69.219","display":"Unspecified symptoms and signs involving cognitive functions following other nontraumatic intracranial hemorrhage"},{"code":"I69.220","display":"Aphasia following other nontraumatic intracranial hemorrhage"},{"code":"I69.221","display":"Dysphasia following other nontraumatic intracranial hemorrhage"},{"code":"I69.222","display":"Dysarthria following other nontraumatic intracranial hemorrhage"},{"code":"I69.223","display":"Fluency disorder following other nontraumatic intracranial hemorrhage"},{"code":"I69.228","display":"Other speech and language deficits following other nontraumatic intracranial hemorrhage"},{"code":"I69.231","display":"Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right dominant side"},{"code":"I69.232","display":"Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left dominant side"},{"code":"I69.233","display":"Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side"},{"code":"I69.234","display":"Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side"},{"code":"I69.239","display":"Monoplegia of upper limb following other nontraumatic intracranial hemorrhage affecting unspecified side"},{"code":"I69.241","display":"Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right dominant side"},{"code":"I69.242","display":"Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left dominant side"},{"code":"I69.243","display":"Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting right non-dominant side"},{"code":"I69.244","display":"Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting left non-dominant side"},{"code":"I69.249","display":"Monoplegia of lower limb following other nontraumatic intracranial hemorrhage affecting unspecified side"},{"code":"I69.251","display":"Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right dominant side"},{"code":"I69.252","display":"Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left dominant side"},{"code":"I69.253","display":"Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting right non-dominant side"},{"code":"I69.254","display":"Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting left non-dominant side"},{"code":"I69.259","display":"Hemiplegia and hemiparesis following other nontraumatic intracranial hemorrhage affecting unspecified side"},{"code":"I69.261","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right dominant side"},{"code":"I69.262","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left dominant side"},{"code":"I69.263","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting right non-dominant side"},{"code":"I69.264","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting left non-dominant side"},{"code":"I69.265","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage, bilateral"},{"code":"I69.269","display":"Other paralytic syndrome following other nontraumatic intracranial hemorrhage affecting unspecified side"},{"code":"I69.290","display":"Apraxia following other nontraumatic intracranial hemorrhage"},{"code":"I69.291","display":"Dysphagia following other nontraumatic intracranial hemorrhage"},{"code":"I69.292","display":"Facial weakness following other nontraumatic intracranial hemorrhage"},{"code":"I69.293","display":"Ataxia following other nontraumatic intracranial hemorrhage"},{"code":"I69.298","display":"Other sequelae of other nontraumatic intracranial hemorrhage"},{"code":"I69.30","display":"Unspecified sequelae of cerebral infarction"},{"code":"I69.31","display":"Cognitive deficits following cerebral infarction"},{"code":"I69.310","display":"Attention and concentration deficit following cerebral infarction"},{"code":"I69.311","display":"Memory deficit following cerebral infarction"},{"code":"I69.312","display":"Visuospatial deficit and spatial neglect following cerebral infarction"},{"code":"I69.313","display":"Psychomotor deficit following cerebral infarction"},{"code":"I69.314","display":"Frontal lobe and executive function deficit following cerebral infarction"},{"code":"I69.315","display":"Cognitive social or emotional deficit following cerebral infarction"},{"code":"I69.318","display":"Other symptoms and signs involving cognitive functions following cerebral infarction"},{"code":"I69.319","display":"Unspecified symptoms and signs involving cognitive functions following cerebral infarction"},{"code":"I69.320","display":"Aphasia following cerebral infarction"},{"code":"I69.321","display":"Dysphasia following cerebral infarction"},{"code":"I69.322","display":"Dysarthria following cerebral infarction"},{"code":"I69.323","display":"Fluency disorder following cerebral infarction"},{"code":"I69.328","display":"Other speech and language deficits following cerebral infarction"},{"code":"I69.331","display":"Monoplegia of upper limb following cerebral infarction affecting right dominant side"},{"code":"I69.332","display":"Monoplegia of upper limb following cerebral infarction affecting left dominant side"},{"code":"I69.333","display":"Monoplegia of upper limb following cerebral infarction affecting right non-dominant side"},{"code":"I69.334","display":"Monoplegia of upper limb following cerebral infarction affecting left non-dominant side"},{"code":"I69.339","display":"Monoplegia of upper limb following cerebral infarction affecting unspecified side"},{"code":"I69.341","display":"Monoplegia of lower limb following cerebral infarction affecting right dominant side"},{"code":"I69.342","display":"Monoplegia of lower limb following cerebral infarction affecting left dominant side"},{"code":"I69.343","display":"Monoplegia of lower limb following cerebral infarction affecting right non-dominant side"},{"code":"I69.344","display":"Monoplegia of lower limb following cerebral infarction affecting left non-dominant side"},{"code":"I69.349","display":"Monoplegia of lower limb following cerebral infarction affecting unspecified side"},{"code":"I69.351","display":"Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side"},{"code":"I69.352","display":"Hemiplegia and hemiparesis following cerebral infarction affecting left dominant side"},{"code":"I69.353","display":"Hemiplegia and hemiparesis following cerebral infarction affecting right non-dominant side"},{"code":"I69.354","display":"Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side"},{"code":"I69.359","display":"Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side"},{"code":"I69.361","display":"Other paralytic syndrome following cerebral infarction affecting right dominant side"},{"code":"I69.362","display":"Other paralytic syndrome following cerebral infarction affecting left dominant side"},{"code":"I69.363","display":"Other paralytic syndrome following cerebral infarction affecting right non-dominant side"},{"code":"I69.364","display":"Other paralytic syndrome following cerebral infarction affecting left non-dominant side"},{"code":"I69.365","display":"Other paralytic syndrome following cerebral infarction, bilateral"},{"code":"I69.369","display":"Other paralytic syndrome following cerebral infarction affecting unspecified side"},{"code":"I69.390","display":"Apraxia following cerebral infarction"},{"code":"I69.391","display":"Dysphagia following cerebral infarction"},{"code":"I69.392","display":"Facial weakness following cerebral infarction"},{"code":"I69.393","display":"Ataxia following cerebral infarction"},{"code":"I69.398","display":"Other sequelae of cerebral infarction"},{"code":"I69.80","display":"Unspecified sequelae of other cerebrovascular disease"},{"code":"I69.81","display":"Cognitive deficits following other cerebrovascular disease"},{"code":"I69.810","display":"Attention and concentration deficit following other cerebrovascular disease"},{"code":"I69.811","display":"Memory deficit following other cerebrovascular disease"},{"code":"I69.812","display":"Visuospatial deficit and spatial neglect following other cerebrovascular disease"},{"code":"I69.813","display":"Psychomotor deficit following other cerebrovascular disease"},{"code":"I69.814","display":"Frontal lobe and executive function deficit following other cerebrovascular disease"},{"code":"I69.815","display":"Cognitive social or emotional deficit following other cerebrovascular disease"},{"code":"I69.818","display":"Other symptoms and signs involving cognitive functions following other cerebrovascular disease"},{"code":"I69.819","display":"Unspecified symptoms and signs involving cognitive functions following other cerebrovascular disease"},{"code":"I69.820","display":"Aphasia following other cerebrovascular disease"},{"code":"I69.821","display":"Dysphasia following other cerebrovascular disease"},{"code":"I69.822","display":"Dysarthria following other cerebrovascular disease"},{"code":"I69.823","display":"Fluency disorder following other cerebrovascular disease"},{"code":"I69.828","display":"Other speech and language deficits following other cerebrovascular disease"},{"code":"I69.831","display":"Monoplegia of upper limb following other cerebrovascular disease affecting right dominant side"},{"code":"I69.832","display":"Monoplegia of upper limb following other cerebrovascular disease affecting left dominant side"},{"code":"I69.833","display":"Monoplegia of upper limb following other cerebrovascular disease affecting right non-dominant side"},{"code":"I69.834","display":"Monoplegia of upper limb following other cerebrovascular disease affecting left non-dominant side"},{"code":"I69.839","display":"Monoplegia of upper limb following other cerebrovascular disease affecting unspecified side"},{"code":"I69.841","display":"Monoplegia of lower limb following other cerebrovascular disease affecting right dominant side"},{"code":"I69.842","display":"Monoplegia of lower limb following other cerebrovascular disease affecting left dominant side"},{"code":"I69.843","display":"Monoplegia of lower limb following other cerebrovascular disease affecting right non-dominant side"},{"code":"I69.844","display":"Monoplegia of lower limb following other cerebrovascular disease affecting left non-dominant side"},{"code":"I69.849","display":"Monoplegia of lower limb following other cerebrovascular disease affecting unspecified side"},{"code":"I69.851","display":"Hemiplegia and hemiparesis following other cerebrovascular disease affecting right dominant side"},{"code":"I69.852","display":"Hemiplegia and hemiparesis following other cerebrovascular disease affecting left dominant side"},{"code":"I69.853","display":"Hemiplegia and hemiparesis following other cerebrovascular disease affecting right non-dominant side"},{"code":"I69.854","display":"Hemiplegia and hemiparesis following other cerebrovascular disease affecting left non-dominant side"},{"code":"I69.859","display":"Hemiplegia and hemiparesis following other cerebrovascular disease affecting unspecified side"},{"code":"I69.861","display":"Other paralytic syndrome following other cerebrovascular disease affecting right dominant side"},{"code":"I69.862","display":"Other paralytic syndrome following other cerebrovascular disease affecting left dominant side"},{"code":"I69.863","display":"Other paralytic syndrome following other cerebrovascular disease affecting right non-dominant side"},{"code":"I69.864","display":"Other paralytic syndrome following other cerebrovascular disease affecting left non-dominant side"},{"code":"I69.865","display":"Other paralytic syndrome following other cerebrovascular disease, bilateral"},{"code":"I69.869","display":"Other paralytic syndrome following other cerebrovascular disease affecting unspecified side"},{"code":"I69.890","display":"Apraxia following other cerebrovascular disease"},{"code":"I69.891","display":"Dysphagia following other cerebrovascular disease"},{"code":"I69.892","display":"Facial weakness following other cerebrovascular disease"},{"code":"I69.893","display":"Ataxia following other cerebrovascular disease"},{"code":"I69.898","display":"Other sequelae of other cerebrovascular disease"},{"code":"I69.90","display":"Unspecified sequelae of unspecified cerebrovascular disease"},{"code":"I69.91","display":"Cognitive deficits following unspecified cerebrovascular disease"},{"code":"I69.910","display":"Attention and concentration deficit following unspecified cerebrovascular disease"},{"code":"I69.911","display":"Memory deficit following unspecified cerebrovascular disease"},{"code":"I69.912","display":"Visuospatial deficit and spatial neglect following unspecified cerebrovascular disease"},{"code":"I69.913","display":"Psychomotor deficit following unspecified cerebrovascular disease"},{"code":"I69.914","display":"Frontal lobe and executive function deficit following unspecified cerebrovascular disease"},{"code":"I69.915","display":"Cognitive social or emotional deficit following unspecified cerebrovascular disease"},{"code":"I69.918","display":"Other symptoms and signs involving cognitive functions following unspecified cerebrovascular disease"},{"code":"I69.919","display":"Unspecified symptoms and signs involving cognitive functions following unspecified cerebrovascular disease"},{"code":"I69.920","display":"Aphasia following unspecified cerebrovascular disease"},{"code":"I69.921","display":"Dysphasia following unspecified cerebrovascular disease"},{"code":"I69.922","display":"Dysarthria following unspecified cerebrovascular disease"},{"code":"I69.923","display":"Fluency disorder following unspecified cerebrovascular disease"},{"code":"I69.928","display":"Other speech and language deficits following unspecified cerebrovascular disease"},{"code":"I69.931","display":"Monoplegia of upper limb following unspecified cerebrovascular disease affecting right dominant side"},{"code":"I69.932","display":"Monoplegia of upper limb following unspecified cerebrovascular disease affecting left dominant side"},{"code":"I69.933","display":"Monoplegia of upper limb following unspecified cerebrovascular disease affecting right non-dominant side"},{"code":"I69.934","display":"Monoplegia of upper limb following unspecified cerebrovascular disease affecting left non-dominant side"},{"code":"I69.939","display":"Monoplegia of upper limb following unspecified cerebrovascular disease affecting unspecified side"},{"code":"I69.941","display":"Monoplegia of lower limb following unspecified cerebrovascular disease affecting right dominant side"},{"code":"I69.942","display":"Monoplegia of lower limb following unspecified cerebrovascular disease affecting left dominant side"},{"code":"I69.943","display":"Monoplegia of lower limb following unspecified cerebrovascular disease affecting right non-dominant side"},{"code":"I69.944","display":"Monoplegia of lower limb following unspecified cerebrovascular disease affecting left non-dominant side"},{"code":"I69.949","display":"Monoplegia of lower limb following unspecified cerebrovascular disease affecting unspecified side"},{"code":"I69.951","display":"Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right dominant side"},{"code":"I69.952","display":"Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left dominant side"},{"code":"I69.953","display":"Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting right non-dominant side"},{"code":"I69.954","display":"Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting left non-dominant side"},{"code":"I69.959","display":"Hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side"},{"code":"I69.961","display":"Other paralytic syndrome following unspecified cerebrovascular disease affecting right dominant side"},{"code":"I69.962","display":"Other paralytic syndrome following unspecified cerebrovascular disease affecting left dominant side"},{"code":"I69.963","display":"Other paralytic syndrome following unspecified cerebrovascular disease affecting right non-dominant side"},{"code":"I69.964","display":"Other paralytic syndrome following unspecified cerebrovascular disease affecting left non-dominant side"},{"code":"I69.965","display":"Other paralytic syndrome following unspecified cerebrovascular disease, bilateral"},{"code":"I69.969","display":"Other paralytic syndrome following unspecified cerebrovascular disease affecting unspecified side"},{"code":"I69.990","display":"Apraxia following unspecified cerebrovascular disease"},{"code":"I69.991","display":"Dysphagia following unspecified cerebrovascular disease"},{"code":"I69.992","display":"Facial weakness following unspecified cerebrovascular disease"},{"code":"I69.993","display":"Ataxia following unspecified cerebrovascular disease"},{"code":"I69.998","display":"Other sequelae following unspecified cerebrovascular disease"},{"code":"I70.0","display":"Atherosclerosis of aorta"},{"code":"I70.1","display":"Atherosclerosis of renal artery"},{"code":"I70.201","display":"Unspecified atherosclerosis of native arteries of extremities, right leg"},{"code":"I70.202","display":"Unspecified atherosclerosis of native arteries of extremities, left leg"},{"code":"I70.203","display":"Unspecified atherosclerosis of native arteries of extremities, bilateral legs"},{"code":"I70.208","display":"Unspecified atherosclerosis of native arteries of extremities, other extremity"},{"code":"I70.209","display":"Unspecified atherosclerosis of native arteries of extremities, unspecified extremity"},{"code":"I70.211","display":"Atherosclerosis of native arteries of extremities with intermittent claudication, right leg"},{"code":"I70.212","display":"Atherosclerosis of native arteries of extremities with intermittent claudication, left leg"},{"code":"I70.213","display":"Atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs"},{"code":"I70.218","display":"Atherosclerosis of native arteries of extremities with intermittent claudication, other extremity"},{"code":"I70.219","display":"Atherosclerosis of native arteries of extremities with intermittent claudication, unspecified extremity"},{"code":"I70.221","display":"Atherosclerosis of native arteries of extremities with rest pain, right leg"},{"code":"I70.222","display":"Atherosclerosis of native arteries of extremities with rest pain, left leg"},{"code":"I70.223","display":"Atherosclerosis of native arteries of extremities with rest pain, bilateral legs"},{"code":"I70.228","display":"Atherosclerosis of native arteries of extremities with rest pain, other extremity"},{"code":"I70.229","display":"Atherosclerosis of native arteries of extremities with rest pain, unspecified extremity"},{"code":"I70.231","display":"Atherosclerosis of native arteries of right leg with ulceration of thigh"},{"code":"I70.232","display":"Atherosclerosis of native arteries of right leg with ulceration of calf"},{"code":"I70.233","display":"Atherosclerosis of native arteries of right leg with ulceration of ankle"},{"code":"I70.234","display":"Atherosclerosis of native arteries of right leg with ulceration of heel and midfoot"},{"code":"I70.235","display":"Atherosclerosis of native arteries of right leg with ulceration of other part of foot"},{"code":"I70.238","display":"Atherosclerosis of native arteries of right leg with ulceration of other part of lower leg"},{"code":"I70.239","display":"Atherosclerosis of native arteries of right leg with ulceration of unspecified site"},{"code":"I70.241","display":"Atherosclerosis of native arteries of left leg with ulceration of thigh"},{"code":"I70.242","display":"Atherosclerosis of native arteries of left leg with ulceration of calf"},{"code":"I70.243","display":"Atherosclerosis of native arteries of left leg with ulceration of ankle"},{"code":"I70.244","display":"Atherosclerosis of native arteries of left leg with ulceration of heel and midfoot"},{"code":"I70.245","display":"Atherosclerosis of native arteries of left leg with ulceration of other part of foot"},{"code":"I70.248","display":"Atherosclerosis of native arteries of left leg with ulceration of other part of lower leg"},{"code":"I70.249","display":"Atherosclerosis of native arteries of left leg with ulceration of unspecified site"},{"code":"I70.25","display":"Atherosclerosis of native arteries of other extremities with ulceration"},{"code":"I70.261","display":"Atherosclerosis of native arteries of extremities with gangrene, right leg"},{"code":"I70.262","display":"Atherosclerosis of native arteries of extremities with gangrene, left leg"},{"code":"I70.263","display":"Atherosclerosis of native arteries of extremities with gangrene, bilateral legs"},{"code":"I70.268","display":"Atherosclerosis of native arteries of extremities with gangrene, other extremity"},{"code":"I70.269","display":"Atherosclerosis of native arteries of extremities with gangrene, unspecified extremity"},{"code":"I70.291","display":"Other atherosclerosis of native arteries of extremities, right leg"},{"code":"I70.292","display":"Other atherosclerosis of native arteries of extremities, left leg"},{"code":"I70.293","display":"Other atherosclerosis of native arteries of extremities, bilateral legs"},{"code":"I70.298","display":"Other atherosclerosis of native arteries of extremities, other extremity"},{"code":"I70.299","display":"Other atherosclerosis of native arteries of extremities, unspecified extremity"},{"code":"I70.8","display":"Atherosclerosis of other arteries"},{"code":"I70.90","display":"Unspecified atherosclerosis"},{"code":"I70.91","display":"Generalized atherosclerosis"},{"code":"I70.92","display":"Chronic total occlusion of artery of the extremities"},{"code":"I71.00","display":"Dissection of unspecified site of aorta"},{"code":"I71.01","display":"Dissection of thoracic aorta"},{"code":"I71.02","display":"Dissection of abdominal aorta"},{"code":"I71.03","display":"Dissection of thoracoabdominal aorta"},{"code":"I71.1","display":"Thoracic aortic aneurysm, ruptured"},{"code":"I71.2","display":"Thoracic aortic aneurysm, without rupture"},{"code":"I71.3","display":"Abdominal aortic aneurysm, ruptured"},{"code":"I71.4","display":"Abdominal aortic aneurysm, without rupture"},{"code":"I71.5","display":"Thoracoabdominal aortic aneurysm, ruptured"},{"code":"I71.6","display":"Thoracoabdominal aortic aneurysm, without rupture"},{"code":"I71.8","display":"Aortic aneurysm of unspecified site, ruptured"},{"code":"I71.9","display":"Aortic aneurysm of unspecified site, without rupture"},{"code":"I72.0","display":"Aneurysm of carotid artery"},{"code":"I72.1","display":"Aneurysm of artery of upper extremity"},{"code":"I72.2","display":"Aneurysm of renal artery"},{"code":"I72.3","display":"Aneurysm of iliac artery"},{"code":"I72.4","display":"Aneurysm of artery of lower extremity"},{"code":"I72.5","display":"Aneurysm of other precerebral arteries"},{"code":"I72.6","display":"Aneurysm of vertebral artery"},{"code":"I72.8","display":"Aneurysm of other specified arteries"},{"code":"I72.9","display":"Aneurysm of unspecified site"},{"code":"I73.00","display":"Raynaud\u0027s syndrome without gangrene"},{"code":"I73.01","display":"Raynaud\u0027s syndrome with gangrene"},{"code":"I73.1","display":"Thromboangiitis obliterans [Buerger\u0027s disease]"},{"code":"I73.81","display":"Erythromelalgia"},{"code":"I73.89","display":"Other specified peripheral vascular diseases"},{"code":"I73.9","display":"Peripheral vascular disease, unspecified"},{"code":"I74.01","display":"Saddle embolus of abdominal aorta"},{"code":"I74.09","display":"Other arterial embolism and thrombosis of abdominal aorta"},{"code":"I74.10","display":"Embolism and thrombosis of unspecified parts of aorta"},{"code":"I74.11","display":"Embolism and thrombosis of thoracic aorta"},{"code":"I74.19","display":"Embolism and thrombosis of other parts of aorta"},{"code":"I74.2","display":"Embolism and thrombosis of arteries of the upper extremities"},{"code":"I74.3","display":"Embolism and thrombosis of arteries of the lower extremities"},{"code":"I74.4","display":"Embolism and thrombosis of arteries of extremities, unspecified"},{"code":"I74.5","display":"Embolism and thrombosis of iliac artery"},{"code":"I74.8","display":"Embolism and thrombosis of other arteries"},{"code":"I74.9","display":"Embolism and thrombosis of unspecified artery"},{"code":"I75.011","display":"Atheroembolism of right upper extremity"},{"code":"I75.012","display":"Atheroembolism of left upper extremity"},{"code":"I75.013","display":"Atheroembolism of bilateral upper extremities"},{"code":"I75.019","display":"Atheroembolism of unspecified upper extremity"},{"code":"I75.021","display":"Atheroembolism of right lower extremity"},{"code":"I75.022","display":"Atheroembolism of left lower extremity"},{"code":"I75.023","display":"Atheroembolism of bilateral lower extremities"},{"code":"I75.029","display":"Atheroembolism of unspecified lower extremity"},{"code":"I75.81","display":"Atheroembolism of kidney"},{"code":"I75.89","display":"Atheroembolism of other site"},{"code":"I77.0","display":"Arteriovenous fistula, acquired"},{"code":"I77.1","display":"Stricture of artery"},{"code":"I77.2","display":"Rupture of artery"},{"code":"I77.3","display":"Arterial fibromuscular dysplasia"},{"code":"I77.4","display":"Celiac artery compression syndrome"},{"code":"I77.5","display":"Necrosis of artery"},{"code":"I77.6","display":"Arteritis, unspecified"},{"code":"I77.70","display":"Dissection of unspecified artery"},{"code":"I77.71","display":"Dissection of carotid artery"},{"code":"I77.72","display":"Dissection of iliac artery"},{"code":"I77.73","display":"Dissection of renal artery"},{"code":"I77.74","display":"Dissection of vertebral artery"},{"code":"I77.75","display":"Dissection of other precerebral arteries"},{"code":"I77.76","display":"Dissection of artery of upper extremity"},{"code":"I77.77","display":"Dissection of artery of lower extremity"},{"code":"I77.79","display":"Dissection of other specified artery"},{"code":"I77.810","display":"Thoracic aortic ectasia"},{"code":"I77.811","display":"Abdominal aortic ectasia"},{"code":"I77.812","display":"Thoracoabdominal aortic ectasia"},{"code":"I77.819","display":"Aortic ectasia, unspecified site"},{"code":"I77.89","display":"Other specified disorders of arteries and arterioles"},{"code":"I77.9","display":"Disorder of arteries and arterioles, unspecified"},{"code":"I78.0","display":"Hereditary hemorrhagic telangiectasia"},{"code":"I78.1","display":"Nevus, non-neoplastic"},{"code":"I78.8","display":"Other diseases of capillaries"},{"code":"I78.9","display":"Disease of capillaries, unspecified"},{"code":"I79.0","display":"Aneurysm of aorta in diseases classified elsewhere"},{"code":"I79.1","display":"Aortitis in diseases classified elsewhere"},{"code":"I79.8","display":"Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere"},{"code":"I80.00","display":"Phlebitis and thrombophlebitis of superficial vessels of unspecified lower extremity"},{"code":"I80.01","display":"Phlebitis and thrombophlebitis of superficial vessels of right lower extremity"},{"code":"I80.02","display":"Phlebitis and thrombophlebitis of superficial vessels of left lower extremity"},{"code":"I80.03","display":"Phlebitis and thrombophlebitis of superficial vessels of lower extremities, bilateral"},{"code":"I80.10","display":"Phlebitis and thrombophlebitis of unspecified femoral vein"},{"code":"I80.11","display":"Phlebitis and thrombophlebitis of right femoral vein"},{"code":"I80.12","display":"Phlebitis and thrombophlebitis of left femoral vein"},{"code":"I80.13","display":"Phlebitis and thrombophlebitis of femoral vein, bilateral"},{"code":"I80.201","display":"Phlebitis and thrombophlebitis of unspecified deep vessels of right lower extremity"},{"code":"I80.202","display":"Phlebitis and thrombophlebitis of unspecified deep vessels of left lower extremity"},{"code":"I80.203","display":"Phlebitis and thrombophlebitis of unspecified deep vessels of lower extremities, bilateral"},{"code":"I80.209","display":"Phlebitis and thrombophlebitis of unspecified deep vessels of unspecified lower extremity"},{"code":"I80.211","display":"Phlebitis and thrombophlebitis of right iliac vein"},{"code":"I80.212","display":"Phlebitis and thrombophlebitis of left iliac vein"},{"code":"I80.213","display":"Phlebitis and thrombophlebitis of iliac vein, bilateral"},{"code":"I80.219","display":"Phlebitis and thrombophlebitis of unspecified iliac vein"},{"code":"I80.221","display":"Phlebitis and thrombophlebitis of right popliteal vein"},{"code":"I80.222","display":"Phlebitis and thrombophlebitis of left popliteal vein"},{"code":"I80.223","display":"Phlebitis and thrombophlebitis of popliteal vein, bilateral"},{"code":"I80.229","display":"Phlebitis and thrombophlebitis of unspecified popliteal vein"},{"code":"I80.231","display":"Phlebitis and thrombophlebitis of right tibial vein"},{"code":"I80.232","display":"Phlebitis and thrombophlebitis of left tibial vein"},{"code":"I80.233","display":"Phlebitis and thrombophlebitis of tibial vein, bilateral"},{"code":"I80.239","display":"Phlebitis and thrombophlebitis of unspecified tibial vein"},{"code":"I80.291","display":"Phlebitis and thrombophlebitis of other deep vessels of right lower extremity"},{"code":"I80.292","display":"Phlebitis and thrombophlebitis of other deep vessels of left lower extremity"},{"code":"I80.293","display":"Phlebitis and thrombophlebitis of other deep vessels of lower extremity, bilateral"},{"code":"I80.299","display":"Phlebitis and thrombophlebitis of other deep vessels of unspecified lower extremity"},{"code":"I80.3","display":"Phlebitis and thrombophlebitis of lower extremities, unspecified"},{"code":"I80.8","display":"Phlebitis and thrombophlebitis of other sites"},{"code":"I80.9","display":"Phlebitis and thrombophlebitis of unspecified site"},{"code":"I81","display":"Portal vein thrombosis"},{"code":"I82.0","display":"Budd-Chiari syndrome"},{"code":"I82.1","display":"Thrombophlebitis migrans"},{"code":"I82.210","display":"Acute embolism and thrombosis of superior vena cava"},{"code":"I82.211","display":"Chronic embolism and thrombosis of superior vena cava"},{"code":"I82.220","display":"Acute embolism and thrombosis of inferior vena cava"},{"code":"I82.221","display":"Chronic embolism and thrombosis of inferior vena cava"},{"code":"I82.290","display":"Acute embolism and thrombosis of other thoracic veins"},{"code":"I82.291","display":"Chronic embolism and thrombosis of other thoracic veins"},{"code":"I82.3","display":"Embolism and thrombosis of renal vein"},{"code":"I82.401","display":"Acute embolism and thrombosis of unspecified deep veins of right lower extremity"},{"code":"I82.402","display":"Acute embolism and thrombosis of unspecified deep veins of left lower extremity"},{"code":"I82.403","display":"Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral"},{"code":"I82.409","display":"Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity"},{"code":"I82.411","display":"Acute embolism and thrombosis of right femoral vein"},{"code":"I82.412","display":"Acute embolism and thrombosis of left femoral vein"},{"code":"I82.413","display":"Acute embolism and thrombosis of femoral vein, bilateral"},{"code":"I82.419","display":"Acute embolism and thrombosis of unspecified femoral vein"},{"code":"I82.421","display":"Acute embolism and thrombosis of right iliac vein"},{"code":"I82.422","display":"Acute embolism and thrombosis of left iliac vein"},{"code":"I82.423","display":"Acute embolism and thrombosis of iliac vein, bilateral"},{"code":"I82.429","display":"Acute embolism and thrombosis of unspecified iliac vein"},{"code":"I82.431","display":"Acute embolism and thrombosis of right popliteal vein"},{"code":"I82.432","display":"Acute embolism and thrombosis of left popliteal vein"},{"code":"I82.433","display":"Acute embolism and thrombosis of popliteal vein, bilateral"},{"code":"I82.439","display":"Acute embolism and thrombosis of unspecified popliteal vein"},{"code":"I82.441","display":"Acute embolism and thrombosis of right tibial vein"},{"code":"I82.442","display":"Acute embolism and thrombosis of left tibial vein"},{"code":"I82.443","display":"Acute embolism and thrombosis of tibial vein, bilateral"},{"code":"I82.449","display":"Acute embolism and thrombosis of unspecified tibial vein"},{"code":"I82.491","display":"Acute embolism and thrombosis of other specified deep vein of right lower extremity"},{"code":"I82.492","display":"Acute embolism and thrombosis of other specified deep vein of left lower extremity"},{"code":"I82.493","display":"Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral"},{"code":"I82.499","display":"Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity"},{"code":"I82.4Y1","display":"Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity"},{"code":"I82.4Y2","display":"Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity"},{"code":"I82.4Y3","display":"Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral"},{"code":"I82.4Y9","display":"Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity"},{"code":"I82.4Z1","display":"Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity"},{"code":"I82.4Z2","display":"Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity"},{"code":"I82.4Z3","display":"Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral"},{"code":"I82.4Z9","display":"Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity"},{"code":"I82.501","display":"Chronic embolism and thrombosis of unspecified deep veins of right lower extremity"},{"code":"I82.502","display":"Chronic embolism and thrombosis of unspecified deep veins of left lower extremity"},{"code":"I82.503","display":"Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral"},{"code":"I82.509","display":"Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity"},{"code":"I82.511","display":"Chronic embolism and thrombosis of right femoral vein"},{"code":"I82.512","display":"Chronic embolism and thrombosis of left femoral vein"},{"code":"I82.513","display":"Chronic embolism and thrombosis of femoral vein, bilateral"},{"code":"I82.519","display":"Chronic embolism and thrombosis of unspecified femoral vein"},{"code":"I82.521","display":"Chronic embolism and thrombosis of right iliac vein"},{"code":"I82.522","display":"Chronic embolism and thrombosis of left iliac vein"},{"code":"I82.523","display":"Chronic embolism and thrombosis of iliac vein, bilateral"},{"code":"I82.529","display":"Chronic embolism and thrombosis of unspecified iliac vein"},{"code":"I82.531","display":"Chronic embolism and thrombosis of right popliteal vein"},{"code":"I82.532","display":"Chronic embolism and thrombosis of left popliteal vein"},{"code":"I82.533","display":"Chronic embolism and thrombosis of popliteal vein, bilateral"},{"code":"I82.539","display":"Chronic embolism and thrombosis of unspecified popliteal vein"},{"code":"I82.541","display":"Chronic embolism and thrombosis of right tibial vein"},{"code":"I82.542","display":"Chronic embolism and thrombosis of left tibial vein"},{"code":"I82.543","display":"Chronic embolism and thrombosis of tibial vein, bilateral"},{"code":"I82.549","display":"Chronic embolism and thrombosis of unspecified tibial vein"},{"code":"I82.591","display":"Chronic embolism and thrombosis of other specified deep vein of right lower extremity"},{"code":"I82.592","display":"Chronic embolism and thrombosis of other specified deep vein of left lower extremity"},{"code":"I82.593","display":"Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral"},{"code":"I82.599","display":"Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity"},{"code":"I82.5Y1","display":"Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity"},{"code":"I82.5Y2","display":"Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity"},{"code":"I82.5Y3","display":"Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral"},{"code":"I82.5Y9","display":"Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity"},{"code":"I82.5Z1","display":"Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity"},{"code":"I82.5Z2","display":"Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity"},{"code":"I82.5Z3","display":"Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral"},{"code":"I82.5Z9","display":"Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity"},{"code":"I82.601","display":"Acute embolism and thrombosis of unspecified veins of right upper extremity"},{"code":"I82.602","display":"Acute embolism and thrombosis of unspecified veins of left upper extremity"},{"code":"I82.603","display":"Acute embolism and thrombosis of unspecified veins of upper extremity, bilateral"},{"code":"I82.609","display":"Acute embolism and thrombosis of unspecified veins of unspecified upper extremity"},{"code":"I82.611","display":"Acute embolism and thrombosis of superficial veins of right upper extremity"},{"code":"I82.612","display":"Acute embolism and thrombosis of superficial veins of left upper extremity"},{"code":"I82.613","display":"Acute embolism and thrombosis of superficial veins of upper extremity, bilateral"},{"code":"I82.619","display":"Acute embolism and thrombosis of superficial veins of unspecified upper extremity"},{"code":"I82.621","display":"Acute embolism and thrombosis of deep veins of right upper extremity"},{"code":"I82.622","display":"Acute embolism and thrombosis of deep veins of left upper extremity"},{"code":"I82.623","display":"Acute embolism and thrombosis of deep veins of upper extremity, bilateral"},{"code":"I82.629","display":"Acute embolism and thrombosis of deep veins of unspecified upper extremity"},{"code":"I82.701","display":"Chronic embolism and thrombosis of unspecified veins of right upper extremity"},{"code":"I82.702","display":"Chronic embolism and thrombosis of unspecified veins of left upper extremity"},{"code":"I82.703","display":"Chronic embolism and thrombosis of unspecified veins of upper extremity, bilateral"},{"code":"I82.709","display":"Chronic embolism and thrombosis of unspecified veins of unspecified upper extremity"},{"code":"I82.711","display":"Chronic embolism and thrombosis of superficial veins of right upper extremity"},{"code":"I82.712","display":"Chronic embolism and thrombosis of superficial veins of left upper extremity"},{"code":"I82.713","display":"Chronic embolism and thrombosis of superficial veins of upper extremity, bilateral"},{"code":"I82.719","display":"Chronic embolism and thrombosis of superficial veins of unspecified upper extremity"},{"code":"I82.721","display":"Chronic embolism and thrombosis of deep veins of right upper extremity"},{"code":"I82.722","display":"Chronic embolism and thrombosis of deep veins of left upper extremity"},{"code":"I82.723","display":"Chronic embolism and thrombosis of deep veins of upper extremity, bilateral"},{"code":"I82.729","display":"Chronic embolism and thrombosis of deep veins of unspecified upper extremity"},{"code":"I82.811","display":"Embolism and thrombosis of superficial veins of right lower extremity"},{"code":"I82.812","display":"Embolism and thrombosis of superficial veins of left lower extremity"},{"code":"I82.813","display":"Embolism and thrombosis of superficial veins of lower extremities, bilateral"},{"code":"I82.819","display":"Embolism and thrombosis of superficial veins of unspecified lower extremity"},{"code":"I82.890","display":"Acute embolism and thrombosis of other specified veins"},{"code":"I82.891","display":"Chronic embolism and thrombosis of other specified veins"},{"code":"I82.90","display":"Acute embolism and thrombosis of unspecified vein"},{"code":"I82.91","display":"Chronic embolism and thrombosis of unspecified vein"},{"code":"I82.A11","display":"Acute embolism and thrombosis of right axillary vein"},{"code":"I82.A12","display":"Acute embolism and thrombosis of left axillary vein"},{"code":"I82.A13","display":"Acute embolism and thrombosis of axillary vein, bilateral"},{"code":"I82.A19","display":"Acute embolism and thrombosis of unspecified axillary vein"},{"code":"I82.A21","display":"Chronic embolism and thrombosis of right axillary vein"},{"code":"I82.A22","display":"Chronic embolism and thrombosis of left axillary vein"},{"code":"I82.A23","display":"Chronic embolism and thrombosis of axillary vein, bilateral"},{"code":"I82.A29","display":"Chronic embolism and thrombosis of unspecified axillary vein"},{"code":"I82.B11","display":"Acute embolism and thrombosis of right subclavian vein"},{"code":"I82.B12","display":"Acute embolism and thrombosis of left subclavian vein"},{"code":"I82.B13","display":"Acute embolism and thrombosis of subclavian vein, bilateral"},{"code":"I82.B19","display":"Acute embolism and thrombosis of unspecified subclavian vein"},{"code":"I82.B21","display":"Chronic embolism and thrombosis of right subclavian vein"},{"code":"I82.B22","display":"Chronic embolism and thrombosis of left subclavian vein"},{"code":"I82.B23","display":"Chronic embolism and thrombosis of subclavian vein, bilateral"},{"code":"I82.B29","display":"Chronic embolism and thrombosis of unspecified subclavian vein"},{"code":"I82.C11","display":"Acute embolism and thrombosis of right internal jugular vein"},{"code":"I82.C12","display":"Acute embolism and thrombosis of left internal jugular vein"},{"code":"I82.C13","display":"Acute embolism and thrombosis of internal jugular vein, bilateral"},{"code":"I82.C19","display":"Acute embolism and thrombosis of unspecified internal jugular vein"},{"code":"I82.C21","display":"Chronic embolism and thrombosis of right internal jugular vein"},{"code":"I82.C22","display":"Chronic embolism and thrombosis of left internal jugular vein"},{"code":"I82.C23","display":"Chronic embolism and thrombosis of internal jugular vein, bilateral"},{"code":"I82.C29","display":"Chronic embolism and thrombosis of unspecified internal jugular vein"},{"code":"I83.001","display":"Varicose veins of unspecified lower extremity with ulcer of thigh"},{"code":"I83.002","display":"Varicose veins of unspecified lower extremity with ulcer of calf"},{"code":"I83.003","display":"Varicose veins of unspecified lower extremity with ulcer of ankle"},{"code":"I83.004","display":"Varicose veins of unspecified lower extremity with ulcer of heel and midfoot"},{"code":"I83.005","display":"Varicose veins of unspecified lower extremity with ulcer other part of foot"},{"code":"I83.008","display":"Varicose veins of unspecified lower extremity with ulcer other part of lower leg"},{"code":"I83.009","display":"Varicose veins of unspecified lower extremity with ulcer of unspecified site"},{"code":"I83.011","display":"Varicose veins of right lower extremity with ulcer of thigh"},{"code":"I83.012","display":"Varicose veins of right lower extremity with ulcer of calf"},{"code":"I83.013","display":"Varicose veins of right lower extremity with ulcer of ankle"},{"code":"I83.014","display":"Varicose veins of right lower extremity with ulcer of heel and midfoot"},{"code":"I83.015","display":"Varicose veins of right lower extremity with ulcer other part of foot"},{"code":"I83.018","display":"Varicose veins of right lower extremity with ulcer other part of lower leg"},{"code":"I83.019","display":"Varicose veins of right lower extremity with ulcer of unspecified site"},{"code":"I83.021","display":"Varicose veins of left lower extremity with ulcer of thigh"},{"code":"I83.022","display":"Varicose veins of left lower extremity with ulcer of calf"},{"code":"I83.023","display":"Varicose veins of left lower extremity with ulcer of ankle"},{"code":"I83.024","display":"Varicose veins of left lower extremity with ulcer of heel and midfoot"},{"code":"I83.025","display":"Varicose veins of left lower extremity with ulcer other part of foot"},{"code":"I83.028","display":"Varicose veins of left lower extremity with ulcer other part of lower leg"},{"code":"I83.029","display":"Varicose veins of left lower extremity with ulcer of unspecified site"},{"code":"I83.10","display":"Varicose veins of unspecified lower extremity with inflammation"},{"code":"I83.11","display":"Varicose veins of right lower extremity with inflammation"},{"code":"I83.12","display":"Varicose veins of left lower extremity with inflammation"},{"code":"I83.201","display":"Varicose veins of unspecified lower extremity with both ulcer of thigh and inflammation"},{"code":"I83.202","display":"Varicose veins of unspecified lower extremity with both ulcer of calf and inflammation"},{"code":"I83.203","display":"Varicose veins of unspecified lower extremity with both ulcer of ankle and inflammation"},{"code":"I83.204","display":"Varicose veins of unspecified lower extremity with both ulcer of heel and midfoot and inflammation"},{"code":"I83.205","display":"Varicose veins of unspecified lower extremity with both ulcer other part of foot and inflammation"},{"code":"I83.208","display":"Varicose veins of unspecified lower extremity with both ulcer of other part of lower extremity and inflammation"},{"code":"I83.209","display":"Varicose veins of unspecified lower extremity with both ulcer of unspecified site and inflammation"},{"code":"I83.211","display":"Varicose veins of right lower extremity with both ulcer of thigh and inflammation"},{"code":"I83.212","display":"Varicose veins of right lower extremity with both ulcer of calf and inflammation"},{"code":"I83.213","display":"Varicose veins of right lower extremity with both ulcer of ankle and inflammation"},{"code":"I83.214","display":"Varicose veins of right lower extremity with both ulcer of heel and midfoot and inflammation"},{"code":"I83.215","display":"Varicose veins of right lower extremity with both ulcer other part of foot and inflammation"},{"code":"I83.218","display":"Varicose veins of right lower extremity with both ulcer of other part of lower extremity and inflammation"},{"code":"I83.219","display":"Varicose veins of right lower extremity with both ulcer of unspecified site and inflammation"},{"code":"I83.221","display":"Varicose veins of left lower extremity with both ulcer of thigh and inflammation"},{"code":"I83.222","display":"Varicose veins of left lower extremity with both ulcer of calf and inflammation"},{"code":"I83.223","display":"Varicose veins of left lower extremity with both ulcer of ankle and inflammation"},{"code":"I83.224","display":"Varicose veins of left lower extremity with both ulcer of heel and midfoot and inflammation"},{"code":"I83.225","display":"Varicose veins of left lower extremity with both ulcer other part of foot and inflammation"},{"code":"I83.228","display":"Varicose veins of left lower extremity with both ulcer of other part of lower extremity and inflammation"},{"code":"I83.229","display":"Varicose veins of left lower extremity with both ulcer of unspecified site and inflammation"},{"code":"I83.811","display":"Varicose veins of right lower extremity with pain"},{"code":"I83.812","display":"Varicose veins of left lower extremity with pain"},{"code":"I83.813","display":"Varicose veins of bilateral lower extremities with pain"},{"code":"I83.819","display":"Varicose veins of unspecified lower extremity with pain"},{"code":"I83.891","display":"Varicose veins of right lower extremity with other complications"},{"code":"I83.892","display":"Varicose veins of left lower extremity with other complications"},{"code":"I83.893","display":"Varicose veins of bilateral lower extremities with other complications"},{"code":"I83.899","display":"Varicose veins of unspecified lower extremity with other complications"},{"code":"I83.90","display":"Asymptomatic varicose veins of unspecified lower extremity"},{"code":"I83.91","display":"Asymptomatic varicose veins of right lower extremity"},{"code":"I83.92","display":"Asymptomatic varicose veins of left lower extremity"},{"code":"I83.93","display":"Asymptomatic varicose veins of bilateral lower extremities"},{"code":"I86.0","display":"Sublingual varices"},{"code":"I86.1","display":"Scrotal varices"},{"code":"I86.2","display":"Pelvic varices"},{"code":"I86.3","display":"Vulval varices"},{"code":"I86.4","display":"Gastric varices"},{"code":"I86.8","display":"Varicose veins of other specified sites"},{"code":"I87.001","display":"Postthrombotic syndrome without complications of right lower extremity"},{"code":"I87.002","display":"Postthrombotic syndrome without complications of left lower extremity"},{"code":"I87.003","display":"Postthrombotic syndrome without complications of bilateral lower extremity"},{"code":"I87.009","display":"Postthrombotic syndrome without complications of unspecified extremity"},{"code":"I87.011","display":"Postthrombotic syndrome with ulcer of right lower extremity"},{"code":"I87.012","display":"Postthrombotic syndrome with ulcer of left lower extremity"},{"code":"I87.013","display":"Postthrombotic syndrome with ulcer of bilateral lower extremity"},{"code":"I87.019","display":"Postthrombotic syndrome with ulcer of unspecified lower extremity"},{"code":"I87.021","display":"Postthrombotic syndrome with inflammation of right lower extremity"},{"code":"I87.022","display":"Postthrombotic syndrome with inflammation of left lower extremity"},{"code":"I87.023","display":"Postthrombotic syndrome with inflammation of bilateral lower extremity"},{"code":"I87.029","display":"Postthrombotic syndrome with inflammation of unspecified lower extremity"},{"code":"I87.031","display":"Postthrombotic syndrome with ulcer and inflammation of right lower extremity"},{"code":"I87.032","display":"Postthrombotic syndrome with ulcer and inflammation of left lower extremity"},{"code":"I87.033","display":"Postthrombotic syndrome with ulcer and inflammation of bilateral lower extremity"},{"code":"I87.039","display":"Postthrombotic syndrome with ulcer and inflammation of unspecified lower extremity"},{"code":"I87.091","display":"Postthrombotic syndrome with other complications of right lower extremity"},{"code":"I87.092","display":"Postthrombotic syndrome with other complications of left lower extremity"},{"code":"I87.093","display":"Postthrombotic syndrome with other complications of bilateral lower extremity"},{"code":"I87.099","display":"Postthrombotic syndrome with other complications of unspecified lower extremity"},{"code":"I87.1","display":"Compression of vein"},{"code":"I87.2","display":"Venous insufficiency (chronic) (peripheral)"},{"code":"I87.301","display":"Chronic venous hypertension (idiopathic) without complications of right lower extremity"},{"code":"I87.302","display":"Chronic venous hypertension (idiopathic) without complications of left lower extremity"},{"code":"I87.303","display":"Chronic venous hypertension (idiopathic) without complications of bilateral lower extremity"},{"code":"I87.309","display":"Chronic venous hypertension (idiopathic) without complications of unspecified lower extremity"},{"code":"I87.311","display":"Chronic venous hypertension (idiopathic) with ulcer of right lower extremity"},{"code":"I87.312","display":"Chronic venous hypertension (idiopathic) with ulcer of left lower extremity"},{"code":"I87.313","display":"Chronic venous hypertension (idiopathic) with ulcer of bilateral lower extremity"},{"code":"I87.319","display":"Chronic venous hypertension (idiopathic) with ulcer of unspecified lower extremity"},{"code":"I87.321","display":"Chronic venous hypertension (idiopathic) with inflammation of right lower extremity"},{"code":"I87.322","display":"Chronic venous hypertension (idiopathic) with inflammation of left lower extremity"},{"code":"I87.323","display":"Chronic venous hypertension (idiopathic) with inflammation of bilateral lower extremity"},{"code":"I87.329","display":"Chronic venous hypertension (idiopathic) with inflammation of unspecified lower extremity"},{"code":"I87.331","display":"Chronic venous hypertension (idiopathic) with ulcer and inflammation of right lower extremity"},{"code":"I87.332","display":"Chronic venous hypertension (idiopathic) with ulcer and inflammation of left lower extremity"},{"code":"I87.333","display":"Chronic venous hypertension (idiopathic) with ulcer and inflammation of bilateral lower extremity"},{"code":"I87.339","display":"Chronic venous hypertension (idiopathic) with ulcer and inflammation of unspecified lower extremity"},{"code":"I87.391","display":"Chronic venous hypertension (idiopathic) with other complications of right lower extremity"},{"code":"I87.392","display":"Chronic venous hypertension (idiopathic) with other complications of left lower extremity"},{"code":"I87.393","display":"Chronic venous hypertension (idiopathic) with other complications of bilateral lower extremity"},{"code":"I87.399","display":"Chronic venous hypertension (idiopathic) with other complications of unspecified lower extremity"},{"code":"I87.8","display":"Other specified disorders of veins"},{"code":"I87.9","display":"Disorder of vein, unspecified"},{"code":"I88.0","display":"Nonspecific mesenteric lymphadenitis"},{"code":"I88.1","display":"Chronic lymphadenitis, except mesenteric"},{"code":"I88.8","display":"Other nonspecific lymphadenitis"},{"code":"I88.9","display":"Nonspecific lymphadenitis, unspecified"},{"code":"I89.0","display":"Lymphedema, not elsewhere classified"},{"code":"I89.1","display":"Lymphangitis"},{"code":"I89.8","display":"Other specified noninfective disorders of lymphatic vessels and lymph nodes"},{"code":"I89.9","display":"Noninfective disorder of lymphatic vessels and lymph nodes, unspecified"},{"code":"I95.0","display":"Idiopathic hypotension"},{"code":"I95.1","display":"Orthostatic hypotension"},{"code":"I95.89","display":"Other hypotension"},{"code":"I95.9","display":"Hypotension, unspecified"},{"code":"I96","display":"Gangrene, not elsewhere classified"},{"code":"I99.8","display":"Other disorder of circulatory system"},{"code":"I99.9","display":"Unspecified disorder of circulatory system"},{"code":"J10.82","display":"Influenza due to other identified influenza virus with myocarditis"},{"code":"J30.5","display":"Allergic rhinitis due to food"},{"code":"J85.0","display":"Gangrene and necrosis of lung"},{"code":"J91.0","display":"Malignant pleural effusion"},{"code":"K31.7","display":"Polyp of stomach and duodenum"},{"code":"K52.2","display":"Allergic and dietetic gastroenteritis and colitis"},{"code":"K52.21","display":"Food protein-induced enterocolitis syndrome"},{"code":"K52.22","display":"Food protein-induced enteropathy"},{"code":"K52.29","display":"Other allergic and dietetic gastroenteritis and colitis"},{"code":"K55.0","display":"Acute vascular disorders of intestine"},{"code":"K55.011","display":"Focal (segmental) acute (reversible) ischemia of small intestine"},{"code":"K55.012","display":"Diffuse acute (reversible) ischemia of small intestine"},{"code":"K55.019","display":"Acute (reversible) ischemia of small intestine, extent unspecified"},{"code":"K55.021","display":"Focal (segmental) acute infarction of small intestine"},{"code":"K55.022","display":"Diffuse acute infarction of small intestine"},{"code":"K55.029","display":"Acute infarction of small intestine, extent unspecified"},{"code":"K55.031","display":"Focal (segmental) acute (reversible) ischemia of large intestine"},{"code":"K55.032","display":"Diffuse acute (reversible) ischemia of large intestine"},{"code":"K55.039","display":"Acute (reversible) ischemia of large intestine, extent unspecified"},{"code":"K55.041","display":"Focal (segmental) acute infarction of large intestine"},{"code":"K55.042","display":"Diffuse acute infarction of large intestine"},{"code":"K55.049","display":"Acute infarction of large intestine, extent unspecified"},{"code":"K55.051","display":"Focal (segmental) acute (reversible) ischemia of intestine, part unspecified"},{"code":"K55.052","display":"Diffuse acute (reversible) ischemia of intestine, part unspecified"},{"code":"K55.059","display":"Acute (reversible) ischemia of intestine, part and extent unspecified"},{"code":"K55.061","display":"Focal (segmental) acute infarction of intestine, part unspecified"},{"code":"K55.062","display":"Diffuse acute infarction of intestine, part unspecified"},{"code":"K55.069","display":"Acute infarction of intestine, part and extent unspecified"},{"code":"K55.1","display":"Chronic vascular disorders of intestine"},{"code":"K55.8","display":"Other vascular disorders of intestine"},{"code":"K55.9","display":"Vascular disorder of intestine, unspecified"},{"code":"K63.5","display":"Polyp of colon"},{"code":"K64.0","display":"First degree hemorrhoids"},{"code":"K64.1","display":"Second degree hemorrhoids"},{"code":"K64.2","display":"Third degree hemorrhoids"},{"code":"K64.3","display":"Fourth degree hemorrhoids"},{"code":"K64.4","display":"Residual hemorrhoidal skin tags"},{"code":"K64.5","display":"Perianal venous thrombosis"},{"code":"K64.8","display":"Other hemorrhoids"},{"code":"K64.9","display":"Unspecified hemorrhoids"},{"code":"K90.41","display":"Non-celiac gluten sensitivity"},{"code":"L04.0","display":"Acute lymphadenitis of face, head and neck"},{"code":"L04.1","display":"Acute lymphadenitis of trunk"},{"code":"L04.2","display":"Acute lymphadenitis of upper limb"},{"code":"L04.3","display":"Acute lymphadenitis of lower limb"},{"code":"L04.8","display":"Acute lymphadenitis of other sites"},{"code":"L04.9","display":"Acute lymphadenitis, unspecified"},{"code":"L20.0","display":"Besnier\u0027s prurigo"},{"code":"L20.81","display":"Atopic neurodermatitis"},{"code":"L20.82","display":"Flexural eczema"},{"code":"L20.83","display":"Infantile (acute) (chronic) eczema"},{"code":"L20.84","display":"Intrinsic (allergic) eczema"},{"code":"L20.89","display":"Other atopic dermatitis"},{"code":"L20.9","display":"Atopic dermatitis, unspecified"},{"code":"L22","display":"Diaper dermatitis"},{"code":"L23.0","display":"Allergic contact dermatitis due to metals"},{"code":"L23.1","display":"Allergic contact dermatitis due to adhesives"},{"code":"L23.2","display":"Allergic contact dermatitis due to cosmetics"},{"code":"L23.3","display":"Allergic contact dermatitis due to drugs in contact with skin"},{"code":"L23.4","display":"Allergic contact dermatitis due to dyes"},{"code":"L23.5","display":"Allergic contact dermatitis due to other chemical products"},{"code":"L23.6","display":"Allergic contact dermatitis due to food in contact with the skin"},{"code":"L23.7","display":"Allergic contact dermatitis due to plants, except food"},{"code":"L23.81","display":"Allergic contact dermatitis due to animal (cat) (dog) dander"},{"code":"L23.89","display":"Allergic contact dermatitis due to other agents"},{"code":"L23.9","display":"Allergic contact dermatitis, unspecified cause"},{"code":"L24.0","display":"Irritant contact dermatitis due to detergents"},{"code":"L24.1","display":"Irritant contact dermatitis due to oils and greases"},{"code":"L24.2","display":"Irritant contact dermatitis due to solvents"},{"code":"L24.3","display":"Irritant contact dermatitis due to cosmetics"},{"code":"L24.4","display":"Irritant contact dermatitis due to drugs in contact with skin"},{"code":"L24.5","display":"Irritant contact dermatitis due to other chemical products"},{"code":"L24.6","display":"Irritant contact dermatitis due to food in contact with skin"},{"code":"L24.7","display":"Irritant contact dermatitis due to plants, except food"},{"code":"L24.81","display":"Irritant contact dermatitis due to metals"},{"code":"L24.89","display":"Irritant contact dermatitis due to other agents"},{"code":"L24.9","display":"Irritant contact dermatitis, unspecified cause"},{"code":"L25.0","display":"Unspecified contact dermatitis due to cosmetics"},{"code":"L25.1","display":"Unspecified contact dermatitis due to drugs in contact with skin"},{"code":"L25.2","display":"Unspecified contact dermatitis due to dyes"},{"code":"L25.3","display":"Unspecified contact dermatitis due to other chemical products"},{"code":"L25.4","display":"Unspecified contact dermatitis due to food in contact with skin"},{"code":"L25.5","display":"Unspecified contact dermatitis due to plants, except food"},{"code":"L25.8","display":"Unspecified contact dermatitis due to other agents"},{"code":"L25.9","display":"Unspecified contact dermatitis, unspecified cause"},{"code":"L27.0","display":"Generalized skin eruption due to drugs and medicaments taken internally"},{"code":"L27.1","display":"Localized skin eruption due to drugs and medicaments taken internally"},{"code":"L27.2","display":"Dermatitis due to ingested food"},{"code":"L27.8","display":"Dermatitis due to other substances taken internally"},{"code":"L27.9","display":"Dermatitis due to unspecified substance taken internally"},{"code":"L30.0","display":"Nummular dermatitis"},{"code":"L30.2","display":"Cutaneous autosensitization"},{"code":"L30.8","display":"Other specified dermatitis"},{"code":"L30.9","display":"Dermatitis, unspecified"},{"code":"L50.0","display":"Allergic urticaria"},{"code":"L50.1","display":"Idiopathic urticaria"},{"code":"L50.2","display":"Urticaria due to cold and heat"},{"code":"L50.3","display":"Dermatographic urticaria"},{"code":"L50.4","display":"Vibratory urticaria"},{"code":"L50.5","display":"Cholinergic urticaria"},{"code":"L50.6","display":"Contact urticaria"},{"code":"L50.8","display":"Other urticaria"},{"code":"L50.9","display":"Urticaria, unspecified"},{"code":"L56.0","display":"Drug phototoxic response"},{"code":"L56.1","display":"Drug photoallergic response"},{"code":"L56.2","display":"Photocontact dermatitis [berloque dermatitis]"},{"code":"L56.3","display":"Solar urticaria"},{"code":"L56.4","display":"Polymorphous light eruption"},{"code":"L56.8","display":"Other specified acute skin changes due to ultraviolet radiation"},{"code":"L56.9","display":"Acute skin change due to ultraviolet radiation, unspecified"},{"code":"L57.8","display":"Other skin changes due to chronic exposure to nonionizing radiation"},{"code":"L57.9","display":"Skin changes due to chronic exposure to nonionizing radiation, unspecified"},{"code":"L58.0","display":"Acute radiodermatitis"},{"code":"L58.1","display":"Chronic radiodermatitis"},{"code":"L58.9","display":"Radiodermatitis, unspecified"},{"code":"L59.0","display":"Erythema ab igne [dermatitis ab igne]"},{"code":"L59.8","display":"Other specified disorders of the skin and subcutaneous tissue related to radiation"},{"code":"L59.9","display":"Disorder of the skin and subcutaneous tissue related to radiation, unspecified"},{"code":"M31.0","display":"Hypersensitivity angiitis"},{"code":"N26.2","display":"Page kidney"},{"code":"R00.0","display":"Tachycardia, unspecified"},{"code":"R00.1","display":"Bradycardia, unspecified"},{"code":"R00.2","display":"Palpitations"},{"code":"R00.8","display":"Other abnormalities of heart beat"},{"code":"R00.9","display":"Unspecified abnormalities of heart beat"},{"code":"R01.0","display":"Benign and innocent cardiac murmurs"},{"code":"R01.1","display":"Cardiac murmur, unspecified"},{"code":"R01.2","display":"Other cardiac sounds"},{"code":"R03.0","display":"Elevated blood-pressure reading, without diagnosis of hypertension"},{"code":"R03.1","display":"Nonspecific low blood-pressure reading"},{"code":"R07.2","display":"Precordial pain"},{"code":"R07.82","display":"Intercostal pain"},{"code":"R07.89","display":"Other chest pain"},{"code":"R07.9","display":"Chest pain, unspecified"},{"code":"R09.89","display":"Other specified symptoms and signs involving the circulatory and respiratory systems"},{"code":"R10.0","display":"Acute abdomen"},{"code":"R10.10","display":"Upper abdominal pain, unspecified"},{"code":"R10.11","display":"Right upper quadrant pain"},{"code":"R10.12","display":"Left upper quadrant pain"},{"code":"R10.13","display":"Epigastric pain"},{"code":"R10.2","display":"Pelvic and perineal pain"},{"code":"R10.30","display":"Lower abdominal pain, unspecified"},{"code":"R10.31","display":"Right lower quadrant pain"},{"code":"R10.32","display":"Left lower quadrant pain"},{"code":"R10.33","display":"Periumbilical pain"},{"code":"R10.811","display":"Right upper quadrant abdominal tenderness"},{"code":"R10.812","display":"Left upper quadrant abdominal tenderness"},{"code":"R10.813","display":"Right lower quadrant abdominal tenderness"},{"code":"R10.814","display":"Left lower quadrant abdominal tenderness"},{"code":"R10.815","display":"Periumbilic abdominal tenderness"},{"code":"R10.816","display":"Epigastric abdominal tenderness"},{"code":"R10.817","display":"Generalized abdominal tenderness"},{"code":"R10.819","display":"Abdominal tenderness, unspecified site"},{"code":"R10.821","display":"Right upper quadrant rebound abdominal tenderness"},{"code":"R10.822","display":"Left upper quadrant rebound abdominal tenderness"},{"code":"R10.823","display":"Right lower quadrant rebound abdominal tenderness"},{"code":"R10.824","display":"Left lower quadrant rebound abdominal tenderness"},{"code":"R10.825","display":"Periumbilic rebound abdominal tenderness"},{"code":"R10.826","display":"Epigastric rebound abdominal tenderness"},{"code":"R10.827","display":"Generalized rebound abdominal tenderness"},{"code":"R10.829","display":"Rebound abdominal tenderness, unspecified site"},{"code":"R10.84","display":"Generalized abdominal pain"},{"code":"R10.9","display":"Unspecified abdominal pain"},{"code":"R11.0","display":"Nausea"},{"code":"R11.10","display":"Vomiting, unspecified"},{"code":"R11.11","display":"Vomiting without nausea"},{"code":"R11.12","display":"Projectile vomiting"},{"code":"R11.14","display":"Bilious vomiting"},{"code":"R11.2","display":"Nausea with vomiting, unspecified"},{"code":"R18.0","display":"Malignant ascites"},{"code":"R29.700","display":"NIHSS score 0"},{"code":"R29.701","display":"NIHSS score 1"},{"code":"R29.702","display":"NIHSS score 2"},{"code":"R29.703","display":"NIHSS score 3"},{"code":"R29.704","display":"NIHSS score 4"},{"code":"R29.705","display":"NIHSS score 5"},{"code":"R29.706","display":"NIHSS score 6"},{"code":"R29.707","display":"NIHSS score 7"},{"code":"R29.708","display":"NIHSS score 8"},{"code":"R29.709","display":"NIHSS score 9"},{"code":"R29.710","display":"NIHSS score 10"},{"code":"R29.711","display":"NIHSS score 11"},{"code":"R29.712","display":"NIHSS score 12"},{"code":"R29.713","display":"NIHSS score 13"},{"code":"R29.714","display":"NIHSS score 14"},{"code":"R29.715","display":"NIHSS score 15"},{"code":"R29.716","display":"NIHSS score 16"},{"code":"R29.717","display":"NIHSS score 17"},{"code":"R29.718","display":"NIHSS score 18"},{"code":"R29.719","display":"NIHSS score 19"},{"code":"R29.720","display":"NIHSS score 20"},{"code":"R29.721","display":"NIHSS score 21"},{"code":"R29.722","display":"NIHSS score 22"},{"code":"R29.723","display":"NIHSS score 23"},{"code":"R29.724","display":"NIHSS score 24"},{"code":"R29.725","display":"NIHSS score 25"},{"code":"R29.726","display":"NIHSS score 26"},{"code":"R29.727","display":"NIHSS score 27"},{"code":"R29.728","display":"NIHSS score 28"},{"code":"R29.729","display":"NIHSS score 29"},{"code":"R29.730","display":"NIHSS score 30"},{"code":"R29.731","display":"NIHSS score 31"},{"code":"R29.732","display":"NIHSS score 32"},{"code":"R29.733","display":"NIHSS score 33"},{"code":"R29.734","display":"NIHSS score 34"},{"code":"R29.735","display":"NIHSS score 35"},{"code":"R29.736","display":"NIHSS score 36"},{"code":"R29.737","display":"NIHSS score 37"},{"code":"R29.738","display":"NIHSS score 38"},{"code":"R29.739","display":"NIHSS score 39"},{"code":"R29.740","display":"NIHSS score 40"},{"code":"R29.741","display":"NIHSS score 41"},{"code":"R29.742","display":"NIHSS score 42"},{"code":"R50.81","display":"Fever presenting with conditions classified elsewhere"},{"code":"R50.9","display":"Fever, unspecified"},{"code":"R53.0","display":"Neoplastic (malignant) related fatigue"},{"code":"R53.1","display":"Weakness"},{"code":"R53.81","display":"Other malaise"},{"code":"R53.82","display":"Chronic fatigue, unspecified"},{"code":"R53.83","display":"Other fatigue"},{"code":"R55","display":"Syncope and collapse"},{"code":"R57.0","display":"Cardiogenic shock"},{"code":"R57.1","display":"Hypovolemic shock"},{"code":"R57.8","display":"Other shock"},{"code":"R57.9","display":"Shock, unspecified"},{"code":"R58","display":"Hemorrhage, not elsewhere classified"},{"code":"R59.0","display":"Localized enlarged lymph nodes"},{"code":"R59.1","display":"Generalized enlarged lymph nodes"},{"code":"R59.9","display":"Enlarged lymph nodes, unspecified"},{"code":"R65.21","display":"Severe sepsis with septic shock"},{"code":"R78.71","display":"Abnormal lead level in blood"},{"code":"R78.79","display":"Finding of abnormal level of heavy metals in blood"},{"code":"R78.89","display":"Finding of other specified substances, not normally found in blood"},{"code":"R78.9","display":"Finding of unspecified substance, not normally found in blood"},{"code":"R79.0","display":"Abnormal level of blood mineral"},{"code":"R79.1","display":"Abnormal coagulation profile"},{"code":"R79.81","display":"Abnormal blood-gas level"},{"code":"R79.82","display":"Elevated C-reactive protein (CRP)"},{"code":"R79.89","display":"Other specified abnormal findings of blood chemistry"},{"code":"R79.9","display":"Abnormal finding of blood chemistry, unspecified"},{"code":"R83.0","display":"Abnormal level of enzymes in cerebrospinal fluid"},{"code":"R83.1","display":"Abnormal level of hormones in cerebrospinal fluid"},{"code":"R83.2","display":"Abnormal level of other drugs, medicaments and biological substances in cerebrospinal fluid"},{"code":"R83.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid"},{"code":"R83.4","display":"Abnormal immunological findings in cerebrospinal fluid"},{"code":"R83.5","display":"Abnormal microbiological findings in cerebrospinal fluid"},{"code":"R83.6","display":"Abnormal cytological findings in cerebrospinal fluid"},{"code":"R83.8","display":"Other abnormal findings in cerebrospinal fluid"},{"code":"R83.9","display":"Unspecified abnormal finding in cerebrospinal fluid"},{"code":"R84.0","display":"Abnormal level of enzymes in specimens from respiratory organs and thorax"},{"code":"R84.1","display":"Abnormal level of hormones in specimens from respiratory organs and thorax"},{"code":"R84.2","display":"Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax"},{"code":"R84.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax"},{"code":"R84.4","display":"Abnormal immunological findings in specimens from respiratory organs and thorax"},{"code":"R84.5","display":"Abnormal microbiological findings in specimens from respiratory organs and thorax"},{"code":"R84.6","display":"Abnormal cytological findings in specimens from respiratory organs and thorax"},{"code":"R84.7","display":"Abnormal histological findings in specimens from respiratory organs and thorax"},{"code":"R84.8","display":"Other abnormal findings in specimens from respiratory organs and thorax"},{"code":"R84.9","display":"Unspecified abnormal finding in specimens from respiratory organs and thorax"},{"code":"R85.0","display":"Abnormal level of enzymes in specimens from digestive organs and abdominal cavity"},{"code":"R85.1","display":"Abnormal level of hormones in specimens from digestive organs and abdominal cavity"},{"code":"R85.2","display":"Abnormal level of other drugs, medicaments and biological substances in specimens from digestive organs and abdominal cavity"},{"code":"R85.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity"},{"code":"R85.4","display":"Abnormal immunological findings in specimens from digestive organs and abdominal cavity"},{"code":"R85.5","display":"Abnormal microbiological findings in specimens from digestive organs and abdominal cavity"},{"code":"R85.610","display":"Atypical squamous cells of undetermined significance on cytologic smear of anus (ASC-US)"},{"code":"R85.611","display":"Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of anus (ASC-H)"},{"code":"R85.612","display":"Low grade squamous intraepithelial lesion on cytologic smear of anus (LGSIL)"},{"code":"R85.613","display":"High grade squamous intraepithelial lesion on cytologic smear of anus (HGSIL)"},{"code":"R85.614","display":"Cytologic evidence of malignancy on smear of anus"},{"code":"R85.615","display":"Unsatisfactory cytologic smear of anus"},{"code":"R85.616","display":"Satisfactory anal smear but lacking transformation zone"},{"code":"R85.618","display":"Other abnormal cytological findings on specimens from anus"},{"code":"R85.619","display":"Unspecified abnormal cytological findings in specimens from anus"},{"code":"R85.69","display":"Abnormal cytological findings in specimens from other digestive organs and abdominal cavity"},{"code":"R85.7","display":"Abnormal histological findings in specimens from digestive organs and abdominal cavity"},{"code":"R85.89","display":"Other abnormal findings in specimens from digestive organs and abdominal cavity"},{"code":"R85.9","display":"Unspecified abnormal finding in specimens from digestive organs and abdominal cavity"},{"code":"R86.0","display":"Abnormal level of enzymes in specimens from male genital organs"},{"code":"R86.1","display":"Abnormal level of hormones in specimens from male genital organs"},{"code":"R86.2","display":"Abnormal level of other drugs, medicaments and biological substances in specimens from male genital organs"},{"code":"R86.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in specimens from male genital organs"},{"code":"R86.4","display":"Abnormal immunological findings in specimens from male genital organs"},{"code":"R86.5","display":"Abnormal microbiological findings in specimens from male genital organs"},{"code":"R86.6","display":"Abnormal cytological findings in specimens from male genital organs"},{"code":"R86.7","display":"Abnormal histological findings in specimens from male genital organs"},{"code":"R86.8","display":"Other abnormal findings in specimens from male genital organs"},{"code":"R86.9","display":"Unspecified abnormal finding in specimens from male genital organs"},{"code":"R87.0","display":"Abnormal level of enzymes in specimens from female genital organs"},{"code":"R87.1","display":"Abnormal level of hormones in specimens from female genital organs"},{"code":"R87.2","display":"Abnormal level of other drugs, medicaments and biological substances in specimens from female genital organs"},{"code":"R87.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in specimens from female genital organs"},{"code":"R87.4","display":"Abnormal immunological findings in specimens from female genital organs"},{"code":"R87.5","display":"Abnormal microbiological findings in specimens from female genital organs"},{"code":"R87.610","display":"Atypical squamous cells of undetermined significance on cytologic smear of cervix (ASC-US)"},{"code":"R87.611","display":"Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of cervix (ASC-H)"},{"code":"R87.612","display":"Low grade squamous intraepithelial lesion on cytologic smear of cervix (LGSIL)"},{"code":"R87.613","display":"High grade squamous intraepithelial lesion on cytologic smear of cervix (HGSIL)"},{"code":"R87.614","display":"Cytologic evidence of malignancy on smear of cervix"},{"code":"R87.615","display":"Unsatisfactory cytologic smear of cervix"},{"code":"R87.616","display":"Satisfactory cervical smear but lacking transformation zone"},{"code":"R87.618","display":"Other abnormal cytological findings on specimens from cervix uteri"},{"code":"R87.619","display":"Unspecified abnormal cytological findings in specimens from cervix uteri"},{"code":"R87.620","display":"Atypical squamous cells of undetermined significance on cytologic smear of vagina (ASC-US)"},{"code":"R87.621","display":"Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)"},{"code":"R87.622","display":"Low grade squamous intraepithelial lesion on cytologic smear of vagina (LGSIL)"},{"code":"R87.623","display":"High grade squamous intraepithelial lesion on cytologic smear of vagina (HGSIL)"},{"code":"R87.624","display":"Cytologic evidence of malignancy on smear of vagina"},{"code":"R87.625","display":"Unsatisfactory cytologic smear of vagina"},{"code":"R87.628","display":"Other abnormal cytological findings on specimens from vagina"},{"code":"R87.629","display":"Unspecified abnormal cytological findings in specimens from vagina"},{"code":"R87.69","display":"Abnormal cytological findings in specimens from other female genital organs"},{"code":"R87.7","display":"Abnormal histological findings in specimens from female genital organs"},{"code":"R87.89","display":"Other abnormal findings in specimens from female genital organs"},{"code":"R87.9","display":"Unspecified abnormal finding in specimens from female genital organs"},{"code":"R88.8","display":"Abnormal findings in other body fluids and substances"},{"code":"R89.0","display":"Abnormal level of enzymes in specimens from other organs, systems and tissues"},{"code":"R89.1","display":"Abnormal level of hormones in specimens from other organs, systems and tissues"},{"code":"R89.2","display":"Abnormal level of other drugs, medicaments and biological substances in specimens from other organs, systems and tissues"},{"code":"R89.3","display":"Abnormal level of substances chiefly nonmedicinal as to source in specimens from other organs, systems and tissues"},{"code":"R89.4","display":"Abnormal immunological findings in specimens from other organs, systems and tissues"},{"code":"R89.5","display":"Abnormal microbiological findings in specimens from other organs, systems and tissues"},{"code":"R89.6","display":"Abnormal cytological findings in specimens from other organs, systems and tissues"},{"code":"R89.7","display":"Abnormal histological findings in specimens from other organs, systems and tissues"},{"code":"R89.8","display":"Other abnormal findings in specimens from other organs, systems and tissues"},{"code":"R89.9","display":"Unspecified abnormal finding in specimens from other organs, systems and tissues"},{"code":"R90.81","display":"Abnormal echoencephalogram"},{"code":"R90.89","display":"Other abnormal findings on diagnostic imaging of central nervous system"},{"code":"R92.2","display":"Inconclusive mammogram"},{"code":"R92.8","display":"Other abnormal and inconclusive findings on diagnostic imaging of breast"},{"code":"R93.0","display":"Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified"},{"code":"R93.1","display":"Abnormal findings on diagnostic imaging of heart and coronary circulation"},{"code":"R93.2","display":"Abnormal findings on diagnostic imaging of liver and biliary tract"},{"code":"R93.3","display":"Abnormal findings on diagnostic imaging of other parts of digestive tract"},{"code":"R93.4","display":"Abnormal findings on diagnostic imaging of urinary organs"},{"code":"R93.41","display":"Abnormal radiologic findings on diagnostic imaging of renal pelvis, ureter, or bladder"},{"code":"R93.421","display":"Abnormal radiologic findings on diagnostic imaging of right kidney"},{"code":"R93.422","display":"Abnormal radiologic findings on diagnostic imaging of left kidney"},{"code":"R93.429","display":"Abnormal radiologic findings on diagnostic imaging of unspecified kidney"},{"code":"R93.49","display":"Abnormal radiologic findings on diagnostic imaging of other urinary organs"},{"code":"R93.5","display":"Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum"},{"code":"R93.6","display":"Abnormal findings on diagnostic imaging of limbs"},{"code":"R93.7","display":"Abnormal findings on diagnostic imaging of other parts of musculoskeletal system"},{"code":"R93.8","display":"Abnormal findings on diagnostic imaging of other specified body structures"},{"code":"R93.811","display":"Abnormal radiologic findings on diagnostic imaging of right testicle"},{"code":"R93.812","display":"Abnormal radiologic findings on diagnostic imaging of left testicle"},{"code":"R93.813","display":"Abnormal radiologic findings on diagnostic imaging of testicles, bilateral"},{"code":"R93.819","display":"Abnormal radiologic findings on diagnostic imaging of unspecified testicle"},{"code":"R93.89","display":"Abnormal findings on diagnostic imaging of other specified body structures"},{"code":"R93.9","display":"Diagnostic imaging inconclusive due to excess body fat of patient"},{"code":"R94.01","display":"Abnormal electroencephalogram [EEG]"},{"code":"R94.02","display":"Abnormal brain scan"},{"code":"R94.09","display":"Abnormal results of other function studies of central nervous system"},{"code":"R94.110","display":"Abnormal electro-oculogram [EOG]"},{"code":"R94.111","display":"Abnormal electroretinogram [ERG]"},{"code":"R94.112","display":"Abnormal visually evoked potential [VEP]"},{"code":"R94.113","display":"Abnormal oculomotor study"},{"code":"R94.118","display":"Abnormal results of other function studies of eye"},{"code":"R94.120","display":"Abnormal auditory function study"},{"code":"R94.121","display":"Abnormal vestibular function study"},{"code":"R94.128","display":"Abnormal results of other function studies of ear and other special senses"},{"code":"R94.130","display":"Abnormal response to nerve stimulation, unspecified"},{"code":"R94.131","display":"Abnormal electromyogram [EMG]"},{"code":"R94.138","display":"Abnormal results of other function studies of peripheral nervous system"},{"code":"R94.2","display":"Abnormal results of pulmonary function studies"},{"code":"R94.30","display":"Abnormal result of cardiovascular function study, unspecified"},{"code":"R94.31","display":"Abnormal electrocardiogram [ECG] [EKG]"},{"code":"R94.39","display":"Abnormal result of other cardiovascular function study"},{"code":"R94.4","display":"Abnormal results of kidney function studies"},{"code":"R94.5","display":"Abnormal results of liver function studies"},{"code":"R94.6","display":"Abnormal results of thyroid function studies"},{"code":"R94.7","display":"Abnormal results of other endocrine function studies"},{"code":"R94.8","display":"Abnormal results of function studies of other organs and systems"},{"code":"R97.0","display":"Elevated carcinoembryonic antigen [CEA]"},{"code":"R97.1","display":"Elevated cancer antigen 125 [CA 125]"},{"code":"R97.2","display":"Elevated prostate specific antigen [PSA]"},{"code":"R97.20","display":"Elevated prostate specific antigen [PSA]"},{"code":"R97.21","display":"Rising PSA following treatment for malignant neoplasm of prostate"},{"code":"R97.8","display":"Other abnormal tumor markers"},{"code":"T78.00XA","display":"Anaphylactic reaction due to unspecified food, initial encounter"},{"code":"T78.00XD","display":"Anaphylactic reaction due to unspecified food, subsequent encounter"},{"code":"T78.00XS","display":"Anaphylactic reaction due to unspecified food, sequela"},{"code":"T78.01XA","display":"Anaphylactic reaction due to peanuts, initial encounter"},{"code":"T78.01XD","display":"Anaphylactic reaction due to peanuts, subsequent encounter"},{"code":"T78.01XS","display":"Anaphylactic reaction due to peanuts, sequela"},{"code":"T78.02XA","display":"Anaphylactic reaction due to shellfish (crustaceans), initial encounter"},{"code":"T78.02XD","display":"Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter"},{"code":"T78.02XS","display":"Anaphylactic reaction due to shellfish (crustaceans), sequela"},{"code":"T78.03XA","display":"Anaphylactic reaction due to other fish, initial encounter"},{"code":"T78.03XD","display":"Anaphylactic reaction due to other fish, subsequent encounter"},{"code":"T78.03XS","display":"Anaphylactic reaction due to other fish, sequela"},{"code":"T78.04XA","display":"Anaphylactic reaction due to fruits and vegetables, initial encounter"},{"code":"T78.04XD","display":"Anaphylactic reaction due to fruits and vegetables, subsequent encounter"},{"code":"T78.04XS","display":"Anaphylactic reaction due to fruits and vegetables, sequela"},{"code":"T78.05XA","display":"Anaphylactic reaction due to tree nuts and seeds, initial encounter"},{"code":"T78.05XD","display":"Anaphylactic reaction due to tree nuts and seeds, subsequent encounter"},{"code":"T78.05XS","display":"Anaphylactic reaction due to tree nuts and seeds, sequela"},{"code":"T78.06XA","display":"Anaphylactic reaction due to food additives, initial encounter"},{"code":"T78.06XD","display":"Anaphylactic reaction due to food additives, subsequent encounter"},{"code":"T78.06XS","display":"Anaphylactic reaction due to food additives, sequela"},{"code":"T78.07XA","display":"Anaphylactic reaction due to milk and dairy products, initial encounter"},{"code":"T78.07XD","display":"Anaphylactic reaction due to milk and dairy products, subsequent encounter"},{"code":"T78.07XS","display":"Anaphylactic reaction due to milk and dairy products, sequela"},{"code":"T78.08XA","display":"Anaphylactic reaction due to eggs, initial encounter"},{"code":"T78.08XD","display":"Anaphylactic reaction due to eggs, subsequent encounter"},{"code":"T78.08XS","display":"Anaphylactic reaction due to eggs, sequela"},{"code":"T78.09XA","display":"Anaphylactic reaction due to other food products, initial encounter"},{"code":"T78.09XD","display":"Anaphylactic reaction due to other food products, subsequent encounter"},{"code":"T78.09XS","display":"Anaphylactic reaction due to other food products, sequela"},{"code":"T78.1XXA","display":"Other adverse food reactions, not elsewhere classified, initial encounter"},{"code":"T78.1XXD","display":"Other adverse food reactions, not elsewhere classified, subsequent encounter"},{"code":"T78.1XXS","display":"Other adverse food reactions, not elsewhere classified, sequela"},{"code":"T78.2XXA","display":"Anaphylactic shock, unspecified, initial encounter"},{"code":"T78.40XA","display":"Allergy, unspecified, initial encounter"},{"code":"T78.49XA","display":"Other allergy, initial encounter"},{"code":"Z00.00","display":"Encounter for general adult medical examination without abnormal findings"},{"code":"Z00.01","display":"Encounter for general adult medical examination with abnormal findings"},{"code":"Z00.110","display":"Health examination for newborn under 8 days old"},{"code":"Z00.111","display":"Health examination for newborn 8 to 28 days old"},{"code":"Z00.121","display":"Encounter for routine child health examination with abnormal findings"},{"code":"Z00.129","display":"Encounter for routine child health examination without abnormal findings"},{"code":"Z00.2","display":"Encounter for examination for period of rapid growth in childhood"},{"code":"Z00.3","display":"Encounter for examination for adolescent development state"},{"code":"Z00.5","display":"Encounter for examination of potential donor of organ and tissue"},{"code":"Z00.6","display":"Encounter for examination for normal comparison and control in clinical research program"},{"code":"Z00.70","display":"Encounter for examination for period of delayed growth in childhood without abnormal findings"},{"code":"Z00.71","display":"Encounter for examination for period of delayed growth in childhood with abnormal findings"},{"code":"Z00.8","display":"Encounter for other general examination"},{"code":"Z01.00","display":"Encounter for examination of eyes and vision without abnormal findings"},{"code":"Z01.01","display":"Encounter for examination of eyes and vision with abnormal findings"},{"code":"Z01.10","display":"Encounter for examination of ears and hearing without abnormal findings"},{"code":"Z01.110","display":"Encounter for hearing examination following failed hearing screening"},{"code":"Z01.118","display":"Encounter for examination of ears and hearing with other abnormal findings"},{"code":"Z01.12","display":"Encounter for hearing conservation and treatment"},{"code":"Z01.20","display":"Encounter for dental examination and cleaning without abnormal findings"},{"code":"Z01.21","display":"Encounter for dental examination and cleaning with abnormal findings"},{"code":"Z01.30","display":"Encounter for examination of blood pressure without abnormal findings"},{"code":"Z01.31","display":"Encounter for examination of blood pressure with abnormal findings"},{"code":"Z01.411","display":"Encounter for gynecological examination (general) (routine) with abnormal findings"},{"code":"Z01.419","display":"Encounter for gynecological examination (general) (routine) without abnormal findings"},{"code":"Z01.42","display":"Encounter for cervical smear to confirm findings of recent normal smear following initial abnormal smear"},{"code":"Z01.810","display":"Encounter for preprocedural cardiovascular examination"},{"code":"Z01.811","display":"Encounter for preprocedural respiratory examination"},{"code":"Z01.812","display":"Encounter for preprocedural laboratory examination"},{"code":"Z01.818","display":"Encounter for other preprocedural examination"},{"code":"Z01.82","display":"Encounter for allergy testing"},{"code":"Z01.83","display":"Encounter for blood typing"},{"code":"Z01.84","display":"Encounter for antibody response examination"},{"code":"Z01.89","display":"Encounter for other specified special examinations"},{"code":"Z02.0","display":"Encounter for examination for admission to educational institution"},{"code":"Z02.1","display":"Encounter for pre-employment examination"},{"code":"Z02.2","display":"Encounter for examination for admission to residential institution"},{"code":"Z02.3","display":"Encounter for examination for recruitment to armed forces"},{"code":"Z02.4","display":"Encounter for examination for driving license"},{"code":"Z02.5","display":"Encounter for examination for participation in sport"},{"code":"Z02.6","display":"Encounter for examination for insurance purposes"},{"code":"Z02.71","display":"Encounter for disability determination"},{"code":"Z02.79","display":"Encounter for issue of other medical certificate"},{"code":"Z02.81","display":"Encounter for paternity testing"},{"code":"Z02.82","display":"Encounter for adoption services"},{"code":"Z02.83","display":"Encounter for blood-alcohol and blood-drug test"},{"code":"Z02.89","display":"Encounter for other administrative examinations"},{"code":"Z02.9","display":"Encounter for administrative examinations, unspecified"},{"code":"Z03.6","display":"Encounter for observation for suspected toxic effect from ingested substance ruled out"},{"code":"Z03.71","display":"Encounter for suspected problem with amniotic cavity and membrane ruled out"},{"code":"Z03.72","display":"Encounter for suspected placental problem ruled out"},{"code":"Z03.73","display":"Encounter for suspected fetal anomaly ruled out"},{"code":"Z03.74","display":"Encounter for suspected problem with fetal growth ruled out"},{"code":"Z03.75","display":"Encounter for suspected cervical shortening ruled out"},{"code":"Z03.79","display":"Encounter for other suspected maternal and fetal conditions ruled out"},{"code":"Z03.89","display":"Encounter for observation for other suspected diseases and conditions ruled out"},{"code":"Z04.41","display":"Encounter for examination and observation following alleged adult rape"},{"code":"Z04.42","display":"Encounter for examination and observation following alleged child rape"},{"code":"Z04.71","display":"Encounter for examination and observation following alleged adult physical abuse"},{"code":"Z04.72","display":"Encounter for examination and observation following alleged child physical abuse"},{"code":"Z04.8","display":"Encounter for examination and observation for other specified reasons"},{"code":"Z04.81","display":"Encounter for examination and observation of victim following forced sexual exploitation"},{"code":"Z04.82","display":"Encounter for examination and observation of victim following forced labor exploitation"},{"code":"Z04.89","display":"Encounter for examination and observation for other specified reasons"},{"code":"Z04.9","display":"Encounter for examination and observation for unspecified reason"},{"code":"Z05.0","display":"Observation and evaluation of newborn for suspected cardiac condition ruled out"},{"code":"Z05.2","display":"Observation and evaluation of newborn for suspected neurological condition ruled out"},{"code":"Z05.3","display":"Observation and evaluation of newborn for suspected respiratory condition ruled out"},{"code":"Z05.41","display":"Observation and evaluation of newborn for suspected genetic condition ruled out"},{"code":"Z05.42","display":"Observation and evaluation of newborn for suspected metabolic condition ruled out"},{"code":"Z05.43","display":"Observation and evaluation of newborn for suspected immunologic condition ruled out"},{"code":"Z05.5","display":"Observation and evaluation of newborn for suspected gastrointestinal condition ruled out"},{"code":"Z05.6","display":"Observation and evaluation of newborn for suspected genitourinary condition ruled out"},{"code":"Z05.71","display":"Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out"},{"code":"Z05.72","display":"Observation and evaluation of newborn for suspected musculoskeletal condition ruled out"},{"code":"Z05.73","display":"Observation and evaluation of newborn for suspected connective tissue condition ruled out"},{"code":"Z05.8","display":"Observation and evaluation of newborn for other specified suspected condition ruled out"},{"code":"Z05.9","display":"Observation and evaluation of newborn for unspecified suspected condition ruled out"},{"code":"Z08","display":"Encounter for follow-up examination after completed treatment for malignant neoplasm"},{"code":"Z09","display":"Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm"},{"code":"Z12.0","display":"Encounter for screening for malignant neoplasm of stomach"},{"code":"Z12.10","display":"Encounter for screening for malignant neoplasm of intestinal tract, unspecified"},{"code":"Z12.11","display":"Encounter for screening for malignant neoplasm of colon"},{"code":"Z12.12","display":"Encounter for screening for malignant neoplasm of rectum"},{"code":"Z12.13","display":"Encounter for screening for malignant neoplasm of small intestine"},{"code":"Z12.2","display":"Encounter for screening for malignant neoplasm of respiratory organs"},{"code":"Z12.31","display":"Encounter for screening mammogram for malignant neoplasm of breast"},{"code":"Z12.39","display":"Encounter for other screening for malignant neoplasm of breast"},{"code":"Z12.4","display":"Encounter for screening for malignant neoplasm of cervix"},{"code":"Z12.5","display":"Encounter for screening for malignant neoplasm of prostate"},{"code":"Z12.6","display":"Encounter for screening for malignant neoplasm of bladder"},{"code":"Z12.71","display":"Encounter for screening for malignant neoplasm of testis"},{"code":"Z12.72","display":"Encounter for screening for malignant neoplasm of vagina"},{"code":"Z12.73","display":"Encounter for screening for malignant neoplasm of ovary"},{"code":"Z12.79","display":"Encounter for screening for malignant neoplasm of other genitourinary organs"},{"code":"Z12.81","display":"Encounter for screening for malignant neoplasm of oral cavity"},{"code":"Z12.82","display":"Encounter for screening for malignant neoplasm of nervous system"},{"code":"Z12.83","display":"Encounter for screening for malignant neoplasm of skin"},{"code":"Z12.89","display":"Encounter for screening for malignant neoplasm of other sites"},{"code":"Z12.9","display":"Encounter for screening for malignant neoplasm, site unspecified"},{"code":"Z13.0","display":"Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism"},{"code":"Z13.1","display":"Encounter for screening for diabetes mellitus"},{"code":"Z13.21","display":"Encounter for screening for nutritional disorder"},{"code":"Z13.220","display":"Encounter for screening for lipoid disorders"},{"code":"Z13.228","display":"Encounter for screening for other metabolic disorders"},{"code":"Z13.29","display":"Encounter for screening for other suspected endocrine disorder"},{"code":"Z13.5","display":"Encounter for screening for eye and ear disorders"},{"code":"Z13.6","display":"Encounter for screening for cardiovascular disorders"},{"code":"Z13.71","display":"Encounter for nonprocreative screening for genetic disease carrier status"},{"code":"Z13.79","display":"Encounter for other screening for genetic and chromosomal anomalies"},{"code":"Z13.810","display":"Encounter for screening for upper gastrointestinal disorder"},{"code":"Z13.811","display":"Encounter for screening for lower gastrointestinal disorder"},{"code":"Z13.818","display":"Encounter for screening for other digestive system disorders"},{"code":"Z13.820","display":"Encounter for screening for osteoporosis"},{"code":"Z13.828","display":"Encounter for screening for other musculoskeletal disorder"},{"code":"Z13.83","display":"Encounter for screening for respiratory disorder NEC"},{"code":"Z13.84","display":"Encounter for screening for dental disorders"},{"code":"Z13.850","display":"Encounter for screening for traumatic brain injury"},{"code":"Z13.858","display":"Encounter for screening for other nervous system disorders"},{"code":"Z13.88","display":"Encounter for screening for disorder due to exposure to contaminants"},{"code":"Z13.89","display":"Encounter for screening for other disorder"},{"code":"Z13.9","display":"Encounter for screening, unspecified"},{"code":"Z32.00","display":"Encounter for pregnancy test, result unknown"},{"code":"Z32.02","display":"Encounter for pregnancy test, result negative"},{"code":"Z32.2","display":"Encounter for childbirth instruction"},{"code":"Z32.3","display":"Encounter for childcare instruction"},{"code":"Z36","display":"Encounter for antenatal screening of mother"},{"code":"Z36.0","display":"Encounter for antenatal screening for chromosomal anomalies"},{"code":"Z36.1","display":"Encounter for antenatal screening for raised alphafetoprotein level"},{"code":"Z36.2","display":"Encounter for other antenatal screening follow-up"},{"code":"Z36.3","display":"Encounter for antenatal screening for malformations"},{"code":"Z36.4","display":"Encounter for antenatal screening for fetal growth retardation"},{"code":"Z36.5","display":"Encounter for antenatal screening for isoimmunization"},{"code":"Z36.81","display":"Encounter for antenatal screening for hydrops fetalis"},{"code":"Z36.82","display":"Encounter for antenatal screening for nuchal translucency"},{"code":"Z36.83","display":"Encounter for fetal screening for congenital cardiac abnormalities"},{"code":"Z36.84","display":"Encounter for antenatal screening for fetal lung maturity"},{"code":"Z36.85","display":"Encounter for antenatal screening for Streptococcus B"},{"code":"Z36.86","display":"Encounter for antenatal screening for cervical length"},{"code":"Z36.87","display":"Encounter for antenatal screening for uncertain dates"},{"code":"Z36.88","display":"Encounter for antenatal screening for fetal macrosomia"},{"code":"Z36.89","display":"Encounter for other specified antenatal screening"},{"code":"Z36.8A","display":"Encounter for antenatal screening for other genetic defects"},{"code":"Z36.9","display":"Encounter for antenatal screening, unspecified"},{"code":"Z42.1","display":"Encounter for breast reconstruction following mastectomy"},{"code":"Z42.8","display":"Encounter for other plastic and reconstructive surgery following medical procedure or healed injury"},{"code":"Z43.8","display":"Encounter for attention to other artificial openings"},{"code":"Z43.9","display":"Encounter for attention to unspecified artificial opening"},{"code":"Z44.001","display":"Encounter for fitting and adjustment of unspecified right artificial arm"},{"code":"Z44.002","display":"Encounter for fitting and adjustment of unspecified left artificial arm"},{"code":"Z44.009","display":"Encounter for fitting and adjustment of unspecified artificial arm, unspecified arm"},{"code":"Z44.011","display":"Encounter for fitting and adjustment of complete right artificial arm"},{"code":"Z44.012","display":"Encounter for fitting and adjustment of complete left artificial arm"},{"code":"Z44.019","display":"Encounter for fitting and adjustment of complete artificial arm, unspecified arm"},{"code":"Z44.021","display":"Encounter for fitting and adjustment of partial artificial right arm"},{"code":"Z44.022","display":"Encounter for fitting and adjustment of partial artificial left arm"},{"code":"Z44.029","display":"Encounter for fitting and adjustment of partial artificial arm, unspecified arm"},{"code":"Z44.101","display":"Encounter for fitting and adjustment of unspecified right artificial leg"},{"code":"Z44.102","display":"Encounter for fitting and adjustment of unspecified left artificial leg"},{"code":"Z44.109","display":"Encounter for fitting and adjustment of unspecified artificial leg, unspecified leg"},{"code":"Z44.111","display":"Encounter for fitting and adjustment of complete right artificial leg"},{"code":"Z44.112","display":"Encounter for fitting and adjustment of complete left artificial leg"},{"code":"Z44.119","display":"Encounter for fitting and adjustment of complete artificial leg, unspecified leg"},{"code":"Z44.121","display":"Encounter for fitting and adjustment of partial artificial right leg"},{"code":"Z44.122","display":"Encounter for fitting and adjustment of partial artificial left leg"},{"code":"Z44.129","display":"Encounter for fitting and adjustment of partial artificial leg, unspecified leg"},{"code":"Z44.30","display":"Encounter for fitting and adjustment of external breast prosthesis, unspecified breast"},{"code":"Z44.31","display":"Encounter for fitting and adjustment of external right breast prosthesis"},{"code":"Z44.32","display":"Encounter for fitting and adjustment of external left breast prosthesis"},{"code":"Z44.8","display":"Encounter for fitting and adjustment of other external prosthetic devices"},{"code":"Z44.9","display":"Encounter for fitting and adjustment of unspecified external prosthetic device"},{"code":"Z45.010","display":"Encounter for checking and testing of cardiac pacemaker pulse generator [battery]"},{"code":"Z45.018","display":"Encounter for adjustment and management of other part of cardiac pacemaker"},{"code":"Z45.02","display":"Encounter for adjustment and management of automatic implantable cardiac defibrillator"},{"code":"Z45.09","display":"Encounter for adjustment and management of other cardiac device"},{"code":"Z45.1","display":"Encounter for adjustment and management of infusion pump"},{"code":"Z45.2","display":"Encounter for adjustment and management of vascular access device"},{"code":"Z45.31","display":"Encounter for adjustment and management of implanted visual substitution device"},{"code":"Z45.320","display":"Encounter for adjustment and management of bone conduction device"},{"code":"Z45.321","display":"Encounter for adjustment and management of cochlear device"},{"code":"Z45.328","display":"Encounter for adjustment and management of other implanted hearing device"},{"code":"Z45.41","display":"Encounter for adjustment and management of cerebrospinal fluid drainage device"},{"code":"Z45.42","display":"Encounter for adjustment and management of neurostimulator"},{"code":"Z45.49","display":"Encounter for adjustment and management of other implanted nervous system device"},{"code":"Z45.811","display":"Encounter for adjustment or removal of right breast implant"},{"code":"Z45.812","display":"Encounter for adjustment or removal of left breast implant"},{"code":"Z45.819","display":"Encounter for adjustment or removal of unspecified breast implant"},{"code":"Z45.82","display":"Encounter for adjustment or removal of myringotomy device (stent) (tube)"},{"code":"Z45.89","display":"Encounter for adjustment and management of other implanted devices"},{"code":"Z45.9","display":"Encounter for adjustment and management of unspecified implanted device"},{"code":"Z46.82","display":"Encounter for fitting and adjustment of non-vascular catheter"},{"code":"Z46.89","display":"Encounter for fitting and adjustment of other specified devices"},{"code":"Z46.9","display":"Encounter for fitting and adjustment of unspecified device"},{"code":"Z47.1","display":"Aftercare following joint replacement surgery"},{"code":"Z47.2","display":"Encounter for removal of internal fixation device"},{"code":"Z47.31","display":"Aftercare following explantation of shoulder joint prosthesis"},{"code":"Z47.32","display":"Aftercare following explantation of hip joint prosthesis"},{"code":"Z47.33","display":"Aftercare following explantation of knee joint prosthesis"},{"code":"Z47.81","display":"Encounter for orthopedic aftercare following surgical amputation"},{"code":"Z47.82","display":"Encounter for orthopedic aftercare following scoliosis surgery"},{"code":"Z47.89","display":"Encounter for other orthopedic aftercare"},{"code":"Z48.00","display":"Encounter for change or removal of nonsurgical wound dressing"},{"code":"Z48.01","display":"Encounter for change or removal of surgical wound dressing"},{"code":"Z48.02","display":"Encounter for removal of sutures"},{"code":"Z48.03","display":"Encounter for change or removal of drains"},{"code":"Z48.1","display":"Encounter for planned postprocedural wound closure"},{"code":"Z48.21","display":"Encounter for aftercare following heart transplant"},{"code":"Z48.22","display":"Encounter for aftercare following kidney transplant"},{"code":"Z48.23","display":"Encounter for aftercare following liver transplant"},{"code":"Z48.24","display":"Encounter for aftercare following lung transplant"},{"code":"Z48.280","display":"Encounter for aftercare following heart-lung transplant"},{"code":"Z48.288","display":"Encounter for aftercare following multiple organ transplant"},{"code":"Z48.290","display":"Encounter for aftercare following bone marrow transplant"},{"code":"Z48.298","display":"Encounter for aftercare following other organ transplant"},{"code":"Z48.3","display":"Aftercare following surgery for neoplasm"},{"code":"Z48.810","display":"Encounter for surgical aftercare following surgery on the sense organs"},{"code":"Z48.811","display":"Encounter for surgical aftercare following surgery on the nervous system"},{"code":"Z48.812","display":"Encounter for surgical aftercare following surgery on the circulatory system"},{"code":"Z48.813","display":"Encounter for surgical aftercare following surgery on the respiratory system"},{"code":"Z48.814","display":"Encounter for surgical aftercare following surgery on the teeth or oral cavity"},{"code":"Z48.815","display":"Encounter for surgical aftercare following surgery on the digestive system"},{"code":"Z48.816","display":"Encounter for surgical aftercare following surgery on the genitourinary system"},{"code":"Z48.817","display":"Encounter for surgical aftercare following surgery on the skin and subcutaneous tissue"},{"code":"Z48.89","display":"Encounter for other specified surgical aftercare"},{"code":"Z51.0","display":"Encounter for antineoplastic radiation therapy"},{"code":"Z51.11","display":"Encounter for antineoplastic chemotherapy"},{"code":"Z51.12","display":"Encounter for antineoplastic immunotherapy"},{"code":"Z51.5","display":"Encounter for palliative care"},{"code":"Z51.6","display":"Encounter for desensitization to allergens"},{"code":"Z51.81","display":"Encounter for therapeutic drug level monitoring"},{"code":"Z51.89","display":"Encounter for other specified aftercare"},{"code":"Z55.0","display":"Illiteracy and low-level literacy"},{"code":"Z55.1","display":"Schooling unavailable and unattainable"},{"code":"Z55.2","display":"Failed school examinations"},{"code":"Z55.3","display":"Underachievement in school"},{"code":"Z55.4","display":"Educational maladjustment and discord with teachers and classmates"},{"code":"Z55.8","display":"Other problems related to education and literacy"},{"code":"Z55.9","display":"Problems related to education and literacy, unspecified"},{"code":"Z56.0","display":"Unemployment, unspecified"},{"code":"Z56.1","display":"Change of job"},{"code":"Z56.2","display":"Threat of job loss"},{"code":"Z56.3","display":"Stressful work schedule"},{"code":"Z56.4","display":"Discord with boss and workmates"},{"code":"Z56.5","display":"Uncongenial work environment"},{"code":"Z56.6","display":"Other physical and mental strain related to work"},{"code":"Z56.81","display":"Sexual harassment on the job"},{"code":"Z56.82","display":"Military deployment status"},{"code":"Z56.89","display":"Other problems related to employment"},{"code":"Z56.9","display":"Unspecified problems related to employment"},{"code":"Z57.0","display":"Occupational exposure to noise"},{"code":"Z57.1","display":"Occupational exposure to radiation"},{"code":"Z57.2","display":"Occupational exposure to dust"},{"code":"Z57.31","display":"Occupational exposure to environmental tobacco smoke"},{"code":"Z57.39","display":"Occupational exposure to other air contaminants"},{"code":"Z57.4","display":"Occupational exposure to toxic agents in agriculture"},{"code":"Z57.5","display":"Occupational exposure to toxic agents in other industries"},{"code":"Z57.6","display":"Occupational exposure to extreme temperature"},{"code":"Z57.7","display":"Occupational exposure to vibration"},{"code":"Z57.8","display":"Occupational exposure to other risk factors"},{"code":"Z57.9","display":"Occupational exposure to unspecified risk factor"},{"code":"Z59.0","display":"Homelessness"},{"code":"Z59.1","display":"Inadequate housing"},{"code":"Z59.2","display":"Discord with neighbors, lodgers and landlord"},{"code":"Z59.3","display":"Problems related to living in residential institution"},{"code":"Z59.4","display":"Lack of adequate food and safe drinking water"},{"code":"Z59.5","display":"Extreme poverty"},{"code":"Z59.6","display":"Low income"},{"code":"Z59.7","display":"Insufficient social insurance and welfare support"},{"code":"Z59.8","display":"Other problems related to housing and economic circumstances"},{"code":"Z59.9","display":"Problem related to housing and economic circumstances, unspecified"},{"code":"Z60.0","display":"Problems of adjustment to life-cycle transitions"},{"code":"Z60.2","display":"Problems related to living alone"},{"code":"Z60.3","display":"Acculturation difficulty"},{"code":"Z60.4","display":"Social exclusion and rejection"},{"code":"Z60.5","display":"Target of (perceived) adverse discrimination and persecution"},{"code":"Z60.8","display":"Other problems related to social environment"},{"code":"Z60.9","display":"Problem related to social environment, unspecified"},{"code":"Z62.0","display":"Inadequate parental supervision and control"},{"code":"Z62.1","display":"Parental overprotection"},{"code":"Z62.21","display":"Child in welfare custody"},{"code":"Z62.22","display":"Institutional upbringing"},{"code":"Z62.29","display":"Other upbringing away from parents"},{"code":"Z62.3","display":"Hostility towards and scapegoating of child"},{"code":"Z62.6","display":"Inappropriate (excessive) parental pressure"},{"code":"Z62.810","display":"Personal history of physical and sexual abuse in childhood"},{"code":"Z62.811","display":"Personal history of psychological abuse in childhood"},{"code":"Z62.812","display":"Personal history of neglect in childhood"},{"code":"Z62.813","display":"Personal history of forced labor or sexual exploitation in childhood"},{"code":"Z62.819","display":"Personal history of unspecified abuse in childhood"},{"code":"Z62.820","display":"Parent-biological child conflict"},{"code":"Z62.821","display":"Parent-adopted child conflict"},{"code":"Z62.822","display":"Parent-foster child conflict"},{"code":"Z62.890","display":"Parent-child estrangement NEC"},{"code":"Z62.891","display":"Sibling rivalry"},{"code":"Z62.898","display":"Other specified problems related to upbringing"},{"code":"Z62.9","display":"Problem related to upbringing, unspecified"},{"code":"Z63.0","display":"Problems in relationship with spouse or partner"},{"code":"Z63.1","display":"Problems in relationship with in-laws"},{"code":"Z63.31","display":"Absence of family member due to military deployment"},{"code":"Z63.32","display":"Other absence of family member"},{"code":"Z63.4","display":"Disappearance and death of family member"},{"code":"Z63.5","display":"Disruption of family by separation and divorce"},{"code":"Z63.6","display":"Dependent relative needing care at home"},{"code":"Z63.71","display":"Stress on family due to return of family member from military deployment"},{"code":"Z63.72","display":"Alcoholism and drug addiction in family"},{"code":"Z63.79","display":"Other stressful life events affecting family and household"},{"code":"Z63.8","display":"Other specified problems related to primary support group"},{"code":"Z63.9","display":"Problem related to primary support group, unspecified"},{"code":"Z64.0","display":"Problems related to unwanted pregnancy"},{"code":"Z64.1","display":"Problems related to multiparity"},{"code":"Z64.4","display":"Discord with counselors"},{"code":"Z65.0","display":"Conviction in civil and criminal proceedings without imprisonment"},{"code":"Z65.1","display":"Imprisonment and other incarceration"},{"code":"Z65.2","display":"Problems related to release from prison"},{"code":"Z65.3","display":"Problems related to other legal circumstances"},{"code":"Z65.4","display":"Victim of crime and terrorism"},{"code":"Z65.5","display":"Exposure to disaster, war and other hostilities"},{"code":"Z65.8","display":"Other specified problems related to psychosocial circumstances"},{"code":"Z65.9","display":"Problem related to unspecified psychosocial circumstances"},{"code":"Z69.010","display":"Encounter for mental health services for victim of parental child abuse"},{"code":"Z69.011","display":"Encounter for mental health services for perpetrator of parental child abuse"},{"code":"Z69.020","display":"Encounter for mental health services for victim of non-parental child abuse"},{"code":"Z69.021","display":"Encounter for mental health services for perpetrator of non-parental child abuse"},{"code":"Z69.11","display":"Encounter for mental health services for victim of spousal or partner abuse"},{"code":"Z69.12","display":"Encounter for mental health services for perpetrator of spousal or partner abuse"},{"code":"Z69.81","display":"Encounter for mental health services for victim of other abuse"},{"code":"Z69.82","display":"Encounter for mental health services for perpetrator of other abuse"},{"code":"Z70.0","display":"Counseling related to sexual attitude"},{"code":"Z70.1","display":"Counseling related to patient\u0027s sexual behavior and orientation"},{"code":"Z70.2","display":"Counseling related to sexual behavior and orientation of third party"},{"code":"Z70.3","display":"Counseling related to combined concerns regarding sexual attitude, behavior and orientation"},{"code":"Z70.8","display":"Other sex counseling"},{"code":"Z70.9","display":"Sex counseling, unspecified"},{"code":"Z71.0","display":"Person encountering health services to consult on behalf of another person"},{"code":"Z71.1","display":"Person with feared health complaint in whom no diagnosis is made"},{"code":"Z71.2","display":"Person consulting for explanation of examination or test findings"},{"code":"Z71.3","display":"Dietary counseling and surveillance"},{"code":"Z71.41","display":"Alcohol abuse counseling and surveillance of alcoholic"},{"code":"Z71.42","display":"Counseling for family member of alcoholic"},{"code":"Z71.51","display":"Drug abuse counseling and surveillance of drug abuser"},{"code":"Z71.52","display":"Counseling for family member of drug abuser"},{"code":"Z71.6","display":"Tobacco abuse counseling"},{"code":"Z71.7","display":"Human immunodeficiency virus [HIV] counseling"},{"code":"Z71.81","display":"Spiritual or religious counseling"},{"code":"Z71.82","display":"Exercise counseling"},{"code":"Z71.83","display":"Encounter for nonprocreative genetic counseling"},{"code":"Z71.89","display":"Other specified counseling"},{"code":"Z71.9","display":"Counseling, unspecified"},{"code":"Z73.0","display":"Burn-out"},{"code":"Z73.1","display":"Type A behavior pattern"},{"code":"Z73.2","display":"Lack of relaxation and leisure"},{"code":"Z73.3","display":"Stress, not elsewhere classified"},{"code":"Z73.4","display":"Inadequate social skills, not elsewhere classified"},{"code":"Z73.5","display":"Social role conflict, not elsewhere classified"},{"code":"Z73.6","display":"Limitation of activities due to disability"},{"code":"Z73.810","display":"Behavioral insomnia of childhood, sleep-onset association type"},{"code":"Z73.811","display":"Behavioral insomnia of childhood, limit setting type"},{"code":"Z73.812","display":"Behavioral insomnia of childhood, combined type"},{"code":"Z73.819","display":"Behavioral insomnia of childhood, unspecified type"},{"code":"Z73.89","display":"Other problems related to life management difficulty"},{"code":"Z73.9","display":"Problem related to life management difficulty, unspecified"},{"code":"Z74.01","display":"Bed confinement status"},{"code":"Z74.09","display":"Other reduced mobility"},{"code":"Z74.1","display":"Need for assistance with personal care"},{"code":"Z74.2","display":"Need for assistance at home and no other household member able to render care"},{"code":"Z74.3","display":"Need for continuous supervision"},{"code":"Z74.8","display":"Other problems related to care provider dependency"},{"code":"Z74.9","display":"Problem related to care provider dependency, unspecified"},{"code":"Z75.0","display":"Medical services not available in home"},{"code":"Z75.1","display":"Person awaiting admission to adequate facility elsewhere"},{"code":"Z75.2","display":"Other waiting period for investigation and treatment"},{"code":"Z75.3","display":"Unavailability and inaccessibility of health-care facilities"},{"code":"Z75.4","display":"Unavailability and inaccessibility of other helping agencies"},{"code":"Z75.5","display":"Holiday relief care"},{"code":"Z75.8","display":"Other problems related to medical facilities and other health care"},{"code":"Z75.9","display":"Unspecified problem related to medical facilities and other health care"},{"code":"Z76.0","display":"Encounter for issue of repeat prescription"},{"code":"Z76.1","display":"Encounter for health supervision and care of foundling"},{"code":"Z76.2","display":"Encounter for health supervision and care of other healthy infant and child"},{"code":"Z76.3","display":"Healthy person accompanying sick person"},{"code":"Z76.4","display":"Other boarder to healthcare facility"},{"code":"Z76.5","display":"Malingerer [conscious simulation]"},{"code":"Z76.81","display":"Expectant parent(s) prebirth pediatrician visit"},{"code":"Z76.89","display":"Persons encountering health services in other specified circumstances"},{"code":"Z79.01","display":"Long term (current) use of anticoagulants"},{"code":"Z79.02","display":"Long term (current) use of antithrombotics/antiplatelets"},{"code":"Z79.1","display":"Long term (current) use of non-steroidal anti-inflammatories (NSAID)"},{"code":"Z79.2","display":"Long term (current) use of antibiotics"},{"code":"Z79.3","display":"Long term (current) use of hormonal contraceptives"},{"code":"Z79.4","display":"Long term (current) use of insulin"},{"code":"Z79.51","display":"Long term (current) use of inhaled steroids"},{"code":"Z79.52","display":"Long term (current) use of systemic steroids"},{"code":"Z79.810","display":"Long term (current) use of selective estrogen receptor modulators (SERMs)"},{"code":"Z79.811","display":"Long term (current) use of aromatase inhibitors"},{"code":"Z79.818","display":"Long term (current) use of other agents affecting estrogen receptors and estrogen levels"},{"code":"Z79.82","display":"Long term (current) use of aspirin"},{"code":"Z79.83","display":"Long term (current) use of bisphosphonates"},{"code":"Z79.84","display":"Long term (current) use of oral hypoglycemic drugs"},{"code":"Z79.891","display":"Long term (current) use of opiate analgesic"},{"code":"Z79.899","display":"Other long term (current) drug therapy"},{"code":"Z85.00","display":"Personal history of malignant neoplasm of unspecified digestive organ"},{"code":"Z85.01","display":"Personal history of malignant neoplasm of esophagus"},{"code":"Z85.020","display":"Personal history of malignant carcinoid tumor of stomach"},{"code":"Z85.028","display":"Personal history of other malignant neoplasm of stomach"},{"code":"Z85.030","display":"Personal history of malignant carcinoid tumor of large intestine"},{"code":"Z85.038","display":"Personal history of other malignant neoplasm of large intestine"},{"code":"Z85.040","display":"Personal history of malignant carcinoid tumor of rectum"},{"code":"Z85.048","display":"Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus"},{"code":"Z85.05","display":"Personal history of malignant neoplasm of liver"},{"code":"Z85.060","display":"Personal history of malignant carcinoid tumor of small intestine"},{"code":"Z85.068","display":"Personal history of other malignant neoplasm of small intestine"},{"code":"Z85.07","display":"Personal history of malignant neoplasm of pancreas"},{"code":"Z85.09","display":"Personal history of malignant neoplasm of other digestive organs"},{"code":"Z85.110","display":"Personal history of malignant carcinoid tumor of bronchus and lung"},{"code":"Z85.118","display":"Personal history of other malignant neoplasm of bronchus and lung"},{"code":"Z85.12","display":"Personal history of malignant neoplasm of trachea"},{"code":"Z85.20","display":"Personal history of malignant neoplasm of unspecified respiratory organ"},{"code":"Z85.21","display":"Personal history of malignant neoplasm of larynx"},{"code":"Z85.22","display":"Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses"},{"code":"Z85.230","display":"Personal history of malignant carcinoid tumor of thymus"},{"code":"Z85.238","display":"Personal history of other malignant neoplasm of thymus"},{"code":"Z85.29","display":"Personal history of malignant neoplasm of other respiratory and intrathoracic organs"},{"code":"Z85.3","display":"Personal history of malignant neoplasm of breast"},{"code":"Z85.40","display":"Personal history of malignant neoplasm of unspecified female genital organ"},{"code":"Z85.41","display":"Personal history of malignant neoplasm of cervix uteri"},{"code":"Z85.42","display":"Personal history of malignant neoplasm of other parts of uterus"},{"code":"Z85.43","display":"Personal history of malignant neoplasm of ovary"},{"code":"Z85.44","display":"Personal history of malignant neoplasm of other female genital organs"},{"code":"Z85.45","display":"Personal history of malignant neoplasm of unspecified male genital organ"},{"code":"Z85.46","display":"Personal history of malignant neoplasm of prostate"},{"code":"Z85.47","display":"Personal history of malignant neoplasm of testis"},{"code":"Z85.48","display":"Personal history of malignant neoplasm of epididymis"},{"code":"Z85.49","display":"Personal history of malignant neoplasm of other male genital organs"},{"code":"Z85.50","display":"Personal history of malignant neoplasm of unspecified urinary tract organ"},{"code":"Z85.51","display":"Personal history of malignant neoplasm of bladder"},{"code":"Z85.520","display":"Personal history of malignant carcinoid tumor of kidney"},{"code":"Z85.528","display":"Personal history of other malignant neoplasm of kidney"},{"code":"Z85.53","display":"Personal history of malignant neoplasm of renal pelvis"},{"code":"Z85.54","display":"Personal history of malignant neoplasm of ureter"},{"code":"Z85.59","display":"Personal history of malignant neoplasm of other urinary tract organ"},{"code":"Z85.6","display":"Personal history of leukemia"},{"code":"Z85.71","display":"Personal history of Hodgkin lymphoma"},{"code":"Z85.72","display":"Personal history of non-Hodgkin lymphomas"},{"code":"Z85.79","display":"Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues"},{"code":"Z85.810","display":"Personal history of malignant neoplasm of tongue"},{"code":"Z85.818","display":"Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx"},{"code":"Z85.819","display":"Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx"},{"code":"Z85.820","display":"Personal history of malignant melanoma of skin"},{"code":"Z85.821","display":"Personal history of Merkel cell carcinoma"},{"code":"Z85.828","display":"Personal history of other malignant neoplasm of skin"},{"code":"Z85.830","display":"Personal history of malignant neoplasm of bone"},{"code":"Z85.831","display":"Personal history of malignant neoplasm of soft tissue"},{"code":"Z85.840","display":"Personal history of malignant neoplasm of eye"},{"code":"Z85.841","display":"Personal history of malignant neoplasm of brain"},{"code":"Z85.848","display":"Personal history of malignant neoplasm of other parts of nervous tissue"},{"code":"Z85.850","display":"Personal history of malignant neoplasm of thyroid"},{"code":"Z85.858","display":"Personal history of malignant neoplasm of other endocrine glands"},{"code":"Z85.89","display":"Personal history of malignant neoplasm of other organs and systems"},{"code":"Z85.9","display":"Personal history of malignant neoplasm, unspecified"},{"code":"Z86.000","display":"Personal history of in-situ neoplasm of breast"},{"code":"Z86.001","display":"Personal history of in-situ neoplasm of cervix uteri"},{"code":"Z86.008","display":"Personal history of in-situ neoplasm of other site"},{"code":"Z86.010","display":"Personal history of colonic polyps"},{"code":"Z86.012","display":"Personal history of benign carcinoid tumor"},{"code":"Z86.018","display":"Personal history of other benign neoplasm"},{"code":"Z86.03","display":"Personal history of neoplasm of uncertain behavior"},{"code":"Z86.711","display":"Personal history of pulmonary embolism"},{"code":"Z86.718","display":"Personal history of other venous thrombosis and embolism"},{"code":"Z86.72","display":"Personal history of thrombophlebitis"},{"code":"Z86.73","display":"Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits"},{"code":"Z86.74","display":"Personal history of sudden cardiac arrest"},{"code":"Z86.79","display":"Personal history of other diseases of the circulatory system"},{"code":"Z87.892","display":"Personal history of anaphylaxis"},{"code":"Z88.0","display":"Allergy status to penicillin"},{"code":"Z88.1","display":"Allergy status to other antibiotic agents status"},{"code":"Z88.2","display":"Allergy status to sulfonamides status"},{"code":"Z88.3","display":"Allergy status to other anti-infective agents status"},{"code":"Z88.4","display":"Allergy status to anesthetic agent status"},{"code":"Z88.5","display":"Allergy status to narcotic agent status"},{"code":"Z88.6","display":"Allergy status to analgesic agent status"},{"code":"Z88.7","display":"Allergy status to serum and vaccine status"},{"code":"Z88.8","display":"Allergy status to other drugs, medicaments and biological substances status"},{"code":"Z88.9","display":"Allergy status to unspecified drugs, medicaments and biological substances status"},{"code":"Z91.010","display":"Allergy to peanuts"},{"code":"Z91.011","display":"Allergy to milk products"},{"code":"Z91.012","display":"Allergy to eggs"},{"code":"Z91.013","display":"Allergy to seafood"},{"code":"Z91.018","display":"Allergy to other foods"},{"code":"Z91.02","display":"Food additives allergy status"},{"code":"Z91.030","display":"Bee allergy status"},{"code":"Z91.038","display":"Other insect allergy status"},{"code":"Z91.040","display":"Latex allergy status"},{"code":"Z91.041","display":"Radiographic dye allergy status"},{"code":"Z91.048","display":"Other nonmedicinal substance allergy status"},{"code":"Z91.09","display":"Other allergy status, other than to drugs and biological substances"},{"code":"Z94.1","display":"Heart transplant status"},{"code":"Z94.3","display":"Heart and lungs transplant status"},{"code":"Z95.0","display":"Presence of cardiac pacemaker"},{"code":"Z95.1","display":"Presence of aortocoronary bypass graft"},{"code":"Z95.2","display":"Presence of prosthetic heart valve"},{"code":"Z95.3","display":"Presence of xenogenic heart valve"},{"code":"Z95.4","display":"Presence of other heart-valve replacement"},{"code":"Z95.5","display":"Presence of coronary angioplasty implant and graft"},{"code":"Z95.810","display":"Presence of automatic (implantable) cardiac defibrillator"},{"code":"Z95.811","display":"Presence of heart assist device"},{"code":"Z95.812","display":"Presence of fully implantable artificial heart"},{"code":"Z95.818","display":"Presence of other cardiac implants and grafts"},{"code":"Z95.820","display":"Peripheral vascular angioplasty status with implants and grafts"},{"code":"Z95.828","display":"Presence of other vascular implants and grafts"},{"code":"Z95.9","display":"Presence of cardiac and vascular implant and graft, unspecified"},{"code":"Z98.61","display":"Coronary angioplasty status"},{"code":"Z98.62","display":"Peripheral vascular angioplasty status"}]}]}}